literature_id,reaction_id,assay_type,assay_details,solvent_buffer,ph,ph_details,temperature_celsius,expression_host,expression_vector,expression_induction
PMID32027716,reaction_1,in vitro,Discontinuous colorimetric assay measuring citrulline production based on the Fearon method.,"50 mM Tris, 20 mM NaCl",8.5,,20.0,Escherichia coli BL21 (DE3) Tuner cells,pCA24N,0.5 mM IPTG at 30°C for 4 h
PMID32027883,reaction_1,in vitro,Kinetic analysis with recombinant protein expressed in E. coli.,250 mM Tris-HCl,7.2,,,Escherichia coli BL21,pET30a,
PMID32027883,reaction_2,in vitro,Kinetic analysis with recombinant protein expressed in E. coli.,250 mM Tris-HCl,7.2,,,Escherichia coli BL21,pET30a,
PMID32027883,reaction_3,in vitro,Kinetic analysis with recombinant protein expressed in E. coli.,100 mM sodium phosphate,7.4,,,Escherichia coli BL21,pET30a,
PMID32027883,reaction_4,in vitro,Kinetic analysis with recombinant protein expressed in E. coli.,100 mM sodium phosphate,7.4,,,Escherichia coli BL21,pET30a,
PMID32027883,reaction_5,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_6,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_7,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_8,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_9,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_10,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_11,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_12,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_13,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_14,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,0.10 mM potassium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET30a,
PMID32027883,reaction_15,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,250 mM Tris-HCl,7.2,,,Escherichia coli BL21,pET30a,
PMID32027883,reaction_16,in vitro,Enzyme assay with recombinant protein expressed in E. coli.,100 mM sodium phosphate,7.4,,,Escherichia coli BL21,pET30a,
PMID32031984,reaction_1,in vivo,"Inhibition study in HepG2 human liver cancer cells. Cell surface α2,6-sialylation levels were measured by flow cytometry using FITC-labeled Sambucus nigra lectin (SNA).",Hanks solution containing 4% bovine serum albumin and 0.1% sodium azide,,Not specified for the assay; cell culture at 37°C implies physiological pH.,37.0,HepG2 cells (endogenous expression),,
PMID32031984,reaction_2,in vivo,"Inhibition study in HepG2 human liver cancer cells. Cell surface α2,3-sialylation levels were measured by flow cytometry using FITC-labeled Maackia amurensis lectin (MAL).",Hanks solution containing 4% bovine serum albumin and 0.1% sodium azide,,Not specified for the assay; cell culture at 37°C implies physiological pH.,37.0,HepG2 cells (endogenous expression),,
PMID32033404,reaction_1,in vitro,Hydrogen/deuterium exchange mass spectrometry (HDX-MS) was used to monitor structural changes of the enzyme during the reaction with its insoluble substrate.,50 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,,Expressed under control of the methanol-dependent alcohol oxidase (AOX) promoter.
PMID32033404,reaction_2,in vitro,Analysis of oxidative modifications by LC-MS/MS after incubation with ascorbic acid to characterize auto-oxidative damage.,50 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,,Expressed under control of the methanol-dependent alcohol oxidase (AOX) promoter.
PMID32034864,reaction_1,in vitro,Biochemical activity assay measuring pyrophosphate release via malachite green method.,"50 mM MES, 50 mM CAPS, 100 mM Tris, 10 mM MgCl2, 5 mU/µl inorganic pyrophosphatase",7.5,,30.0,"Escherichia coli BL 21 cells (DE3, Agilent)",pET300/NT-DEST,"Auto-induction media, 4h at 37°C followed by 16h at 21°C."
PMID32034864,reaction_2,in vitro,Biochemical activity assay measuring pyrophosphate release via malachite green method.,"50 mM MES, 50 mM CAPS, 100 mM Tris, 10 mM MgCl2, 5 mU/µl inorganic pyrophosphatase",7.5,,30.0,"Escherichia coli BL 21 cells (DE3, Agilent)",pET300/NT-DEST,"Auto-induction media, 4h at 37°C followed by 16h at 21°C."
PMID32034864,reaction_3,in vitro,Biochemical activity assay measuring pyrophosphate release via malachite green method.,"50 mM MES, 50 mM CAPS, 100 mM Tris, 10 mM MgCl2, 5 mU/µl inorganic pyrophosphatase",7.5,,30.0,"Escherichia coli BL 21 cells (DE3, Agilent)",pET300/NT-DEST,"Auto-induction media, 4h at 37°C followed by 16h at 21°C."
PMID32034864,reaction_4,in vitro,Biochemical activity assay measuring pyrophosphate release via malachite green method.,"50 mM MES, 50 mM CAPS, 100 mM Tris, 10 mM MgCl2, 5 mU/µl inorganic pyrophosphatase",7.5,,30.0,"Escherichia coli BL 21 cells (DE3, Agilent)",pET300/NT-DEST,"Auto-induction media, 4h at 37°C followed by 16h at 21°C."
PMID32034864,reaction_5,in vitro,Biochemical activity assay measuring pyrophosphate release via malachite green method.,"50 mM MES, 50 mM CAPS, 100 mM Tris, 10 mM MgCl2, 5 mU/µl inorganic pyrophosphatase",7.5,,30.0,"Escherichia coli BL 21 cells (DE3, Agilent)",pET300/NT-DEST,"Auto-induction media, 4h at 37°C followed by 16h at 21°C."
PMID32034864,reaction_6,in vitro,Biochemical activity assay measuring pyrophosphate release via malachite green method.,"50 mM MES, 50 mM CAPS, 100 mM Tris, 10 mM MgCl2, 10% glycerol, 5 mU/µl inorganic pyrophosphatase",7.5,,30.0,"Escherichia coli BL 21 cells (DE3, Agilent)",pET300/NT-DEST,"Auto-induction media, 4h at 37°C followed by 16h at 21°C."
PMID32034864,reaction_7,in vitro,PDS assay performed as described by Koschmieder et al. (2017).,,,,,,,
PMID32034864,reaction_8,in vitro,Biochemical assay modified according to Sherman (1991).,"1.5 M bis-Tris, 2.5 mM EDTA, 0.01% Tween 80",7.5,,,,,
PMID32034864,reaction_9,in vitro,HPPD activity assay according to Busch et al. (2009).,,,,,,,
PMID32034864,reaction_10,in vitro,Co-crystallization with inhibitor to solve protein-inhibitor complex structure.,Crystallization buffer: 29.9 % PEG 1500,,,18.0,Escherichia coli BL21 (DE3),pET21a,"1 mM IPTG at OD 0.8, cultured overnight at 18°C."
PMID32035229,reaction_1,in vitro,Assay with expressed enzyme,,,,,Sf9 insect cells,,
PMID32035229,reaction_2,in vitro,Assay with purified enzyme,,,,,Escherichia coli,,
PMID32035229,reaction_3,in vitro,Substrate specificity study,,,,,Escherichia coli,,
PMID32035229,reaction_4,in vitro,Substrate specificity study,,,,,Escherichia coli,,
PMID32035229,reaction_5,in vitro,Substrate specificity study,,,,,Escherichia coli,,
PMID32035229,reaction_6,in vitro,Substrate specificity study,,,,,Escherichia coli,,
PMID32035229,reaction_7,in vitro,Substrate specificity study,,,,,Escherichia coli,,
PMID32035229,reaction_8,in vitro,Substrate specificity study,,,,,Escherichia coli,,
PMID32035229,reaction_9,in vitro,Substrate specificity study,,,,,Escherichia coli,,
PMID32035229,reaction_10,in vitro,Substrate specificity study,,,,,Sf9 insect cells,,
PMID32035229,reaction_11,in vitro,Substrate specificity study,,,,,Sf9 insect cells,,
PMID32035229,reaction_12,in vitro,,,,,,,,
PMID32035229,reaction_13,in vitro,,,,,,,,
PMID32035229,reaction_14,in vitro,,,,,,,,
PMID32035229,reaction_15,in vitro,,,,,,,,
PMID32035229,reaction_16,in vitro,,,,,,,,
PMID32035229,reaction_17,in vitro,,,,,,,,
PMID32035229,reaction_18,in vitro,,,,,,,,
PMID32035229,reaction_19,in vivo,Postprandial study in 28 healthy women. Measured newly formed retinyl esters in the triglyceride-rich lipoprotein (TRL) fraction 3 hours after a 120 mg dose of β-carotene.,,,,,,,
PMID32036315,reaction_1,in vitro,Spectrophotometric assay measuring formation of 2-hydroxymuconic semialdehyde at 375 nm.,PBS,7.5,,30.0,E. coli BL21 (DE3),pET28a (+),0.5 mM IPTG at 20°C overnight
PMID32036315,reaction_2,in vitro,Spectrophotometric assay measuring formation of ring-cleavage product at 382 nm.,PBS,7.5,,30.0,E. coli BL21 (DE3),,
PMID32036315,reaction_3,in vitro,Spectrophotometric assay measuring formation of ring-cleavage product at 388 nm.,PBS,7.5,,30.0,E. coli BL21 (DE3),,
PMID32036315,reaction_4,in vitro,Spectrophotometric assay measuring formation of ring-cleavage product at 379 nm.,PBS,7.5,,30.0,E. coli BL21 (DE3),,
PMID32036315,reaction_5,in vitro,Spectrophotometric assay measuring formation of ring-cleavage product at 290 nm.,PBS,7.5,,30.0,E. coli BL21 (DE3),,
PMID32039339,reaction_1,in vitro,Stopped-flow kinetics under single-turnover conditions to measure the reductive half-reaction.,50 mM Tris buffer with 3 mM CaCl2,7.5,,10.0,Escherichia coli,,
PMID32039339,reaction_2,in vitro,Stopped-flow kinetics to measure the reduction of the Ca2+-free enzyme form (holoXox).,50 mM Tris buffer with excess EDTA,7.5,,10.0,Escherichia coli,,
PMID32039339,reaction_3,in vitro,Stopped-flow kinetics (absorbance and fluorescence quenching) to measure the fast reconstitution pathway.,50 mM Tris buffer with 3 mM CaCl2,7.5,,10.0,Escherichia coli,,
PMID32039339,reaction_4,in vitro,Stopped-flow tryptophan fluorescence quenching to measure PQQ binding in the absence of Ca2+.,50 mM Tris buffer with excess EDTA,7.5,,10.0,Escherichia coli,,
PMID32039339,reaction_5,in vitro,Stopped-flow kinetics to measure Ca2+ binding to the holoXox form.,50 mM Tris buffer,7.5,,10.0,Escherichia coli,,
PMID32039339,reaction_6,in vitro,"Stopped-flow kinetics to measure the incorporation rate of Ca2+ into the reduced, Ca2+-free enzyme (holoXred).",50 mM Tris buffer,7.5,,10.0,Escherichia coli,,
PMID32039339,reaction_7,in vitro,Inferred from analysis of kinetic amplitudes in stopped-flow experiments as a function of Ca2+ concentration.,50 mM Tris buffer,7.5,,10.0,Escherichia coli,,
PMID32039535,reaction_1,in vitro,Enzymatic assay-based screening for inhibitors.,,,,,,,
PMID32041093,reaction_1,in vitro,Enzyme activity assay on desalted crude leaf extract.,"30 mM MOPS-NaOH (pH 7.5), 10 mM MgCl2, 15 mM UDP-glucose, 10 mM fructose-6-phosphate (F6P), and 10 mM glucose-6-phosphate (G6P)",7.5,,30.0,Saccharum officinarum,pBI121-SoSPS1,Constitutive expression under CaMV 35S promoter
PMID32041093,reaction_2,in vitro,Enzyme activity assay on desalted crude leaf extract.,1 M sodium acetate buffer (pH 4.5) and 0.25 M sucrose,4.5,,37.0,Saccharum officinarum,,
PMID32041093,reaction_3,in vitro,Enzyme activity assay on desalted crude leaf extract.,"20 mM Tris-HCl (pH 7.0), 100 mM sucrose, and 4 mM UDP",7.0,,37.0,Saccharum officinarum,,
PMID32042062,reaction_1,in vitro,Acetyltransferase activity assay to test modulation by hNAA50 and HYPK.,"75 mM HEPES, pH 7.0, 120 mM NaCl, and 1 mM DTT",7.0,,25.0,sf9 cells,,
PMID32042062,reaction_2,in vitro,Kinetic assay,"75 mM HEPES, pH 7.0, 120 mM NaCl, and 1 mM DTT",7.0,,25.0,BL21 (DE3) Escherichia coli cells,,
PMID32042062,reaction_3,in vitro,Kinetic assay,"75 mM HEPES, pH 7.0, 120 mM NaCl, and 1 mM DTT",7.0,,25.0,sf9 cells (for hNatA) and E. coli (for hNAA50),,
PMID32042062,reaction_4,in vitro,Kinetic assay,"75 mM HEPES, pH 7.0, 120 mM NaCl, and 1 mM DTT",7.0,,25.0,sf9 cells (for hNatA/HYPK) and E. coli (for hNAA50),,
PMID32042062,reaction_5,in vitro,[14C]-Ac-CoA-based Nt-acetylation assay using immunoprecipitated enzyme from HeLa cells.,"50 mM Tris-HCl pH 8.5, 1 mM EDTA, 10% Glycerol",8.5,,37.0,HeLa cells,pcDNA3.1/NAA15-WT-V5,Immunoprecipitated using V5-tag mouse monoclonal antibody.
PMID32042199,reaction_1,in vitro,Multi-step reaction characterized by LC-HR-MS of enzyme modification and by coupled assays with BioD.,50 mM HEPES-NaOH,8.0,,30.0,E. coli BL21-CodonPlus(DE3)-RIL,pHIS8,0.1 mM IPTG at 25°C overnight
PMID32042199,reaction_2,in vitro,"Activity was confirmed in a coupled assay where the substrate, DAN-carbamic acid, was generated in situ by BioU.",50 mM HEPES-NaOH,8.0,,30.0,E. coli BL21-CodonPlus(DE3)-RIL,pET26b(+),Recombinant EcBioD was purified from the strain in the same manner as described for BioU.
PMID32044025,reaction_1,in vivo,Whole-cell biocatalysis using recombinant C. testosteroni CNB-2. Activity was tested in a 1 ml reaction mixture containing 0.02 g cells (wet weight).,20 mM phosphate-buffered saline (PBS),7.0,,30.0,Comamonas testosteroni CNB-2,pVLT33MmP1-JA (for NDHase) and pBBR1 MCS-5_SL (for GroES-EL chaperone),"Induction at OD600=0.1, maintained for 14h at 30°C."
PMID32044030,reaction_1,in vitro,Spectrophotometric assay monitoring NAD(P)H conversion at 340 nm for kinetics. Bioconversion products analyzed by GC and TLC.,100 mM Tris-HCl buffer,6.0,,40.0,Escherichia coli BL21(DE3),pET26b(+),"1 mM IPTG, 22 °C, 20 hr"
PMID32044030,reaction_2,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,,,
PMID32044030,reaction_3,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,,,
PMID32044030,reaction_4,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,,,
PMID32044030,reaction_5,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,,,
PMID32044030,reaction_6,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,,,
PMID32044030,reaction_7,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,Escherichia coli BL21(DE3),pET26b(+),
PMID32044030,reaction_8,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,Escherichia coli BL21(DE3),pET26b(+),
PMID32044030,reaction_9,in vitro,,100 mM Tris-HCl buffer,6.0,,40.0,,,
PMID32044699,reaction_1,in vitro,Enzyme activity and thermostability assays on purified protein.,10 mM Tris-HCl buffer,7.5,,60.0,Escherichia coli BL21 (DE3),pET-20b(+),0.1 mM IPTG at 20 °C for 16 h
PMID32050067,reaction_1,in vitro,Product formation confirmed by UPLC-MS/MS from a reaction mixture at 37°C. Kinetic parameters were measured separately using a DCPIP microplate assay.,"For synthesis: 25 mM Tris-HCl (pH 7.5), 1 mM DTT, 2.5 mM MgCl2. For kinetics: 100 mM HEPES (pH 7.5).",7.5,,37.0,Escherichia coli Rosetta (DE3),pET-30a(+),"0.1 mM IPTG, 18 °C, 18 h"
PMID32050067,reaction_2,in vivo,Product identified by UPLC-MS/MS from culture supernatant of recombinant E. coli Rosetta (DE3) expressing AhyI. The acyl-ACP substrate was provided by the host's metabolism.,Luria-Bertani (LB) medium,,,18.0,Escherichia coli Rosetta (DE3),pET-30a(+),"0.1 mM IPTG, 18 °C, 18 h"
PMID32050067,reaction_3,in vivo,Product identified by UPLC-MS/MS from culture supernatant of recombinant E. coli Rosetta (DE3) expressing AhyI. The acyl-ACP substrate was provided by the host's metabolism.,Luria-Bertani (LB) medium,,,18.0,Escherichia coli Rosetta (DE3),pET-30a(+),"0.1 mM IPTG, 18 °C, 18 h"
PMID32050067,reaction_4,in vivo,Product identified by UPLC-MS/MS from culture supernatant of recombinant E. coli Rosetta (DE3) expressing AhyI. The acyl-ACP substrate was provided by the host's metabolism.,Luria-Bertani (LB) medium,,,18.0,Escherichia coli Rosetta (DE3),pET-30a(+),"0.1 mM IPTG, 18 °C, 18 h"
PMID32050067,reaction_5,in vivo,Product identified by UPLC-MS/MS from culture supernatant of recombinant E. coli Rosetta (DE3) expressing AhyI. The acyl-ACP substrate was provided by the host's metabolism.,Luria-Bertani (LB) medium,,,18.0,Escherichia coli Rosetta (DE3),pET-30a(+),"0.1 mM IPTG, 18 °C, 18 h"
PMID32050067,reaction_6,in vivo,Product identified by UPLC-MS/MS from culture supernatant of recombinant E. coli Rosetta (DE3) expressing AhyI. The acyl-ACP substrate was provided by the host's metabolism.,Luria-Bertani (LB) medium,,,18.0,Escherichia coli Rosetta (DE3),pET-30a(+),"0.1 mM IPTG, 18 °C, 18 h"
PMID32051560,reaction_1,in vitro,in vitro enzyme assay with UHPLC-Orbitrap MS detection for kinetics,"50 mM KCl, 1 mM MgCl2, 50 mM Tris-HCl, 2 mM ascorbic acid, 1 mM α-ketoglutarate, 100 μM (NH4)2Fe(SO4)2·6H2O",8.0,,37.0,Escherichia coli BL21 (DE3),pRSFDuet-1,"0.2 mM IPTG, overnight induction"
PMID32051560,reaction_2,in vitro,in vitro enzyme assay with UHPLC-Orbitrap MS detection for kinetics,"50 mM KCl, 1 mM MgCl2, 50 mM Tris-HCl, 2 mM ascorbic acid, 1 mM α-ketoglutarate, 100 μM (NH4)2Fe(SO4)2·6H2O",8.0,,37.0,Escherichia coli BL21 (DE3),pRSFDuet-1,"0.2 mM IPTG, overnight induction"
PMID32051560,reaction_3,in vitro,in vitro enzyme assay with LC-MS/MS detection of digested nucleosides,"50 mM KCl, 1 mM MgCl2, 50 mM Tris-HCl, 2 mM ascorbic acid, 1 mM α-ketoglutarate, 100 μM (NH4)2Fe(SO4)2·6H2O",8.0,,37.0,Escherichia coli BL21 (DE3),pRSFDuet-1,"0.2 mM IPTG, overnight induction"
PMID32051560,reaction_4,in vitro,in vitro enzyme assay with LC-MS/MS detection of digested nucleosides,"50 mM KCl, 1 mM MgCl2, 50 mM Tris-HCl, 2 mM ascorbic acid, 1 mM α-ketoglutarate, 100 μM (NH4)2Fe(SO4)2·6H2O",8.0,,37.0,Escherichia coli BL21 (DE3),pRSFDuet-1,"0.2 mM IPTG, overnight induction"
PMID32051560,reaction_5,in vitro,in vitro enzyme assay with LC-MS/MS detection of digested nucleosides,"50 mM KCl, 1 mM MgCl2, 50 mM Tris-HCl, 2 mM ascorbic acid, 1 mM α-ketoglutarate, 100 μM (NH4)2Fe(SO4)2·6H2O",8.0,,37.0,Escherichia coli BL21 (DE3),pRSFDuet-1,"0.2 mM IPTG, overnight induction"
PMID32051772,reaction_1,in vitro,Steady-state activity measurements monitoring dithionite oxidation.,50 mM potassium phosphate buffer with 50 mM total KCl/KNO2 ionic strength.,7.0,Inferred from general methods for spectroscopic measurements.,10.0,Escherichia coli C41(DE3),pET22b,"0.3 mM IPTG, 0.1 mM CuSO4, 0.3 mM 5-aminolevulinic acid, 20 °C, overnight"
PMID32051772,reaction_2,in vitro,Steady-state activity measurements monitoring dithionite oxidation.,50 mM potassium phosphate buffer with 50 mM total KCl/KNO2 ionic strength.,7.0,Inferred from general methods for spectroscopic measurements.,10.0,Escherichia coli BL21(DE3),pETM-11,"0.5 mM IPTG, 0.1 mM CuSO4, 20 °C, overnight"
PMID32051772,reaction_3,in vitro,Steady-state activity measurements monitoring dithionite oxidation.,50 mM potassium phosphate buffer with 50 mM total KCl/KNO2 ionic strength.,7.0,Inferred from general methods for spectroscopic measurements.,10.0,,,
PMID32051772,reaction_4,in vitro,Laser flash photolysis monitoring intraprotein electron transfer.,50 mM potassium phosphate buffer with 200 µM NADH and 50 mM N-methyl nicotinamide (NMN).,7.0,,10.0,,,
PMID32051772,reaction_5,in vitro,Stopped-flow spectroscopy monitoring interprotein electron transfer.,50 mM potassium phosphate buffer,7.0,Inferred from general methods.,10.0,,,
PMID32051772,reaction_6,in vitro,Stopped-flow spectroscopy monitoring interprotein electron transfer between deconstructed domains.,50 mM potassium phosphate buffer,7.0,Inferred from general methods.,10.0,,,
PMID32051772,reaction_7,in vitro,Laser flash photolysis monitoring inter-copper electron transfer.,50 mM potassium phosphate buffer with 200 µM NADH and 50 mM N-methyl nicotinamide (NMN).,7.0,,10.0,,,
PMID32054270,reaction_1,in vivo,Intracellular accumulation of D-xylose in engineered S. cerevisiae.,SD medium,5.0,"pH was set to 5.0 for the facilitator/symporter assay, which characterized the transport mechanism.",30.0,Saccharomyces cerevisiae EBY.VW4000,pJFE3 or pJFE3-yEGFP3,
PMID32054270,reaction_2,in vivo,Glucose consumption assay and growth assay in engineered S. cerevisiae.,SD medium supplemented with CSM-URA and 20 g/L glucose,,,30.0,Saccharomyces cerevisiae EBY.VW4000,pJFE3,
PMID32054270,reaction_3,in vivo,Growth assay on plates.,SD medium with 20 g/L mannose,,,30.0,,,
PMID32054270,reaction_4,in vivo,Growth assay on plates.,SD medium with 20 g/L fructose,,,30.0,,,
PMID32054270,reaction_5,in vivo,Intracellular accumulation of D-xylose in engineered S. cerevisiae.,SD medium,5.0,pH was set to 5.0 for the facilitator/symporter assay.,30.0,,,
PMID32054270,reaction_6,in vivo,Intracellular accumulation assay and growth assay.,SD medium,,,30.0,,,
PMID32054270,reaction_7,in vivo,Intracellular accumulation assay and growth assay.,SD medium,,,30.0,,,
PMID32054270,reaction_8,in vivo,Growth assay on plates.,SD medium with 20 g/L glucose,,,30.0,,,
PMID32054839,reaction_1,in vitro,Enzyme kinetics and product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_2,in vitro,Enzyme kinetics and product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_3,in vitro,Enzyme kinetics and product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_4,in vitro,Enzyme kinetics and product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_5,in vitro,Enzyme kinetics and product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_6,in vitro,Product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_7,in vitro,Product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_8,in vitro,Product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_9,in vitro,Product specificity assay,100 mM HEPES-NaOH buffer,7.5,,30.0,Escherichia coli BL21,pCold I,
PMID32054839,reaction_10,in vivo,Whole-cell bioconversion by recombinant E. coli,M9 medium,,,30.0,Escherichia coli Rosetta2 (DE3),pET15b-Gm4CL-3-GmCHS-1 and pET15b-Gm4CL-3-GmCHS-1-GmCHIL,"1.0 mM IPTG, 18°C, 20h"
PMID32054864,reaction_1,in vivo,Assayed in whole HEK293 and HeLa cells. Galactosylation status of free GPIs was measured by flow cytometry using T5 mAb and western blot. Galactosylation of protein-linked GPIs (on CD59) was analyzed by LC-ESI-MS/MS.,,,,37.0,HEK293 cells,,
PMID32054864,reaction_2,in vitro,GM1 synthase activity assay using membrane fractions from HEK293 cells. Activity also confirmed in vivo by measuring cell surface GM1a levels with CTxB via flow cytometry.,"25 mM HEPES (pH 7.2), 10 mM MnCl2, 0.4% Triton X-100, 100 µM UDP-Gal",7.2,,37.0,HEK293 cells,,
PMID32054864,reaction_3,in vivo,Activity inferred from knockout and rescue experiments in PIGS-KO HEK293 cells. The requirement of enzymatic activity was confirmed as the D144A catalytically inactive mutant failed to rescue downstream GM1 synthesis and GPI galactosylation.,,,,37.0,PIGS-UGCG-DKO HEK293 cells,,
PMID32054864,reaction_4,in vivo,Activity inferred from knockout (B4GALT5 single KO and B4GALT5/B4GALT6 triple KO) and rescue experiments in PIGS-KO HEK293 cells. The requirement of enzymatic activity was confirmed as the B4GALT5 D300A catalytically inactive mutant failed to rescue GPI galactosylation.,,,,37.0,PIGS-B4GALT5-B4GALT6-TKO HEK293 cells,,
PMID32055924,reaction_1,in vitro,Enzyme activity assays using crude protein extracts from transformed Physcomitrella patens.,"0.1 M Tris–HCl, 1 mM dithiothreitol, 1 mM diethyldithiocarbamate",7.0,Optimum pH determined to be around 7.0,25.0,Physcomitrella patens,pTHUbiGate,Expressed under the control of the maize ubiquitin promotor.
PMID32055924,reaction_2,in vitro,Enzyme activity assays using crude protein extracts from wild-type Physcomitrella patens.,"0.1 M Tris–HCl, 1 mM dithiothreitol, 1 mM diethyldithiocarbamate",7.0,Optimum pH determined to be around 7.0,25.0,,,
PMID32056499,reaction_1,in vitro,Enzyme activity and kinetic analysis,50 mM Na2HPO4–NaH2PO4 buffer,6.0,,90.0,E. coli BL21,pET30a,
PMID32056499,reaction_2,in vitro,Decolorization of synthetic dye,50 mM Na2HPO4-NaH2PO4 buffer,7.5,,70.0,E. coli BL21,pET30a,
PMID32056499,reaction_3,in vitro,Decolorization of synthetic dye,50 mM Na2HPO4-NaH2PO4 buffer,7.5,,70.0,E. coli BL21,pET30a,
PMID32056499,reaction_4,in vitro,Decolorization of synthetic dye,50 mM Na2HPO4-NaH2PO4 buffer,8.0,,70.0,E. coli BL21,pET30a,
PMID32056499,reaction_5,in vitro,Decolorization of synthetic dye,50 mM Na2HPO4-NaH2PO4 buffer,7.5,,70.0,E. coli BL21,pET30a,
PMID32057065,reaction_1,in vitro,Bioluminescence assay,"50 mM Tris-HCl, 2 mM CaCl2",8.5,,,E. coli BL21-Gold (DE3) Codon Plus (RIPL),pET22b,"1 mM IPTG at OD590 0.6-0.8, 37 °C for 3h"
PMID32057065,reaction_2,in vitro,Trp fluorescence quenching assay to determine dissociation constant,"5 mM EDTA, 20 mM Tris-HCl",7.2,,20.0,,,
PMID32059844,reaction_1,in vitro,Enzyme activity was assayed by measuring the increase in absorbance at 340 nm caused by the reduction of NAD+ to NADH.,"20 mM potassium phosphate buffer, 0.2 mM MnCl2, and 300 mM KCl",7.6,,,E. coli BL21 (DE3),,
PMID32060291,reaction_1,in vitro,Reconstitution of Fd-dependent plastoquinone reduction in thylakoid membranes from M55 mutant (ΔndhB) of Synechocystis 6803. Activity was monitored by chlorophyll fluorescence.,"0.5 M sorbitol, 10 mM MgCl2, 10 mM NaCl, 10 mM HEPES, and 5 mM sodium phosphate, pH 7.5",7.5,,,"The NDH-1LΔV complex was purified from native Thermosynechococcus elongatus BP-1. Ferredoxin, NdhV, and NdhO subunits were recombinantly expressed in Escherichia coli Rosetta (DE3).",pMAL vector (for recombinant proteins),"0.1 mM IPTG, 18 °C, overnight (for recombinant proteins)"
PMID32060650,reaction_1,in vitro,Coupled spectrophotometric assay,"100 mM multicomponent buffer (2.5 mM citric acid, 2.5 mM Bis–Tris, 2.5 mM Tris and 2.5 mM CHES)",9.0,,30.0,,,
PMID32060650,reaction_2,in vitro,Coupled spectrophotometric assay,"100 mM multicomponent buffer (2.5 mM citric acid, 2.5 mM Bis–Tris, 2.5 mM Tris and 2.5 mM CHES)",9.0,,30.0,,,
PMID32060650,reaction_3,in vitro,Direct spectrophotometric assay,"100 mM multicomponent buffer (2.5 mM citric acid, 2.5 mM Bis–Tris, 2.5 mM Tris and 2.5 mM CHES)",9.0,,30.0,,,
PMID32060650,reaction_4,in vitro,Direct spectrophotometric assay,"100 mM multicomponent buffer (2.5 mM citric acid, 2.5 mM Bis–Tris, 2.5 mM Tris and 2.5 mM CHES)",7.2,,30.0,,,
PMID32060694,reaction_1,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG468),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_2,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG468),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_3,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG468),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_4,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG469),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_5,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG469),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_6,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG469),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_7,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG673),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_8,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG673),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_9,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG673),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_10,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG674),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_11,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG674),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_12,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG674),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_13,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG675),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_14,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG675),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_15,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG675),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_16,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG654),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_17,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG654),"0.1 mM IPTG, 4 h, 37 °C"
PMID32060694,reaction_18,in vitro,Enzymatic assay with purified recombinant protein,Britton-Robinson’s buffer,6.5,,28.0,Escherichia coli BL21(DE3) pLysS,pRSET A (recombinant plasmid pGG654),"0.1 mM IPTG, 4 h, 37 °C"
PMID32061966,reaction_1,in vivo,Production in engineered Methylosinus trichosporium OB3b,Nitrate mineral salt (NMS) medium with 5 µM CuSO4,7.0,Maintained at 7.0 in bioreactor experiments. Flask pH not specified.,30.0,Methylosinus trichosporium OB3b,pAWP89,Expression under control of a strong Ptac promoter
PMID32067260,reaction_1,in vitro,"Aminoacylation assay using L-[2,3-3H] aspartic acid.","100 mM Hepes, 2 mM ATP, 4 mM MgCl2, 10 µM aspartic acid",7.5,,25.0,Escherichia coli DH5α,"pPTC001 (WT), pPC007 (Chimera-D), pPC008 (Chimera-N)",1 mM IPTG for 30 minutes
PMID32067260,reaction_2,in vitro,"Aminoacylation assay using L-[2,3-3H] aspartic acid.","100 mM Hepes, 2 mM ATP, 4 mM MgCl2, 10 µM aspartic acid",7.5,,25.0,Escherichia coli DH5α,"pPTC001 (WT), pPC007 (Chimera-D), pPC008 (Chimera-N)",1 mM IPTG for 30 minutes
PMID32073825,reaction_1,in vitro,Enzyme kinetics and substrate specificity assays with purified recombinant enzyme.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_2,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_3,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_4,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_5,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_6,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_7,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_8,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32073825,reaction_9,in vitro,Donor substrate specificity study.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli BL21(DE3),pMCSG7,"0.1 mM IPTG, 16 °C, 20 h"
PMID32074393,reaction_1_SfaA,in vitro,"LC-MS for product quantification, 13C-NMR for intermediate identification, and Mössbauer spectroscopy for ferryl intermediate detection.",Not specified,,,,,,
PMID32074393,reaction_2_ScoE,in vitro,LC-MS for product quantification and X-ray crystallography for structural analysis.,Not specified,,,,,,
PMID32074393,reaction_3_Sav607,in vitro,LC-MS for product quantification.,Not specified,,,,,,
PMID32080177,reaction_1,in vitro,"Activity was confirmed by MALDI-TOF MS using 5-aminopentyl G0, by glycan microarray analysis on a panel of N-glycans, and the reaction complex was characterized by X-ray crystallography.","25 mM Tris, 150 mM NaCl",7.5,pH 7.5 was used for activity assays. Crystallization was at pH 8.5.,,HEK293F cells,pHLSec-12His-GFP-TEV-HsFUT8,Transient transfection using PEI-MAX. Valproic acid (2.2 mM) was added 24 hours post-transfection. Protein harvested from supernatant 6 days post-transfection.
PMID32082134,reaction_1,in vivo,Phosphorylation levels were measured in cerebral cortex lysates from 12-month-old 3xTg-AD mice using Western blotting and Immunohistochemistry. The study manipulated miR-369 levels to observe changes in phosphorylation.,RIPA buffer with a proteinase inhibitor (for tissue lysis),,,,Mus musculus (3xTg-AD mice),,
PMID32082134,reaction_2,in vivo,Phosphorylation levels were measured in cerebral cortex lysates from 12-month-old 3xTg-AD mice using Western blotting and Immunohistochemistry. The study manipulated miR-369 levels to observe changes in phosphorylation.,RIPA buffer with a proteinase inhibitor (for tissue lysis),,,,Mus musculus (3xTg-AD mice),,
PMID32085442,reaction_1,in vivo,"The enzyme's function was investigated by analyzing knockout (lacs2-3) and overexpression (LACS2-OEs) Arabidopsis lines. Experiments involved profiling downstream metabolites (cuticular wax and cutin monomers) and measuring physiological parameters like cuticle permeability, chlorophyll leaching, water loss, and ion leakage.","Plants were grown on solid Murashige and Skoog (MS) medium with 1% sucrose, then transplanted to soil.",,,22.0,Arabidopsis thaliana,,Constitutive expression driven by the UBQ10 promoter in transgenic Arabidopsis lines.
PMID32085896,reaction_1,in vitro,DNA cleavage assay using FAM-labeled DNA substrate,"50 mM HEPES pH 7.2, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5% glycerol and 15% DMSO",7.2,Standard assay pH. Optimum pH is 8.0-9.0.,37.0,Escherichia coli BL21 (DE3) pLysS,pGEX-6P-1,0.2 mM IPTG at 18 C overnight
PMID32085896,reaction_2,in vitro,DNA cleavage assay using FAM-labeled DNA substrate,"50 mM HEPES pH 7.2, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5% glycerol and 15% DMSO",7.2,,37.0,Escherichia coli BL21 (DE3) pLysS,pGEX-6P-1,0.2 mM IPTG at 18 C overnight
PMID32085896,reaction_3,in vitro,DNA cleavage assay using FAM-labeled DNA substrate,"50 mM HEPES pH 7.2, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5% glycerol and 15% DMSO",7.2,,37.0,Escherichia coli BL21 (DE3) pLysS,pGEX-6P-1,0.2 mM IPTG at 18 C overnight
PMID32085896,reaction_4,in vitro,DNA cleavage assay using FAM-labeled DNA substrate,"50 mM HEPES pH 7.2, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5% glycerol and 15% DMSO",7.2,,37.0,Escherichia coli BL21 (DE3) pLysS,pGEX-6P-1,0.2 mM IPTG at 18 C overnight
PMID32085896,reaction_5,in vitro,DNA cleavage assay using FAM-labeled DNA substrate,"50 mM HEPES pH 7.2, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5% glycerol and 15% DMSO",7.2,,37.0,Escherichia coli BL21 (DE3) pLysS,pGEX-6P-1,0.2 mM IPTG at 18 C overnight
PMID32085896,reaction_6,in vitro,DNA cleavage assay using FAM-labeled DNA substrate,"50 mM HEPES pH 7.2, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5% glycerol and 15% DMSO",7.2,,37.0,Escherichia coli BL21 (DE3) pLysS,pGEX-6P-1,0.2 mM IPTG at 18 C overnight
PMID32086045,reaction_1,in vitro,Enzyme activity assay measuring relative activity at various pH values.,Various buffers used for pH range: citrate buffer (pH 2-6); phosphate buffer (pH 6-7); Tris (pH 7-9); sodium carbonate buffer (pH 9-11).,,Activity was measured across a pH range of 2 to 11. Optimal activity was observed at pH 8.,37.0,E. coli BL21,pET28a(+),"0.5 mM IPTG, 30 °C, overnight"
PMID32086051,reaction_1,in vitro,Enzyme inhibition assay monitoring the decrease in NADPH absorbance at 340 nm.,0.1 M Potassium Phosphate buffer,7.2,pH of the homogenization buffer; assay buffer pH not explicitly stated.,37.0,,,
PMID32086387,reaction_1,in vitro,"Activity assessed in human endothelial cell cultures (HRvEC, HUVEC) by immunoblotting for the phosphorylated product, p-ACC (Ser79), following ZIKV infection and/or drug treatment.","F12K media supplemented with 10% FBS, 1% penicillin–streptomycin, endothelial cell growth supplement (6 mg/ml), and heparin (0.1 mg/ml).",7.4,Inferred from standard cell culture conditions.,37.0,Endogenous expression in primary human retinal vascular endothelial cells (HRvEC) and human umbilical vein endothelial cells (HUVEC).,,
PMID32087552,reaction_1,in vitro,Biochemical characterization reviewed from multiple studies.,,,,,,,
PMID32087552,reaction_2,in vitro,Biochemical characterization reviewed from multiple studies.,,,Activity is increased by acidic conditions.,,,,
PMID32087552,reaction_3,in vitro,Biochemical characterization reviewed from multiple studies.,,,,,,,
PMID32087552,reaction_4,in vitro,Assayed based on the oxidation of soya bean phospholipid liposomes.,,,,,,,
PMID32090335,reaction_1,in vitro,"Multiple assays conducted: kinetic characterization (coupled colorimetric DA-67 assay), stability tests, and histamine reduction experiments (quantified by RP-HPLC).",25 mM PIPES (for kinetics) or 20 mM sodium phosphate buffer (for reduction/stability),7.2,"pH 7.2 for kinetics, pH 8.0 for reduction/stability in buffer, and pH 5.8 for stability in FeSSIF.",37.0,Natural source (porcine kidney),,
PMID32092071,reaction_1,in vivo,"Growth assays of wild-type and mutant strains on various methanogenic substrates (methanol, TMA, DMS, acetate) were used to assess enzyme function. In vitro thermal stability of the purified enzyme complex was also measured via a SYPRO Orange–based Thermofluor assay.",bicarbonate-buffered HS liquid medium,,"Bicarbonate-buffered medium used for growth assays. For in vitro Thermofluor assays, the buffer was 50 mM NaH2PO4, 300 mM NaCl, 50 mM biotin, pH = 8.0.",36.0,Methanosarcina acetivorans,,
PMID32092071,reaction_2,in vivo,The gene mcmA (MA4545) was deleted in M. acetivorans. The McrA protein from the mutant was purified and analyzed by MALDI-TOF-MS to confirm the loss of the S-methylcysteine modification.,bicarbonate-buffered HS liquid medium,,,37.0,Methanosarcina acetivorans,,
PMID32094184,reaction_1,in vitro,Spectrophotometric activity assay measuring reduction of electron acceptor.,25 mM borate buffer,9.5,,30.0,Escherichia coli,,
PMID32094184,reaction_2,in vitro,Spectrophotometric activity assay measuring reduction of electron acceptor.,25 mM borate buffer,9.5,,30.0,Escherichia coli,,
PMID32094184,reaction_3,in vitro,Spectrophotometric activity assay measuring reduction of electron acceptor.,25 mM borate buffer,9.5,,30.0,Escherichia coli,,
PMID32094331,reaction_1,in vitro,Isothermal titration calorimetry (ITC) was used to measure binding affinity of the enzyme to the insoluble substrate LRP. Pull-down assays were also performed with LRP.,20 mM MES buffer pH 6,6.0,Condition for ITC binding assay.,5.0,Pichia pastoris X-33,pPICZαA,
PMID32098824,reaction_1,in vivo,Sulfide oxidation by recombinant E. coli cell suspension expressing SQR.,50 mM Tris buffer,8.0,pH inferred from similar assays in the same study.,,Escherichia coli BL21(DE3),pBBR5-sqr,
PMID32098824,reaction_2,in vivo,Sulfide oxidation by recombinant E. coli cell suspension co-expressing SQR and PDO.,50 mM Tris buffer,8.0,pH inferred from similar assays in the same study.,,Escherichia coli BL21(DE3),pBBR5-sqr-pdo,
PMID32098824,reaction_3,in vivo,Sulfide oxidation by whole-cell suspension of Synechococcus sp. PCC7002.,50 mM Tris buffer,8.0,,30.0,,,
PMID32099742,reaction_1,in vitro,Standard assay for kinetics and characterization. A separate whole-cell bioconversion was also performed.,0.1 M potassium phosphate buffer,7.0,,30.0,Escherichia coli BL21 (DE3),pET28a-lrldh,"10 g/L lactose at 28 °C, 150 rpm for 12 h"
PMID32099742,reaction_2,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32099742,reaction_3,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32099742,reaction_4,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32099742,reaction_5,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32099742,reaction_6,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32099742,reaction_7,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32099742,reaction_8,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32099742,reaction_9,in vitro,Substrate specificity assay.,0.1 M potassium phosphate buffer,7.0,,35.0,,,
PMID32101345,reaction_1,in vitro,Steady-state kinetic assays and gram-scale synthesis.,"50 mM sodium dihydrogen phosphate buffer, pH 7.0, 3 mM β-mercaptoethanol",7.0,,40.0,E. coli KRX,pJF23,"For pilot-scale: induction with 1 g/L L-rhamnose, temperature shifted to 16°C for 14h."
PMID32101345,reaction_2,in vitro,Steady-state kinetic assays.,"50 mM sodium dihydrogen phosphate buffer, pH 7.0, 3 mM β-mercaptoethanol",7.0,,40.0,E. coli KRX,pJF23,"For pilot-scale: induction with 1 g/L L-rhamnose, temperature shifted to 16°C for 14h."
PMID32101363,reaction_1,in vitro,Activity assessment on NB4 cell lysate using a kit.,,,,,,,
PMID32101363,reaction_2,in vitro,Activity assessment on isolated mitochondria from NB4 cells and oxygen consumption rate in permeabilized NB4 cells.,,,,,,,
PMID32101363,reaction_3,in vitro,Activity assessment on isolated mitochondria from NB4 cells and oxygen consumption rate in permeabilized NB4 cells.,,,,,,,
PMID32101363,reaction_4,in vitro,Activity assessment on isolated mitochondria from NB4 cells.,,,,,,,
PMID32101363,reaction_5,in vitro,Activity assessment on isolated mitochondria from NB4 cells.,,,,,,,
PMID32102842,reaction_1,in vitro,Enzyme kinetic assay coupled to NADH oxidation via pyruvate kinase and lactate dehydrogenase.,"100 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 10 mM KCl, 10 mM DL-Dithiothreitol (DTT), 0.3 mM NADH, 5 U pyruvate kinase (PK), 5 U Lactate dehydrogenase (LDH), 0.5 mM phosphoenolpyruvate (PEP) and 1 mM ATP",8.0,,25.0,Escherichia coli BL21 (DE3),pET28a or pMCSG7,"1 mM IPTG, 30°C, 16 hours"
PMID32102842,reaction_2,in vitro,Enzyme kinetic assay coupled to NADH oxidation via pyruvate kinase and lactate dehydrogenase.,"100 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 10 mM KCl, 10 mM DL-Dithiothreitol (DTT), 0.3 mM NADH, 5 U pyruvate kinase (PK), 5 U Lactate dehydrogenase (LDH), 0.5 mM phosphoenolpyruvate (PEP) and 1 mM ATP",8.0,,25.0,Escherichia coli BL21 (DE3),pET28a,"1 mM IPTG, 30°C, 16 hours"
PMID32103318,reaction_1,in vitro,Kinetic parameter determination for wild-type and mutant enzymes.,100 mM Tris-HCl buffer,8.5,,37.0,Escherichia coli BL21(DE3),pET28a-gshA,"0.4 mM IPTG, 30°C for 16 h"
PMID32103318,reaction_2,in vitro,"Kinetic studies, high-throughput screening, and small-scale production.",100 mM Tris-HCl buffer,8.5,,37.0,Escherichia coli BL21(DE3),pET28a-gshA,"0.4 mM IPTG, 30°C for 16 h"
PMID32103318,reaction_3,in vitro,PPK activity assay and use in a coupled reaction system for ATP regeneration.,100 mM Tris-HCl,8.5,,37.0,Escherichia coli BW25113,pBAD/Myc-HisC,"0.1 mM L-arabinose, 30°C for 16 h"
PMID32105687,reaction_1,in vitro,Coupled assay with pyruvate kinase (PK) and lactate dehydrogenase (LDH) monitoring NADH oxidation.,"0.1 M HEPES (pH 7.5), 100 mM KCl, 1.5 mM ATP, 1 mM MgSO4, 1 mM phosphoenolpyruvate, 0.2 mM NADH, 2.5% (v/v) DMSO, 2% (v/v) glycerol, 1.6 U/ml PK and 2.3 U/ml LDH",7.5,,37.0,Escherichia coli BL21 – Codon Plus (DE3) RIL,pET28a(+),"0.5 mM IPTG, 18°C, 20 h"
PMID32105687,reaction_2,in vitro,Coupled assay with pyruvate kinase (PK) and lactate dehydrogenase (LDH) monitoring NADH oxidation.,"0.1 M HEPES (pH 7.5), 100 mM KCl, 1.5 mM ATP, 1 mM MgSO4, 1 mM phosphoenolpyruvate, 0.2 mM NADH, 2.5% (v/v) DMSO, 2% (v/v) glycerol, 1.6 U/ml PK and 2.3 U/ml LDH",7.5,,37.0,Escherichia coli BL21 – Codon Plus (DE3) RIL,pET28a(+),"0.5 mM IPTG, 18°C, 20 h"
PMID32105687,reaction_3,in vitro,Coupled assay with pyruvate kinase (PK) and lactate dehydrogenase (LDH) monitoring NADH oxidation.,"0.1 M HEPES (pH 7.5), 100 mM KCl, 1.5 mM ATP, 1 mM MgSO4, 1 mM phosphoenolpyruvate, 0.2 mM NADH, 2.5% (v/v) DMSO, 2% (v/v) glycerol, 1.6 U/ml PK and 2.3 U/ml LDH",7.5,,37.0,Escherichia coli BL21 – Codon Plus (DE3) RIL,pET28a(+),"0.5 mM IPTG, 18°C, 20 h"
PMID32105687,reaction_4,in vitro,Coupled assay with pyruvate kinase (PK) and lactate dehydrogenase (LDH) monitoring NADH oxidation.,"0.1 M HEPES (pH 7.5), 100 mM KCl, 1.5 mM ATP, 1 mM MgSO4, 1 mM phosphoenolpyruvate, 0.2 mM NADH, 2.5% (v/v) DMSO, 2% (v/v) glycerol, 1.6 U/ml PK and 2.3 U/ml LDH",7.5,,37.0,Escherichia coli BL21 – Codon Plus (DE3) RIL,pET28a(+),"0.5 mM IPTG, 18°C, 20 h"
PMID32107984,reaction_1,in silico,Molecular docking simulation using PatchDock and FireDock to calculate binding energy between the enzyme and the substrate homogentisate.,,,,,,,
PMID32111831,reaction_1,in vitro,Fluorescence-based coupled assay for kinetics.,"50 mM Tris, 0.193 mM EGTA, 1 mM MgCl2, 1 mM DTT, 5 μM sodium cholate",8.0,"Optimal pH for catalysis mentioned in text, citing Towler et al.5. MS assay also at pH 8.",30.0,Escherichia coli BL21(DE3) pRareS and E. coli BL21-PLysS Rosetta2 cells (Novagen),modified pET28 vector,Induction at 18°C or 22°C.
PMID32111831,reaction_2,in vitro,MALDI-ToF-ToF analysis to identify product.,"50 mM Tris, 0.193 mM EGTA, 1 mM MgCl2, 1 mM DTT, 5 μM sodium cholate, 0.04 mM Myr-CoA",8.0,,30.0,Escherichia coli BL21(DE3) pRareS and E. coli BL21-PLysS Rosetta2 cells (Novagen),modified pET28 vector,Induction at 18°C or 22°C.
PMID32111831,reaction_3,in vitro,"Co-crystallization experiment to trap reaction states (substrate, tetrahedral intermediate, and product).","100 mM sodium citrate, 16–18% (v/w) PEG 4K, 5 mM NiCl2, 2.5% (v/v) glycerol",4.5,,20.0,Escherichia coli BL21(DE3) pRareS,modified pET28 vector,20 h at 18 °C in Overnight Express Instant TB auto-induction medium
PMID32111831,reaction_4,in vitro,MALDI-ToF-ToF analysis to identify product.,"50 mM Tris, 0.193 mM EGTA, 1 mM MgCl2, 1 mM DTT, 5 μM sodium cholate, 0.04 mM Myr-CoA",8.0,,30.0,E. coli BL21-PLysS Rosetta2 cells (Novagen),modified pET28 vector,Growth at 22 °C and induction.
PMID32111831,reaction_5,in vitro,MALDI-ToF-ToF analysis to identify product.,"50 mM Tris, 0.193 mM EGTA, 1 mM MgCl2, 1 mM DTT, 5 μM sodium cholate, 0.04 mM Myr-CoA",8.0,,30.0,E. coli BL21-PLysS Rosetta2 cells (Novagen),modified pET28 vector,Growth at 22 °C and induction.
PMID32111831,reaction_6,in vitro,Co-crystallization experiment to trap reaction states.,"0.1 M MgCl2, 0.2 M NaCl, 0.1 M sodium citrate and 18–24% (w/v) PEG 6 K or 8 K",5.6,,20.0,E. coli BL21-PLysS Rosetta2 cells (Novagen),modified pET28 vector,Growth at 22 °C and induction.
PMID32112503,reaction_1,in vitro,Steady-state kinetic assay by monitoring the decrease in absorbance at 340 nm. In vivo function was confirmed by complementation assay in E. coli JP1111.,50 mM Bis-tris,5.5,,30.0,E. coli BL21 (DE3),pET22,"0.5 mM IPTG, 16 h at 20°C"
PMID32112503,reaction_2,in vitro,Triclosan inhibition assay performed as a control by monitoring NADH oxidation.,100 mM phosphate buffer,7.5,,,,,
PMID32113843,reaction_1,in vitro,"in vitro assay using purified human recombinant KAT2 enzyme. Enzyme activity was detected via the fluorescence signal of the end product, kynurenic acid.",,,,,,,
PMID32114761,reaction_1,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_2,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_3,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_4,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_5,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_6,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_7,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_8,in vitro,Time-dependent enzyme inactivation assay,Not specified,8.0,,,,,
PMID32114761,reaction_9,in vitro,Time-dependent enzyme inactivation assay,Not specified,6.5,,,,,
PMID32114761,reaction_10,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_11,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114761,reaction_12,in vitro,Time-dependent enzyme inactivation assay,Not specified,,Not specified,,,,
PMID32114907,reaction_1,in vitro,HPLC analysis of cleavage products from reaction with purified LcpK30.,Not specified,,,,,,
PMID32114907,reaction_2,in vitro,Measurement of oxygen consumption activity.,Not specified,,,,,,
PMID32114907,reaction_3,in vitro,Analysis of reaction mixture containing purified LcpNVL3 by gel permeation chromatography (GPC).,Not specified,,,,,,
PMID32114907,reaction_4,in vitro,Measurement of oxygen consumption activity and UV-Vis spectral analysis.,Not specified,,,,,,
PMID32114907,reaction_5,in vitro,"The text states the enzyme was identified and has poly(cis-1,4-isoprene) cleavage activity.",Not specified,,,,,,
PMID32114907,reaction_6,in vitro,Analysis of reaction with purified RoxA35Y.,Not specified,,,,,,
PMID32114907,reaction_7,in vitro,"Measurement of oxygen consumption and poly(cis-1,4-isoprene) cleavage activities.",Not specified,,,,,,
PMID32114907,reaction_8,in vitro,Inhibition study with tungsten.,Not specified,,,,,,
PMID32115644,reaction_1,in vitro,"Cell-based luciferase reporter assay in transiently transfected HEK293T cells. Activity was measured indirectly via product (1α,25-dihydroxycholecalciferol) activation of the co-transfected Vitamin D Receptor (VDR).",Cell culture medium,,Not specified; standard cell culture conditions assumed.,,HEK293T cells,pCMV6 or p3X FLAG 4.1,"Transient co-transfection of plasmids, followed by cell culture for 48 hours before assay."
PMID32115688,reaction_1,in vitro,Activity was assessed by measuring the complete oxidation of 1-14C palmitate to 14CO2 in isolated liver mitochondria from wild-type and heterozygous mice.,Not specified,,,,Endogenous expression in Mus musculus (transgenic model),,
PMID32117938,reaction_1,in vivo,Whole-cell bioconversion in E. coli BL21(DE3) expressing COMT. Substrate was 1 mM caffeic acid.,"M9 modified salt medium with 40 g/L glucose, methionine and other supplements.",,"Not specified, standard M9 medium.",26.0,Escherichia coli BL21 (DE3),,
PMID32117938,reaction_2,in vivo,Whole-cell bioconversion in E. coli BL21(DE3) expressing Module 1 enzymes. Substrate was 3 mM tyrosine.,"M9 modified salt medium with 40 g/L glucose, methionine and other supplements.",,"Not specified, standard M9 medium.",26.0,Escherichia coli BL21 (DE3),,
PMID32117938,reaction_3,in vivo,"Whole-cell bioconversion in E. coli BL21(DE3) ΔlacZ expressing Module 2 enzymes. Substrate was 2 mM ferulic acid, with an additional 1 mM fed at 15h.","M9 modified salt medium with 40 g/L glucose, methionine and other supplements.",,"Not specified, standard M9 medium.",26.0,Escherichia coli BL21 (DE3) ΔlacZ,,
PMID32117938,reaction_4,in vivo,Mono-culture bioconversion in E. coli BL21(DE3) from 1 mM caffeic acid.,"M9 modified salt medium with 40 g/L glucose, methionine and other supplements.",,"Not specified, standard M9 medium.",26.0,Escherichia coli BL21 (DE3),,
PMID32117938,reaction_5,in vivo,"Co-culture bioconversion from 3 mM tyrosine. Strain 1 (E. coli BL21(DE3)) with Module 1 enzymes, Strain 2 (E. coli BL21(DE3) ΔlacZ) with Module 2 enzymes.","M9 modified salt medium with 40 g/L glucose, methionine and other supplements.",,"Not specified, standard M9 medium.",26.0,Escherichia coli BL21 (DE3) and Escherichia coli BL21 (DE3) ΔlacZ,,
PMID32117944,reaction_1,in vitro,Enzyme activity assay with purified recombinant protein,50 mM CHES buffer,9.5,,55.0,E. coli C2566,pET-28a (+),
PMID32117944,reaction_2,in vitro,Enzyme activity assay with purified recombinant protein,50 mM CHES buffer,9.5,,55.0,E. coli C2566,pET-28a (+),
PMID32117944,reaction_3,in vitro,Enzyme activity assay with purified recombinant protein,50 mM CHES buffer,9.5,,55.0,E. coli C2566,pET-28a (+),
PMID32117944,reaction_4,in vitro,Enzyme activity assay with purified recombinant protein,50 mM CHES buffer,9.5,,55.0,E. coli C2566,pET-28a (+),
PMID32120232,reaction_1,in vitro,"Spectrophotometric assay monitoring the reduction of 2,6-dichlorophenol indophenol (DCPIP) at 600 nm.",50 mM phosphate buffer,7.0,,50.0,Aspergillus nidulans A773,pEXPYR,"Maltose-induced expression in optimized medium (61.0 g/L maltose, 26.4 g/L CSL, 13.8 g/L NaNO3) at 37 °C, 250 RPM for 72 h."
PMID32123662,reaction_1,in vivo,Squalene production measured in whole cells of engineered Synechocystis sp. PCC 6803.,BG11 medium,7.0,pH was buffered to 7.0 with 20mM HEPES for experiments with 50mM NaHCO3 supplementation. pH of standard BG11 medium was not specified.,30.0,Synechocystis sp. PCC 6803 (∆shc background strain),pEERM5’_BSS (for genomic integration at the shc locus),"Expression driven by the PnrsB promoter, induced by addition of 2.5 µM NiCl2 to the growth medium."
PMID32125480,reaction_1,in vitro,Kinetic parameters were determined from the Lineweaver-Burk plot.,"70 mM Tris-HCl, and 2.5 mM MgCl2",8.0,Optimal pH for the reaction.,32.0,Escherichia coli BL21 (DE3),pMBPtev,
PMID32125648,reaction_1,in vitro,First step of a two-step tandem reaction converting HMF to FDCA.,100 mmol/L potassium phosphate buffer,7.0,,25.0,Pichia pastoris,pPICZα-A,"Resuspended in BMMY medium with 0.5% methanol, induced for 4 days at 28°C."
PMID32125648,reaction_2,in vitro,"Second step of a two-step tandem reaction, performing Baeyer-Villiger oxidation.",ethyl acetate/tBuOH (1:1 v/v),5.5,pH adjusted with triethylamine after extraction of substrates from the first reaction step.,40.0,,,
PMID32130469,reaction_1,in vitro,Enzyme assays of CSO2 for kinetics and stability determination.,100 mM sodium bicarbonate buffer,9.0,Optimal pH range for activity is 6.5-10.0. Assays were performed at pH 9.0.,20.0,Escherichia coli T7 Express,pET-28a-CSO2,0.1 mM IPTG at 16 °C for 16 h
PMID32130469,reaction_2,in vitro,Two-enzyme cascade reaction system for vanillin synthesis from ferulic acid.,100 mM sodium bicarbonate buffer,9.0,,20.0,Escherichia coli T7 Express,,
PMID32131594,reaction_1,in vitro,Stopped-flow absorption spectroscopy and Freeze-quench Mössbauer spectroscopy under single-turnover conditions.,50 mM Tris-HCl,7.5,,5.0,E. coli BL21(DE3),pET-28a,Isopropyl β-D-1-thiogalactopyranoside at 27 °C for 4 hours
PMID32131594,reaction_2,in vitro,Stopped-flow absorption spectroscopy and Freeze-quench Mössbauer spectroscopy under single-turnover conditions.,50 mM Tris-HCl,7.5,,5.0,E. coli BL21(DE3),pET-28a,Isopropyl β-D-1-thiogalactopyranoside at 27 °C for 4 hours
PMID32131594,reaction_3,in vitro,Stopped-flow absorption spectroscopy under single-turnover conditions.,50 mM Tris-HCl,7.5,,5.0,E. coli BL21(DE3),pET-28a,Isopropyl β-D-1-thiogalactopyranoside at 27 °C for 4 hours
PMID32131594,reaction_4,in vitro,Stopped-flow absorption spectroscopy and Freeze-quench Mössbauer spectroscopy under single-turnover conditions.,50 mM Tris-HCl,7.5,,5.0,E. coli BL21(DE3),pET-28a,Isopropyl β-D-1-thiogalactopyranoside at 27 °C for 4 hours
PMID32133382,reaction_1,in vitro,NADPH oxidation coupled to H2O2 reduction via the E. coli Trx/TrxR system. Activity was monitored as the decrease in absorbance at 340 nm.,50 mM HEPES,,pH not specified for HEPES buffer,,Escherichia coli BL21 (DE3),pET-30a,1 mM IPTG
PMID32133382,reaction_2,in vitro,Ferrithiocyanate assay measuring H2O2 consumption.,0.5% glycerol/0.03 × PBS,,pH not specified for PBS buffer,25.0,Escherichia coli BL21 (DE3),pET-30a,1 mM IPTG
PMID32133382,reaction_3,in vitro,Metal-catalyzed oxidation (MFO) assay to assess protection of plasmid DNA from hydroxyl radical-induced nicking.,Not specified,,Not specified,37.0,Escherichia coli BL21 (DE3),pET-30a,1 mM IPTG
PMID32140842,reaction_1,in vitro,Kinetic analysis of purified recombinant enzyme.,50 mM Tris-HCl,7.5,,28.0,Streptomyces lividans 66,pGM1190,thiostrepton (50 μg/mL)
PMID32140842,reaction_2,in vitro,Kinetic analysis with 5 mM L-threonine.,50 mM Tris-HCl,7.5,,28.0,,,
PMID32140842,reaction_3,in vitro,Kinetic analysis with 5 mM L-threonine.,50 mM Tris-HCl,7.5,,28.0,,,
PMID32140842,reaction_4,in vitro,Kinetic analysis with 5 mM L-threonine.,50 mM Tris-HCl,7.5,,28.0,,,
PMID32140842,reaction_5,in vitro,Kinetic analysis with 5 mM L-threonine.,50 mM Tris-HCl,7.5,,28.0,,,
PMID32140842,reaction_6,in vitro,Kinetic analysis with 5 mM L-threonine.,50 mM Tris-HCl,7.5,,28.0,,,
PMID32140842,reaction_7,in vitro,Kinetic analysis with 5 mM fluoroacetaldehyde.,50 mM Tris-HCl,7.5,,28.0,,,
PMID32141742,reaction_1,in vivo,Overexpression of LcLAR1 in Arabidopsis thaliana ans mutant,,,in vivo experiment,21.0,Arabidopsis thaliana ans mutant (CS2105579),pCB2004-LcLAR1,Constitutive expression via 35S promoter
PMID32141742,reaction_2,in vivo,Overexpression of LcLAR1 in wild type tobacco (G28),,,in vivo experiment,25.0,Nicotiana tabacum (G28),pCB2004-LcLAR1,Constitutive expression via 35S promoter
PMID32144268,reaction_1,in vitro,Activity assay performed on immunoprecipitated endogenous or HA-tagged SAHH from cell lysates.,"SAHH assay buffer (from Adenosylhomocysteinase Activity Fluorometric Assay Kit, K807-100, Biovision)",,,,HEK293T,pCDH-SAHH-HA,Lentiviral transduction
PMID32145238,reaction_1,in vitro,Enzymatic cross-linking to form an acid-induced protein gel.,"Thermally denatured egg white protein (TD-EWP) solution (50 mg/mL in water, pH 7.5) with added Glucono delta-lactone (0.16 g/g protein).",4.6,Final pH after 3h incubation with GDL at 40°C.,40.0,,,
PMID32145238,reaction_2,in vitro,Enzymatic cross-linking of TD-EWP in a 10% (v/v) grape seed oil emulsion to form an acid-induced emulsion gel.,"TD-EWP solution (50 mg/mL) emulsified with 10% (v/v) grape seed oil, with added Glucono delta-lactone (0.16 g/g protein).",4.6,Final pH after 3h incubation with GDL at 40°C.,40.0,,,
PMID32146179,reaction_1,in vitro,Fluorescent lipid II-based transglycosylation inhibition assay,"50 mM HEPES, 200 mM NaCl, 10 mM CaCl2, 0.04 % Triton X-100, 25 % DMSO, 1 U/µL muramidase",7.5,,30.0,Escherichia coli,,
PMID32146811,crude_1,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_2,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_3,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_4,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_5,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_6,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_7,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_8,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_9,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_10,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_11,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_12,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_13,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_14,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_15,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_16,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_17,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_18,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_19,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_20,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_21,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_22,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_23,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_24,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_25,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_26,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_27,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_28,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_29,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_30,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_31,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,crude_32,in vitro,cell-free crude enzyme solution,"0.1 M sodium phosphate buffer, pH 7.4, containing 1.5 mM 2-mercaptoethanol, 20% glycerol (v/v)",7.4,,37.0,,,
PMID32146811,bddet2_1,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bddet2_2,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90b1_1,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90b1_2,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90a1_1,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90a1_2,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90a1_3,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90d2_1,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90d2_2,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp90d2_3,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp85a1_ecoli_1,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp85a1_ecoli_2,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp85a1_ecoli_3,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp85a1_ecoli_4,in vitro,Recombinant enzyme assay,"MBP column buffer (200 mM NaCl, 20 mM Tris-Cl, 1.0 mM EDTA, pH 7.4)",7.4,,37.0,Escherichia coli BL21+,,
PMID32146811,bdcyp85a1_yeast_1,in vivo,Heterologous expression and conversion in yeast cells,"YPL medium (galactose, 20 g L−1, yeast extract, 10 g L−1, bactopeptone, 10 g L−1)",,,28.0,Saccharomyces cerevisiae WAT11,,
PMID32146811,bdcyp85a1_yeast_2,in vivo,Heterologous expression and conversion in yeast cells,"YPL medium (galactose, 20 g L−1, yeast extract, 10 g L−1, bactopeptone, 10 g L−1)",,,28.0,Saccharomyces cerevisiae WAT11,,
PMID32146930,reaction_1,in vitro,Transglucosylation reaction with purified enzyme to synthesize luteolin glucoside.,100 mM sodium phosphate buffer,8.0,,40.0,Corynebacterium glutamicum ATCC 13032,pXMJ19 (construct pXDGAS-his),"300 mM isopropyl β-D-1-thiogalactopyranoside, 24 h culture at 30°C"
PMID32146930,reaction_2,in vitro,Comparative transglucosylation reaction with purified enzyme.,100 mM sodium phosphate buffer,8.0,,40.0,Escherichia coli,,
PMID32146930,reaction_3,in vitro,"Measurement of hydrolytic activity using the DNS method to determine fructose release, as a proxy for overall polymerization and hydrolysis activity.",100 mM sodium phosphate,8.0,,40.0,Corynebacterium glutamicum ATCC 13032,pXMJ19 (construct pXDGAS-his),"300 mM isopropyl β-D-1-thiogalactopyranoside, 24 h culture at 30°C"
PMID32146930,reaction_4,in vitro,"Measurement of hydrolytic activity using the DNS method to determine fructose release, as a proxy for overall polymerization and hydrolysis activity.",100 mM sodium phosphate,8.0,,45.0,Escherichia coli,,
PMID32149287,reaction_1,in vitro,Single turnover assay with tritiated tRNA and initial velocity studies with radiolabelled queuine.,buffer solution optimised for maximal enzymatic activity,7.4,physiological pH,37.0,,,
PMID32149287,reaction_2,in vitro,Initial velocity studies using radiolabelled guanine.,buffer solution optimised for maximal enzymatic activity,7.4,physiological pH,37.0,,,
PMID32149287,reaction_3,in vitro,EMSA assay to trap and detect a covalent intermediate.,,,,37.0,,,
PMID32152525,reaction_1,in vitro,Enzyme activity was measured by monitoring the oxidation of NADH at 340 nm.,"30 mM PIPES, 150 mM NaCl",6.8,,25.0,,,
PMID32153057,reaction_1,in vitro,Kinetic spectrophotometric measurement of enzyme activity in sperm-free supernatant of human semen.,"Phosphate-buffered saline with 50% ethanol was used for sample treatment. The assay itself used a commercial kit buffer (Spectrum Diagnostics, Hannover, Germany).",,Not specified,37.0,,,
PMID32153807,reaction_1,in vitro,ex vivo spectrophotometric assay on plasma from rats treated with Spirulina platensis extract,"Assay performed using a kit from SIGMA ALDRICH, GERMANY. Buffer composition not specified.",,,,,,
PMID32153807,reaction_2,in vitro,ex vivo fluorimetric assay on plasma from rats treated with Spirulina platensis extract,"Assay performed using a kit from SIGMA ALDRICH, GERMANY. LCAT Substrate Reagent was mixed with Assay Buffer and plasma.",,,37.0,,,
PMID32154242,reaction_1,in vitro,Spectrophotometric assay on crude cell extracts,67 mM phosphate buffer,7.4,,30.0,,,
PMID32154242,reaction_2,in vitro,Spectrophotometric assay on crude cell extracts,67 mM phosphate buffer,7.4,,30.0,,,
PMID32154242,reaction_3,in vitro,Spectrophotometric assay on crude cell extracts,67 mM phosphate buffer,7.4,,30.0,,,
PMID32154242,reaction_4,in vitro,Spectrophotometric assay on crude cell extracts,67 mM phosphate buffer,7.4,,30.0,,,
PMID32154242,reaction_5,in vitro,Spectrophotometric assay on crude cell extracts,67 mM phosphate buffer,7.4,,30.0,,,
PMID32154242,reaction_6,in vivo,Fed-batch fermentation in a 5-L bioreactor,Fermentation medium containing about 70 g/L glucose; 1 g/L triammonium citrate; 12 g/L yeast extract; 2 g/L K2HPO4·3H2O; 6.5 g/L sodium acetate; 0.25 g/L MgSO4·7H2O; 0.0225 g/L FeSO4·7H2O; 0.0075 g/L ZnSO4·7H2O; and 0.0038 g/L MnSO4·H2O.,7.0,Maintained by automatic addition of 6 M acetic acid and 6 M NaOH,50.0,,,
PMID32154242,reaction_7,in vivo,Batch fermentation in a 1-L bioreactor,Fermentation medium containing about 70 g/L glucose; 1 g/L triammonium citrate; 12 g/L yeast extract; 2 g/L K2HPO4·3H2O; 6.5 g/L sodium acetate; 0.25 g/L MgSO4·7H2O; 0.0225 g/L FeSO4·7H2O; 0.0075 g/L ZnSO4·7H2O; and 0.0038 g/L MnSO4·H2O.,7.0,Maintained by automatic addition of 6 M acetic acid and 6 M NaOH,50.0,,,
PMID32155529,reaction_1_in_vitro,in vitro,Amplified Luminescent Proximity Homogeneous Assay (ALPHA) to measure inhibition.,"50 mM HEPES, 0.01% (v/v) Tween 20, 0.1% (w/v) bovine serum albumin",7.5,,,,,
PMID32155529,reaction_2_in_cellulo,in vivo,Western Blotting and Immunofluorescence in MKN45 cells to detect histone methylation levels after inhibitor treatment.,Cell culture medium (RPMI-1640 or DMEM) with 10% FBS,,,37.0,,,
PMID32156771,reaction_1,in vitro,Kinetic parameter determination using purified recombinant protein,50 mM phosphate buffer,6.2,,25.0,Escherichia coli LMG194,pBAD/His,"0.2% (w/v) L-arabinose, 20 h, 37°C"
PMID32156771,reaction_2,in vitro,Kinetic parameter determination using purified recombinant protein,50 mM phosphate buffer,6.2,,25.0,Escherichia coli LMG194,pBAD/His,"0.2% (w/v) L-arabinose, 20 h, 37°C"
PMID32156771,reaction_3,in vitro,Kinetic parameter determination using purified recombinant protein,50 mM phosphate buffer,6.2,,25.0,Escherichia coli LMG194,pBAD/His,"0.2% (w/v) L-arabinose, 20 h, 37°C"
PMID32156771,reaction_4,in vitro,Kinetic parameter determination using purified recombinant protein,50 mM phosphate buffer,6.2,,25.0,Escherichia coli LMG194,pBAD/His,"0.2% (w/v) L-arabinose, 20 h, 37°C"
PMID32156808,reaction_1,in vitro,Microtiter plate assay with purified enzyme,"50 mM Tris-HCl, 5% ethanol",8.0,,37.0,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_2,in vivo,Whole-cell assay with E. coli BL21(DE3) expressing the enzyme. Activity measured by monitoring p-nitrophenol formation at 410 nm.,50 mM Tris-HCl buffer,8.0,,37.0,E. coli BL21(DE3),pET-28b,"100 µM IPTG, 16°C, overnight"
PMID32156808,reaction_3,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_4,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_5,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_6,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_7,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_8,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_9,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_10,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_11,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_12,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_13,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32156808,reaction_14,in vitro,"Standard assay with purified enzyme, followed by extraction and GC-MS analysis of the decarboxylated ketone product. Conditions as per reference 11.",,,,,E. coli T7 strains,pET-28b,"1 mM IPTG, 16°C, overnight"
PMID32158501,reaction_1,in vitro,Turbidimetric assay monitoring the degradation of a 0.8 mg/mL PASC suspension.,"50 mM sodium phosphate buffer, pH 6.0",6.0,,30.0,Pichia pastoris X-33,,
PMID32158501,reaction_2,in vitro,Turbidimetric assay monitoring PASC degradation. LPMO was at 3 µM and NcCDHIIA was varied from 0.5 to 3.0 µM.,"50 mM potassium phosphate buffer, pH 6.0",6.0,,30.0,Pichia pastoris X-33,,
PMID32158501,reaction_3,in vitro,Turbidimetric assay monitoring PASC degradation.,"50 mM sodium phosphate buffer, pH 6.0",6.0,,30.0,Pichia pastoris X-33,,
PMID32158501,reaction_4,in vitro,"Turbidimetric assay with sequential H2O2 titration and electrochemical H2O2 detection. H2O2 was added in aliquots of 20, 40, or 80 µM.","50 mM sodium phosphate buffer, pH 6.0",6.0,,30.0,Pichia pastoris X-33,,
PMID32158501,reaction_5,in vitro,Product analysis by MALDI-MS. H2O2 was added in four batches of 30 µM over 30 min to a final concentration of 120 µM.,"25 mM TRIS, pH 6.0",6.0,,30.0,Pichia pastoris X-33,,
PMID32159929,reaction_1_cyt_bo3,in vitro,Oxygen consumption rate measured by a Clark-type oxygen electrode.,"20 mM NaPi, 50 mM NaCl, 0.02% DDM",8.0,,25.0,Escherichia coli GO195,pIRHisA,
PMID32159929,reaction_2_cyt_bdI,in vitro,Oxygen consumption rate measured by a Clark-type oxygen electrode.,"20 mM NaPi, 50 mM NaCl, 0.02% DDM",8.0,,25.0,Escherichia coli C43 (DE3) Δbo3,pet17b-cydABX-StrepII,
PMID32160528,reaction_1,in vitro,Spectrophotometric continuous assay monitoring NADPH consumption at 340 nm.,"0.05 M BisTris pH 6.5, 0.05 M potassium acetate, 0.5 mM magnesium acetate, 10% (w/v) sucrose",6.5,,30.0,Saccharomyces cerevisiae BJ2168 (for FAS); Escherichia coli BL21 Star (DE3) (for recombinant γ-subunit),pET151/D-TOPO (for γ-subunit),"0.5 mM IPTG, 18°C, 16h (for γ-subunit)"
PMID32160528,reaction_2,in vitro,Measurement of NADPH consumption in the absence of acetyl-CoA and malonyl-CoA.,"0.05 M BisTris pH 6.5, 0.05 M potassium acetate, 0.5 mM magnesium acetate, 10% (w/v) sucrose",6.5,,30.0,,,
PMID32162142,reaction_1,in vitro,In-gel activity assay using non-denaturated polyacrylamide gel electrophoresis (PAGE) on total protein extracted from leaves. The gel was stained with hypoxanthine as the substrate.,Not specified,,,,Oryza sativa L. (Kitaake),pCUBI1390 (over-expression) and LH-FAD2-1390RNAi (RNAi),Constitutive expression in transgenic rice lines generated via Agrobacterium-mediated transformation.
PMID32168758,reaction_1,in vitro,Lactate dehydrogenase coupled enzyme assay,"50 mM TRIS-HCl, 50 mM KCl, 10 mM MgCl2, 5% w/v PEG 200, 1 mM DTT",7.5,,25.0,Escherichia coli BLR21,pET16b,
PMID32168758,reaction_2,in vitro,Lactate dehydrogenase coupled enzyme assay,"50 mM TRIS-HCl, 50 mM KCl, 10 mM MgCl2, 5% w/v PEG 200, 1 mM DTT",7.5,,25.0,Escherichia coli BLR21,pET16b,
PMID32168758,reaction_3,in vitro,Lactate dehydrogenase coupled enzyme assay,"50 mM TRIS-HCl, 50 mM KCl, 10 mM MgCl2, 5% w/v PEG 200, 1 mM DTT",7.5,,25.0,Escherichia coli BLR21,pET16b,
PMID32168758,reaction_4,in vitro,Lactate dehydrogenase coupled enzyme assay,"50 mM TRIS-HCl, 50 mM KCl, 10 mM MgCl2, 5% w/v PEG 200, 1 mM DTT",7.5,,25.0,Escherichia coli BLR21,pET16b,
PMID32168758,reaction_5,in vitro,Lactate dehydrogenase coupled enzyme assay,"50 mM TRIS-HCl, 50 mM KCl, 10 mM MgCl2, 5% w/v PEG 200, 1 mM DTT",7.5,,25.0,Escherichia coli BLR21,pET16b,
PMID32169960,reaction_1,in vitro,"Activity assay with purified, His-tagged enzyme reconstituted into proteoliposomes.","50 mM Hepes pH=7.4, 300 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 5 mM cellobiose",7.4,,,Saccharomyces cerevisiae (Strain INVSc1),pYES2/NT C,Induced with 20 g/L galactose for 6 h at 30°C.
PMID32169960,reaction_2,in vitro,"Activity assay with purified, His-tagged enzyme reconstituted into proteoliposomes.","50 mM Hepes pH=7.4, 300 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 5 mM cellobiose",7.4,,,Saccharomyces cerevisiae (Strain INVSc1),pYES2/NT C,Induced with 20 g/L galactose for 6 h at 30°C.
PMID32169960,reaction_3,in vitro,"Activity assay with purified, His-tagged enzyme reconstituted into proteoliposomes.","50 mM Hepes pH=7.4, 300 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 5 mM cellobiose",7.4,,,Saccharomyces cerevisiae (Strain INVSc1),pYES2/NT C,Induced with 20 g/L galactose for 6 h at 30°C.
PMID32169960,reaction_4,in vitro,"Activity assay with purified, His-tagged enzyme reconstituted into proteoliposomes.","50 mM Hepes pH=7.4, 300 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 5 mM cellobiose",7.4,,,Saccharomyces cerevisiae (Strain INVSc1),pYES2/NT C,Induced with 20 g/L galactose for 6 h at 30°C.
PMID32169960,reaction_5,in vitro,"Activity assay with purified, His-tagged enzyme reconstituted into proteoliposomes.","50 mM Hepes pH=7.4, 300 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 5 mM cellobiose",7.4,,,Saccharomyces cerevisiae (Strain INVSc1),pYES2/NT C,Induced with 20 g/L galactose for 6 h at 30°C.
PMID32169960,reaction_6,in vitro,"Activity assay with purified, His-tagged enzyme reconstituted into proteoliposomes.","50 mM Hepes pH=7.4, 300 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 5 mM cellobiose",7.4,,,Saccharomyces cerevisiae (Strain INVSc1),pYES2/NT C,Induced with 20 g/L galactose for 6 h at 30°C.
PMID32170014,reaction_1,in vivo,Cell-based assays in HEK293 cells measuring enzyme stability via a SM-luciferase fusion reporter. Squalene accumulation upon inhibition was measured by GC-MS. Direct binding was confirmed by in vitro photoaffinity labeling using isolated membrane fractions.,"Cell culture in medium (e.g., containing fetal calf serum or lipoprotein-deficient serum). For ubiquitination assay, cells were lysed in buffer with protease inhibitors and N-ethylmaleimide.",,,,HEK293 cells,pCMV-AC-FLAG-ELuc,Constitutive expression from CMV promoter in stably transfected cells.
PMID32171154,reaction_1,in vitro,Enzyme inhibition kinetic study to determine Ki values.,"0.1 M Tris-HCl, 50 mM MgCl2",8.0,,25.0,,,
PMID32171656,reaction_1,in vitro,Spectrophotometric assay measuring the increase in absorbance at 340 nm.,100 mM potassium phosphate buffer (PBS),7.0,pH for kinetic parameter determination.,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Transfer to SC-U medium supplemented with 2% galactose and 1% raffinose for 24 h.
PMID32171656,reaction_2,in vitro,Spectrophotometric assay measuring the increase in absorbance at 340 nm.,100 mM potassium phosphate buffer (PBS),7.0,pH for kinetic parameter determination.,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Transfer to SC-U medium supplemented with 2% galactose and 1% raffinose for 24 h.
PMID32171656,reaction_3,in vitro,Spectrophotometric assay measuring the increase in absorbance at 340 nm.,100 mM potassium phosphate buffer (PBS),7.0,pH for kinetic parameter determination.,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Transfer to SC-U medium supplemented with 2% galactose and 1% raffinose for 24 h.
PMID32171790,reaction_1,in vitro,Enzyme activity determined by measuring CoA release from (R)-3HB-CoA using DTNB. The reaction was initiated by adding 50 µg of the crude protein.,100 mM Tris-Cl buffer,7.8,,20.0,Cupriavidus necator PHB⁻ 4,pBBR1-ProCnJ60,
PMID32171790,reaction_2,in vivo,Heterologous expression in C. necator PHB⁻ 4 and measurement of PHA accumulation from fructose as the carbon source.,Mineral medium (MM),,,20.0,Cupriavidus necator PHB⁻ 4,pBBR1-ProCnJ60,Cultivated for 48h in MM with 1% (v/v) fructose and 50 mg/L Kanamycin.
PMID32171790,reaction_3,in vivo,Heterologous expression in C. necator PHB⁻ 4 and measurement of PHA accumulation from fructose as the carbon source.,Mineral medium (MM),,,30.0,Cupriavidus necator PHB⁻ 4,pBBR1-ProCnJ60,Cultivated for 48h in MM with 1% (v/v) fructose and 50 mg/L Kanamycin.
PMID32171790,reaction_4,in vitro and in vivo,Tested via in vitro assay with (R)-3HB-CoA and in vivo heterologous expression in C. necator PHB⁻ 4 with fructose.,In vitro: 100 mM Tris-Cl buffer; In vivo: Mineral medium (MM),7.8,for in vitro assay,20.0,Cupriavidus necator PHB⁻ 4,pBBR1-ProCnJ56,
PMID32171906,reaction_1,in vitro,Enzyme activity measurement with 60 µM 2E-butenoyl-CoA.,"50 mM Tris, 50 mM KCl, 50 µg mL-1 BSA, pH 9.0",9.0,,25.0,E. coli BL21DE3,pETDuet-1 (for EcTFE-α-His) and pACYC-Duet-1 (for EcTFE-β),
PMID32171906,reaction_2,in vitro,Coupled assay where substrate was generated from 60 µM 2E-butenoyl-CoA by the ECH activity.,"50 mM Tris, 50 mM KCl, 50 µg mL-1 BSA, pH 9.0, with 1 mM NAD+ and 1 mM CoA",9.0,,25.0,E. coli BL21DE3,pETDuet-1 (for EcTFE-α-His) and pACYC-Duet-1 (for EcTFE-β),
PMID32171906,reaction_3,in vitro,Enzyme activity measurement with 60 µM acetoacetyl-CoA.,"50 mM Tris, 50 mM KCl, 50 µg mL-1 BSA, pH 8.5, with 1 mM NAD+, 0.5 mM CoA and 5 mM MgCl2",8.5,,25.0,E. coli BL21DE3,pETDuet-1 (for EcTFE-α-His) and pACYC-Duet-1 (for EcTFE-β),
PMID32171906,reaction_4,in vitro,Enzyme activity measurement with 60 µM 2E-decenoyl-CoA.,"50 mM Tris, 50 mM KCl, 50 µg mL-1 BSA, pH 9.0",9.0,,25.0,E. coli BL21DE3,pETDuet-1 (for EcTFE-α-His) and pACYC-Duet-1 (for EcTFE-β),
PMID32171906,reaction_5,in vitro,Coupled assay where substrate was generated from 60 µM 2E-decenoyl-CoA by the ECH activity.,"50 mM Tris, 50 mM KCl, 50 µg mL-1 BSA, pH 9.0, with 1 mM NAD+ and 1 mM CoA",9.0,,25.0,E. coli BL21DE3,pETDuet-1 (for EcTFE-α-His) and pACYC-Duet-1 (for EcTFE-β),
PMID32171906,reaction_6,in vitro,Enzyme activity measurement with 60 µM 2E-hexadecenoyl-CoA.,"50 mM Tris, 50 mM KCl, 50 µg mL-1 BSA, pH 9.0",9.0,,25.0,E. coli BL21DE3,pETDuet-1 (for EcTFE-α-His) and pACYC-Duet-1 (for EcTFE-β),
PMID32171906,reaction_7,in vitro,Coupled assay where substrate was generated from 60 µM 2E-hexadecenoyl-CoA by the ECH activity.,"50 mM Tris, 50 mM KCl, 50 µg mL-1 BSA, pH 9.0, with 1 mM NAD+ and 1 mM CoA",9.0,,25.0,E. coli BL21DE3,pETDuet-1 (for EcTFE-α-His) and pACYC-Duet-1 (for EcTFE-β),
PMID32172349,reaction_1,in vitro,"Bioconversion using Ca-alginate immobilized, permeabilized (CTAB), and cross-linked (glutaraldehyde) whole Zymomonas mobilis cells.",Aqueous solution containing substrates. pH was controlled by adding 7.0 mol/L NaOH solution.,6.4,This pH was used for stability and scale-up tests after an optimal range of 6.4-6.8 was determined.,39.0,,,
PMID32175634,reaction_1,in vitro,Enzyme kinetics assay with purified enzyme.,Details provided in Supporting Information.,,Details provided in Supporting Information.,,"Escherichia coli BW25113 (∆ldhA, dld::cat)",,
PMID32175634,reaction_2,in vitro,Enzyme kinetics assay with purified enzyme.,Details provided in Supporting Information.,,Details provided in Supporting Information.,,"Escherichia coli BW25113 (∆ldhA, dld::cat)",,
PMID32175634,reaction_3,in vivo,Resting cell catalysis for D-lactate production in engineered E. coli.,Details provided in Supporting Information.,,Details provided in Supporting Information.,,"Escherichia coli BW25113 (∆ldhA, dld::cat)",,
PMID32178258,reaction_1,in vitro,Assay with highly purified BVDV RdRp.,"50 mM Hepes, 10 mM KCl, 10 mM DTT, 1 mM MgCl2, 2mM MnCl2, and 0.5% igepal",8.0,,30.0,,,
PMID32178258,reaction_2,in vitro,Isolated replication complex (RC) assay.,"RCs were resuspended in 10 mM Tris, 10 mM NaCl, 15% glycerol. Full reaction buffer not specified.",7.8,,,,,
PMID32178974,reaction_1,in vitro,Inhibition assay to determine the potency of compound 1. Products were analyzed by GC-MS.,Not specified,,Not specified,37.0,,,
PMID32180104,reaction_1,in vitro,in vitro enzyme reactions,,,,,,,
PMID32180104,reaction_2,in vitro,in vitro enzyme reactions,,,,,,,
PMID32180104,reaction_3,in vitro,in vitro enzyme reactions,,,,,,,
PMID32180104,reaction_4,in vitro,in vitro enzyme reactions,,,,,,,
PMID32180104,reaction_5,in vitro,in vitro enzyme reactions,,,,,,,
PMID32180104,reaction_6,in vitro,in vitro enzyme reactions,,,,,,,
PMID32180104,reaction_7,in vitro,in vitro enzyme reactions,,,,,,,
PMID32180316,reaction_1,in vitro,Coupled assay measuring the formation of the product holo-ACP via its free thiol group using Ellman's Reagent (DTNB).,"50 mM Tris, 1 mM MgCl2",7.5,,25.0,E. coli C43 (DE3),pET28a,
PMID32180316,reaction_2,in vitro,Coupled assay using EnzChek Phosphate Assay Kit to measure phosphate consumption.,"50 mM Tris, 1 mM MgCl2",7.5,,25.0,E. coli C43 (DE3),pET28a,
PMID32180325,reaction_1,in vitro,Assay with purified recombinant GST-tagged BchX and BchY-BchZ proteins.,"100 mM HEPES-NaOH, 10 mM MgCl2, 9.2% (w/v) glycerol, 5 mM EDTA, 1 mM dithiothreitol, and 0.7 mM sodium dithionite",7.5,,34.0,Escherichia coli BL21 (DE3),pGEX-6P-1 (constructs pHGX1 and pHGYZ1),"0.1 mM IPTG, 16°C, overnight"
PMID32180325,reaction_2,in vitro,Assay with purified recombinant GST-tagged BchX and BchY-BchZ proteins.,"100 mM HEPES-NaOH, 10 mM MgCl2, 9.2% (w/v) glycerol, 5 mM EDTA, 1 mM dithiothreitol, and 0.7 mM sodium dithionite",7.5,,34.0,Escherichia coli BL21 (DE3),pGEX-6P-1 (constructs pHGX1 and pHGYZ1),"0.1 mM IPTG, 16°C, overnight"
PMID32181246,reaction_1,in vitro,"Colorimetric assay on cell lysate and purified enzyme measuring the conjugation of 1-chloro-2,4-dinitrobenzene with reduced glutathione at 340 nm.",50 mM Tris-HCl (for characterization studies),6.0,Optimal pH. The enzyme is stable in the pH range 4-7.,40.0,Lactobacillus plantarum KU720558,,
PMID32181246,reaction_2,in vitro,"Indirect colorimetric assay on cell lysate and purified enzyme. GPx activity is coupled to glutathione reductase, and the rate of NADPH oxidation is measured at 340 nm.",50 mM Tris-HCl (for characterization studies),6.0,Optimal pH. The enzyme is stable in the pH range 4-7.,40.0,Lactobacillus plantarum KU720558,,
PMID32182320,reaction_1,in vitro,"The experimental investigation involved protein expression, purification, and X-ray crystallography of the enzyme in complex with substrate (hyoscyamine) and co-substrate/analogs (2-OG, NOG). No kinetic assays were performed.","200 mM sodium formate, 20% PEG 3350",,,20.0,Escherichia coli BL21(DE3) Magic,pMCSG19,"0.2 mM IPTG, 16°C, overnight"
PMID32182513,reaction_1,in vitro,Spectrophotometric assay monitoring the consumption of NADH at 340 nm.,"50 mM Tris-HCl buffer (pH 8.2), 37.5 mM (NH4)2SO4, 7.5 mM α-ketoglutaric acid, 0.75 mM CaCl2",8.2,,30.0,,,
PMID32182513,reaction_2,in vitro,Spectrophotometric assay monitoring the consumption of NADH at 340 nm.,"50 mM Tris-HCl buffer (pH 8.2), 37.5 mM (NH4)2SO4, 7.5 mM α-ketoglutaric acid, 0.75 mM CaCl2",8.2,,30.0,,,
PMID32182513,reaction_3,in vitro,Spectrophotometric assay monitoring the consumption of NADPH at 340 nm.,"50 mM Tris-HCl buffer (pH 8.2), 37.5 mM (NH4)2SO4, 7.5 mM α-ketoglutaric acid, 0.75 mM CaCl2",8.2,,30.0,,,
PMID32182513,reaction_4,in vitro,Spectrophotometric assay monitoring the consumption of NADPH at 340 nm.,"50 mM Tris-HCl buffer (pH 8.2), 37.5 mM (NH4)2SO4, 7.5 mM α-ketoglutaric acid, 0.75 mM CaCl2",8.2,,30.0,,,
PMID32182513,reaction_5,in vitro,Colorimetric assay measuring the formation of L-Glutamic acid γ-monohydroxamate at 540 nm after reaction with ferric chloride reagent.,"50 mM Tris-HCl buffer (pH 7.6), 20 mM hydroxylamine hydrochloride, 50 mM MgSO4, 50 mM glutamate and 10 mM ATP",7.6,,30.0,,,
PMID32182513,reaction_6,in vitro,Colorimetric assay measuring the formation of L-Glutamic acid γ-monohydroxamate at 540 nm after reaction with ferric chloride reagent.,"50 mM Tris-HCl buffer (pH 7.6), 20 mM hydroxylamine hydrochloride, 50 mM MgSO4, 50 mM glutamate and 10 mM ATP",7.6,,30.0,,,
PMID32182756,reaction_1,in vivo,"Reaction occurs endogenously in cultured human breast cancer cells (MCF7, MDA-MB-231). Product (Q-tRNA) levels were quantified from cell lysates via Northern blot on 3-acrylamidophenylboronic acid (APB) gels.","Eagle’s minimum essential medium with 10% FBS, 10 µg/mL bovine insulin, and 10 nM β-estradiol (for MCF7 cells)",,"Standard cell culture conditions, typically pH 7.2-7.4",37.0,,,
PMID32184398,reaction_1,in vitro,HJ cleavage assay,"50 mM Tris-HCl, 1 mM DTT, 10 mM MgCl2",8.0,,30.0,Escherichia coli BL21 (DE3),modified pET15D,"0.2 mM IPTG, 16 °C, 12-16 h"
PMID32184398,reaction_2,in vitro,HJ cleavage assay,"50 mM Tris-HCl, 1 mM DTT, 10 mM MgCl2",8.0,,30.0,Escherichia coli BL21 (DE3),modified pET15D,"0.2 mM IPTG, 16 °C, 12-16 h"
PMID32184398,reaction_3,in vitro,HJ cleavage assay,"50 mM Tris-HCl, 1 mM DTT, 10 mM MgCl2",8.0,,30.0,Escherichia coli BL21 (DE3),modified pET15D,"0.2 mM IPTG, 16 °C, 12-16 h"
PMID32184968,reaction_1,in vitro,ADP Glo assay for IC50 determination.,,,,,,,
PMID32184968,reaction_2,in vitro,Transcreener assay for IC50 determination.,,,,,,,
PMID32188856,reaction_1,in vitro,Enzymatic assay monitoring the absorbance of NADH at 340 nm. This is referred to as the reductase activity.,Tris-NaCl buffer,7.5,,37.0,Escherichia coli BL21(DE3),pET15,"1 mM IPTG, 16 °C, 16 h"
PMID32188856,reaction_2,in vitro,Enzymatic assay monitoring the absorbance of NADH at 340 nm. This is referred to as the dehydrogenase activity.,Tris-NaCl buffer,8.8,,37.0,Escherichia coli BL21(DE3),pET15,"1 mM IPTG, 16 °C, 16 h"
PMID32190117,reaction_1,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_2,in vitro,Two-enzyme system for in situ H2O2 generation.,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_3,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_4,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_5,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_6,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_7,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_8,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_9,in vitro,,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_10,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_11,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_12,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_13,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_14,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_15,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_16,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_17,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_18,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_19,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_20,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_21,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_22,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_23,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_24,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_25,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32190117,reaction_26,in vitro,One-pot three-enzyme cascade,"50 mM NaH2PO4, 500 mM NaCl, pH 7.4",7.4,,30.0,,,
PMID32192841,reaction_1,in vitro,Kinetic analysis of purified recombinant enzyme expressed in E. coli.,100 mM Tris-HCl buffer,8.5,,25.0,Escherichia coli BL21-CodonPlus(DE3)-RIL,pET28a,"1 mM isopropyl β-D-1-thiogalactopyranoside, 18 °C for 16 h"
PMID32192841,reaction_2,in vitro,Kinetic analysis of purified recombinant enzyme expressed in E. coli.,100 mM Tris-HCl buffer,8.5,,25.0,Escherichia coli BL21-CodonPlus(DE3)-RIL,pET28a,"1 mM isopropyl β-D-1-thiogalactopyranoside, 18 °C for 16 h"
PMID32192841,reaction_3,in vitro,Kinetic analysis of purified recombinant enzyme expressed in E. coli.,100 mM Tris-HCl buffer,8.5,,25.0,Escherichia coli BL21-CodonPlus(DE3)-RIL,pET28a,"1 mM isopropyl β-D-1-thiogalactopyranoside, 18 °C for 16 h"
PMID32192841,reaction_4,in vitro,Kinetic analysis of purified recombinant enzyme expressed in E. coli.,100 mM Tris-HCl buffer,8.5,,25.0,Escherichia coli BL21-CodonPlus(DE3)-RIL,pET28a,"1 mM isopropyl β-D-1-thiogalactopyranoside, 18 °C for 16 h"
PMID32196091,reaction_1,in vitro,in vitro enzyme assay with reconstituted system,"50 uM HEPES, 1 μM MgCl2",7.4,"pH of purification buffer, assumed for assay",37.0,Escherichia coli BL21(DE3),pET17b (co-transformed with pGRO12 for GroEL/ES chaperones),"0.5 mM IPTG, 4 mg/ml arabinose, 27.5°C, 16 hours"
PMID32196091,reaction_2,in vitro,in vitro enzyme assay with reconstituted system,"50 uM HEPES, 1 μM MgCl2",7.4,"pH of purification buffer, assumed for assay",37.0,Escherichia coli BL21(DE3),pET17b (co-transformed with pGRO12 for GroEL/ES chaperones),"0.5 mM IPTG, 4 mg/ml arabinose, 27.5°C, 16 hours"
PMID32196091,reaction_3,in vitro,in vitro enzyme assay with reconstituted system,"50 uM HEPES, 1 μM MgCl2",7.4,"pH of purification buffer, assumed for assay",37.0,Escherichia coli BL21(DE3),pET17b (co-transformed with pGRO12 for GroEL/ES chaperones),"0.5 mM IPTG, 4 mg/ml arabinose, 27.5°C, 16 hours"
PMID32196942,reaction_1,in vitro,Coupled spectrophotometric assay monitoring NADH oxidation at 340 nm with glyceraldehyde 3-phosphate dehydrogenase.,50 mM Tris-HCl (pH 7.5) or 50 mM acetate buffer (pH 5.5),,Activity studied at pH 5.5 and pH 7.5.,25.0,Escherichia coli BL21 DE3,pTrcHisA,
PMID32196942,reaction_2,in vitro,Coupled spectrophotometric assay monitoring NADH oxidation at 340 nm with glyceraldehyde 3-phosphate dehydrogenase.,50 mM Tris-HCl (pH 7.5) or 50 mM acetate buffer (pH 5.5),,Activity studied at pH 5.5 and pH 7.5.,25.0,Escherichia coli BL21 DE3,,
PMID32196942,reaction_3,in vitro,Coupled spectrophotometric assay monitoring NADH oxidation at 340 nm with glyceraldehyde 3-phosphate dehydrogenase.,50 mM Tris-HCl (pH 7.5) or 50 mM acetate buffer (pH 5.5),,Activity studied at pH 5.5 and pH 7.5.,25.0,,,
PMID32198047,reaction_1,in vitro,Fusion protein substrate phosphorylation assay,"50 mM Tris, pH 8.0, 10 mM MgCl2, 12 μM CaM, 0.1 mg/ml BSA, 10 mM DTT, 1.3 mM CaCl2",8.0,,30.0,Sf21 or High Five cells,Bac-to-bac baculovirus expression system,
PMID32198047,reaction_2,in vitro,Fusion protein substrate phosphorylation assay,"50 mM Tris, pH 8.0, 10 mM MgCl2, 12 μM CaM, 0.1 mg/ml BSA, 10 mM DTT, 1.3 mM CaCl2",8.0,,30.0,Sf21 or High Five cells,Bac-to-bac baculovirus expression system,
PMID32198779,reaction_1,in vitro,Spectrophotometric assay monitoring NADPH oxidation at 340 nm.,"0.1 M Tris-HCl, 50 mM MgCl2",8.0,,,,,
PMID32198779,reaction_2,in vitro,Spectrophotometric assay for inhibition studies and co-crystallization.,"0.1 M Tris-HCl, 50 mM MgCl2",8.0,,,,,
PMID32200327,reaction_1,in vitro,Spectrophotometric assay determining absorbance at 290 nm.,potassium phosphate buffer,7.4,,25.0,Escherichia coli,,
PMID32201979,reaction_1,in vitro,Enzyme kinetics assay with purified recombinant protein.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,E. coli B834 (DE3),pSBETa,"1 mM IPTG, 23°C, 21 hours"
PMID32201979,reaction_2,in vitro,Enzyme kinetics assay with purified recombinant protein.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,E. coli B834 (DE3),pSBETa,"1 mM IPTG, 23°C, 21 hours"
PMID32201979,reaction_3,in vitro,Enzyme kinetics assay with purified recombinant protein. Severe substrate inhibition observed.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,E. coli B834 (DE3),pSBETa,"1 mM IPTG, 23°C, 21 hours"
PMID32201979,reaction_4,in vitro,Enzyme kinetics assay with purified recombinant protein. Severe substrate inhibition observed.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,E. coli B834 (DE3),pSBETa,"1 mM IPTG, 23°C, 21 hours"
PMID32201979,reaction_5,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32201979,reaction_6,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32201979,reaction_7,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32201979,reaction_8,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32201979,reaction_9,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32201979,reaction_10,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32201979,reaction_11,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32201979,reaction_12,in vitro,Substrate versatility assay.,"20-mM Tris–HCl, pH 8.0",8.0,,30.0,,,
PMID32203655,reaction_1,in vivo,Deracemization using recombinant resting whole cells of E. coli at gram scale (5.8 mmol).,50 mM NaPi buffer,7.5,,35.0,Escherichia coli BL21 (DE3),pET-28a,
PMID32203655,reaction_2,in vitro,Kinetic parameter determination using purified enzyme.,50 mM NaPi buffer,7.5,,45.0,Escherichia coli BL21 (DE3),pET-28a,
PMID32203655,reaction_3,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_4,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_5,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_6,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_7,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_8,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_9,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_10,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_11,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_12,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_13,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_14,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_15,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_16,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_17,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_18,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_19,in vivo,Deracemization using recombinant resting whole cells of E. coli at semipreparative scale (0.4 mmol).,50 mM NaPi buffer,7.5,,35.0,,,
PMID32203655,reaction_20,in vitro,Specific activity determination using purified enzyme.,50 mM NaPi buffer,7.5,,45.0,,,
PMID32203655,reaction_21,in vitro,Specific activity determination using purified enzyme.,50 mM NaPi buffer,7.5,,45.0,,,
PMID32203655,reaction_22,in vitro,Specific activity determination using purified enzyme.,50 mM NaPi buffer,7.5,,45.0,,,
PMID32204912,reaction_1,in vitro,LPEAT assay using microsomal protein from transfected CHO-K1 cells.,Not specified,,,,CHO-K1 cells,pCXN2.1,
PMID32204912,reaction_2,in vitro,LPEAT assay using microsomal protein from transfected CHO-K1 cells.,Not specified,,,,CHO-K1 cells,pCXN2.1,
PMID32204912,reaction_3,in vitro,LPCAT assay using microsomal protein from transfected CHO-K1 cells with 15 µM 22:6-CoA and 25 µM 16:0 LPC.,Not specified,,,,CHO-K1 cells,pCXN2.1,
PMID32204912,reaction_4,in vitro,LPGAT assay using microsomal protein from transfected CHO-K1 cells with 22:6-CoA.,Not specified,,,,CHO-K1 cells,pCXN2.1,
PMID32204912,reaction_5,in vitro,LPLAT assay using microsomal protein from transfected CHO-K1 cells with 22:6-CoA.,Not specified,,,,CHO-K1 cells,pCXN2.1,
PMID32204912,reaction_6,in vitro,LPEAT activity measured in microsomes isolated from Neuro 2A cells after siRNA-mediated knockdown to confirm endogenous enzyme function. Assay conditions were 25 µM 16:0 LPE and 15 µM 22:6-CoA.,Not specified,,,,Neuro 2A cells,,
PMID32205346,reaction_1,in vivo,"Phenotypic analysis of mutants in B. thailandensis, including determination of minimum inhibitory concentrations (MICs), growth rates, and killing curves (MDK99).",LB broth and LB agar,,Not specified,37.0,Burkholderia thailandensis strain E260,,
PMID32205453,reaction_1,in vitro,Enzyme activity measured in crude leaf extracts.,"50 mM potassium phosphate buffer (pH 7.0), 0.1 mM DHA, and 2.5 mM GSH",7.0,,4.0,Arabidopsis thaliana,,
PMID32205453,reaction_2,in vitro,Enzyme activity measured in crude leaf extracts.,"50 mM potassium phosphate buffer (pH 7.0), 1 mM ASC, and 0.2 mM NADH",7.0,,4.0,Arabidopsis thaliana,,
PMID32205454,reaction_1,in vitro,Enzyme activity assay with purified recombinant MBP-CEK1 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector,
PMID32205454,reaction_2,in vitro,Enzyme activity assay with purified recombinant MBP-CEK1 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector,
PMID32205454,reaction_3,in vitro,Enzyme activity assay with purified recombinant MBP-CEK2 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector (pJL103),
PMID32205454,reaction_4,in vitro,Enzyme activity assay with purified recombinant MBP-CEK2 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector (pJL103),
PMID32205454,reaction_5,in vitro,Enzyme activity assay with purified recombinant MBP-CEK3 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector (pJL104),
PMID32205454,reaction_6,in vitro,Enzyme activity assay with purified recombinant MBP-CEK3 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector (pJL104),
PMID32205454,reaction_7,in vitro,Enzyme activity assay with purified recombinant MBP-CEK4 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector (pJL105),
PMID32205454,reaction_8,in vitro,Enzyme activity assay with purified recombinant MBP-CEK4 protein. Product formation was detected using [g-32P]ATP.,,,,,Escherichia coli strain C41 (DE3),pMAL-c5x vector (pJL105),
PMID32206501,reaction_1,in vivo,Whole-cell bioconversion using recombinant E. coli strains.,"Bioconversion medium: (NH4)2SO4 5 g/L, KH2PO4 1.5 g/L, MgSO4·7H2O 1 g/L, FeSO4·7H2O 1 g/L, VC 5 mM, CaCl2 1 mM, glucose 54 g/L, α-KG 26.2 g/L, l-Ile 26.2 g/L, and IPTG 0.1 mM",7.0,,37.0,Escherichia coli BL21(DE3),pET-28a(+)-ido,0.1 mM IPTG
PMID32208897,reaction_1,in vivo,"Experiments were conducted in cultured human dental pulp cells (hDPCs). Enzyme activity was inferred from changes in H3K4me3 levels following shRNA-mediated knockdown of KDM5A, measured by Western blot and Chromatin Immunoprecipitation (ChIP)-PCR.","Mineralization medium (MM) containing DMEM supplemented with 5% FBS, 50 μg/L ascorbic acid, 10 mM β-glycerophosphate and 10^-7 M dexamethasone.",,Not specified in text.,37.0,human dental pulp cells (hDPCs) (endogenous expression),,
PMID32209662,reaction_1,in vitro,"Enzyme activity was quantified in vitro using homogenates from cultured cells or mouse tissues with a fluorescent substrate (1-O-pyrenedecyl-sn-glycero-3-phosphoethanolamine) and NADPH. Enzyme function was further confirmed by siRNA knockdown, in cellulo labeling experiments, and lipidomic analysis of CRISPR/Cas9 knockout cells and knockout mice.",Not specified in text (refers to previous work),,Not specified for in vitro assay. Cell culture was at physiological pH.,37.0,"HEK293T cells, HAP1 cells","pEGF-N1 (for GFP-fusion protein); other expression plasmids from Dharmacon or Origine, some with C-terminal 6x myc tags.",Transient transfection in mammalian cells using TurboFect or Turbofectin.
PMID32220614,reaction_1,in vivo,Whole-cell biocatalysis converting dethiobiotin (DTB) to biotin.,minimal media,,,,Escherichia coli BS1011,pBS412,Induced with 0 to 1 mM isopropyl-β-D-thiogalactoside (IPTG).
PMID32220614,reaction_2,in vivo,Whole-cell biocatalysis converting octanoic acid to free lipoic acid.,minimal media supplemented with octanoic acid,,,,Escherichia coli,inducible plasmid,Induced with 0 to 0.04 mM IPTG.
PMID32220614,reaction_3,in vivo,De novo biosynthesis of thiamine in an engineered E. coli strain.,minimal media,,,,Escherichia coli,plasmid with a strong constitutive promoter,Constitutive expression of the thiCEFSGH operon.
PMID32222467,reaction_1,in vitro,Colorimetric enzyme assay measuring DTT consumption with DTNB.,"10 mM MgCl2, 30 mM KCl, 25 mM Tris",8.0,,37.0,E. coli BL21 (DE3) LysS,pET16b,1 mM IPTG for 2h
PMID32222467,reaction_2,in vitro,Colorimetric enzyme assay measuring DTT consumption with DTNB.,"10 mM MgCl2, 30 mM KCl, 25 mM Tris",8.0,,37.0,E. coli BL21 (DE3) LysS,pET16b,1 mM IPTG for 2h
PMID32226297,reaction_1,in vitro,Enzyme inhibition assays for various compounds as cited in the review.,,,,,,,
PMID32226297,reaction_2,in vitro,Activity demonstrated in breast cancer cells.,,,,,,,
PMID32226807,reaction_1_aminopyrine_demethylation,in vitro,Inhibition assay using rat liver microsomes (RLM) by measuring formaldehyde production.,"50 mM Tris-HCl buffer (pH 7.4) supplemented with 150 mM KCI and 10 mM MgCl2, 1% acetonitrile, 0.8 mg/ml Tween 80",7.4,,37.0,,,
PMID32226807,reaction_A1_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A1_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A3_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A3_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A4_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A4_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A5_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A5_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A6_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_A6_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E1_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E1_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E2_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E3_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E3_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E4_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E4_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E5_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_E5_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_C1_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_C1_hydrolysis_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM) without NADPH-regenerating system.,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_C1_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_C1_hydrolysis_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM) without NADPH-regenerating system.,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_T1_metabolism_RLM,in vitro,Metabolic stability assay in rat liver microsomes (RLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32226807,reaction_T1_metabolism_HLM,in vitro,Metabolic stability assay in human liver microsomes (HLM).,50 mM TRIS-HCl buffer (pH 7.4) containing 3.3 mM MgCl2,7.4,,37.0,,,
PMID32229210,reaction_1,in vitro,Standard polymerase assay with Cy3-labeled primed DNA substrate (p22/t59).,"20 mM Tris-HCl pH 8.0, 2 mM DTT, 100 μg/mL BSA, 2 mM MgCl2, and 200 μM dNTPs",8.0,,65.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32229210,reaction_2,in vitro,3'–5' exonuclease assay with Cy3-labeled ssDNA.,"20 mM Tris-HCl pH 8.0, 2 mM DTT, 100 μg/mL BSA, and 2 mM MgCl2",8.0,,65.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32229210,reaction_3,in vitro,Mismatch extension assay with an A/G mismatch at the primer 3' end.,"20 mM Tris-HCl pH 8.0, 2 mM DTT, 100 μg/mL BSA, 2 mM MgCl2, and 200 μM dNTPs",8.0,,65.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32229210,reaction_4,in vitro,Mismatch extension assay with a G/G mismatch at the primer 3' end.,"20 mM Tris-HCl pH 8.0, 2 mM DTT, 100 μg/mL BSA, 2 mM MgCl2, and 200 μM dNTPs",8.0,,65.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32229210,reaction_5,in vitro,Mismatch extension assay with a T/G mismatch at the primer 3' end.,"20 mM Tris-HCl pH 8.0, 2 mM DTT, 100 μg/mL BSA, 2 mM MgCl2, and 200 μM dNTPs",8.0,,65.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32229210,reaction_6,in vitro,Uracil bypass assay using a template containing a uracil base.,"20 mM Tris-HCl pH 8.0, 2 mM DTT, 100 μg/mL BSA, 2 mM MgCl2, and 200 μM dNTPs",8.0,,65.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32229210,reaction_7,in vitro,AP site bypass assay using a template containing an apurinic/apyrimidinic site.,"20 mM Tris-HCl pH 8.0, 2 mM DTT, 100 μg/mL BSA, 2 mM MgCl2, and 200 μM dNTPs",8.0,,65.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32229210,reaction_8,in vitro,Routine PCR amplification,"50 mM Tris-Cl pH 8.0, 0.1 mg/ml BSA, 5 mM Mg2+, 50 mM NaCl",8.0,,72.0,Escherichia coli BL21 (DE3) RIL,pET-30a(+),0.8 mM IPTG for 12 h at room temperature
PMID32230972,reaction_1,in vitro,Biotransformation with purified recombinant enzyme,100 mM sodium acetate buffer,3.5,,25.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_2,in vitro,Biotransformation with purified recombinant enzyme,100 mM sodium acetate buffer,3.5,,25.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_3,in vitro,Biotransformation with purified recombinant enzyme,100 mM sodium acetate buffer,3.5,,25.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_4,in vitro,Photometric enzyme activity assay,100 mM sodium acetate buffer,3.5,Optimal pH,40.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_5,in vitro,Manganese peroxidase activity assay,100 mM malonate buffer,3.5,,30.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_6,in vitro,Carotene degradation assay,100 mM sodium acetate buffer,3.5,,40.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_7,in vitro,Carotene degradation assay,100 mM sodium acetate buffer,3.5,,40.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_8,in vitro,Decolorization assay,100 mM sodium acetate buffer,3.5,,40.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32230972,reaction_9,in vitro,Decolorization assay,100 mM sodium acetate buffer,3.5,,40.0,Komagataella pfaﬃi GS115,pPIC9,daily addition of 1% (v/v) methanol
PMID32233056,reaction_1,in vitro,"Assay performed with purified, N-terminally GST-tagged IboH. A whole-cell assay using live E. coli expressing GST-iboH was also performed for product isolation.",,,,,Escherichia coli,,
PMID32233071,reaction_1,in vivo,Whole-cell biocatalysis using engineered Pseudomonas putida S12 (strain P. putida_Ohec) expressing HMFO.,"Mineral medium (5.23 g/L K2HPO4, 2.46 g/L NaH2PO4, 0.8 g/L NH4Cl, 0.2 g/L Na2SO4, 0.14 g/L MgCl2, 0.04 g/L EDTA, 0.015 g/L FeSO4·7H2O, and trace metals) with 50 mM glycerol as carbon source.",8.0,"Optimal pH for FDCA production by the whole-cell biocatalyst, determined from testing a range of pH 6 to 9.",35.0,Pseudomonas putida S12 (ATCC 700801),pHECHMFO,Constitutive expression from the strong constitutive HCE promoter.
PMID32234590,reaction_1,in vivo,Production of 3-HP in engineered Pseudomonas denitrificans strains under growing and non-growing conditions.,"Growing cells: Modified M9 medium (8 g/L sodium acetate, 1 g/L yeast extract, 1 g/L NH4Cl, 1 g/L NaCl, 0.25 g/L MgSO4) with 100 mM potassium phosphate buffer. Non-growing cells: 100 mM potassium phosphate buffer with 10 g/L sodium acetate.",7.0,,37.0,Pseudomonas denitrificans ZAP01,pUCPK-AM,Expression driven by native constitutive promoter PNP1.
PMID32234590,reaction_2,in vivo,Production of 3-HP in engineered Pseudomonas denitrificans strains to assess the effect of Acc overexpression.,"Modified M9 medium (8 g/L sodium acetate, 1 g/L yeast extract, 1 g/L NH4Cl, 1 g/L NaCl, 0.25 g/L MgSO4) with 100 mM potassium phosphate buffer.",7.0,,37.0,Pseudomonas denitrificans ZAP,pUCPK-AM,Expression driven by native constitutive promoter PNP2.
PMID32234783,reaction_1,in vitro,"Protein expression, purification, and crystallization for X-ray structure determination.","0.1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes), pH 7.5, and 1.5 M lithium sulfate, 3 mM NADPH",7.5,Crystallization buffer,16.0,Escherichia coli BL21(DE3),pET-28(+),"0.4 mM isopropyl β-D-thiogalactopyranoside, 16 °C for 18 h"
PMID32234783,reaction_2,in vitro,"Protein expression, purification, and crystallization for X-ray structure determination.","0.1 M Hepes, pH 7.5, 20% (wt/vol) PEG 4,000, 10% (wt/vol) isopropanol, 0.05% (vol/vol) n-octyl-β-D-glucoside, and 6 mM NADPH",7.5,Crystallization buffer,4.0,Escherichia coli BL21(DE3),pET-22b(+),"0.4 mM isopropyl β-D-thiogalactopyranoside, 16 °C for 18 h"
PMID32235505,reaction_1,in vitro,Single turnover fluorescence assay measuring NADH production.,100 mM Tris-Bicine,8.5,,,Escherichia coli BL21(DE3),pET24d,"0.5 mM IPTG, 18 °C, overnight"
PMID32235505,reaction_2,in vitro,Single turnover fluorescence assay measuring NADH production.,100 mM Tris-Bicine,8.5,,,Escherichia coli BL21(DE3),pET24d,"0.5 mM IPTG, 18 °C, overnight"
PMID32236231,reaction_1,in vitro,NMR-based enzymatic assay,"100.0 mM HEPES buffer, pH 7.0, containing 100 mM KH2PO4 and 10% D2O",7.0,,25.0,,,
PMID32236231,reaction_2,in vitro,NMR-based enzymatic assay to test substrate stability,"100.0 mM HEPES buffer, pH 7.0, containing 100 mM KH2PO4 and 10% D2O",7.0,,25.0,,,
PMID32241438,reaction_1,in vitro,Modification of gelatinized corn starch,20 mM sodium phosphate buffer,6.0,,60.0,,,
PMID32241438,reaction_2,in vitro,Control experiment to test activity on corn starch,20 mM sodium phosphate buffer,6.0,,60.0,Escherichia coli BL21 (DE3),pET-15b,
PMID32241438,reaction_3,in vitro,Hydrolysis of α-CD produced in situ by CGTase in a dual-enzyme system,20 mM sodium phosphate buffer,6.0,,60.0,Escherichia coli BL21 (DE3),pET-15b,
PMID32241438,reaction_4,in vitro,Hydrolysis of β-CD produced in situ by CGTase in a dual-enzyme system,20 mM sodium phosphate buffer,6.0,,60.0,Escherichia coli BL21 (DE3),pET-15b,
PMID32246282,reaction_1,in vitro,Polarographic measurement of oxygen production using a Clark-type oxygen electrode.,100 mM KPi,7.0,,20.0,E. coli BL21(DE3) pLysS,pET28a-AoCld,"119 µg/mL IPTG at OD600=0.5, temperature reduced from 37 to 25°C, harvested 7h after induction."
PMID32246282,reaction_2,in vitro,Equilibrium binding titrations by UV-visible spectroscopy and EPR spectroscopy.,100 mM citrate–phosphate buffer or 100 mM KPi buffer,5.0,Also tested at pH 5.8,21.0,,,
PMID32246282,reaction_3,in vitro,Equilibrium binding titrations by UV-visible spectroscopy and EPR spectroscopy.,100 mM KPi,7.0,,21.0,,,
PMID32246282,reaction_4,in vitro,Equilibrium binding titrations by UV-visible spectroscopy and EPR spectroscopy.,100 mM KPi buffer or 100 mM Tris buffer,7.0,"Also tested at pH 5.0, 5.8, and 8.0",21.0,,,
PMID32246827,reaction_1,in vitro,"Steady-state UV-kinetics assay with 300 µM NADPH, 10 µM enzyme, and varied FAD concentration. Pre-steady-state stopped-flow kinetics, ITC for NADP+ binding, and NMR spectroscopy for FAD binding and NADP+ kinetics were also used.","50 mM bis-tris, 50 mM NaCl, 1 mM DTT",6.5,,20.0,E. coli,pET21b,Induced at OD(600) of 0.6
PMID32246827,reaction_2,in vitro,"Steady-state UV-kinetics assay with 300 µM NADPH, 10 µM enzyme, and varied FAD concentration. Pre-steady-state stopped-flow kinetics, ITC for NADP+ binding, and NMR spectroscopy for FAD binding and NADP+ kinetics were also used.","50 mM bis-tris, 50 mM NaCl, 1 mM DTT",6.5,,20.0,E. coli,pET21b,Induced at OD(600) of 0.6
PMID32246827,reaction_3,in vitro,"Steady-state UV-kinetics assay with 300 µM NADPH, 10 µM enzyme, and varied FAD concentration. Pre-steady-state stopped-flow kinetics, ITC for NADP+ binding, and NMR spectroscopy for NADP+ kinetics were also used.","50 mM bis-tris, 50 mM NaCl, 1 mM DTT",6.5,,20.0,E. coli,pET21b,Induced at OD(600) of 0.6
PMID32246945,reaction_1,in vivo,Mixed-culture whole-cell biotransformation with resting cells (C_CYP21_b5 strain).,50 mM potassium phosphate buffer (pH 7.4) supplemented with 2% glycerol and 150 µg/mL polymyxin B,7.4,,30.0,Escherichia coli C43(DE3),p21b_bRED(-27) and pREP4-groESL_cytb5,"1 mM IPTG, 1 mM δ-aminolevulinic acid, 4 mg/mL L-arabinose, 30°C, 24h"
PMID32246945,reaction_2,in vitro,Reconstituted in vitro assay with 4 µM purified CAT1 and 200 µM premedrol.,100 mM Tris-HCl buffer,7.8,,37.0,Escherichia coli BL21(DE3),,
PMID32246945,reaction_3,in vivo,"Whole-cell steroid conversion with resting cells, used as a model system for optimizing CAT1 expression.",100 mM KPi buffer containing 500 mM glucose,7.4,,37.0,Escherichia coli BL21(DE3),pET22b_T7_CAT1 and derivatives with modified promoters.,Autoinduction in M9CAauto medium.
PMID32246945,reaction_4,in vitro,Reconstituted in vitro assay with 4 µM purified CAT1 and 200 µM medrane.,100 mM Tris-HCl buffer,7.8,,37.0,,,
PMID32247165,reaction_1_sGDH,in vitro,"Various assays including kinetic analysis, voltammetry, and spectroelectrochemistry are described.",Buffer composition influences kinetics; phosphate ions interact with the enzyme. A specific example from an experiment is 20 mM PIPES buffer.,7.0,"Broad pH range of operation (6-8). The optimum for the reduction half-reaction is pH 7. The overall optimum for the enzymatic conversion is dependent on the second substrate (acceptor), e.g., pH 6 with DCIP, pH 9 with Wurster's Blue.",37.0,"Escherichia coli, Klebsiella pneumoniae, Pichia pastoris",,
PMID32247165,reaction_2_mGDH,in vitro,Enzyme assays with artificial electron acceptors.,,8.5,The enzyme has a rather sharp pH optimum around pH 8.5.,,,,
PMID32247276,reaction_1,in vitro,in-solution activity assay,"50 mM MES, pH 6.5",6.5,,40.0,Escherichia coli BL21 (DE3),pET28a(+),0.5 mM IPTG for 2.5 h at 37 °C
PMID32247276,reaction_2,in vitro,in-solution activity assay,"50 mM phosphate buffer, pH 7.5",7.5,,,,,
PMID32247276,reaction_3,in vitro,in-solution activity assay,"50 mM phosphate buffer, pH 7.5",7.5,,,,,
PMID32247276,reaction_4,in vitro,in-flow synthesis using LrNDT-IMER,"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_5,in vitro,in-flow synthesis using co-immobilized CpUP/AhPNP-IMER,"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_6,in vitro,in-flow synthesis using LrNDT-IMER,"2 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_7,in vitro,in-flow synthesis using co-immobilized CpUP/AhPNP-IMER,"2 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_8,in vitro,in-flow synthesis using LrNDT-IMER,"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_9,in vitro,in-flow synthesis using co-immobilized CpUP/AhPNP-IMER,"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_10,in vitro,in-flow synthesis using LrNDT-IMER with 20 mM sugar donor,"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_11,in vitro,in-flow synthesis using LrNDT-IMER,"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_12,in vitro,in-flow synthesis using LrNDT-IMER,"10 mM phosphate buffer, pH 7.0",7.0,,25.0,,,
PMID32247276,reaction_13,in vitro,in-flow stability study (hydrolytic side reaction),"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247276,reaction_14,in vitro,in-flow stability study (hydrolytic side reaction),"10 mM phosphate buffer, pH 7.0",7.0,,37.0,,,
PMID32247733,reaction_1,in vitro,enzymatic IDO1 inhibition assay,Not specified,,Not specified,,,,
PMID32247733,reaction_2,in vitro,enzymatic TDO inhibition assay,Not specified,,Not specified,,,,
PMID32247733,reaction_3,in vivo,cellular IDO1 inhibitory activity tested using HeLa cells,Not specified,,Not specified,,,,
PMID32248970,reaction_1,in vitro,Steady-state kinetic analysis monitoring the oxidation of the electron donor B0428.,20 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer,5.5,,25.0,Escherichia coli,,
PMID32251275,reaction_1,in vitro,Enzymatic activity assay measuring octadecanal production by GC-MS.,"20 mM HEPES pH 7.5, 200 mM KCl, 0.5 mM MgCl2, and 0.5 mM TCEP",7.5,,30.0,Escherichia coli BL21(DE3) with pG-KJE8 chaperone plasmid,pET24a (modified),1 mM IPTG at 20°C overnight
PMID32251275,reaction_2,in vitro,"Coupled enzymatic assay with AAR and ADO, measuring heptadecane production by GC-MS.","20 mM HEPES pH 7.5, 200 mM KCl, 0.5 mM MgCl2, and 0.5 mM TCEP",7.5,,30.0,Escherichia coli BL21(DE3),pET24a (modified),"AAR: 1 mM IPTG at 20°C overnight; ADO: 1 mM IPTG, 1 mM FeSO4 at 30°C for 5h"
PMID32252458,reaction_1,in vitro,Fluorometric inhibitor screening assay using a commercial kit.,Aromatase assay buffer. Inhibitors were dissolved in dimethyl sulfoxide (DMSO).,,Not specified for the assay. In silico ligand preparation was done at pH 7.4 ± 1.0.,37.0,Not specified (commercial recombinant human aromatase stock),,
PMID32255260,reaction_1,in vitro,Anaerobic assay monitoring NO production with an ISO-NOP electrode.,50 mM HEPES buffer,6.5,,,Escherichia coli BL21(DE3),pET-26b(+),"0.5 mM IPTG, 1.0 mM CuSO4, 50 μg/mL hemin, 18ºC for 16 hrs"
PMID32255260,reaction_2,in vitro,Anaerobic assay monitoring NO production with an ISO-NOP electrode.,50 mM HEPES buffer,6.5,,,Escherichia coli BL21(DE3),pET-26b(+),"0.5 mM IPTG, 1.0 mM CuSO4, 18ºC for 16 hrs"
PMID32255260,reaction_3,in vitro,Anaerobic assay monitoring NO production with an ISO-NOP electrode.,50 mM HEPES buffer,6.5,,,Escherichia coli BL21(DE3),pET-26b(+),"0.5 mM IPTG, 1.0 mM CuSO4, 18ºC for 16 hrs"
PMID32255260,reaction_4,in vitro,Anaerobic assay monitoring NO production with an ISO-NOP electrode.,50 mM HEPES buffer,6.5,,,Escherichia coli BL21(DE3),pET-26b(+),"0.5 mM IPTG, 1.0 mM CuSO4, 18ºC for 16 hrs"
PMID32255260,reaction_5,in vitro,Anaerobic assay monitoring NO production with an ISO-NOP electrode.,50 mM HEPES buffer,6.5,,,Escherichia coli BL21,pETM-11,"0.3 mM IPTG, 0.1 mM CuSO4, 20ºC for 16 hrs"
PMID32255260,reaction_6,in vitro,Anaerobic assay monitoring NO production with an ISO-NOP electrode.,50 mM HEPES buffer,6.5,,,Escherichia coli,,
PMID32255260,reaction_7,in vitro,Anaerobic assay monitoring NO production with an ISO-NOP electrode.,50 mM HEPES buffer,6.5,,,Escherichia coli,,"2.0 mM IPTG, 1mM CuSO4, 24 hrs"
PMID32255505,reaction_1,in vivo,Whole-cell fermentation for mevalonate production from glucose.,"M9Y medium with 20 g/L glucose. M9Y medium: M9 minimal medium supplemented with 0.5 % yeast extract, 0.008 g/L D-(+)-biotin, 0.2 g/L citrate, 0.008 g/L nicotinic acid, 0.032 g/L pyridoxine and 1 mL/L trace metal solution.",,Not specified,37.0,Escherichia coli MG1655,pMeAES,0.1 mM IPTG
PMID32255505,reaction_2,in vivo,Whole-cell fermentation for mevalonate production from cellobiose.,"M9Y medium with 20 g/L cellobiose. M9Y medium: M9 minimal medium supplemented with 0.5 % yeast extract, 0.008 g/L D-(+)-biotin, 0.2 g/L citrate, 0.008 g/L nicotinic acid, 0.032 g/L pyridoxine and 1 mL/L trace metal solution.",,Not specified,37.0,Escherichia coli MG1655,pMeAES-BGL,0.1 mM IPTG
PMID32256210,reaction_1,in vivo,Chromatin Immunoprecipitation (ChIP) assay in U87MG human glioma cells to measure histone methylation at the PDK1 gene promoter.,Cells cultured in complete medium. ChIP performed using Chromatin Immunoprecipitation (ChIP) Assay Kit (Abcam).,,Not specified,37.0,U87MG human glioma cells,"pSLIK lentivirus expression system (for overexpression), shRNA lentivirus from GenePharma (for knockdown)",Lentiviral transduction followed by puromycin selection (2 µg/ml for 72h)
PMID32256210,reaction_2,in vivo,Chromatin Immunoprecipitation (ChIP) assay in U87MG human glioma cells to measure histone methylation at the PDK1 gene locus.,Cells cultured in complete medium. ChIP performed using Chromatin Immunoprecipitation (ChIP) Assay Kit (Abcam).,,Not specified,37.0,U87MG human glioma cells,"pSLIK lentivirus expression system (for overexpression), shRNA lentivirus from GenePharma (for knockdown)",Lentiviral transduction followed by puromycin selection (2 µg/ml for 72h)
PMID32257583,reaction_1,in vitro,Oxygen consumption assays for kinetics and 1H-NMR for product analysis.,Not specified,,Not specified,,,,
PMID32257583,reaction_2,in vitro,Oxygen consumption assays for kinetics and 1H-NMR for product analysis.,Not specified,,Not specified,,,,
PMID32257739,reaction_1,in vivo,Functional characterization by expressing native and mutated EPSPS genes in E. coli BL21(DE3) and measuring cell growth (OD600) in basal salt media supplemented with 8.768% (518.4 mM) glyphosate.,"Basal salt media (5.8 g/L K2HPO4, 4.5 g/L KH2PO4, 2 g/L (NH4)2SO4, 1 mg/L FeSO4·7H2O, 0.16 g/L MgCl2·2H2O, 20 mg/L CaCl2, 2 mg/L Na2MoO4 and 1 mg/L MnCl2)",,Not specified,37.0,Escherichia coli BL21(DE3),Gateway™ pDEST14™,"0.5 mM IPTG, 37°C, 3h"
PMID32258005,reaction_1,in vivo,Whole-cell conversion in engineered Saccharomyces cerevisiae during fermentation.,"Fermentation medium (FM) composed of KH2PO4, (NH4)2SO4, MgSO4·7H2O, glucose, vitamin solution, and trace metal solution.",5.0,Controlled at 5 by adding 5 mol/L NaOH.,30.0,Saccharomyces cerevisiae CEN.PK2-1C,pRS425 (multi-copy plasmid),Expressed under the control of the PGAL7 promoter in a GAL80 deleted strain.
PMID32258005,reaction_2,in vivo,Whole-cell conversion in engineered Saccharomyces cerevisiae during fermentation.,"Fermentation medium (FM) composed of KH2PO4, (NH4)2SO4, MgSO4·7H2O, glucose, vitamin solution, and trace metal solution.",5.0,Controlled at 5 by adding 5 mol/L NaOH.,30.0,Saccharomyces cerevisiae CEN.PK2-1C,Genomic integration,Expressed under the control of the PGAL7 promoter in a GAL80 deleted strain.
PMID32258005,reaction_3,in vivo,Whole-cell conversion in engineered Saccharomyces cerevisiae during fermentation.,"Fermentation medium (FM) composed of KH2PO4, (NH4)2SO4, MgSO4·7H2O, glucose, vitamin solution, and trace metal solution.",5.0,Controlled at 5 by adding 5 mol/L NaOH.,30.0,Saccharomyces cerevisiae CEN.PK2-1C,Genomic integration,Expressed under the control of the PGAL7 promoter in a GAL80 deleted strain.
PMID32258011,reaction_1,in vivo,Whole-cell biotransformation using recombinant E. coli BL21 (DE3) and its engineered derivatives.,LB medium with 1% L-sorbose,,Not specified,30.0,Engineered Escherichia coli BL21 (DE3) derivatives with knockouts of aldosterone reductase and PTS-related genes.,"pMD19-T-Simple with PcspA promoter (for SDH), pET28a (for SNDH)",SDH was expressed constitutively from the PcspA promoter. SNDH expression was induced with 0.3 mM IPTG. Fermentation was conducted at 30°C.
PMID32269094,reaction_1,in vivo,pH and chloride concentration measurement in cytotoxic granules (CG) of live primary murine CTLs using a genetically encoded sensor GzmB-ClopHensorN(Q69M).,"Extracellular buffer: 2 mM HEPES, 140 mM NaCl, 4.5 mM KCl, and 2 mM MgCl2",7.4,"Assumed physiological pH of the extracellular buffer, not explicitly stated.",22.0,Primary murine cytotoxic T lymphocytes (CTLs),,
PMID32270839,reaction_1,in vitro,The reaction was characterized experimentally as cited in the text (ref 38). This paper is a computational study and does not provide specific experimental conditions.,,,,,,,
PMID32275065,reaction_1,in vivo,LC-MS analysis of glucosinolate levels in whole leaves of Arabidopsis thaliana plants after inoculation with Blumeria graminis or Golovinomyces orontii.,in vivo,,in vivo experiment,22.0,,,
PMID32275065,reaction_2,in vivo,Fungal penetration resistance and sporulation bioassays on Arabidopsis thaliana plants using knockout mutants.,in vivo,,in vivo experiment,22.0,,,
PMID32275825,reaction_1,in vitro,BIOMOL® Green biochemical assay measuring pyrophosphate release for screening and mode of inhibition studies.,"30 mM Tris, 140 mM NaCl, 30 mM KCl, 40 mM MgCl2, 0.01% (v/v) Brij-35, 1 mM DTT",8.0,,23.0,Escherichia coli BL21 DE3,pET15b TEV vector,"Autoinduction media, grown at 37°C until OD600 0.8, then 22°C overnight."
PMID32275825,reaction_2,in vitro,BIOMOL® Green biochemical assay measuring pyrophosphate release for screening and mode of inhibition studies.,"30 mM Tris, 140 mM NaCl, 30 mM KCl, 40 mM MgCl2, 0.01% (v/v) Brij-35, 1 mM DTT",8.0,,23.0,Sf9 cells,pFASTBac,"Baculovirus infection of Sf9 cells at 1.5 x 10^6 cells/ml, incubated at 26.5°C for 72h."
PMID32275825,reaction_3,in vitro,X-ray crystallography by co-crystallization,"23-28% PEG 3350, 0.2 M potassium formate",7.25,pH range 7.0-7.5,18.0,Escherichia coli,pET-15 derived vector,
PMID32275991,reaction_1,in vitro,"The physical interaction between EcCsdB and EcSelD was studied by intrinsic fluorescence spectroscopy (IFS), analytical ultracentrifugation (SE-AUC), differential scanning calorimetry (DSC), and small-angle X-ray scattering (SAXS).","10 mM KPB, pH 7.4 with 150 mM NaCl",7.4,,25.0,E. coli BL21 (DE3),csdB-pUC118,"1.0 mM IPTG, 37 °C, 4 h"
PMID32275991,reaction_2,in vitro,"The physical interaction between EcSelD and EcCsdB was studied by intrinsic fluorescence spectroscopy (IFS), analytical ultracentrifugation (SE-AUC), differential scanning calorimetry (DSC), and small-angle X-ray scattering (SAXS).","10 mM KPB, pH 7.4 with 150 mM NaCl",7.4,,25.0,E. coli BL21 (DE3),selD-pET-28a(+),"Not specified in detail, refers to Silva and Serrão et al, 2015 [7]."
PMID32276527,reaction_1,in vivo,Comparative growth assays of Chlamydomonas reinhardtii strains expressing wild-type or mutant PTXD in phosphite-supplemented medium to assess enzyme efficiency.,TA-Phi medium (tris-acetate-phosphite),,"Not specified for the reaction, only for the growth medium.",22.0,Chlamydomonas reinhardtii T222+,IR-int (for chloroplast expression); pChlamy-4 (for nuclear expression),Constitutive expression driven by psaA promoter (chloroplast) or Hsp70A-RbcS2 promoter (nuclear).
PMID32277030,reaction_1,in vivo,Enzyme activity was assessed in cultured HeLa cells by measuring the properties of the resulting heparan sulfate product. The product was isolated and its ability to bind antithrombin and inhibit Factor Xa was measured.,Cell culture medium,,"Standard cell culture conditions, likely physiological pH ~7.4",37.0,HeLa cells,,
PMID32277030,reaction_2,in vivo,Enzyme activity was assessed in cultured HeLa cells by measuring the properties of the resulting heparan sulfate product. The product's ability to bind neuropilin-1 (NRP1) was measured by flow cytometry.,Cell culture medium,,"Standard cell culture conditions, likely physiological pH ~7.4",37.0,HeLa cells,,
PMID32278419,reaction_1,in vitro,Indirect ratiometric fluorescence assay. The enzymatic oxidation of ascorbic acid was coupled to a chemical reaction where the remaining ascorbic acid inhibits the oxidation of thiamine by KMnO4. The fluorescence of the oxidized thiamine product was measured.,100 mmol L-1 PBS,7.8,,35.0,,,
PMID32279151,reaction_1,in vivo,Phenotypic rescue experiment. Synthetic peptides were added to the growth medium of tpst mutants to observe their effect on fructose-suppressed root growth.,1/2 Murashige and Skoog (MS) medium with 1.2% (wt/vol) agar and 1% fructose.,,Not specified,22.0,Arabidopsis thaliana (for complementation lines),pCMV-1305 with a C-terminal 3xHA tag,Transformation via Agrobacterium strain GV3101 using the floral dip method.
PMID32279151,reaction_2,in vivo,Phenotypic rescue experiment. Synthetic peptides were added to the growth medium of tpst mutants to observe their effect on fructose-suppressed root growth.,1/2 Murashige and Skoog (MS) medium with 1.2% (wt/vol) agar and 1% fructose.,,Not specified,22.0,Arabidopsis thaliana (for complementation lines),pCMV-1305 with a C-terminal 3xHA tag,Transformation via Agrobacterium strain GV3101 using the floral dip method.
PMID32280587,reaction_1,in vivo,"Whole-cell catalysis in P. putida. Production of the oxidized product, flaviolin, was measured by absorbance at 340 nm.",LB medium supplemented with 0-400 mM glucose.,,"Not specified, standard LB medium used.",30.0,Pseudomonas putida KT2440,pBADT,0.2% w/v L-arabinose
PMID32280587,reaction_2,in vivo,Measurement of intracellular p-coumaroyl-CoA accumulation in P. putida by LC-MS/MS.,LB medium supplemented with 100 mM glucose and 5 mM p-coumarate.,,"Not specified, standard LB medium used.",30.0,Pseudomonas putida KT2440,pBADT-fcs,0.2% w/v L-arabinose
PMID32280587,reaction_3,in vivo,"Whole-cell catalysis in P. putida for bisdemethoxycurcumin production, quantified by HPLC.","LB medium supplemented with 100 mM glucose, 2% w/v L-arabinose, and 5 mM p-coumarate.",,"Not specified, standard LB medium used.",30.0,Pseudomonas putida KT2440 Δech,pBADT-CUS,2% w/v L-arabinose
PMID32281473,reaction_1,in vitro,Kinetic parameter determination,100 mM sodium phosphate buffer,7.0,,30.0,E. coli (strain E. cloni® 10 G),pRham™ C-His Kan vector,Induced with 0.2% rhamnose and 0.2% arabinose at 37°C for 17h. Co-expressed with pGro7 chaperones (GroESL).
PMID32281473,reaction_2,in vitro,Kinetic parameter determination,100 mM sodium phosphate buffer,7.0,,30.0,E. coli (strain E. cloni® 10 G),pRham™ C-His Kan vector,Induced with 0.2% rhamnose and 0.2% arabinose at 37°C for 17h. Co-expressed with pGro7 chaperones (GroESL).
PMID32281473,reaction_3,in vitro,Kinetic parameter determination,100 mM sodium phosphate buffer,7.0,,30.0,E. coli (strain E. cloni® 10 G),pRham™ C-His Kan vector,Induced with 0.2% rhamnose and 0.2% arabinose at 37°C for 17h. Co-expressed with pGro7 chaperones (GroESL).
PMID32281473,reaction_4,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_5,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_6,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_7,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_8,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_9,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_10,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_11,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_12,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_13,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_14,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_15,in vitro,Substrate specificity assay,100 mM sodium phosphate,7.0,,30.0,,,
PMID32281473,reaction_16,in vitro,Alcohol:NDMA oxidoreductase activity assay,10 mM potassium phosphate buffer,7.0,,30.0,,,
PMID32281473,reaction_17,in vitro,Alcohol:NDMA oxidoreductase activity assay,10 mM potassium phosphate buffer,7.0,,30.0,,,
PMID32281473,reaction_18,in vitro,Alcohol:NDMA oxidoreductase activity assay,10 mM potassium phosphate buffer,7.0,,30.0,,,
PMID32281473,reaction_19,in vitro,Alcohol:NDMA oxidoreductase activity assay,10 mM potassium phosphate buffer,7.0,,30.0,,,
PMID32281473,reaction_20,in vitro,Alcohol:NDMA oxidoreductase activity assay,10 mM potassium phosphate buffer,7.0,,30.0,,,
PMID32281473,reaction_21,in vitro,Alcohol:NDMA oxidoreductase activity assay,10 mM potassium phosphate buffer,7.0,,30.0,,,
PMID32282952,reaction_1,in vitro,Kinetic parameter determination using ABTS as substrate.,50 mM sodium acetate buffer (pH 4.5) for routine assays; citrate-phosphate buffer (pH 5.0) for optimal pH and temperature,5.0,Optimal pH for activity,50.0,,,
PMID32282952,reaction_2,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_3,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_4,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_5,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_6,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_7,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_8,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_9,in vitro,Substrate specificity assay,50 mM sodium acetate buffer,4.5,,30.0,,,
PMID32282952,reaction_10,in vitro,Dye decolorization assay. 20 μL purified laccase sample (3.2 U) was added to 380 μL dye solution.,50 mM NaOAc-HAc buffer solution,4.5,,30.0,,,
PMID32282952,reaction_11,in vitro,Dye decolorization assay. 20 μL purified laccase sample (3.2 U) was added to 380 μL dye solution.,50 mM NaOAc-HAc buffer solution,4.5,,30.0,,,
PMID32282952,reaction_12,in vitro,Dye decolorization assay. 20 μL purified laccase sample (3.2 U) was added to 380 μL dye solution.,50 mM NaOAc-HAc buffer solution,4.5,,30.0,,,
PMID32282952,reaction_13,in vitro,Dye decolorization assay. 20 μL purified laccase sample (3.2 U) was added to 380 μL dye solution.,50 mM NaOAc-HAc buffer solution,4.5,,30.0,,,
PMID32282952,reaction_14,in vitro,Dye decolorization assay. 20 μL purified laccase sample (3.2 U) was added to 380 μL dye solution.,50 mM NaOAc-HAc buffer solution,4.5,,30.0,,,
PMID32283297,reaction_1,in vitro,Fluorometric assay using Epigenase LSD1 Demethylase Activity/Inhibition Assay Kit,LSD1 assay buffer,,,37.0,,,
PMID32283299,reaction_1,in vitro,Enzyme inhibition assay using extracted chitin synthase. Product formation was quantified using a WGA-HRP linked colorimetric assay.,50 mM Tris-HCl buffer,7.5,,,,,
PMID32292026,reaction_1,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_2,in vitro,,50 mM phosphate buffer,5.5,,30.0,,,
PMID32292026,reaction_3,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_4,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_5,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_6,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_7,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_8,in vitro,,50 mM phosphate buffer,5.5,,30.0,,,
PMID32292026,reaction_9,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_10,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_11,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_12,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_13,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_14,in vitro,,50 mM phosphate buffer,5.5,,30.0,,,
PMID32292026,reaction_15,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_16,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_17,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_18,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_19,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_20,in vitro,,50 mM phosphate buffer,5.5,,30.0,,,
PMID32292026,reaction_21,in vitro,,50 mM phosphate buffer,7.0,,30.0,,,
PMID32292026,reaction_22,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32292026,reaction_23,in vitro,,50 mM phosphate buffer,7.0,,30.0,Aspergillus oryzae,,
PMID32293154,reaction_1,in vitro,Bioluminescence activity measurement in solution.,Not specified,,,22.0,Escherichia coli,pCold I,Cold shock induction
PMID32296055,reaction_1,in vitro,Spectrophotometric assay monitoring NADPH consumption at 340 nm.,"The specific reaction buffer for kinetics was not fully defined, but related experiments used buffers such as 50 mM Tris-HCl (pH 7.8), 0.5 M KCl, 3 mM EDTA, and 1 mM DTT.",7.8,pH of buffer used in related experiments like SEC-SAXS and purification.,35.0,Escherichia coli BL21(DE3),pET-22b(+),"1 mM IPTG, 18°C, 3 days"
PMID32296684,reaction_1,in vitro,Enzyme activity assay with purified enzyme for kinetics. Cell-free extracts used for biotransformation.,1 M NH4Cl-NH3·H2O buffer (for kinetics); 0.1 M PBS buffer (for biotransformation),8.5,,30.0,Escherichia coli BL21 (DE3),pET28a(+),"0.3 mM IPTG, 25°C, 15 h"
PMID32296684,reaction_2,in vitro,Enzyme activity assay with purified enzyme for kinetics.,100 mM glycine-NaOH buffer,9.5,,30.0,,,
PMID32296684,reaction_3,in vitro,Substrate specificity assay,1 M NH4Cl-NH3·H2O buffer,8.5,,30.0,,,
PMID32296684,reaction_4,in vitro,Substrate specificity assay,1 M NH4Cl-NH3·H2O buffer,8.5,,30.0,,,
PMID32296684,reaction_5,in vitro,Substrate specificity assay,1 M NH4Cl-NH3·H2O buffer,8.5,,30.0,,,
PMID32296684,reaction_6,in vitro,Substrate specificity assay,1 M NH4Cl-NH3·H2O buffer,8.5,,30.0,,,
PMID32296684,reaction_7,in vitro,Substrate specificity assay,1 M NH4Cl-NH3·H2O buffer,8.5,,30.0,,,
PMID32296684,reaction_8,in vitro,Substrate specificity assay,1 M NH4Cl-NH3·H2O buffer,8.5,,30.0,,,
PMID32296684,reaction_9,in vitro,Substrate specificity assay,100 mM glycine-NaOH buffer,9.5,,30.0,,,
PMID32296684,reaction_10,in vitro,Substrate specificity assay,100 mM glycine-NaOH buffer,9.5,,30.0,,,
PMID32296684,reaction_11,in vitro,Substrate specificity assay,100 mM glycine-NaOH buffer,9.5,,30.0,,,
PMID32296684,reaction_12,in vitro,Substrate specificity assay,100 mM glycine-NaOH buffer,9.5,,30.0,,,
PMID32296998,reaction_1,in vitro,in crystallo metal soaking experiment under both aerobic and anoxic conditions,Cryoprotective mother liquor containing 25% (v/v) glycerol and 5 mM each of MnCl2 and (NH4)2Fe(SO4)2. Anoxic experiments additionally contained 30 mM sodium dithionite and 0.5 mM phenosafranin.,7.5,"pH of the buffer used for protein purification, assumed for crystallization and soaking experiments.",100.0,Escherichia coli Rosetta 2 (DE3),pET22b,"1 mM isopropyl-b-d-thiogalactopyranoside, 37 °C, 4 h"
PMID32296998,reaction_2,in vitro,in crystallo metal soaking experiment under anoxic conditions,"Cryoprotective mother liquor containing 5 mM each of MnCl2 and (NH4)2Fe(SO4)2, 30 mM sodium dithionite, 0.5 mM phenosafranin and 25% (v/v) glycerol.",7.5,"pH of the buffer used for protein purification, assumed for crystallization and soaking experiments.",100.0,Escherichia coli Rosetta 2 (DE3),pET22b,"1 mM isopropyl-b-d-thiogalactopyranoside, 37 °C, 4 h"
PMID32296998,reaction_3,in vitro,in crystallo metal soaking experiment under aerobic conditions,Air-saturated cryoprotective mother liquor containing 25% (v/v) glycerol and 5 mM each of MnCl2 and (NH4)2Fe(SO4)2.,7.5,"pH of the buffer used for protein purification, assumed for crystallization and soaking experiments.",100.0,Escherichia coli Rosetta 2 (DE3),pET22b,"1 mM isopropyl-b-d-thiogalactopyranoside, 37 °C, 4 h"
PMID32301564,reaction_1,in vitro,"NMR chemical shift perturbation titration and multifrequency (9 GHz, 95 GHz) EPR spectroscopy were used to study the binding equilibrium.","20 mM NaPi, 100 mM NaCl, pH 6.0",6.0,,20.0,,,
PMID32303871,reaction_1,in vitro,DszC enzyme assay measuring DBTO2 production.,binding buffer,4.0,,16.0,E. coli BL21(DE3),pET28a,"0.2 mM IPTG, 16 °C, 16 h"
PMID32305411,reaction_1,in vitro,Pulsed EPR (HYSCORE) spectroscopy on redox-poised NarGHI-enriched inner membrane vesicles (IMVs) to characterize the stabilized semiquinone intermediate.,100 mM MOPS and 5 mM EDTA,7.5,,-183.15,"E. coli strain JCB4023ubiE (RK4353, ΔnapA-B, narG::ery, narZ::Ω, SpcR, ΔubiE::KanR)",pVA700,Expression from narGHJI operon under control of the tac promoter. Cells grown in Terrific Broth under semi-anaerobic conditions at 37 °C.
PMID32307572,reaction_1,in vitro,Spectrophotometric assay measuring ferric thiocyanate complex formation at 460 nm.,40 mM potassium phosphate,7.5,pH mentioned in the legend for Figure 2.,25.0,Escherichia coli BL21 (DE3),pET15b,"0.3 mM IPTG, 18 °C, 16 h"
PMID32307572,reaction_2,in vitro,Competitive assay measuring the reduction in ferric thiocyanate formation in the presence of DTT.,40 mM potassium phosphate,7.5,Inferred from the cyanide sulfurtransferase assay conditions.,25.0,Escherichia coli BL21 (DE3),pET15b,"0.3 mM IPTG, 18 °C, 16 h"
PMID32307572,reaction_3,in vitro,Competitive assay measuring the reduction in ferric thiocyanate formation in the presence of glutathione.,40 mM potassium phosphate,7.5,Inferred from the cyanide sulfurtransferase assay conditions.,25.0,Escherichia coli BL21 (DE3),pET15b,"0.3 mM IPTG, 18 °C, 16 h"
PMID32308735,reaction_1,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_2,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_3,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_4,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_5,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_6,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_7,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_8,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_9,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308735,reaction_10,in vitro,,50 mM sodium phosphate buffer,7.0,,30.0,,,
PMID32308737,reaction_1,in vitro,Continuous spectrophotometric assay using the coupled enzymatic assay K-URONIC kit.,"Not specified, part of K-URONIC kit.",7.5,Assays conducted at pH 7.5 for comparison with literature. The determined pH optimum is 7.0.,22.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_2,in vitro,Continuous spectrophotometric assay using the coupled enzymatic assay K-URONIC kit.,"Not specified, part of K-URONIC kit.",7.5,Assays conducted at pH 7.5 for comparison with literature. The determined pH optimum is 7.0.,40.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_3,in vitro,Continuous spectrophotometric assay using the coupled enzymatic assay K-URONIC kit.,"Not specified, part of K-URONIC kit.",7.5,Assays conducted at pH 7.5 for comparison with literature. The determined pH optimum is 7.0.,22.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_4,in vitro,Continuous spectrophotometric assay using the coupled enzymatic assay K-URONIC kit.,"Not specified, part of K-URONIC kit.",7.5,Assays conducted at pH 7.5 for comparison with literature. The determined pH optimum is 7.0.,22.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_5,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,40.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_6,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_7,in vitro,DNSA assay monitoring release of reducing sugars.,Sodium acetate buffer,5.5,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_8,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_9,in vitro,DNSA assay monitoring release of reducing sugars.,Sodium acetate buffer,5.5,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_10,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_11,in vitro,DNSA assay monitoring release of reducing sugars.,Sodium acetate buffer,5.5,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_12,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,40.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_13,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_14,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,80.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_15,in vitro,DNSA assay monitoring release of reducing sugars.,Sodium acetate buffer,5.5,,80.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_16,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,40.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_17,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,65.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_18,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,80.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_19,in vitro,DNSA assay monitoring release of reducing sugars.,Sodium acetate buffer,5.5,,80.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_20,in vitro,DNSA assay monitoring release of reducing sugars.,50 mM sodium phosphate buffer,7.0,,80.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_21,in vitro,DNSA assay monitoring release of reducing sugars.,Sodium acetate buffer,5.5,,80.0,Escherichia coli BL21,modified pET-28a,"1 mM IPTG, 37°C, 4h"
PMID32308737,reaction_22,in vitro,Enzymatic hydrolysis of biomass with DNSA assay for reducing sugar detection.,Not specified,,,60.0,,,
PMID32310661,reaction_1,in vitro,Fluorescence and UV-visible absorption spectroscopy to characterize a photoinduced flavin-protein adduct.,20 mM sodium pyrophosphate and 20 mM sodium phosphate,,Experiments were conducted in a pH range of 6.0 to 10.0. The formation of the photoinduced adduct is pH-dependent with a pKa of 7.3 ± 0.1.,15.0,Recombinant in E. coli (inferred from cited methods),,
PMID32314063,reaction_1,in vitro,Amperometric biosensor measurement on a modified Au-PCB electrode.,0.1 M Phosphate-buffered saline (PBS),7.4,,,,,
PMID32315721,reaction_1,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_2,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_3,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_4,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_5,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_6,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_7,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_8,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_9,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_10,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_11,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_12,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_13,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_14,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_15,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_16,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_17,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_18,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_19,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_20,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_21,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_22,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_23,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_24,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_25,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_26,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_27,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32315721,reaction_28,in vitro,Enzyme assays with recombinantly expressed enzymes in crude HEK293 cell homogenates.,"100 mM NaPi, 1 mM EDTA, 0.05% BSA",7.3,,28.0,HEK293 cells,pDEST-530,
PMID32316447,reaction_1,in vivo,"Overexpression of NtSPS1 in Nicotiana tabacum plants. The final downstream product, solanesol, was quantified in leaves using UPLC.","Plants grown in a substrate containing a mixture of vermiculite and peat (1:2, v/v).",,,30.0,Nicotiana tabacum,pCHF3,
PMID32316447,reaction_2,in vivo,"The maximum carboxylation rate (Vc,max) was calculated from CO2 response curves of photosynthesis measured in leaves at 12 days after sampling.",,,,30.0,Nicotiana tabacum,,
PMID32316603,reaction_1,in vitro,in vitro glycosylation assay with a minimal LLO,,,,,,,
PMID32316603,reaction_2,in vitro,in vitro glycosylation assay with a minimal LLO,,,,,,,
PMID32316603,reaction_3,in vitro,in vitro glycosylation assay with a larger LLO,,,,,,,
PMID32316603,reaction_4,in vitro,in vitro glycosylation assay with a larger LLO,,,,,,,
PMID32316603,reaction_5,in vitro,Glycosylation efficiency assay (inferred),,,,,,,
PMID32316603,reaction_6,in vitro,Glycosylation efficiency assay (inferred),,,,,,,
PMID32322577,reaction_1,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity of expressed sfGFP.,"LB, M9, or GMML medium",,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-PylRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_2,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity of expressed sfGFP.,"LB, M9, or GMML medium",,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-PylRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_3,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity of expressed sfGFP.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-N-PylRS and pET-pylT-sfGFP-TAG27,"1 mM IPTG, 37°C, 12h, with 2 mM ncAA"
PMID32322577,reaction_4,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity of expressed sfGFP.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-N-PylRS and pET-pylT-sfGFP-TAG27,"1 mM IPTG, 37°C, 12h, with 2 mM ncAA"
PMID32322577,reaction_5,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity of expressed sfGFP.,LB medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-N-PylRS and pET-pylT-sfGFP-TAG27,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_6,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity and Western blot.,LB or GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-ZRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_7,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity and Western blot.,LB or GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-ZRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_8,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity and Western blot.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-ZRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_9,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-ZRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_10,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity and Western blot.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-ZRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_11,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity and Western blot.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-ZRS variants and pET-pylT-sfGFP-TAG,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_12,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-N-ZRS and pET-pylT-sfGFP-TAG27,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322577,reaction_13,in vivo,Amber suppression of sfGFP reporter gene in E. coli. Activity measured by fluorescence intensity.,GMML medium,,"Not specified, standard for culture media.",37.0,E. coli BL21 (DE3),pCDF-N-ZRS and pET-pylT-sfGFP-TAG27,"1 mM IPTG, 37°C, 12h, with 1 mM ncAA"
PMID32322725,reaction_1,in vitro,Coupled enzymatic assay with alcohol dehydrogenase (ADH) for kinetic parameter determination.,"25 mM HEPES/KOH, 10 mM MgCl2, 40 mM ethanol, 10 U alcohol dehydrogenase",7.4,,20.0,E. coli M15,pQE30-LbNMNAT,"0.5 mM IPTG, 26°C, overnight"
PMID32322725,reaction_2,in vitro,Direct enzymatic assay with RP-HPLC analysis for kinetic parameter determination.,"25 mM HEPES/KOH, 10 mM MgCl2",7.4,,20.0,E. coli M15,pQE30-LbNMNAT,"0.5 mM IPTG, 26°C, overnight"
PMID32322725,reaction_3,in vitro,Direct enzymatic assay with RP-HPLC analysis to confirm substrate specificity.,"25 mM HEPES/KOH, 10 mM MgCl2",7.4,,20.0,E. coli M15,pQE30-LbNMNAT,"0.5 mM IPTG, 26°C, overnight"
PMID32324773,reaction_1,in vivo,Functional characterization via heterologous overexpression in Arabidopsis thaliana and measurement of resulting nitrate and nitrogen content in seeds.,Plants grown in soil. Seedling assays on Murashige and Skoog (MS) medium with 3% sucrose and 0.9% agarose.,,Not specified for MS medium or soil.,20.0,Arabidopsis thaliana Columbia-0 (Col-0),pB2GW7,Constitutive expression under the CaMV35S promoter. Transformation via Agrobacterium tumefaciens GV3101.
PMID32324965,reaction_1,in vitro,Enzyme kinetics assay,100 mM PBS buffer,7.0,,30.0,E. coli BL21 (DE3),pET-28a(+),"0.2 mM IPTG, induced at 37°C, then incubated at 16°C for 24 h"
PMID32324965,reaction_2,in vitro,Coupled biotransformation for (R)-HPBE production,100 mM PBS buffer,6.0,,30.0,,,
PMID32324965,reaction_3,in vitro,Coupled biotransformation for 1-phenylethanol production,100 mM PBS buffer,6.0,,30.0,,,
PMID32325486,reaction_1,in vivo,Heterologous overexpression of LcHMGS in Nicotiana benthamiana and Arabidopsis thaliana to study effects on downstream metabolite production. The enzyme was also expressed in E. coli for antibody production.,,,,25.0,"Nicotiana benthamiana, Arabidopsis thaliana",pCambia1300S,
PMID32325762,reaction_1,in vivo,"Quantification of the product, 15-cis phytoene, in whole D. salina cells under various conditions, including treatment with herbicides (20 µM chlorpropham, 5 µM norflurazon) and different light intensities and wavelengths.",Modiﬁed Johnsons Medium containing 1.5 M NaCl and 10 mM NaHCO3,,Culture medium contained 10 mM NaHCO3,25.0,,,
PMID32325762,reaction_2,in vivo,"Enzyme activity was investigated by treating whole D. salina cells with a specific inhibitor, norflurazon, and observing the resulting accumulation of the substrate (15-cis phytoene).",Modiﬁed Johnsons Medium containing 1.5 M NaCl and 10 mM NaHCO3,,Culture medium contained 10 mM NaHCO3,25.0,,,
PMID32326167,reaction_1,in vivo,Metabolic engineering in transgenic Chrysanthemum morifolium plants (lines 1240/1 and 1240/2). Product formation was assessed by TLC analysis of leaf extracts.,,,,,Chrysanthemum morifolium Ramat cv. White Snowdon,p1240,"Constitutive expression driven by various promoters (35S, sup, HS, ocs, nos, rbc, ags)."
PMID32327655,reaction_1,in vitro,Steady-state enzyme kinetics measured by RapidFire mass spectrometry.,10 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate,7.4,,37.0,Escherichia coli,pET23(+) or modified pET28,Expression induced with IPTG and L-arabinose at 18-37°C.
PMID32327655,reaction_2,in vitro,Steady-state enzyme kinetics measured by RapidFire mass spectrometry.,10 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate,7.4,,37.0,Escherichia coli,pET23(+) or modified pET28,Expression induced with IPTG and L-arabinose at 18-37°C.
PMID32327655,reaction_3,in vitro,Activity-based metabolite profiling (ABMP) using a mycobacterial metabolite extract. Product identified by untargeted LC-MS.,20 mM TRIS-HCl pH 7.4,7.4,,37.0,,,
PMID32327655,reaction_4,in vitro,"Coupled enzyme assay with lactate dehydrogenase, monitored spectrophotometrically by NADH disappearance.","100 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate, 0.5 U/mL L-lactate dehydrogenase and 1 mM NADH",7.4,,37.0,Escherichia coli C41 (DE3),,
PMID32327655,reaction_5,in vitro,"Coupled enzyme assay with lactate dehydrogenase, monitored spectrophotometrically by NADH disappearance.","100 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate, 0.5 U/mL L-lactate dehydrogenase and 1 mM NADH",7.4,,37.0,Escherichia coli C41 (DE3),,
PMID32327655,reaction_6,in vitro,"Coupled enzyme assay with lactate dehydrogenase, monitored spectrophotometrically by NADH disappearance.","100 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate, 0.5 U/mL L-lactate dehydrogenase and 1 mM NADH",7.4,,37.0,Escherichia coli C41 (DE3),,
PMID32327655,reaction_7,in vitro,"Coupled enzyme assay with lactate dehydrogenase, monitored spectrophotometrically by NADH disappearance.","100 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate, 0.5 U/mL L-lactate dehydrogenase and 1 mM NADH",7.4,,37.0,Escherichia coli C41 (DE3),,
PMID32327655,reaction_8,in vitro,"Coupled enzyme assay with lactate dehydrogenase, monitored spectrophotometrically by NADH disappearance.","100 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate, 0.5 U/mL L-lactate dehydrogenase and 1 mM NADH",7.4,,37.0,Escherichia coli C41 (DE3),,
PMID32327655,reaction_9,in vitro,"Coupled enzyme assay with lactate dehydrogenase, monitored spectrophotometrically by NADH disappearance.","100 mM Tris-HCl pH 7.4 containing 10 µM pyridoxal phosphate, 0.5 U/mL L-lactate dehydrogenase and 1 mM NADH",7.4,,37.0,Escherichia coli C41 (DE3),,
PMID32328400,reaction_1,in vitro,H2O2 consumption assay using whole cells of L. casei IGM394 after 5 hr of logarithmic growth.,PIPES buffer,6.8,,37.0,Lactobacillus casei IGM394,,
PMID32328400,reaction_2,in vitro,H2O2 consumption assay using whole cells of L. casei IGM394 after 5 hr of logarithmic growth.,PIPES buffer,6.8,,37.0,Lactobacillus casei IGM394,,
PMID32328400,reaction_3,in vitro,H2O2 consumption assay using whole cells of L. casei IGM394 after 5 hr of logarithmic growth.,PIPES buffer,6.8,,37.0,Lactobacillus casei IGM394,,
PMID32330361,reaction_1,in vitro,SPE-MS high-throughput inhibition assay,50 mM HEPES buffer,7.5,,20.0,Escherichia coli BL21 (DE3),pET-28a(+),
PMID32330361,reaction_2,in vitro,SPE-MS inhibition assay,Not specified,,,,,,
PMID32330361,reaction_3,in vitro,SPE-MS inhibition assay,Not specified,,,,,,
PMID32330361,reaction_4,in vitro,SPE-MS inhibition assay,Not specified,,,,,,
PMID32330624,reaction_1,in vitro,Fluorescence Anisotropy Spectroscopy (FAS) to determine binding affinity (KDapp).,50 mM potassium phosphate buffer pH 7.4; 500 mM NaCl; 10 mM MgCl2; 1 mM 2-mercaptoethanol and 2% glycerol,7.4,,25.0,Escherichia coli BL21 (λ-DE3),pET32(a)+,"0.5 mM IPTG, 18 °C, 18 h"
PMID32330624,reaction_2,in vitro,Fluorescence Anisotropy Spectroscopy (FAS) to determine binding affinity (KDapp).,50 mM potassium phosphate buffer pH 7.4; 500 mM NaCl; 10 mM MgCl2; 1 mM 2-mercaptoethanol and 2% glycerol,7.4,,25.0,Escherichia coli BL21 (λ-DE3),pET32(a)+,"0.5 mM IPTG, 18 °C, 18 h"
PMID32330624,reaction_3,in vitro,Fluorescence Anisotropy Spectroscopy (FAS) to determine binding affinity (KDapp).,50 mM potassium phosphate buffer pH 7.4; 500 mM NaCl; 10 mM MgCl2; 1 mM 2-mercaptoethanol and 2% glycerol,7.4,,25.0,Escherichia coli BL21 (λ-DE3),pET32(a)+,"0.5 mM IPTG, 18 °C, 18 h"
PMID32330624,reaction_4,in vitro,Fluorescence Anisotropy Spectroscopy (FAS) to determine binding affinity (KDapp).,50 mM potassium phosphate buffer pH 7.4; 500 mM NaCl; 10 mM MgCl2; 1 mM 2-mercaptoethanol and 2% glycerol,7.4,,25.0,Escherichia coli BL21 (λ-DE3),pET32(a)+,"0.5 mM IPTG, 18 °C, 18 h"
PMID32330624,reaction_5,in vitro,Fluorescence Anisotropy Spectroscopy (FAS) to determine binding affinity (KDapp).,50 mM potassium phosphate buffer pH 7.4; 500 mM NaCl; 10 mM MgCl2; 1 mM 2-mercaptoethanol and 2% glycerol,7.4,,25.0,Escherichia coli BL21 (λ-DE3),pET32(a)+,"0.5 mM IPTG, 18 °C, 18 h"
PMID32330624,reaction_6,in vitro,Fluorescence Anisotropy Spectroscopy (FAS) to determine binding affinity (KDapp).,50 mM potassium phosphate buffer pH 7.4; 500 mM NaCl; 10 mM MgCl2; 1 mM 2-mercaptoethanol and 2% glycerol,7.4,,25.0,Escherichia coli BL21 (λ-DE3),pET32(a)+,"0.5 mM IPTG, 18 °C, 18 h"
PMID32330624,reaction_7,in vitro,Fluorescence Anisotropy Spectroscopy (FAS) to determine binding affinity (KDapp).,50 mM potassium phosphate buffer pH 7.4; 500 mM NaCl; 10 mM MgCl2; 1 mM 2-mercaptoethanol and 2% glycerol,7.4,,25.0,Escherichia coli BL21 (λ-DE3),pET32(a)+,"0.5 mM IPTG, 18 °C, 18 h"
PMID32330646,reaction_1,in vitro,Spectrophotometric enzyme inhibition assay measuring uric acid formation at 295 nm.,Phosphate buffer (PB),,Not specified in the provided text.,37.0,,,
PMID32330646,reaction_2,in vitro,Spectrophotometric assay for superoxide generation via NBT reduction at 560 nm.,Buffer,,Not specified in the provided text.,37.0,,,
PMID32331716,reaction_1,in vitro,Kinetic constants were determined using purified Aga2-VP fusion proteins. Dye degradation rates were determined using VP-coated yeast cell wall fragments.,100 mM sodium tartrate,3.5,,25.0,Saccharomyces cerevisiae EBY100,pCTCON2,"Induction in YNB-CAA medium supplemented with 2% (w/v) galactose, 50 µg/mL chloramphenicol, and 500 µM 5-aminolevulinic acid for 16 h."
PMID32331716,reaction_2,in vitro,Kinetic constants were determined using purified Aga2-VP fusion proteins. Dye degradation rates were determined using VP-coated yeast cell wall fragments.,100 mM sodium tartrate,3.5,,25.0,Saccharomyces cerevisiae EBY100,pCTCON2,"Induction in YNB-CAA medium supplemented with 2% (w/v) galactose, 50 µg/mL chloramphenicol, and 500 µM 5-aminolevulinic acid for 16 h."
PMID32331716,reaction_3,in vitro,Kinetic constants were determined using purified Aga2-VP fusion proteins. Dye degradation rates were determined using VP-coated yeast cell wall fragments.,100 mM sodium tartrate,3.5,,25.0,Saccharomyces cerevisiae EBY100,pCTCON2,"Induction in YNB-CAA medium supplemented with 2% (w/v) galactose, 50 µg/mL chloramphenicol, and 500 µM 5-aminolevulinic acid for 16 h."
PMID32331722,reaction_1_La-XoxF,in vitro,DCPIP-linked methanol dehydrogenase activity assay on purified enzyme.,25 mM acetate buffer,5.0,,80.0,,,
PMID32331722,reaction_2_Nd-XoxF,in vitro,DCPIP-linked methanol dehydrogenase activity assay on purified enzyme.,25 mM acetate buffer,5.0,,80.0,,,
PMID32331723,reaction_1,in vitro,Kinetic parameters were determined using purified enzyme.,20 mM Na2HPO4-NaH2PO4 buffer,6.0,Optimal pH for activity.,37.0,Escherichia coli BL21 (DE3),pET21b,"0.4 mM IPTG, 16°C, 24 h"
PMID32331723,reaction_2,in vivo,Whole-cell biotransformation with resting cells.,PBS reaction buffer containing 270 g/L monosodium glutamate and 0.1% Triton X-100,7.4,Assumed from PBS buffer (pH 7.4) used for cell resuspension in other assays. Not explicitly stated for the biotransformation.,,Escherichia coli BL21 (DE3),pET21b-SmLGOX-KatE with engineered RBS sequences,"0.4 mM IPTG, 16°C, 20-24 h"
PMID32334266,reaction_1,in vitro,LANCE Eu time-resolved fluorescence resonance energy transfer (TR-FRET) kinase assay using recombinant enzyme from Carna.,"2 mM DTT, 50 mM HEPES, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween20, pH 7.5",7.5,,25.0,,,
PMID32334266,reaction_2,in vitro,LANCE Eu time-resolved fluorescence resonance energy transfer (TR-FRET) kinase assay using recombinant enzyme from Carna.,"2 mM DTT, 50 mM HEPES, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween20, pH 7.5",7.5,,25.0,,,
PMID32334266,reaction_3,in vivo,p-ACC(Ser79) ELISA in K562 cells. AMPK was activated by adding 12 mM 2-Deoxy-D-glucose to glucose-free media.,glucose free RPMI-1640 supplemented with 10% FBS and 1X penicillin/streptomycin solution,,,37.0,,,
PMID32334266,reaction_4,in vitro,LanthaScreen Eu TR-FRET competitive binding assay using recombinant enzyme from Carna.,1X kinase buffer A (Invitrogen),,,25.0,,,
PMID32334266,reaction_5,in vitro,Eurofins DiscoverX KINOMEscan competitive binding assay.,,,,,,,
PMID32334266,reaction_6,in vitro,Eurofins DiscoverX KINOMEscan competitive binding assay.,,,,,,,
PMID32334266,reaction_7,in vitro,Eurofins DiscoverX KINOMEscan competitive binding assay.,,,,,,,
PMID32334266,reaction_8,in vitro,Eurofins DiscoverX KINOMEscan competitive binding assay.,,,,,,,
PMID32335368,reaction_1,in vivo,Methane-fed membrane biofilm reactor (CH4-MBfR) and serum bottle batch tests,Aqueous medium with pH maintained at 7.2,7.2,±0.2,35.0,,,
PMID32335368,reaction_2,in vivo,Methane-based batch reactor,Aqueous medium,,,,,,
PMID32335504,reaction_1,in vitro,Structural studies using cryo-electron microscopy in lipid nanodiscs and X-ray crystallography. Biochemical data on ATP hydrolysis are also discussed.,,,,,,,
PMID32335504,reaction_2,in vitro,Structural studies using cryo-electron microscopy in lipid nanodiscs and X-ray crystallography. Biochemical data on ATPase activity and photocrosslinking experiments are also discussed.,,,,,,,
PMID32340322,reaction_1,in vivo,Endogenous H2S production and its effects were studied in cultured human dermal fibroblasts from healthy control and Down syndrome individuals.,"Advanced Dulbecco’s Modiﬁed Eagle Medium/nutrient mixture F-12 (DMEM / F-12, 1:1; 1X) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 10 UI/mL of penicillin, 100 µg/mL streptomycin, 2 mM Glutamax™, and 0.1% lactalbumin hydrolysate.",,"Standard cell culture conditions, typically pH ~7.4",37.0,Human dermal fibroblasts,,
PMID32343709,reaction_1,in vitro,Kinase assay with immunoprecipitated FLAG-tagged GRK6 from HEK293T cells and purified recombinant his-tagged human alpha-synuclein. Phosphorylation was detected by autoradiography using [gamma-32P]ATP and by Western blot using a pSer129-alpha-syn specific antibody.,"20 mM Tris, 10 mM NaCl, 10 mM MgCl2 and 1 mM EDTA",,pH not specified for the GRK6 kinase buffer.,30.0,HEK293T cells,pCMV-Tag-2B-GRK6,
PMID32343709,reaction_2,in vitro,Kinase assay with purified recombinant his-tagged CK2-alpha and purified recombinant his-tagged human alpha-synuclein. Phosphorylation was detected by Western blot using a pSer129-alpha-syn specific antibody.,"20 mM Tris pH 7.5, 10 mM NaCl, 10 mM MgCl2 and 1 mM EDTA",7.5,,30.0,Rosetta (DE3) pLys Escherichia coli,pET28c,0.2 mM IPTG at 18°C for 20 hours
PMID32344088,reaction_1,in vitro,"Synthesis of resveratrol 3,5-β-D-diglucoside using co-immobilized enzymes on Ag4-PEI support.","50 mM HEPES buffer, 100 mM sucrose, 0.5 mM piceid (dissolved in 10% dimethyl sulfoxide), and 50 µM UDP",7.0,,30.0,,,
PMID32344088,reaction_2,in vitro,Standard spectrophotometric assay for determination of UGT activity.,50 mM HEPES buffer,8.0,,30.0,,,
PMID32344088,reaction_3,in vitro,Continuous spectrophotometric assay for determination of SuSyAc activity.,"Not specified, but assay contained 1 M sucrose.",8.5,,42.0,,,
PMID32345643,reaction_1,in vivo,Activity was inferred from LC-MS/MS detection of downstream DNA phosphorothioate (PT) modification in E. coli Trans1-T1 expressing the SspABCD system. Loss of PT modification upon mutation of SspA confirmed its desulfurase activity.,,,,,Escherichia coli Trans1-T1,"pWHU732 and derivatives (pWHU4393, pWHU4394, pWHU4395)",
PMID32346138,reaction_1,in vitro,"Chromatin Immunoprecipitation (ChIP) assays followed by qPCR or sequencing, performed on sorted primary medullary thymic epithelial cells (mTECs) from mice to measure H3K27me3 levels at specific gene promoters.","EZ-ChIP Chromatin Immunoprecipitation Kit (Millipore, #17–371)",,Not specified,,Endogenous expression in Mus musculus for ChIP assays; HEK293T cells for co-immunoprecipitation studies.,,
PMID32352790,reaction_1,in vitro,"Enzymatic activity on phosphoric acid swollen cellulose (PASC) was determined by HPAEC analysis of soluble products. For quantification, products were further digested by cellobiohydrolase (CBH) I to release C1-oxidized cellobiose (cellobionic acid).",Not specified,,,,Pichia pastoris X-33,pICZα A,
PMID32352790,reaction_2,in vitro,H2O2 production was measured in the absence of polysaccharide substrate using a Fluorimetric Hydrogen Peroxide Assay Kit.,Not specified,,,,Pichia pastoris X-33,pICZα A,
PMID32353513,reaction_1,in vitro,Fluorometric RdRp assay with self-priming RNA using PicoGreen dye to measure double-stranded RNA formation.,"25 mM Tris/HCl, 1 mM DTT, 150 mM NaCl, 5 mM MgCl2, 0.3 mM MnCl2, 2 U RiboLock Ribonuclease inhibitor, 100 µL PicoGreen Quantitation Reagent",7.5,,30.0,Escherichia coli BL21 (DE3),pET-28a (+),"0.5 mM IPTG, 16 °C, 20 h"
PMID32353513,reaction_2,in vitro,Fluorometric RdRp assay with self-priming RNA using PicoGreen dye to measure double-stranded RNA formation.,"25 mM Tris/HCl, 1 mM DTT, 150 mM NaCl, 5 mM MgCl2, 0.3 mM MnCl2, 2 U RiboLock Ribonuclease inhibitor, 100 µL PicoGreen Quantitation Reagent",7.5,,30.0,Escherichia coli BL21 (DE3),pGEX 6P-1,"0.5 mM IPTG, 16 °C, 20 h"
PMID32353513,reaction_3,in vitro,Fluorometric RdRp assay with self-priming RNA using PicoGreen dye to measure double-stranded RNA formation.,"25 mM Tris/HCl, 1 mM DTT, 150 mM NaCl, 5 mM MgCl2, 0.3 mM MnCl2, 2 U RiboLock Ribonuclease inhibitor, 100 µL PicoGreen Quantitation Reagent",7.5,,30.0,Escherichia coli BL21 (DE3),pGEX 6P-1,"0.5 mM IPTG, 16 °C, 20 h"
PMID32353513,reaction_4,in vitro,Primer extension assay to test for chain termination using [α-32P] ATP.,"25 mM Tris, 150 mM NaCl",8.0,,25.0,Escherichia coli BL21 (DE3),pET-28a (+),"0.5 mM IPTG, 16 °C, 20 h"
PMID32361114,reaction_1,in vivo,Degradation by whole transgenic Arabidopsis thaliana seedlings (chloroplast transformant) in liquid medium.,1/2 MS liquid medium with 0.5% sucrose,5.8,,23.0,Arabidopsis thaliana ecotype Columbia,pDBN-Ch (derived from pDBNBC-02),
PMID32364738,reaction_1,in vitro,Rapid quench-flow kinetics,"50 mM Tris, 100 mM potassium acetate, 0.1 mM EDTA, 12.5 mM magnesium acetate",7.5,,25.0,,,
PMID32364738,reaction_2,in vitro,Rapid quench-flow kinetics,"50 mM Tris, 100 mM potassium acetate, 0.1 mM EDTA, 12.5 mM magnesium acetate",7.5,,25.0,,,
PMID32365662,reaction_1,in vitro,"Enzyme activity was determined by DNS assay. Product synthesis was conducted and analyzed by TLC, HPLC, and HPAEC-PAD. Product structure was confirmed by NMR.",50 mM acetate buffer,6.0,Optimal pH for wild-type enzyme activity. Synthesis reactions were also conducted at pH 6.0.,37.0,E. coli BL21 StarTM (DE3),pET-19b,"0.1 mM IPTG, 30 °C, overnight"
PMID32367441,reaction_1,in vitro,Enzyme activity assay,50 mmol/L HEPES at pH 7.4 with 5 mmol/L of CaCl2,7.4,,30.0,,,
PMID32367441,reaction_2,in vitro,Comparison of catalytic efficiency,50 mmol/L HEPES at pH 7.4 with 5 mmol/L of CaCl2,7.4,,30.0,,,
PMID32367441,reaction_3,in vitro,Initial reaction velocity measurement,50 mmol/L HEPES at pH 7.4 with 5 mmol/L of CaCl2,7.4,,30.0,,,
PMID32367441,reaction_4,in vitro,,125 mmol/L NaCl with 25 mmol/L Tris at pH 7.5,7.5,,30.0,,,
PMID32367441,reaction_5,in vitro,,50 mmol/L HEPES at pH 7.4 with 5 mmol/L of CaCl2,7.4,,30.0,,,
PMID32367441,reaction_6,in vitro,,50 mmol/L HEPES at pH 7.4 with 5 mmol/L of CaCl2,7.4,,30.0,,,
PMID32367441,reaction_7,in vitro,,25 mmol/L Tris at pH 7.5 with 5 mmol/L of MgCl2,7.5,,30.0,,,
PMID32367441,reaction_8,in vitro,Comparison of catalytic efficiency and initial velocity,25 mmol/L Tris at pH 7.5 with 5 mmol/L of MgCl2,7.5,,30.0,,,
PMID32367441,reaction_9,in vitro,Control experiment to confirm enzyme activity,Not specified,,,30.0,,,
PMID32367441,reaction_10,in vitro,Substrate specificity test,Not specified,,,30.0,,,
PMID32367441,reaction_11,in vitro,Substrate specificity test,Not specified,,,30.0,,,
PMID32367441,reaction_12,in vitro,Activity in cultured cells,Phosphate-buffered saline (PBS),,,37.0,,,
PMID32367441,reaction_13,in vitro,Activity in cultured cells,Phosphate-buffered saline (PBS),,,37.0,,,
PMID32367441,reaction_14,in vitro,Activity in cultured cells,Phosphate-buffered saline (PBS),,,37.0,,,
PMID32367441,reaction_15,in vitro,Activity in cultured cells,Phosphate-buffered saline (PBS),,,37.0,,,
PMID32367441,reaction_16,in vitro,Isolated perfused organ,Tyrode’s solution,,,37.0,,,
PMID32367441,reaction_17,in vivo,Reverse microdialysis in renal cortex,Microdialysis perfusate,,,37.0,,,
PMID32367526,reaction_1,in vivo,Measurement of photosynthetic electron transport (ETR) via electrochromic shift (ECS) in whole protonemal tissue by comparing wild-type and knockout mutants.,"20 mM HEPES, pH 7.5 and 10 mM KCl",7.5,,24.0,,,
PMID32367526,reaction_2,in vivo,Measurement of PSII-independent cyclic electron flow (CEF) via electrochromic shift (ECS) in DCMU-treated protonemal tissue by comparing knockout mutants.,"20 µM DCMU, 20 mM HEPES, pH 7.5 and 10 mM KCl",7.5,,24.0,,,
PMID32367526,reaction_3,in vivo,Measurement of PSII-independent cyclic electron flow (CEF) via electrochromic shift (ECS) in DCMU-treated protonemal tissue by comparing knockout mutants.,"20 µM DCMU, 20 mM HEPES, pH 7.5 and 10 mM KCl",7.5,,24.0,,,
PMID32367573,reaction_1,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32367573,reaction_2,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32367573,reaction_3,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32367573,reaction_4,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32367573,reaction_5,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32367573,reaction_6,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32367573,reaction_7,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32367573,reaction_8,in vitro,Bioluminescence activity and emission spectrum measurement.,"A mixture of substrate solution (in 50 mM KPB, pH 6.0), luciferase solution (in 50 mM KPB, pH 8.0, containing 35% glycerol), and additional KPB (500 mM, pH 8.0).",8.0,The final reaction mixture pH is 8.0,,,,
PMID32368512,reaction_1,in vitro,"Enzyme activity measured in homogenates of serum, liver, and kidney from Wistar rats.",Tissues homogenized in ice-cold sucrose solutions. Assay performed using the spectrophotometer method of Yatzidis [30].,,,,"Native enzyme from Wistar rat tissues (serum, liver, kidney)",,
PMID32368512,reaction_2,in vitro,"Enzyme activity measured in homogenates of serum, liver, and kidney from Wistar rats.",Tissues homogenized in ice-cold sucrose solutions. Assay performed using the spectrophotometer method of Yatzidis [30].,,,,"Native enzyme from Wistar rat tissues (serum, liver, kidney)",,
PMID32373581,reaction_1,in vitro,In vitro enzyme activity assay analyzed by TLC (thin layer chromatograph) followed by autoradiography.,,,,,,,
PMID32373581,reaction_2,in vitro,"Multiple assays were used to test different inhibitors, including TLC with autoradiography, DRaCALA, in silico screening followed by in vitro assays, and pyrophosphate production measurement.",,,,,,,
PMID32373581,reaction_3,in vitro,In vitro enzyme activity assay analyzed by HPLC (high performance liquid chromatography).,,,,,,,
PMID32373581,reaction_4,in vitro,"In vitro enzyme activity assay analyzed by circular dichroism (CD) spectroscopy. For some inhibitors, in silico 3-D pharmacophore modeling was used for initial screening.",,,,,,,
PMID32373581,reaction_5,in vitro,"Multiple assays were used to test different inhibitors, including HPLC-MS/MS and in silico screening followed by in vitro assays.",,,,,,,
PMID32373581,reaction_6,in vitro,Screening by DRaCALA (Differential Radial Capillary Action of Ligand Assay) to find inhibitors of c-di-GMP binding to the I-site.,,,,,,,
PMID32373581,reaction_7,in vivo,Screening with an in vivo luciferase reporter assay followed by an in vitro enzyme activity assay.,,,,,,,
PMID32373581,reaction_8,in vitro,FRET (Foster resonance energy transfer)-based in vitro enzyme activity assay.,,,,,,,
PMID32373581,reaction_9,in vitro,In silico (3-D Pharmacophore) prediction followed by in vitro enzyme activity assay measuring pyrophosphate production.,,,,,,,
PMID32379966,reaction_1,in vivo,Whole-bacteria assays measuring ATP levels and oxygen consumption rate (OCR) in M. bovis BCG ΔcydAB complemented with M. tuberculosis cydABDC operon. The cyt-bcc:aa3 respiratory branch was inhibited with Q203.,Middlebrook 7H9 broth medium without glycerol,,Not specified,37.0,M. bovis BCG ΔcydAB,pMV306-cydABDC (integrative) or pMV262 (high-copy),Expression under the control of its native promoter.
PMID32382450,reaction_1,in vitro,Stopped-flow spectroscopy to monitor FAD reduction (k1) and intraprotein heme reduction (k2).,50 mM sodium acetate buffer,4.5,,30.0,Pichia pastoris X-33,,
PMID32382450,reaction_2,in vitro,Stopped-flow spectroscopy under anaerobic conditions.,50 mM sodium acetate buffer,4.5,,30.0,Pichia pastoris X-33,,
PMID32382450,reaction_3,in vitro,Spectrophotometric steady-state assay monitoring cytochrome c reduction at 550 nm.,50 mM sodium acetate buffer,4.5,,30.0,Pichia pastoris X-33,,
PMID32382450,reaction_4,in vitro,Spectrophotometric steady-state assay monitoring DCIP reduction at 520 nm.,50 mM sodium acetate buffer,4.5,,30.0,Pichia pastoris X-33,,
PMID32382450,reaction_5,in vitro,Cyclic and square-wave voltammetry on thiol-modified gold electrodes.,"50 mM sodium acetate, pH 4.5, containing 100 mM KCl",4.5,,23.0,Pichia pastoris X-33,,
PMID32382667,reaction_1,in vitro,Radioactive kinase assay using γ-32P ATP and dephosphorylated casein as substrate.,"50 mM Tris-Cl (pH 7.5), 10 mM MgCl2, 5 mM MnCl2, 1 mM dithiothreitol (DTT), 1 mM β-glycerol phosphate, 1 mM Na3VO4",7.5,Standard assay pH. Optimal pH was found to be 9.0.,30.0,,,
PMID32382667,reaction_2,in vitro,Radioactive kinase assay using γ-32P ATP to screen for substrate specificity.,"50 mM Tris-Cl (pH 7.5), 10 mM MgCl2, 5 mM MnCl2, 1 mM dithiothreitol (DTT), 1 mM β-glycerol phosphate, 1 mM Na3VO4",7.5,,30.0,,,
PMID32382667,reaction_3,in vitro,Radioactive kinase assay using γ-32P ATP to screen for substrate specificity.,"50 mM Tris-Cl (pH 7.5), 10 mM MgCl2, 5 mM MnCl2, 1 mM dithiothreitol (DTT), 1 mM β-glycerol phosphate, 1 mM Na3VO4",7.5,,30.0,,,
PMID32382667,reaction_4,in vitro,Auto-phosphorylation observed during radioactive kinase assays.,"50 mM Tris-Cl (pH 7.5), 10 mM MgCl2, 5 mM MnCl2, 1 mM dithiothreitol (DTT), 1 mM β-glycerol phosphate, 1 mM Na3VO4",7.5,,30.0,,,
PMID32386575,reaction_1,in vivo,"Enzyme function was investigated by complementation of a conditional aftD knockout mutant in M. smegmatis, where cell growth served as a proxy for catalytic activity. Substrate binding specificity was determined separately by in vitro glycan array analysis.",7H9/glycerol/tyloxapol liquid media,,Not specified for in vivo growth medium.,37.0,Escherichia coli BL21 (DE3) pLysS,pNYCOMPS-N23,"0.2 mM IPTG, 22°C, overnight"
PMID32388928,reaction_1,in vivo,Whole-cell biotransformation using engineered Synechococcus elongatus PCC7942. In vitro assays were also performed on crude extracts.,50 mM potassium phosphate buffer,7.5,For in vitro kinetic assay of crude extract.,30.0,Synechococcus elongatus PCC7942,pEL6 (for integration into Neutral Site II),"1 mM IPTG, although significant expression occurred via promoter leakage without induction."
PMID32388928,reaction_2,in vivo,Whole-cell biotransformation using engineered Synechococcus elongatus PCC7942. In vitro assays were also performed on crude extracts.,100 mM Tris–HCl buffer,7.0,For in vitro kinetic assay of crude extract.,30.0,Synechococcus elongatus PCC7942,pEL7 (for integration of Ec-XI/Ps-XDH operon into Neutral Site II),1 mM IPTG
PMID32391185,reaction_1,in vitro,Peroxide shunt pathway assay with HPLC analysis to study pH dependence.,"150 mM HEPES buffer (pH 7.4), 75 mM CHES buffer (pH 9.5), or 150 mM phosphate buffer (pH 10.4)",,pH dependence was studied across a range from 7.4 to 10.4.,25.0,E. coli,CYP121 expression plasmid,Induction with 400 μM IPTG at 28°C for 16 h. Culture supplemented with 300 μM δ-aminolevulinic acid and 35 μM iron (II) ammonium sulfate.
PMID32391185,reaction_2,in vitro,"Peroxide shunt pathway assay. Products were identified and quantified by HPLC, HRMS, and coupled enzyme assays (ADH, FDH) or chemical derivatization (2,4-DNP).",50 mM Tris-HCl,7.4,Main experiments were at pH 7.4. A pH dependence study (pH 7.4-10.4) showed decreased product formation at higher pH.,25.0,E. coli,CYP121 expression plasmid,Induction with 400 μM IPTG at 28°C for 16 h. Culture supplemented with 300 μM δ-aminolevulinic acid and 35 μM iron (II) ammonium sulfate.
PMID32391185,reaction_3,in crystallo,CYP121-cYF-4-OMe co-crystals were soaked in H2O2 to trap the hydroxylated intermediate.,"100 mM MES, 2.0 M ammonium sulfate, 20% glycerol",7.4,,,E. coli,CYP121 expression plasmid,Induction with 400 μM IPTG at 28°C for 16 h. Culture supplemented with 300 μM δ-aminolevulinic acid and 35 μM iron (II) ammonium sulfate.
PMID32391470,reaction_1,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm. NADH concentration was varied.,"20 mM PIPES, pH 7.4",7.4,,25.0,E. coli BL21(DE3),pET21b(+),"1 mM IPTG, 16 °C, overnight"
PMID32391470,reaction_2,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm. FMN concentration was varied.,"20 mM PIPES, pH 7.4",7.4,,25.0,E. coli BL21(DE3),pET21b(+),"1 mM IPTG, 16 °C, overnight"
PMID32391470,reaction_3,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm. FAD concentration was varied.,"20 mM PIPES, pH 7.4",7.4,,25.0,E. coli BL21(DE3),pET21b(+),"1 mM IPTG, 16 °C, overnight"
PMID32391470,reaction_4,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm. Riboflavin concentration was varied.,"20 mM PIPES, pH 7.4",7.4,,25.0,E. coli BL21(DE3),pET21b(+),"1 mM IPTG, 16 °C, overnight"
PMID32391470,reaction_5,in vitro,Spectrophotometric assay monitoring NADPH oxidation at 340 nm. NADPH concentration was varied.,"20 mM PIPES, pH 7.4",7.4,,25.0,E. coli BL21(DE3),pET21b(+),"1 mM IPTG, 16 °C, overnight"
PMID32391470,reaction_6,in vitro,Coupled enzyme assay with product detection by headspace gas chromatography (HS-GC).,"20 mM PIPES, pH 7.0",7.0,,30.0,E. coli BL21(DE3),,
PMID32391487,reaction_1,in vitro,Time course analysis of AMP conversion by free enzyme.,100 mM Tris-HCl,8.0,Optimal pH for free enzyme activity.,30.0,Escherichia coli Rosetta (DE3),pET-28a-ArPPK2,"0.2 mM IPTG, 25 °C, 12 h"
PMID32391487,reaction_2,in vitro,Time course analysis of AMP conversion by immobilized enzyme.,100 mM Tris-HCl,8.0,Optimal pH for nanoflower activity.,30.0,,,
PMID32391487,reaction_3,in vitro,Coupled reaction with ArPPK2 to demonstrate ADP regeneration for G-6-P formation.,100 mM Tris-HCl,8.0,,30.0,Escherichia coli Rosetta,pET-28a-ADP-GK,"Expressed as described for ArPPK2: 0.2 mM IPTG, 25 °C, 12 h"
PMID32393761,reaction_1,in vivo,Chromatin Immunoprecipitation (ChIP-PCR) assay in SW480 and HCT116 cells to detect H3K9me3 enrichment at the p21 promoter.,Cellular environment. ChIP assay involved cell lysis buffer with protease inhibitors.,,"Not specified, reaction occurs in cellular context.",37.0,"Human colorectal cancer cell lines (SW480, HCT116)",,
PMID32393857,reaction_1,in vitro,Microscale thermophoresis (MST) binding assay,"10 mM Hepes, 100 mM NaCl pH 7.5 with addition of 0.03% DDM",7.5,,25.0,Porphyromonas gingivalis W83,,Homologous recombination was used to add a His8-tag to the C terminus of genomic ragB for purification.
PMID32393857,reaction_2,in vitro,Microscale thermophoresis (MST) binding assay,"10 mM Hepes, 100 mM NaCl pH 7.5 with addition of 0.03% DDM",7.5,,25.0,,,
PMID32393857,reaction_3,in vitro,Microscale thermophoresis (MST) binding assay,"10 mM Hepes, 100 mM NaCl pH 7.5 with addition of 0.03% DDM",7.5,,25.0,,,
PMID32393857,reaction_4,in vitro,Microscale thermophoresis (MST) binding assay with FAM-labeled P4,"10 mM Hepes, 100 mM NaCl pH 7.5",7.5,,25.0,,,
PMID32393857,reaction_5,in vitro,Microscale thermophoresis (MST) binding assay,"10 mM Hepes, 100 mM NaCl pH 7.5",7.5,,25.0,Escherichia coli BL21 (DE3),pB22,"0.1% arabinose, ~2.5 h at 37°C"
PMID32393857,reaction_6,in vivo,Growth assay on minimal medium with BSA as sole carbon source (BSA-MM).,"enriched DMEM (10 g/L BSA, 5 mg/L hemin, 0.25 g/L l-cysteine, 0.5 mg/L menadione)",,Not specified,37.0,,,
PMID32393857,reaction_7,in vitro,X-ray crystallography and cryo-electron microscopy (cryo-EM) of RagAB with co-purified bound peptides.,"For cryo-EM: 10 mM HEPES pH 7.5, 100 mM NaCl, 0.03% DDM. For crystallography: 10 mM Hepes, 100 mM NaCl, 0.05% LDAO pH 7.5, then exchanged with C8E4.",7.5,,6.0,,,
PMID32393899,reaction_1,in vitro,Activity assay with purified human recombinant 5-LOX. Also tested in HEK293 cells and primary immune cells.,PBS pH 7.4 containing 1 mM EDTA and 2 mM CaCl2,7.4,,37.0,Escherichia coli BL21,pT3-5-LO,
PMID32393899,reaction_2,in vitro,Activity assay with purified human recombinant 5-LOX. Also tested in HEK293 cells and primary immune cells.,PBS pH 7.4 containing 1 mM EDTA and 2 mM CaCl2,7.4,,37.0,,,
PMID32393899,reaction_3,in vitro,Activity assay with purified human recombinant 5-LOX. Also tested in HEK293 cells and primary immune cells.,PBS pH 7.4 containing 1 mM EDTA and 2 mM CaCl2,7.4,,37.0,,,
PMID32396821,reaction_1,in vitro,Peroxidase-linked assay measuring H2O2 production (initial rates over 2 min) and western blotting using anti-H3K4me2 antibodies (product accumulation over 30 min).,Not specified,,Not specified,,,,
PMID32396821,reaction_2,in vitro,Peroxidase-linked assay measuring H2O2 production (initial rates over 2 min) and western blotting using anti-H3K4me2 antibodies (product accumulation over 30 min).,Not specified,,Not specified,,,,
PMID32396821,reaction_3,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_4,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_5,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_6,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_7,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_8,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_9,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_10,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_11,in vitro,Peroxidase-linked assay,,,,,,,
PMID32396821,reaction_12,in vitro,Peroxidase-linked assay,,,,,,,
PMID32397467,reaction_1,in vitro,"Chemo-enzymatic synthesis of starter-CoA derivative, monitored by HPLC.","Reaction mixture contained 5 mM Mg2+, 5 mM ATP, 1.5 mM CoA, 0.5 mM substrate.",7.5,"Enzyme was purified in a pH 7.5 buffer, reaction pH not explicitly stated but assumed to be similar.",25.0,Escherichia coli BL21 (DE3),,
PMID32397467,reaction_2,in vitro,"Chemo-enzymatic synthesis of starter-CoA derivative, monitored by HPLC.","Reaction mixture contained 5 mM Mg2+, 5 mM ATP, 1.5 mM CoA, 0.5 mM substrate.",7.5,"Enzyme was purified in a pH 7.5 buffer, reaction pH not explicitly stated but assumed to be similar.",25.0,Escherichia coli BL21 (DE3),,
PMID32397467,reaction_3,in vitro,"Chemo-enzymatic synthesis of starter-CoA derivative, monitored by HPLC.","Reaction mixture contained 5 mM Mg2+, 5 mM ATP, 1.5 mM CoA, 0.5 mM substrate.",7.5,"Enzyme was purified in a pH 7.5 buffer, reaction pH not explicitly stated but assumed to be similar.",25.0,Escherichia coli BL21 (DE3),,
PMID32397467,reaction_4,in vitro,Chemo-enzymatic synthesis of 4-coumaroyl-CoA.,100 mM Tris-HCl buffer,7.5,,25.0,Escherichia coli BL21 (DE3),,
PMID32397467,reaction_5,in vitro,Chemo-enzymatic synthesis of Malonyl-CoA with an ATP regeneration system.,100 mM sodium phosphate,7.5,,25.0,Escherichia coli BL21 (DE3),,
PMID32397467,reaction_6,in vitro,Enzyme kinetics assay,"100 mM potassium phosphate, 1 mM EDTA",7.4,,30.0,Escherichia coli BL21 (DE3),,"0.2 mM IPTG, 16 °C, 16 h"
PMID32397467,reaction_7,in vitro,Enzyme kinetics assay,"100 mM potassium phosphate, 1 mM EDTA",7.4,,30.0,Escherichia coli BL21 (DE3),,"0.2 mM IPTG, 16 °C, 16 h"
PMID32397467,reaction_8,in vitro,Enzyme kinetics assay,"100 mM potassium phosphate, 1 mM EDTA",7.4,,30.0,Escherichia coli BL21 (DE3),,"0.2 mM IPTG, 16 °C, 16 h"
PMID32397467,reaction_9,in vitro,Enzyme kinetics assay,"100 mM potassium phosphate, 1 mM EDTA",7.4,,30.0,Escherichia coli BL21 (DE3),,"0.2 mM IPTG, 16 °C, 16 h"
PMID32397467,reaction_10,in vitro,Enzyme kinetics assay,"100 mM potassium phosphate, 1 mM EDTA",7.4,,30.0,Escherichia coli BL21 (DE3),,"0.2 mM IPTG, 16 °C, 16 h"
PMID32397467,reaction_11,in vitro,Enzyme kinetics assay,"100 mM potassium phosphate, 1 mM EDTA",7.4,,30.0,Escherichia coli BL21 (DE3),,"0.2 mM IPTG, 16 °C, 16 h"
PMID32397467,reaction_12,in vitro,Enzyme kinetics assay,"100 mM potassium phosphate, 1 mM EDTA",7.4,,30.0,Escherichia coli BL21 (DE3),,"0.2 mM IPTG, 16 °C, 16 h"
PMID32398013,reaction_1,in vivo,Whole-cell conversion in engineered Saccharomyces cerevisiae strain yQDD001,"YPD-40 medium (40 g L−1 glucose, 20 g L−1 tryptone and 10 g L−1 yeast extract)",,,30.0,Saccharomyces cerevisiae BY4741,,
PMID32399854,reaction_1,in vitro,Dopachrome method using L-DOPA as a substrate,20 mM phosphate buffer,6.8,,25.0,,,
PMID32405654,reaction_1,in vitro,Photometric assay,100 mM K2HPO4/KH2PO4,7.0,,40.0,Escherichia coli SoluBL21,pRSET C,"1 mM IPTG, 25°C, overnight"
PMID32405654,reaction_2,in vitro,Photometric assay,100 mM K2HPO4/KH2PO4,7.0,,40.0,Escherichia coli SoluBL21,,
PMID32405654,reaction_3,in vitro,Photometric assay. DTT was omitted from the assay.,100 mM K2HPO4/KH2PO4,7.0,,40.0,Escherichia coli SoluBL21,,
PMID32405654,reaction_4,in vitro,Photometric assay,100 mM K2HPO4/KH2PO4,7.0,,40.0,Escherichia coli SoluBL21,,
PMID32405654,reaction_5,in vitro,Photometric assay,100 mM K2HPO4/KH2PO4,7.0,,40.0,Escherichia coli SoluBL21,,
PMID32405654,reaction_6,in vitro,Direct photometric assay at 300 nm,100 mM K2HPO4/KH2PO4,7.0,Assay pH. Optimal pH is 7.3.,45.0,Escherichia coli SoluBL21,pRSET C,"1 mM IPTG, 25°C, overnight"
PMID32405654,reaction_7,in vitro,Indirect spectrophotometric assay using hexokinase/G6PDH coupling.,100 mM Tris-HCl,7.5,,40.0,,,
PMID32405654,reaction_8,in vitro,Indirect spectrophotometric assay using hexokinase/G6PDH coupling.,100 mM Tris-HCl,7.5,,40.0,,,
PMID32405654,reaction_9,in vitro,Direct photometric measurement,100 mM K2HPO4/KH2PO4,7.0,,45.0,,,
PMID32405654,reaction_10,in vitro,Direct photometric measurement,100 mM K2HPO4/KH2PO4,7.0,,45.0,,,
PMID32405654,reaction_11,in vitro,Direct photometric measurement,100 mM K2HPO4/KH2PO4,7.0,,45.0,,,
PMID32405654,reaction_12,in vitro,Direct photometric measurement,100 mM K2HPO4/KH2PO4,7.0,,45.0,,,
PMID32405654,reaction_13,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32405654,reaction_14,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32405654,reaction_15,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32405654,reaction_16,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32405654,reaction_17,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32405654,reaction_18,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32405654,reaction_19,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32405654,reaction_20,in vitro,Product formation confirmed by LC-MS analysis.,100 mM K2HPO4/KH2PO4,7.0,,40.0,,,
PMID32409606,reaction_1,in vitro,Enzymatic function analysis with affinity-purified recombinant His-tagged protein.,,,,,Escherichia coli,,
PMID32409606,reaction_2,in vivo,"Heterologous expression in Pichia pastoris, which were then fed syn-pimara-7,15-diene. Function was also confirmed by co-expression in Nicotiana benthamiana.",,,,,Pichia pastoris,,
PMID32409606,reaction_3,in vivo,"Heterologous expression in Pichia pastoris, which were then fed syn-pimara-7,15-diene. Function was also confirmed by co-expression in Nicotiana benthamiana.",,,,,Pichia pastoris,,
PMID32409606,reaction_4,in vivo,Transient expression in Nicotiana benthamiana using the Agroinfiltration method.,,,,,Nicotiana benthamiana,pEAQ-HT,
PMID32409606,reaction_5,in vivo,Pathway reconstitution by transient co-expression of the four cluster genes in Nicotiana benthamiana using Agroinfiltration.,,,,,Nicotiana benthamiana,pEAQ-HT,
PMID32409656,reaction_1,in vitro,ATPase activity was determined by measuring phosphate liberation from ATP using microsomes isolated from transformed yeast. H+ pump function was confirmed separately by a yeast complementation assay.,"50 mM MOPS/MES, 8 mM MgSO4, 5 mM NaN3, 0.25 mM NaMoO4, 25 mM KNO3, 2 mM phosphoenolpyruvate, and 30 μg/mL pyruvate kinase",6.5,pH used for kinetic characterization. The pH optimum was determined to be near 6.5 in a range from pH 5.4 to 8.1.,30.0,Saccharomyces cerevisiae strain RS-72,pMP4409,"Yeast grown in minimal medium with 2% galactose, then transferred to YPD media for 20h for expression."
PMID32409656,reaction_2,in vitro,ATPase activity was determined by measuring phosphate liberation from ATP using microsomes isolated from transformed yeast. H+ pump function was confirmed separately by a yeast complementation assay.,"50 mM MOPS/MES, 8 mM MgSO4, 5 mM NaN3, 0.25 mM NaMoO4, 25 mM KNO3, 2 mM phosphoenolpyruvate, and 30 μg/mL pyruvate kinase",6.5,pH used for kinetic characterization. The pH optimum was determined to be near 6.5 in a range from pH 5.4 to 8.1.,30.0,Saccharomyces cerevisiae strain RS-72,pMP4409,"Yeast grown in minimal medium with 2% galactose, then transferred to YPD media for 20h for expression."
PMID32409656,reaction_3,in vitro,ATPase activity was determined by measuring phosphate liberation from ATP using microsomes isolated from transformed yeast. H+ pump function was confirmed separately by a yeast complementation assay.,"50 mM MOPS/MES, 8 mM MgSO4, 5 mM NaN3, 0.25 mM NaMoO4, 25 mM KNO3, 2 mM phosphoenolpyruvate, and 30 μg/mL pyruvate kinase",6.5,pH used for kinetic characterization. The pH optimum was determined to be near 6.5 in a range from pH 5.4 to 8.1.,30.0,Saccharomyces cerevisiae strain RS-72,pMP4409,"Yeast grown in minimal medium with 2% galactose, then transferred to YPD media for 20h for expression."
PMID32415359,reaction_1,in vitro,Enzyme assay with purified recombinant protein,50 mM Tris-HCl,7.5,,75.0,Escherichia coli (Novagen Rosetta™ (DE3)),pET-46,auto-induction media (ZYM 5052) for 18-24 h
PMID32415359,reaction_2,in vitro,Enzyme assay with purified recombinant protein,50 mM Tris-HCl,7.5,,75.0,Escherichia coli (Novagen Rosetta™ (DE3)),pET-46,auto-induction media (ZYM 5052) for 18-24 h
PMID32415359,reaction_3,in vitro,Enzyme assay with purified recombinant protein,50 mM Tris-HCl,7.5,,75.0,Escherichia coli (Novagen Rosetta™ (DE3)),pET-46,auto-induction media (ZYM 5052) for 18-24 h
PMID32415359,reaction_4,in vitro,Enzyme assay with purified recombinant protein,50 mM Tris-HCl,7.5,,75.0,Escherichia coli (Novagen Rosetta™ (DE3)),pET-46,auto-induction media (ZYM 5052) for 18-24 h
PMID32415359,reaction_5,in vitro,Enzyme assay for substrate specificity screening,50 mM Tris-HCl,7.5,,75.0,Escherichia coli (Novagen Rosetta™ (DE3)),pET-46,auto-induction media (ZYM 5052) for 18-24 h
PMID32415359,reaction_6,in vitro,Enzyme assay for substrate specificity screening,50 mM Tris-HCl,7.5,,75.0,Escherichia coli (Novagen Rosetta™ (DE3)),pET-46,auto-induction media (ZYM 5052) for 18-24 h
PMID32415359,reaction_7,in vitro,Enzyme assay for substrate specificity screening,50 mM Tris-HCl,7.5,,75.0,Escherichia coli (Novagen Rosetta™ (DE3)),pET-46,auto-induction media (ZYM 5052) for 18-24 h
PMID32416191,reaction_1,in vitro,Partitioning of SecA into large unilamellar vesicles (LUVs) was quantified by short-time (15s) glutaraldehyde crosslinking followed by SDS-PAGE densitometry of monomer and dimer bands. Partitioning was also monitored by Trp fluorescence.,"50 mM Hepes-KOH pH 8.0, 100 mM KGlu, 2 mM MgCl2 and 0.5 mM DTT",8.0,,37.0,Escherichia coli BL21,Plasmid with T5 promoter and C-terminal His6-tag,"0.5 mM IPTG, 30°C, 2h"
PMID32417540,reaction_1,in vitro,Continuous enzymatic assay monitoring CoA release.,"100 mM Tris-HCl, 0.15 mM 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB)",7.8,,30.0,Escherichia coli Rosetta2 (DE3),pET47b(+),"100 μM IPTG, 20°C, 20h"
PMID32417540,reaction_2,in vitro,Continuous enzymatic assay monitoring CoA release.,"100 mM Tris-HCl, 0.15 mM 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB)",7.8,,30.0,,,
PMID32417540,reaction_3,in vivo,Cultivation in mineral medium with 0.6% (v/v) palm olein (PO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator H16ΔC,pBBR1-CBP-M-CPF4,
PMID32417540,reaction_4,in vivo,Cultivation in mineral medium with 0.6% (v/v) palm olein (PO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator PHB-4,pBBR1-CBP-M-CPF4,
PMID32417540,reaction_5,in vivo,Cultivation in mineral medium with 0.6% (v/v) palm olein (PO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator PHB-4,pHT1-CBP-M-CPF4,
PMID32417540,reaction_6,in vivo,Cultivation in mineral medium with 0.6% (v/v) palm olein (PO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator Re2058,pHT1-CBP-M-CPF4,
PMID32417540,reaction_7,in vivo,Cultivation in mineral medium with 0.6% (v/v) palm olein (PO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator Re2160,pHT1-CBP-M-CPF4,
PMID32417540,reaction_8,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator H16ΔC,pBBR1-CBP-M-CPF4,
PMID32417540,reaction_9,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator PHB-4,pBBR1-CBP-M-CPF4,
PMID32417540,reaction_10,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator PHB-4,pHT1-CBP-M-CPF4,
PMID32417540,reaction_11,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator Re2058,pHT1-CBP-M-CPF4,
PMID32417540,reaction_12,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator Re2160,pHT1-CBP-M-CPF4,
PMID32417540,reaction_13,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator PHB-4,pHT1-Ccs,
PMID32417540,reaction_14,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator Re2058,pHT1-Ccs,
PMID32417540,reaction_15,in vivo,Cultivation in mineral medium with 0.6% (v/v) crude palm kernel oil (CPKO) as carbon source.,Mineral medium (MM) with 0.054% urea,,,30.0,Cupriavidus necator Re2160,pHT1-Ccs,
PMID32423667,reaction_1,in vitro,Steady-state kinetic assay with purified enzyme using Ellman's reagent to monitor CoASH release.,"100 mM KPi, pH 7.5, 150 mM NaCl, 50 mM L-Ser, 10 µM PLP and 0.2 mM Ellman's reagent",7.5,,25.0,E. coli BL21-Gold (DE3),pET-22b(+),Autoinduction in ZYM-5022 media at 30°C for 20h.
PMID32423667,reaction_2,in vitro,Steady-state kinetic assay with purified enzyme using Ellman's reagent to monitor CoASH release.,"100 mM KPi, pH 7.5, 150 mM NaCl, 50 mM L-Ser, 10 µM PLP and 0.2 mM Ellman's reagent",7.5,,25.0,E. coli BL21-Gold (DE3),pET-22b(+),Autoinduction in ZYM-5022 media at 30°C for 20h.
PMID32423667,reaction_3,in vitro,Steady-state kinetic assay with purified enzyme using Ellman's reagent to monitor CoASH release. Also used for initial library screening with cell lysates.,"100 mM KPi, pH 7.5, 150 mM NaCl, 50 mM L-Ser, 10 µM PLP and 0.2 mM Ellman's reagent",7.5,,25.0,E. coli BL21-Gold (DE3),pET-22b(+),Autoinduction in ZYM-5022 media at 30°C for 20h.
PMID32423667,reaction_4,in vitro,Steady-state kinetic assay with purified enzyme using Ellman's reagent to monitor CoASH release.,"100 mM KPi, pH 7.5, 150 mM NaCl, 50 mM L-Ser, 10 µM PLP and 0.2 mM Ellman's reagent",7.5,,25.0,E. coli BL21-Gold (DE3),pET-22b(+),Autoinduction in ZYM-5022 media at 30°C for 20h.
PMID32423667,reaction_5,in vitro,Activity assay with purified enzyme using Ellman's reagent to monitor CoASH release.,"100 mM KPi, pH 7.5, 150 mM NaCl, 50 mM L-Ser, 10 µM PLP and 0.2 mM Ellman's reagent",7.5,,25.0,E. coli BL21-Gold (DE3),pET-22b(+),Autoinduction in ZYM-5022 media at 30°C for 20h.
PMID32423674,reaction_1,in vitro,Coupled spectrophotometric assay measuring the rate of o-dianisidine oxidation in a high-pressure optical cell. The reaction was monitored at 500 nm.,50 mM sodium acetate buffer,5.1,,25.0,,,
PMID32427050,reaction_1,in vitro,Whole-cell biotransformation with resting cells.,0.2 M acetate buffer,5.0,,25.0,Gluconobacter frateurii CHM 43,,
PMID32427050,reaction_2,in vitro,Whole-cell biotransformation with resting cells. Specific activity was measured in crude membrane fractions.,0.2 M acetate buffer,5.0,,25.0,Gluconobacter frateurii CHM 43,,
PMID32428392,reaction_1,in vitro,AMC fluorescence cleavage assay for kinetics,"100 mM NaCl, 50 mM HEPES [pH = 7.5], 0.01 mg/mL bovine serum albumin (BSA), and 5 mM DTT",7.5,,,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_2,in vitro,AMC fluorescence cleavage assay for kinetics,"100 mM NaCl, 50 mM HEPES [pH = 7.5], 0.01 mg/mL bovine serum albumin (BSA), and 5 mM DTT",7.5,,,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_3,in vitro,AMC fluorescence cleavage assay for kinetics and inhibition,"98% AMC buffer (100 mM NaCl, 50 mM HEPES [pH = 7.5], 0.01 mg/mL BSA, 5 mM DTT) and 2% DMSO",7.5,,,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_4,in vitro,SDS-PAGE gel cleavage assay,"AMC buffer (100 mM NaCl, 50 mM HEPES [pH = 7.5], 0.01 mg/mL bovine serum albumin (BSA), and 5 mM DTT)",7.5,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_5,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_6,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_7,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_8,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_9,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_10,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_11,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_12,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_13,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32428392,reaction_14,in vitro,SDS-PAGE gel cleavage assay,"100 mM NaCl, 5 mM HEPES [pH = 7.4]",7.4,,37.0,T7 express E. coli,pET-15b,"0.5 mM IPTG, 18°C, overnight"
PMID32432915,reaction_1,in vitro,Enzyme activity was measured in fresh liver and kidney tissue homogenates from pigs of different ages.,"potassium phosphate buffer containing 0.6 mM ferrous sulfate, 14 mM ascorbate, 0.7 mM ketoglutarate and 1.4 g L-1 catalase",7.4,,37.0,,,
PMID32433733,reaction_1,in vivo,Dietary intervention in congenic wild-type and Bco1-/- mice to assess impact on plasma cholesterol.,Mice were fed a vitamin A-deficient Western-type diet supplemented with 50 mg/kg of β-carotene for 10 days.,,,24.0,,,
PMID32436380,reaction_1,in vitro,In vitro assay with purified recombinant enzyme for kinetic analysis.,Not specified,8.0,Optimal pH for product formation.,40.0,Escherichia coli BL21(DE3),pQE1a_hMpB,
PMID32436380,reaction_2,in vitro,In vitro assay with purified recombinant enzyme for kinetic analysis.,Not specified,,,30.0,Escherichia coli BL21(DE3),pQE1a_hMbB,
PMID32436380,reaction_3,in vitro,In vitro assay with purified His-tagged recombinant enzyme to test substrate specificity.,Not specified,,,,Escherichia coli BL21(DE3),pQE1a_hAoB,
PMID32436380,reaction_4,in vitro,In vitro assay with purified His-tagged recombinant enzyme to test substrate specificity.,Not specified,,,,Escherichia coli BL21(DE3),pQE1a_hLIB,
PMID32436380,reaction_5,in vitro,In vitro assay with purified His-tagged recombinant enzyme to test substrate specificity.,Not specified,,,,Escherichia coli BL21(DE3),pQE1a_hTmB,
PMID32437808,reaction_1,in vitro,Enzyme activity determination by following the oxidation of NADPH at 340 nm.,50 mM potassium phosphate buffer,6.2,,25.0,,,
PMID32442521,reaction_1,in vitro,Endogenous enzyme activity in primary microglial cell cultures from adult mice. Activity was assessed based on preliminary data of D-serine release into the culture medium.,DMEM/F12 media,,"Not specified for the reaction, but homogenization buffer for analysis was pH 7.5.",,Primary microglial cells from Mus musculus (C57BL6/J wild type),,
PMID32451803,reaction_1,in vitro,resting-cell biotransformation,50 mM disodium hydrogen phosphate-sodium dihydrogen phosphate buffer,7.0,Optimized pH for biotransformation.,45.0,Escherichia coli BL21 (DE3),pET28(a)-dpe and pETDuet-1-MCSIfdh-MCSIIrdh,"1 mM IPTG added at OD600=9, followed by 12h cultivation at 28°C."
PMID32451803,reaction_2,in vitro,One-pot reaction using mixed catalysts (immobilized enzyme and resting cells),disodium hydrogen phosphate-sodium dihydrogen phosphate buffer,7.0,,45.0,Escherichia coli BL21 (DE3),pET28(a)-dpe and pETDuet-1-MCSIfdh-MCSIIrdh,"1 mM IPTG added at OD600=9, followed by 12h cultivation at 28°C."
PMID32453018,reaction_1,in vivo,"Measurement of GABAT protein expression and GABA concentration in cortical infarct regions of rats using ELISA and Western blot after various treatments (waggle needling, routine needling, baclofen).",,,Physiological pH in rat brain,,Endogenous to Sprague–Dawley rat,,
PMID32456285,reaction_1,in vitro,Deneddylation activity assay using mouse brain extracts and recombinant Nedd8 conjugates.,PBS,,pH not specified for PBS buffer.,37.0,Endogenous from Mus musculus brain extract,,
PMID32457294,reaction_1_neddylation,in vitro,In vitro neddylation assay with purified components. Also studied in vivo in HEK293T and Hela cells via immunoprecipitation and western blot.,"50 mM Tris-HCl, 1 mM DTT, 2 mM NaF, 10 mM MgCl2, 5 mM ATP",7.5,,30.0,HEK293T,,
PMID32457294,reaction_2_autophosphorylation,in vivo,Western blot analysis of phosphorylated DNA-PKcs in Hela cells after DNA damage induction by VP-16 or ionizing radiation (IR).,"Cellular environment. Lysis performed in NETN-300 buffer (20 mM Tris-HCl, 300 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40).",8.0,pH of lysis buffer,37.0,Hela,,
PMID32457501,reaction_1,in vivo,Whole-cell conversion assay comparing wild-type and ΔtsdA mutant. Substrate and product concentrations were monitored over time.,Artificial seawater (ASW) marine broth 2216E supplemented with 40 mM thiosulfate,7.35,Initial pH was adjusted to between 7.2 and 7.5.,28.0,Escherichia coli,,
PMID32457501,reaction_2,in vivo,Whole-cell conversion assay comparing wild-type and ΔsoxB mutant. Substrate and product concentrations were monitored over time.,Artificial seawater (ASW) marine broth 2216E supplemented with 40 mM thiosulfate,7.35,Initial pH was adjusted to between 7.2 and 7.5.,28.0,,,
PMID32457501,reaction_3,in vivo,"Whole-cell conversion assay comparing wild-type and ΔsdoA, ΔsdoB, and ΔsdoAB mutants. Substrate and product concentrations were monitored over time.",Artificial seawater (ASW) marine broth 2216E supplemented with 40 mM thiosulfate,7.35,Initial pH was adjusted to between 7.2 and 7.5.,28.0,,,
PMID32459092,reaction_1,in vitro,Pyrophosphatase-coupled cGAS activity assay,"10 mM HEPES, 140 mM NaCl, 0.01% Tween-20, 5 mM MgCl2",7.5,,25.0,Escherichia coli Rosetta 2 (DE3),pET-15b,0.5 mM IPTG at 16 °C for 8-10 h
PMID32459374,reaction_1_CaCYP51,in vitro,CYP51 reconstitution assay for IC50 determination and ligand binding assays for Kd determination.,"0.1 M Tris-HCl, 25% (wt/vol) glycerol",8.1,,37.0,Escherichia coli,,
PMID32459374,reaction_2_HsCYP51,in vitro,"CYP51 reconstitution assay for IC50 determination and ligand binding assays for Kd determination, used for selectivity profiling.","0.1 M Tris-HCl, 25% (wt/vol) glycerol",8.1,,37.0,Escherichia coli,,
PMID32464091,reaction_1,in vitro,Surface Plasmon Resonance (SPR),SPR buffer containing ADP or ATP,,,,,,
PMID32464091,reaction_2,in vitro,Surface Plasmon Resonance (SPR),"SPR buffer with 50 mM NaCl, 1 mM ATP, and 5 µM DnaGC",,,,,,
PMID32464091,reaction_3,in vitro,Leading- and lagging-strand rolling-circle replication assay,,,,,,,
PMID32464091,reaction_4,in vitro,"Destabilized rolling-circle replication assay (lacking b2, SSB, and chi-psi subunits)",,,,,,,
PMID32464091,reaction_5,in vitro,"Destabilized leading-strand rolling-circle assay (lacking b2, SSB, and chi-psi subunits)",,,,,,,
PMID32464091,reaction_6,in vitro,Single-molecule Fluorescence Recovery After Photobleaching (sm-FRAP) rolling-circle assay,TIRF imaging buffer,,,,,,
PMID32464434,reaction_1,in vitro,"In vitro synthesis and post-translational modification of AK3 in a cell-free system, with product analysis using Peptide Mass Fingerprinting (PMF).","Transdirect insect cell system (Shimadu Biotech, Japan) with 50 µM farnesyl diphosphate.",,Not specified,,"Insect cell-free protein synthesis system (Transdirect insect cell, Shimadu Biotech, Japan)",,
PMID32469443,reaction_1,in vivo,Whole-cell anti-mycobacterial activity assay against M. tuberculosis H37Rv and a clinical MDR-TB strain. Activity measured by OD590 and fluorescence (H37Rv) or Löwenstein-Jensen method (MDR-TB).,"Bacterial growth medium (e.g., Löwenstein-Jensen medium).",,,,,,
PMID32470517,reaction_1,in vitro,Isothermal titration calorimetry (ITC) continuous rate assay for kinetics and 31P-NMR for substrate specificity.,"100 mM bicine, 1 mM magnesium acetate",8.5,,30.0,Escherichia coli BL21(DE3),pET45,
PMID32470517,reaction_2,in vitro,Isothermal titration calorimetry (ITC) continuous rate assay for kinetics and 31P-NMR for substrate specificity.,"100 mM bicine, 1 mM magnesium acetate",8.5,,30.0,Escherichia coli BL21(DE3),pET45,
PMID32471859,reaction_1,in vitro,Enzyme activity assay with recombinant MBP-fused DGK4 from E. coli crude extract.,"40 mM Tricine, 1 mM CHAPS, 0.02% Triton X-100, 5 mM MgCl2",,Not specified in the text.,,Escherichia coli C41 (DE3),pMAL-c5x,"2 mM IPTG, 23°C, 20 h"
PMID32471859,reaction_2,in vivo,Chemical complementation of pollen germination defect in dgk2-1/+ dgk4-1/+ mutants.,in vitro pollen germination solid medium,,Not specified,,,,
PMID32471859,reaction_3,in vivo,Pulse-chase radiolabeling of rosette leaves with γ[32P]ATP.,half-strength MS liquid medium,,Not specified,,,,
PMID32472090,reaction_1,in vitro,Decanoic acid hydroxylation assay to measure enzyme activity.,100 mM phosphate buffer,8.0,,30.0,E. coli BL21 (DE3),pET46 Ek/LIC,"0.4 mM IPTG, 16 °C, 18 h"
PMID32472101,reaction_1,in vivo,"Incorporation of ncAA into a reporter protein (GFP or GST-CAM) in E. coli, measured by fluorescence, western blot, and mass spectrometry.",2XTY medium,,Standard E. coli culture conditions,37.0,Escherichia coli DH10B,"pKW-Triple, pO-StrepGFP, pRSF ribo-Q1",1 mM IPTG for protein expression
PMID32472101,reaction_2,in vivo,"Incorporation of ncAA into a reporter protein (GFP or GST-CAM) in E. coli, measured by fluorescence, western blot, and mass spectrometry.",2XTY medium,,Standard E. coli culture conditions,37.0,Escherichia coli DH10B,"pKW-Triple, pO-StrepGFP, pRSF ribo-Q1",1 mM IPTG for protein expression
PMID32472101,reaction_3,in vivo,"Incorporation of ncAA into a reporter protein (GFP or GST-CAM) in E. coli, measured by fluorescence, western blot, and mass spectrometry.",2XTY medium,,Standard E. coli culture conditions,37.0,Escherichia coli DH10B,"pKW-Triple, pO-StrepGFP, pRSF ribo-Q1",1 mM IPTG for protein expression
PMID32472101,reaction_4,in vivo,"Initial activity and orthogonality screening of PylRS/PyltRNA pairs. Activity was measured by suppression of an amber codon (TAG) in a GFP(150TAG)His6 reporter, quantified by fluorescence.","2XTY-STA medium (2XTY medium with 75 μg ml−1 spectinomycin, 25 μg ml−1 tetracycline and 0.5% l-arabinose)",,Standard E. coli culture conditions,37.0,Escherichia coli DH10B,pKW and pBAD vectors,0.5% l-arabinose
PMID32472168,reaction_1,in vitro,Vesicular transport assay using inside-out membrane vesicles from overexpressing HEK293 cells.,"10 mM Tris-HEPES, 250 mM Sucrose",7.4,,37.0,HEK293 cells,,Overexpressed using a mammalian baculovirus system.
PMID32472168,reaction_2,in vitro,Vesicular transport assay using inside-out membrane vesicles from overexpressing HEK293 cells.,"10 mM Tris-HEPES, 250 mM Sucrose",7.4,,37.0,HEK293 cells,,Overexpressed using a mammalian baculovirus system.
PMID32472168,reaction_3,in vitro,Vesicular transport assay using inside-out membrane vesicles from overexpressing HEK293 cells.,"10 mM Tris-HEPES, 250 mM Sucrose",7.4,,37.0,HEK293 cells,,Overexpressed using a mammalian baculovirus system.
PMID32472168,reaction_4,in vitro,Vesicular transport assay using inside-out membrane vesicles from overexpressing HEK293 cells.,"10 mM Tris-HEPES, 250 mM Sucrose",7.4,,37.0,HEK293 cells,,Overexpressed using a mammalian baculovirus system.
PMID32474056,reaction_1,in vivo,Fatty acid production in engineered E. coli strains.,"LB with 1.5 wt% dextrose, 100 mg/L ampicillin, and 1.0 mM IPTG",,Not specified for production experiment.,30.0,"Escherichia coli ML115 (MG1655 ∆fadD, ∆poxB, ∆ackA-pta)",pJMY-EEI82564,1.0 mM IPTG
PMID32483918,reaction_1,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_2,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_3,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_4,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_5,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_6,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_7,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_8,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_9,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32483918,reaction_10,in vitro,Qualitative screen for activity against a panel of flavonoids by comparing reaction samples with no-enzyme controls via HPLC-MS.,Tris buffer or acetate buffer,,"Assays were generally set up for pH 4.0, 5.5, or 7.0. The specific pH for the flavonoid screen was not detailed.",37.0,E. coli BLR (DE3),pET29 (+b),"0.5 mM IPTG, 16 °C, 24 h"
PMID32485238,reaction_1,in vitro,Initial velocity measurements monitoring NADPH formation at 340 nm.,"100 mM Tris-HCl pH 8, 0.05 mM NADP, 5 mM MgCl2, 100 mM KCl, 0.1 mg/ml BSA, 1 mM of L-malate",8.0,,30.0,E. coli BL21 (λDE3),pGAMaeB1 (pET29a derivative),"0.5 mM IPTG, 20°C, 20 hours"
PMID32485238,reaction_2,in vitro,Initial velocity measurements monitoring NADPH consumption at 340 nm.,"100 mM Tris-HCl pH 8, 0.02 mM NADPH, 5 mM MgCl2, 100 mM KCl, 0.1 mg/ml BSA, 10 mM of pyruvate, 10 mM KHCO3",8.0,,30.0,E. coli BL21 (λDE3),pGAMaeB1 (pET29a derivative),"0.5 mM IPTG, 20°C, 20 hours"
PMID32485238,reaction_3,in vitro,Initial velocity measurements monitoring NADPH formation at 340 nm.,"100 mM Tris-HCl pH 8, 5 mM MgCl2, 100 mM KCl, 0.1 mg/ml BSA",8.0,Inferred from general methods section.,30.0,"E. coli BW25113 (for His-tagged), E. coli BL21 (λDE3) (for untagged)",ASKA collection plasmid (His-tagged) or pLHPET29EcMaeB (untagged),"0.5 mM IPTG, 20°C, 20 hours"
PMID32487758,reaction_1,in vivo,Metabolite levels were measured in cultured L. major promastigotes (wild-type vs Δdecr mutant) using targeted liquid chromatography/mass spectrometry (LC/MS). The role in the broader pathway was confirmed by incubating parasites with 13C-labeled linoleic acid and monitoring 13C incorporation into citrate by GC/MS.,"Completely defined medium (CDM) or semi-defined medium (SDM). For metabolic analyses, parasites were in glucose-free CDM supplemented with labeled linoleic acid and 5 mM glutamate.",,"Parasites were incubated at 33°C to mimic amastigote conditions. The pH for this specific experiment was not stated, though differentiation medium is mentioned as pH 5.5.",33.0,Leishmania major,pUC18-based vectors for homologous recombination,Endogenous gene knockout and reinsertion; not an overexpression system.
PMID32488442,reaction_1,in vivo,Whole-cell bioconversion using recombinant E. coli expressing 15-LOX.,50 mM HEPES buffer containing 10% (v/v) ethanol,7.5,initial pH,25.0,Escherichia coli ER2566,pET-28a(+),"0.1 mM IPTG, 16°C for 18 h"
PMID32488442,reaction_2,in vivo,Whole-cell bioconversion using recombinant E. coli co-expressing 15-LOX and epoxide hydrolase.,50 mM HEPES buffer containing 10% (v/v) ethanol,7.5,initial pH,25.0,Escherichia coli ER2566,"Co-transformed plasmids, including pET-28a(+) for 15-LOX.","0.1 mM IPTG, 16°C for 18 h"
PMID32488442,reaction_3,in vitro,Specific activity measurement with purified enzyme.,50 mM HEPES buffer,7.5,initial pH,25.0,,,
PMID32488442,reaction_4,in vitro,Specific activity measurement with purified enzyme.,50 mM HEPES buffer,7.5,initial pH,25.0,,,
PMID32492133,reaction_1,in vitro,Enzyme assay using liver cytosol from MCD diet-fed mice.,100 mM Tris-HCl buffer,7.4,,37.0,,,
PMID32492133,reaction_2,in vitro,Enzyme assay using liver cytosol from MCD diet-fed mice to determine substrate specificity.,100 mM Tris-HCl buffer,7.4,,37.0,,,
PMID32492133,reaction_3,in vitro,Enzyme assay using liver cytosol from MCD diet-fed mice to determine substrate specificity.,100 mM Tris-HCl buffer,7.4,,37.0,,,
PMID32492133,reaction_4,in vitro,Enzyme assay using liver cytosol from MCD diet-fed mice to determine substrate specificity.,100 mM Tris-HCl buffer,7.4,,37.0,,,
PMID32496216,reaction_1,in vitro,"The enzyme was expressed, purified, and crystallized. The reaction itself was not assayed for kinetics or conversion, but its mechanism and substrate binding are discussed based on structural data. The crystal structure was solved in complex with substrate analogs glycerol and sulfate.","Crystallization buffer: 1.8–2.2 M ammonium sulfate, 100 mM Tris pH 7–8. Purification buffer: 20 mM sodium phosphate pH 7.4, 500 mM sodium chloride, 5 mM imidazole.",7.5,Crystallization was performed in 100 mM Tris pH 7-8. The final reported structure used a cryoprotective buffer at pH 7.5.,37.0,Escherichia coli BL21(DE3),p7XNH3,"1 mM IPTG, 37°C, 5h"
PMID32496217,reaction_1,in vitro,Spectrophotometric assay monitoring NADPH consumption at 340 nm.,20 mM sodium acetate buffer,5.0,,25.0,,,
PMID32497258,reaction_1,in vitro,Kinetic parameters were determined using purified N-terminal His6-tagged enzyme. Activity was also measured in cell-free extracts.,200 mM Tris,8.1,,37.0,Escherichia coli BL21(DE3),pET-28bCH (+),autoinduction medium at room temperature
PMID32497258,reaction_2,in vitro,Enzyme activity measured in cell-free extracts using 1 mM acetyl-CoA and 20 mM pyruvate. Activity was monitored by detecting free CoA with DTNB at 412 nm.,Not specified,,,37.0,"Engineered Escherichia coli C strains (e.g., MEC613, MEC626)",pZE12-cimA,0.2 mM IPTG
PMID32500270,reaction_1,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2- or 5-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_2,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_3,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_4,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_5,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_6,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2- or 5-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_7,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2- or 5-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_8,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2- or 5-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_9,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2- or 5-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32500270,reaction_10,in vitro,HPLC-based activity assay,"0.1-M Tris-HCl (pH 8.0), 2- or 5-mM MnCl2",8.0,,30.0,Escherichia coli BL21(DE3)/pLysS,pET28a,
PMID32504107,reaction_1,in vitro,Enzymatic assay measuring succinate production from the oxidation of 5-methylcytosine in genomic DNA. Succinate was quantified using the EnzyChrom Succinate Assay Kit.,"50 mM HEPES (pH 8.0), 75 μM Fe(NH4)2(SO4)2, 2 mM ascorbic acid, and 1 mM alpha-ketoglutaric acid",8.0,,37.0,Escherichia coli BL21 (DE3),pET30c-Streptag-TET2,"0.5 mM IPTG, 16°C, 18 h"
PMID32511919,reaction_1,in vitro,Stopped-flow absorption spectroscopy for kinetics of intermediate decay and single turnover LC-MS for product identification.,"20 mM sodium HEPES, 50 mM NaCl, 5% (v/v) glycerol",7.5,,5.0,Escherichia coli BL21(DE3),pET29a,"0.5 mM IPTG, 18 °C, 16-18 h"
PMID32511919,reaction_2,in vitro,Stopped-flow absorption spectroscopy monitoring the decay of the catalytic intermediate.,"50 mM sodium HEPES, 50 mM NaCl, 5% (v/v) glycerol",7.5,,5.0,Escherichia coli BL21(DE3),pET29a,"0.5 mM IPTG, 18 °C, 16-18 h"
PMID32513704,reaction_1,in vitro,Enzyme activity assay with recombinant protein and HPLC product analysis.,"50 mM Tris·HCl, 0.1% (vol/vol) Triton X-100",7.5,,26.0,Escherichia coli BL21,modified pCW-MBP vector,0.5 mM IPTG and 0.5 mM 5-aminolevulinic acid at 23 °C for 48 h
PMID32517586,reaction_1,in vitro,"Analysis of enzyme redox state by PEG-maleimide modification and SDS-PAGE after incubation with substrate to demonstrate intramolecular electron transfer. The enzyme was pre-reduced with DTT, which was then removed before addition of substrate.",Phosphate Buffered Saline (PBS),7.4,"Assays were performed in PBS, which is typically pH 7.4.",37.0,Escherichia coli BL21(DE3),Maltose binding protein (MBP) fusion vector with a TEV protease cleavage site,0.5 mM IPTG and 0.5 mM ZnCl2 at 25°C overnight
PMID32526261,reaction_1,in vivo,Heterologous expression in E. coli JM109 for PHB production in shake flask experiments.,LB medium supplemented with 20 g/L glucose,,Not specified,30.0,Escherichia coli JM109,pEn-phaC1AB,Constitutive expression under Ppdc promoter from Zymomonas mobilis.
PMID32526261,reaction_2,in vivo,Heterologous expression in E. coli JM109 for PHB production in shake flask experiments.,LB medium supplemented with 20 g/L glucose,,Not specified,25.0,Escherichia coli JM109,pEn-phaC2AB,Constitutive expression under Ppdc promoter from Zymomonas mobilis.
PMID32526261,reaction_3,in vivo,Heterologous expression in E. coli JM109 for PHB production in shake flask experiments.,LB medium supplemented with 20 g/L glucose,,Not specified,30.0,Escherichia coli JM109,pEn-phaECAB,Constitutive expression under Ppdc promoter from Zymomonas mobilis.
PMID32531208,reaction_1,in vitro,Primer extension assay,"10 mM Tris-HCl, 10 mM KCl, 1 mM beta-mercaptoethanol, 2 mM MgCl2",8.0,,30.0,nsp12 in High Five cells (Spodoptera frugiperda); nsp7 and nsp8 in Escherichia coli BL21 (DE3),"pFastBac-1 (for nsp12), pET21a (for nsp7, nsp8)",nsp12: expressed for 48h at 27°C post infection. nsp7/nsp8: induced with 1 mM IPTG for 14-16 hours at 16°C.
PMID32531315,reaction_1,in vitro,DHA consumption monitored by UV absorbance spectroscopy at 277 nm; O2 consumption monitored using an Oxygraph+ system.,"50 mM MES, 100 mM sodium chloride, pH 6.0",6.0,,20.0,Escherichia coli BL21(DE3),pET20b(+),"500 µM IPTG, 5.0 h at 37 °C, 250 RPM"
PMID32531362,reaction_1,in vitro,Overoxidation of the peroxidatic cysteine in an engineered Ahp1-Trx2 complex for crystallographic studies.,"Crystallization solution: 25% polyethylene glycol 3,350, 0.2 M lithium sulfate, 0.1 M HEPES-NaOH, pH 7.5.",7.5,pH of the crystallization reservoir solution.,16.0,Escherichia coli Rosetta (DE3),"pET29a-derived vector for Ahp1, pET28a-derived vector for Trx2",0.2 mM IPTG for four hours at 37 °C
PMID32534087,reaction_1,in vitro,Enzyme activity assay with purified protein.,0.1 M Tris-HCl,8.0,Optimal pH for reductive amination.,55.0,Escherichia coli BL21 (DE3),pET-28a co-expressed with pGro7,"0.3 mM IPTG and 10 mM arabinose, 15°C, 24 h"
PMID32534087,reaction_2,in vitro,Enzyme activity assay with purified protein.,0.1 M Tris-HCl,9.0,Optimal pH for oxidative deamination.,55.0,Escherichia coli BL21 (DE3),pET-28a co-expressed with pGro7,"0.3 mM IPTG and 10 mM arabinose, 15°C, 24 h"
PMID32534087,reaction_3,in vivo,Whole-cell catalysis for product synthesis. Kinetic parameters determined in vitro.,20 mM phosphate buffer,8.0,pH for whole-cell catalysis. Optimal pH for in vitro kinetics is also 8.0.,25.0,Escherichia coli BL21 (DE3),pET-adh1-T7-gdh co-expressed with pGro7,"0.3 mM IPTG and 10 mM arabinose, 15°C, 24 h"
PMID32534087,reaction_4,in vitro,Enzyme activity assay with purified protein.,0.1 M Tris-HCl,8.0,Optimal pH for reductive amination.,55.0,Escherichia coli BL21 (DE3),pET-28a co-expressed with pGro7,"0.3 mM IPTG and 10 mM arabinose, 15°C, 24 h"
PMID32534087,reaction_5,in vitro,Enzyme activity assay with purified protein.,0.1 M Tris-HCl,8.0,Optimal pH for reductive amination.,55.0,Escherichia coli BL21 (DE3),pET-28a co-expressed with pGro7,"0.3 mM IPTG and 10 mM arabinose, 15°C, 24 h"
PMID32534087,reaction_6,in vitro,Enzyme activity assay with purified protein.,0.1 M Tris-HCl,8.0,Optimal pH for reductive amination.,55.0,Escherichia coli BL21 (DE3),pET-28a co-expressed with pGro7,"0.3 mM IPTG and 10 mM arabinose, 15°C, 24 h"
PMID32534087,reaction_7,in vitro,Enzyme activity assay with purified protein.,0.1 M Tris-HCl,8.0,Optimal pH for reductive amination.,55.0,Escherichia coli BL21 (DE3),pET-28a co-expressed with pGro7,"0.3 mM IPTG and 10 mM arabinose, 15°C, 24 h"
PMID32540188,reaction_1,in vitro,UGP activity assay using crude enzyme extract from fungal hyphae.,"Enzyme extraction buffer: 50 mM Tris-hydrochloride (pH 8.5), 1 mM magnesium chloride, 0.5 mM potassium chloride, 10 mM b-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride, and 0.1 % Triton X-100 (v/v). Reaction buffer: Tris-HCl buffer (pH 8.5) containing 1 mM MgCl2.",8.5,Tris-hydrochloride buffer,20.0,,,
PMID32540203,reaction_1,in vivo,Gene expression analysis in fungal mycelium culture after precursor feeding with 1 mM tryptophan.,"Gamborg B5 medium, supplemented with 3% w/v sucrose and buffered with 10 mM MES",6.8,,,,,
PMID32540203,reaction_2,in vivo,Gene expression analysis in fungal mycelium culture after precursor feeding with 1 mM tryptophan.,"Gamborg B5 medium, supplemented with 3% w/v sucrose and buffered with 10 mM MES",6.8,,,,,
PMID32540203,reaction_3,in vivo,Gene expression analysis in fungal mycelium culture after precursor feeding with 1 mM tryptophan.,"Gamborg B5 medium, supplemented with 3% w/v sucrose and buffered with 10 mM MES",6.8,,,,,
PMID32540485,reaction_1,in vitro,Enzyme activity was measured in lysates from both primary cell cultures (neonatal rat cardiomyocytes and adult cardiac fibroblasts) and from tissue (left ventricles of Wistar and SHR rats).,"Commercial Cell SCAD assay kit or Tissue SCAD assay kit (Gen Med, Plymouth, MN, USA), specific components not detailed.",,Not specified,37.0,,,
PMID32541034,reaction_1,in vitro,Lipid aminoacylation (LA) assay with purified recombinant enzyme. Activity also demonstrated in vivo in Aspergillus spp. and heterologously in S. cerevisiae.,"100 mM Na-Hepes pH 7.2, 30 mM KCl, 12 mM MgCl2, 10 mM ATP, 0.1 mg/mL bovine serum albumin",7.2,,30.0,"Saccharomyces cerevisiae, Aspergillus fumigatus, Aspergillus oryzae",,
PMID32541034,reaction_2,in vitro,Lipid aminoacylation (LA) assay with purified recombinant enzyme.,"100 mM Na-Hepes pH 7.2, 30 mM KCl, 12 mM MgCl2, 10 mM ATP, 0.1 mg/mL bovine serum albumin",7.2,,30.0,,,
PMID32541034,reaction_3,in vitro,Lipid deacylation assay with purified recombinant enzyme. Activity also demonstrated in vivo in N. crassa via gene deletion.,"Reaction performed on the product of the LA assay, in 100 mM Na-Hepes pH 7.2, 30 mM KCl, 12 mM MgCl2.",7.2,,30.0,,,
PMID32543104,reaction_1,in vitro,Bioluminescence assay with purified enzyme and synthetic luciferin in buffered solution to determine reaction kinetics.,buffered aqueous solution,,buffered solution,25.0,,,"Details on expression and purification are in the Supporting Information, not in the main text."
PMID32544743,reaction_1,in vitro,Histochemical assay performed on ex vivo coronal brain sections (100 μm thick) from rats to measure enzyme activity.,"0.1 M Tris buffer with 0.6% malic acid, 0.03% nitroblue tetrazolium, 1% dimethylsulfoxide, 0.03% manganese chloride, 0.5% β-NADP and 1.5–3% Triton X-100",8.0,,,,,
PMID32546622,reaction_1,in vitro,ADP-Glo kinase assay,"50 mM HEPES, 50 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 0.025 ng/ml bovine serum albumin (BSA). Substrate (PI) was presented with phosphatidylserine at a 1:3 ratio.",7.5,,,Not specified (commercial synthesis by GenScript),,
PMID32546622,reaction_2,in vitro,ADP-Glo kinase assay,"50 mM HEPES, 50 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 0.025 ng/ml bovine serum albumin (BSA). Substrate (PI(4,5)P2) was presented with phosphatidylserine at a 1:3 ratio.",7.5,,,Not specified (commercial synthesis by GenScript),,
PMID32546622,reaction_3,in vitro,ADP-Glo kinase assay,"50 mM HEPES, 50 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 0.025 ng/ml bovine serum albumin (BSA). Substrate (PI(3)P) was presented with phosphatidylserine at a 1:3 ratio.",7.5,,,Not specified (commercial synthesis by GenScript),,
PMID32546622,reaction_4,in vitro,ADP-Glo kinase assay,"50 mM HEPES, 50 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 0.025 ng/ml bovine serum albumin (BSA). Substrate (PI(4)P) was presented with phosphatidylserine at a 1:3 ratio.",7.5,,,Not specified (commercial synthesis by GenScript),,
PMID32546622,reaction_5,in vitro,ADP-Glo kinase assay,"50 mM HEPES, 50 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 0.025 ng/ml bovine serum albumin (BSA). Substrate (PI(5)P) was presented with phosphatidylserine at a 1:3 ratio.",7.5,,,Not specified (commercial synthesis by GenScript),,
PMID32553892,reaction_1,in vitro,Oxygen consumption assay using a Clark-type electrode.,100 mM disodium pyrophosphate buffer,8.3,,25.0,Escherichia coli BL21(DE3) pLysS,pET11a,"0.1 mM IPTG, 20 °C, 15-18 h"
PMID32553892,reaction_2,in vitro,Oxygen consumption assay using a Clark-type electrode.,100 mM disodium pyrophosphate buffer,8.3,,25.0,Escherichia coli BL21(DE3) pLysS,pET11a,"0.1 mM IPTG, 20 °C, 15-18 h"
PMID32553892,reaction_3,in vitro,Oxygen consumption assay using a Clark-type electrode.,100 mM disodium pyrophosphate buffer,8.3,,25.0,Escherichia coli BL21(DE3) pLysS,pET11a,"0.1 mM IPTG, 20 °C, 15-18 h"
PMID32553892,reaction_4,in vitro,Oxygen consumption assay using a Clark-type electrode.,100 mM disodium pyrophosphate buffer,8.3,,25.0,Escherichia coli BL21(DE3) pLysS,pET11a,"0.1 mM IPTG, 20 °C, 15-18 h"
PMID32553892,reaction_5,in vitro,Oxygen consumption assay using a Clark-type electrode.,100 mM disodium pyrophosphate buffer,8.3,,25.0,Escherichia coli BL21(DE3) pLysS,pET11a,"0.1 mM IPTG, 20 °C, 15-18 h"
PMID32553892,reaction_6,in vitro,Oxygen consumption assay using a Clark-type electrode.,100 mM disodium pyrophosphate buffer,8.3,,25.0,Escherichia coli BL21(DE3) pLysS,pET11a,"0.1 mM IPTG, 20 °C, 15-18 h"
PMID32554222,reaction_1,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_2,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_3,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_4,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_5,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_6,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_7,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_8,in vitro,Functional characterization via heterologous expression.,,,,,Saccharomyces cerevisiae,,
PMID32554222,reaction_9,in vitro,Functional characterization via heterologous expression.,,,,,Saccharomyces cerevisiae,,
PMID32554222,reaction_10,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32554222,reaction_11,in vitro,"Functional activity proven, likely via heterologous expression.",,,,,,,
PMID32556414,reaction_1,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_2,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_3,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_4,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_5,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_6,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_7,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_8,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT C,SC-U induction medium with 2% (w/v) galactose and 1% (w/v) raffinose
PMID32556414,reaction_9,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_10,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_11,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_12,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_13,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_14,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_15,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_16,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_17,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_18,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_19,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_20,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_21,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_22,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_23,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32556414,reaction_24,in vitro,Spectrophotometric assay measuring NADH oxidation at 340 nm,100 mM potassium phosphate buffer,7.0,,30.0,Saccharomyces cerevisiae INVSc1,,
PMID32557076,reaction_1,in vivo,Whole-cell degradation of BTEX mixture (50 mg/L each component) in liquid culture.,"Ramsay minimal medium (RMM): 1.5 g/L KH2PO4, 6.7 g/L Na2H2PO4, 1.0 g/L NH4NO3, 0.2 g/L MgSO4.7H2O, 0.06 g/L FeNH4 citrate, 0.01 g/L CaCl2, and 1 mL/L of trace element solution.",,,28.0,Pseudomonas putida AQ8,,
PMID32557076,reaction_2,in vivo,Whole-cell degradation of BTEX mixture (50 mg/L each component) in liquid culture.,"Ramsay minimal medium (RMM): 1.5 g/L KH2PO4, 6.7 g/L Na2H2PO4, 1.0 g/L NH4NO3, 0.2 g/L MgSO4.7H2O, 0.06 g/L FeNH4 citrate, 0.01 g/L CaCl2, and 1 mL/L of trace element solution.",,,28.0,Pseudomonas putida AQ8,,
PMID32557076,reaction_3,in vivo,Whole-cell degradation of BTEX mixture (50 mg/L each component) in liquid culture.,"Ramsay minimal medium (RMM): 1.5 g/L KH2PO4, 6.7 g/L Na2H2PO4, 1.0 g/L NH4NO3, 0.2 g/L MgSO4.7H2O, 0.06 g/L FeNH4 citrate, 0.01 g/L CaCl2, and 1 mL/L of trace element solution.",,,28.0,Pseudomonas putida AQ8,,
PMID32557076,reaction_4,in vivo,Whole-cell degradation of BTEX mixture (50 mg/L each component) in liquid culture.,"Ramsay minimal medium (RMM): 1.5 g/L KH2PO4, 6.7 g/L Na2H2PO4, 1.0 g/L NH4NO3, 0.2 g/L MgSO4.7H2O, 0.06 g/L FeNH4 citrate, 0.01 g/L CaCl2, and 1 mL/L of trace element solution.",,,28.0,Pseudomonas putida AQ8,,
PMID32557076,reaction_5,in vivo,Whole-cell degradation of BTEX mixture (50 mg/L each component) in liquid culture.,"Ramsay minimal medium (RMM): 1.5 g/L KH2PO4, 6.7 g/L Na2H2PO4, 1.0 g/L NH4NO3, 0.2 g/L MgSO4.7H2O, 0.06 g/L FeNH4 citrate, 0.01 g/L CaCl2, and 1 mL/L of trace element solution.",,,28.0,Pseudomonas putida AQ8,,
PMID32557118,reaction_1,in vitro,Kinetic parameters were determined by monitoring NADH oxidation at 340 nm.,100 mM NaPi buffer,8.0,Optimal pH for reduction activity.,25.0,E. coli BL21 (DE3),pET45b-CtFDH,Grown in Formedium AIM at 30°C overnight.
PMID32557118,reaction_2,in vitro,Kinetic parameters were determined by monitoring NADH oxidation at 340 nm in CO2-equilibrated buffer.,100 mM NaPi buffer,8.0,Optimal pH for reduction activity.,25.0,E. coli BL21 (DE3),pET45b-CtFDH,Grown in Formedium AIM at 30°C overnight.
PMID32557119,reaction_1,in vitro,"Colorimetric assay measuring the H2O2-dependent oxidation of 2,6-dimethoxyphenol to coerulignone.",100 mM sodium acetate buffer,6.0,,60.0,,,
PMID32557119,reaction_2,in vitro,DNS method measuring release of reducing sugars (glucose equivalents).,50 mM NaOAc buffer,5.0,,65.0,,,
PMID32557119,reaction_3,in vitro,Spectrophotometric measurement of p-nitrophenol release from p-nitrophenyl-beta-D-cellobioside (pNPC).,100 mM NaOAc,5.0,,50.0,,,
PMID32560561,reaction_1_APS_DSM642,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_2_APS_DSM644,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_3_APS_DVI-10,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_4_APS_TC2,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_5_APS_TC3,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_6_APS_TC4,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_7_APS_Vib-7,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,8.0,,35.0,,,
PMID32560561,reaction_8_APS_Rod-9,in vitro,Activity measured in cell-free extracts using an AMP-dependent reduction of ferricyanide in the presence of sulfite (reverse reaction).,Tris-HCl buffer,8.0,,35.0,,,
PMID32560561,reaction_9_Sulfite_DSM642,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_10_Sulfite_DSM644,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_11_Sulfite_DVI-10,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_12_Sulfite_TC2,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_13_Sulfite_TC3,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_14_Sulfite_TC4,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,7.5,,27.0,,,
PMID32560561,reaction_15_Sulfite_Vib-7,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,8.0,,35.0,,,
PMID32560561,reaction_16_Sulfite_Rod-9,in vitro,Activity measured in cell-free extracts by monitoring NADH oxidation.,Tris-HCl buffer,8.0,,35.0,,,
PMID32560825,reaction_1,in vivo,"Metabolic profiling of phytosterols in transgenic rice lines (knockdown, knockout, overexpression) was performed using GC-MS to infer enzyme function.",Plants grown in IRRI nutrient solution.,,Not specified for in vivo experiment.,28.0,Oryza sativa japonica cv. Zhonghua 11,"pXU1301 (overexpression), pTCK303 (RNAi), pYLCRISPR/Cas9Pubi-H (CRISPR)",Constitutive expression via Ubi-1 promoter for overexpression and RNAi constructs.
PMID32561281,reaction_1,in vivo,Functional characterization via RNA interference (RNAi) in Grifola frondosa. Effects on mycelial growth and polysaccharide production were measured.,"Fermentation medium: glucose 60 g/L, peptone 6 g/L, KH2PO4 3 g/L and MgSO4·7H2O 1.5 g/L",,Not specified for fermentation medium,28.0,Grifola frondosa CGMCC 5.626,,
PMID32565080,reaction_1,in vitro,Spectrophotometric assay for quinol kinetics and polarographic assay for oxygen kinetics.,"50 mM Tris-HCl, 0.02% EDT-20 (for quinol kinetics); 50 mM Tris-HCl, 1 mM KCN (for oxygen kinetics and inhibitor assays)",7.4,pH 7.5 was used for inhibitor dose response assays.,,Escherichia coli FN102(DE3),pET-15b,"25 µM IPTG at OD600 = 0.6, 30°C, harvested after 12 hours"
PMID32569353,reaction_1,in vitro,"Coupled spectrophotometric assay using peroxidase, TOOS, and 4AA to measure H2O2 production.",McIlvaine (citrate-phosphate) buffer,7.5,,,,,
PMID32569353,reaction_2,in vitro,"Coupled spectrophotometric assay using peroxidase, TOOS, and 4AA to measure H2O2 production.",fully deuterated McIlvaine buffer,7.9,pD value,,,,
PMID32569353,reaction_3,in vitro,"Coupled spectrophotometric assay using peroxidase, TOOS, and 4AA to measure H2O2 production.",McIlvaine (citrate-phosphate) buffer,7.5,,,,,
PMID32569353,reaction_4,in vitro,"Coupled spectrophotometric assay using peroxidase, TOOS, and 4AA to measure H2O2 production.",fully deuterated McIlvaine buffer,7.9,pD value,,,,
PMID32569353,reaction_5,in vitro,"Coupled spectrophotometric assay using peroxidase, TOOS, and 4AA to measure H2O2 production.",McIlvaine (citrate-phosphate) buffer,7.5,,,,,
PMID32569353,reaction_6,in vitro,"Coupled spectrophotometric assay using peroxidase, TOOS, and 4AA to measure H2O2 production.",fully deuterated McIlvaine buffer,7.9,pD value,,,,
PMID32569353,reaction_7,in vitro,Enzymatic synthesis via isotope exchange,0.1 M deuterated phosphate buffer,8.3,pD value,,,,
PMID32569553,reaction_1,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_2,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_3,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_4,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_5,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_6,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_7,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_8,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_9,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_10,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_11,in vitro,Spectrophotometric assay measuring NADH consumption at 340 nm in a coupled assay system.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_12,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32569553,reaction_13,in vitro,Spectrophotometric assay measuring NADH formation at 340 nm.,"100 mM Tris-HCl buffer, 1 mM Mg2+",8.0,,25.0,E. coli BL21(DE3),pET-28a,"0.4 mM IPTG, 20°C, overnight"
PMID32571930,reaction_1,in vitro,Coupled spectrophotometric activity assay monitoring NADH consumption. Product formation also confirmed by LC-MS/MS and Fuchsin assay.,"20 mM Tris·HCl, pH 7.5, 0.1 M KCl",7.5,,25.0,Escherichia coli BL21 (DE3),HT vector (modified pET28a(+)),"0.4 mM IPTG, 18 °C, 16 h"
PMID32571930,reaction_2,in vitro,Coupled spectrophotometric activity assay monitoring NADH consumption. Product formation also confirmed by LC-MS/MS.,"20 mM Tris·HCl, pH 7.5, 0.1 M KCl",7.5,,25.0,Escherichia coli BL21 (DE3),HT vector (modified pET28a(+)),"0.4 mM IPTG, 18 °C, 16 h"
PMID32571930,reaction_3,in vitro,Coupled spectrophotometric activity assay monitoring NADH consumption. Product formation also confirmed by LC-MS/MS.,"20 mM Tris·HCl, pH 7.5, 0.1 M KCl",7.5,,25.0,Escherichia coli BL21 (DE3),HT-KoHpfG (modified pET28a(+)),"0.4 mM IPTG, 18 °C, 16 h"
PMID32571930,reaction_4,in vitro,Spectrophotometric activity assay monitoring the increase in absorbance at 340 nm due to NADH formation.,"20 mM Tris·HCl buffer, pH 9.5, 100 mM KCl",9.5,,25.0,Escherichia coli BL21 (DE3),HT-HhHpfD (modified pET28a(+)),"0.4 mM IPTG, 18 °C, 16 h"
PMID32579353,reaction_1,in vitro,Visible-light photocatalytic H2 production assay with a colloidal heterostructure.,"0.1 M triethanolamine (TEOA), 0.1 M NaCl",6.0,,25.0,Escherichia coli FTH004,,
PMID32579353,reaction_2,in vitro,Protein film electrochemistry (PFE) on a TiO2 electrode in the dark.,"0.2 M MES, 0.1 M NaCl",6.0,,30.0,Escherichia coli FTH004,,
PMID32579353,reaction_3,in vitro,Protein film electrochemistry (PFE) on a pyrolytic graphite 'edge' (PGE) electrode.,0.2 M MES buffer or a mixed buffer system,6.0,,30.0,Escherichia coli FTH004,,
PMID32579353,reaction_4,in vitro,Protein film electrochemistry (PFE) on an indium tin oxide (ITO) electrode.,"0.2 M MES, 0.1 M NaCl",6.0,,30.0,Escherichia coli FTH004,,
PMID32580556,reaction_1,in vitro,Isothermal titration calorimetry (ITC) for thermodynamics and stopped-flow fluorescence kinetics for rates.,"40 mM HEPES, 4 mM MgCl2, pH 7.6",7.6,,25.0,Escherichia coli BL21 (DE3)-RIL,pET28a,
PMID32580556,reaction_2,in vitro,Isothermal titration calorimetry (ITC). Binding measured to PtPP-saturated BaDHPS.,"40 mM HEPES, 4 mM MgCl2, pH 7.6",7.6,,25.0,Escherichia coli BL21 (DE3)-RIL,pET28a,
PMID32580556,reaction_3,in vitro,Isothermal titration calorimetry (ITC). Binding measured to PtPP-saturated BaDHPS.,"40 mM HEPES, 4 mM MgCl2, pH 7.6",7.6,,25.0,Escherichia coli BL21 (DE3)-RIL,pET28a,
PMID32581130,reaction_1,in vivo,Cell-based assay. cGAS activity was indirectly measured by quantifying the phosphorylation of downstream targets STING (pSTING Ser365) and TBK1 (pTBK1 Ser172) in immortalized mouse striatal neuronal cells.,Cell culture medium,,Not specified; experiments were conducted in cell culture conditions.,37.0,"Immortalized mouse striatal neuronal cells (STHdhQ7/Q7, STHdhQ7/Q111, STHdhQ111/Q111)",,
PMID32584503,reaction_1,in vivo,Glutamate content was measured in shoots of wild-type and glu1-4 mutant plants using UHPLC-QQQ-MS to confirm the effect of the enzyme's absence.,Half-strength Murashige and Skoog (MS) medium,5.8,,22.0,Arabidopsis thaliana,,
PMID32586893,reaction_1,in vitro,Recombinant enzyme expressed in E. coli BL21-AI strains engineered to produce phytoene. Products identified by HS-SPME-GC-MS and substrate reduction quantified by HPLC.,LB medium,,Not specified. Reaction in E. coli culture.,16.0,Escherichia coli BL21-AI,,Induced with 0.1% L-arabinose for 16 h.
PMID32586893,reaction_2,in vitro,Recombinant enzyme expressed in E. coli BL21-AI strains engineered to produce lycopene. Products identified by HS-SPME-GC-MS and substrate reduction quantified by HPLC.,LB medium,,Not specified. Reaction in E. coli culture.,16.0,Escherichia coli BL21-AI,,Induced with 0.1% L-arabinose for 16 h.
PMID32586893,reaction_3,in vitro,Recombinant enzyme expressed in E. coli BL21-AI strains engineered to produce δ-carotene. Products identified by HS-SPME-GC-MS and substrate reduction quantified by HPLC.,LB medium,,Not specified. Reaction in E. coli culture.,16.0,Escherichia coli BL21-AI,,Induced with 0.1% L-arabinose for 16 h.
PMID32586893,reaction_4,in vitro,Recombinant enzyme expressed in E. coli BL21-AI strains engineered to produce ε-carotene. Products identified by HS-SPME-GC-MS and substrate reduction quantified by HPLC.,LB medium,,Not specified. Reaction in E. coli culture.,16.0,Escherichia coli BL21-AI,,Induced with 0.1% L-arabinose for 16 h.
PMID32586893,reaction_5,in vitro,Recombinant enzyme expressed in E. coli BL21-AI strains engineered to produce β-carotene. Products identified by HS-SPME-GC-MS and substrate reduction quantified by HPLC.,LB medium,,Not specified. Reaction in E. coli culture.,16.0,Escherichia coli BL21-AI,,Induced with 0.1% L-arabinose for 16 h.
PMID32586893,reaction_6,in vitro,Recombinant enzyme expressed in E. coli BL21-AI strains engineered to produce zeaxanthin. Substrate reduction quantified by HPLC.,LB medium,,Not specified. Reaction in E. coli culture.,16.0,Escherichia coli BL21-AI,,Induced with 0.1% L-arabinose for 16 h.
PMID32591507,reaction_1,in vivo,Measurement of intracellular polyamine levels in HCT116 and DLD-1 CRC cells using LC-MS after genetic knockout or re-expression of SMS.,"Cells cultured in McCoy’s medium or RPMI-1640 medium supplemented with 10% FBS, streptomycin and penicillin.",,"Standard cell culture conditions, pH not explicitly stated.",37.0,HCT116,pLenti6.3-SMS,Lentivirus infection for 48h for re-expression in SMS-KO cells.
PMID32591507,reaction_2,in vitro,Activity measured as release of C14-labeled CO2 from L-[1-C14] ornithine in cell lysates.,"25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM DTT, 0.1% Triton X-100, 0.4 mM L-ornithine, 0.4 mM pyridoxal phosphate.",7.5,,37.0,,,
PMID32591507,reaction_3,in vivo,Acetylation status of FOXO3a was determined in HCT116 and DLD-1 cells by immunoprecipitation of FOXO3a followed by Western blot with an anti-acetylated-lysine antibody.,"Cells lysed in NP-40 lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10% glycerol).",7.5,pH of lysis buffer.,37.0,,,
PMID32595194,reaction_1,in vivo,"Estimation of enzyme activity based on the ratio of product (Arachidonic acid, AA) to substrate (Dihomo-gamma-linolenic acid, DGLA) in plasma samples from a cohort of 436 male patients with acute coronary syndrome.",Human plasma,,,,,,
PMID32596402,reaction_1,in vitro,Spectrometric assay using partially purified enzyme from culture medium.,0.1 M sodium acetate buffer,5.0,,35.0,Aspergillus tubingensis CTM 507,,"Submerged fermentation for 32 hours in a medium containing 20 g/l sucrose, 4 g/l yeast extract, 2 g/l corn steep liquor, 2 g/l peptone, and salts."
PMID32596832,reaction_1,in vitro,Continuous colorimetric pH assay for kinetics; HPTLC and NMR for preparative synthesis.,2 mM Tris buffer (kinetics) or 50 mM Tris-HCl (preparative),8.0,"pH 8.0 for kinetics, pH 8.5 for preparative synthesis.",30.0,Escherichia coli BL21(DE3),pET19b,"auto induction medium, 6h at 37°C then 18h at 30°C"
PMID32596832,reaction_2,in vitro,Continuous colorimetric pH assay performed in the absence of lactose acceptor.,2 mM Tris buffer,8.0,,30.0,,,
PMID32596832,reaction_3,in vitro,in situ 500 MHz 1H NMR spectroscopy monitoring.,20 mM Tris-buffered D2O,,"Not specified, but likely near 8.0 based on other experiments.",30.0,,,
PMID32601391,reaction_1,in vitro,Enzyme kinetics and NMR spectroscopy,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,Escherichia coli BL21 Codon Plus,pET-28b,Auto-induction in lysogeny broth with glucose and lactose at 30°C for 16h.
PMID32601391,reaction_2,in vitro,NMR spectroscopy,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,,,
PMID32601391,reaction_3,in vitro,Enzyme kinetics and NMR spectroscopy,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,Escherichia coli BL21 Codon Plus,pET-28b,"Auto-induction in lysogeny broth with glucose and lactose, pre-induction at 30°C for 8h, then 20°C for 16h."
PMID32601391,reaction_4,in vitro,NMR spectroscopy and specific activity assay,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,,,
PMID32601391,reaction_5,in vitro,NMR spectroscopy,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,Escherichia coli BL21 Codon Plus,,Auto-induction in lysogeny broth with glucose and lactose at 30°C for 16h.
PMID32601391,reaction_6,in vitro,NMR spectroscopy,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,,,
PMID32601391,reaction_7,in vitro,Specific activity assay,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,,,
PMID32601391,reaction_8,in vitro,Specific activity assay,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,,,
PMID32601391,reaction_9,in vitro,Specific activity assay,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,,,
PMID32601391,reaction_10,in vitro,Specific activity assay,"50 mM NaH2PO4, pH 7.0",7.0,,25.0,,,
PMID32601857,reaction_1,in vitro,Spectrophotometric assay for kinetics and characterization.,50 mM acetate buffer,4.5,,40.0,Sphingobacterium ksn-11,,
PMID32601857,reaction_2,in vitro,Spectrophotometric assay for kinetics and characterization.,phosphate buffer,7.0,,40.0,Sphingobacterium ksn-11,,
PMID32601857,reaction_3,in vitro,Spectrophotometric assay for kinetics.,50 mM acetate buffer,4.5,,40.0,Sphingobacterium ksn-11,,
PMID32601857,reaction_4,in vitro,"Transformation study using immobilized laccase in sodium alginate-silicon dioxide-polyvinyl alcohol beads, analyzed by LC-MS.",200 mM acetate buffer,4.5,,40.0,Sphingobacterium ksn-11,,
PMID32601959,reaction_1,in vitro,Enzyme activity assay using crude cell lysate from E. coli.,"100 mM PBS buffer (pH 7.5) containing 15 mM glutamine, 20 mM F6P and 2.5 mM EDTA",7.5,,37.0,Escherichia coli BL21 (DE3),pET-28a(+),1 mM IPTG at 22°C
PMID32608101,reaction_1,in vitro,Activity assessed in cultured normal human liver cells (L-02) by measuring global H3K9me2 levels via Western blot following overexpression or siRNA knockdown of JHDM2A.,Dulbecco minimal Eagle’s medium supplemented with 10% fetal bovine serum,,"Standard cell culture conditions, pH not explicitly stated.",37.0,Normal human liver cells (L-02),pcDNA3.1-JHDM2A (for overexpression),"Transient transfection using Lipofectamine 3000. For knockdown, siRNA (5'-CCACCUAACCUUGGAGCAATT-3') was used."
PMID32608439,reaction_1,in vitro,Fluorescence spectroscopy assay to measure time-dependent spectral changes.,"MeCN/Tris-HCl (1:3, v/v)",7.4,,37.0,,,
PMID32608439,reaction_2,in vitro,Fluorescence spectroscopy assay to measure time-dependent spectral changes.,"MeCN/Tris-HCl (1:3, v/v)",7.4,,37.0,,,
PMID32608439,reaction_3,in vitro,Fluorescence spectroscopy assay. Also tested in vivo in HeLa and HepG-2 cells and in a HepG-2-tumor-bearing nude mouse model.,"MeCN/Tris-HCl (1:3, v/v)",7.4,,37.0,,,
PMID32612982,reaction_1,in vitro,"Standard activity assay (hydrolysis) used for enzyme characterization (pH, temperature, ionic strength, stability).",50 mM sodium phosphate buffer (for standard assay). Sodium citrate and MES buffers were also used for pH profiling.,6.0,Optimal pH determined over a range of 4-8.5.,80.0,E. coli BL21(DE3),pET28b(+),"0.5 mM IPTG, grown for 3 h post-induction."
PMID32612982,reaction_2,in vitro,Transglycosylation assay for synthesis of nucleoside analogs.,"50 mM sodium phosphate buffer, pH 6, 4 M NaCl",6.0,,80.0,E. coli BL21(DE3),,
PMID32612982,reaction_3,in vitro,Transglycosylation assay for synthesis of nucleoside analogs.,"50 mM sodium phosphate buffer, pH 6, 4 M NaCl",6.0,,80.0,E. coli BL21(DE3),,
PMID32612982,reaction_4,in vitro,Transglycosylation assay for synthesis of nucleoside analogs.,"50 mM sodium phosphate buffer, pH 6, 4 M NaCl",6.0,,80.0,E. coli BL21(DE3),,
PMID32612982,reaction_5,in vitro,Transglycosylation assay for synthesis of nucleoside analogs.,"50 mM sodium phosphate buffer, pH 6, 4 M NaCl",6.0,,80.0,E. coli BL21(DE3),,
PMID32612982,reaction_6,in vitro,Transglycosylation assay for synthesis of nucleoside analogs.,"50 mM sodium phosphate buffer, pH 6, 4 M NaCl",6.0,,80.0,E. coli BL21(DE3),,
PMID32615907,reaction_1,in vitro,"Spectrophotometric activity assay on lysates from pooled 24-28hr progeny of heterozygous parents (gfat1B2/TM6, Tb).","20 mM Tris-Cl, 2.5 mM CaCl2, 50 mM NaCl, 10 mM MgCl2, 1 mM dithiothreitol, 10% glycerol and protease inhibitors, with 0.5% Triton X-100",7.5,,37.0,,,
PMID32615907,reaction_2,in vitro,"Spectrophotometric activity assay on lysates from pooled 24-28hr progeny of heterozygous parents (gfat2E1/TM6, Tb).","20 mM Tris-Cl, 2.5 mM CaCl2, 50 mM NaCl, 10 mM MgCl2, 1 mM dithiothreitol, 10% glycerol and protease inhibitors, with 0.5% Triton X-100",7.5,,37.0,,,
PMID32617841,reaction_1,in vivo,Activity measured from whole-cell culture using HPLC. One unit (U) of NDHase activity was defined as the amount of enzyme required to produce 1 μmol of 6-HCP in 1 min.,Luria–Bertani (LB) broth medium,,Not specified,30.0,Comamonas testosteroni CNB-2,pVLT33-based vector with Ptac8 promoter driving Mmp1 polymerase expression,"0.5 mM IPTG added at OD600 of 0.1, followed by incubation at 30 °C for 14 h"
PMID32621793,reaction_1,in vitro,Spectrophotometric assay monitoring the increase in A340 for NADH formation. Kinetics determined for enzyme purified from the soluble fraction.,"0.1 mM Tris-HCl, 0.5 mM EDTA",7.5,,,Gluconacetobacter diazotrophicus PAL5,,
PMID32621793,reaction_2,in vitro,Spectrophotometric assay monitoring the increase in A340 for NADPH formation. Kinetics determined for enzyme purified from the soluble fraction.,"0.1 mM Tris-HCl, 0.5 mM EDTA",7.5,,,Gluconacetobacter diazotrophicus PAL5,,
PMID32626311,reaction_1,in vitro,Activity assay based on hydrolysis of dextrin substrate.,Not specified,6.0,for activity assay,40.0,Paenibacillus alginolyticus,,
PMID32626311,reaction_2,in vitro,Activity assay based on release of glucose from maltose substrate.,Not specified,6.0,for activity assay,40.0,Paenibacillus alginolyticus,,
PMID32626358,reaction_1,in vitro,Spectrophotometric assay measuring the degradation of L-ascorbic acid at 245 nm.,,,The specific pH for the activity assay was not reported.,30.0,,,
PMID32631052,reaction_1,in silico,Molecular dynamics (MD) simulations based on a 3.6 Å cryo-EM structure of the active α2β2 complex trapped in a pre-turnover state with GDP.,"System solvated with TIP3P water in a periodic cuboid box, neutralized with sodium ions, with additional Na+ and Cl- to a salt concentration of ~150 mM.",7.0,Used for setting protonation states of residues via the H++ webserver.,,,,
PMID32632475,reaction_1,in vivo,Measurement of NAD+ and NAD+/NADH ratio in whole cells of wild-type and overexpression strains after culturing.,liquid Complete Yeast Medium (CYM),,pH of CYM medium not specified.,28.0,Ganoderma lucidum,pGL-nmnat,Constitutive expression via Glgpd promoter. Strains constructed using Agrobacterium tumefaciens-mediated transformation (ATMT).
PMID32632475,reaction_2,in vitro,Activity measured in fermentation supernatant using the dinitrosalicylic acid (DNS) method.,50 mM citrate-phosphate buffer,4.0,,50.0,Ganoderma lucidum,,
PMID32632475,reaction_3,in vitro,Activity measured in fermentation supernatant by quantifying released 4-nitrophenol at 410 nm.,citrate-phosphate buffer (50 mM),4.0,"Assumed reaction pH, same as CMCase assay. Reaction was stopped with 1 M sodium carbonate (pH 11.5).",50.0,Ganoderma lucidum,,
PMID32634742,reaction_1,in vitro,Spectrophotometric coupled enzyme assay measuring NAD+ release (NADH consumption).,"100 mM Tris–HCl, 100 mM KCl, 0.5 mM EDTA, 2 mM MgCl2, 0.2 mM NADH, 3 mM ADP, and 10 µM 2,3-diphosphoglycerate with enzyme mixture (0.6 U lactate dehydrogenase, 0.5 U pyruvate kinase, and 0.1 U enolase)",8.0,,37.0,"Escherichia coli (for recombinant protein), Human cell lines (H1299, HSC-1), Mouse Embryonic Fibroblasts (MEFs)",,
PMID32634742,reaction_2,in vitro,Serine/threonine phosphatase assay measuring release of free phosphate.,"50 mM imidazole, 0.2 mM EGTA, 5 mM MgCl2, 0.02% beta-mercaptoethanol, and 0.1 mg/mL bovine serum albumin",,"Tested at pH 6.2, 7.2, 8.2, and 9.2",30.0,Escherichia coli,,
PMID32634742,reaction_3,in vitro,Phosphatase assay measuring release of free phosphate.,"50 mM imidazole, 0.2 mM EGTA, 5 mM MgCl2, 0.02% beta-mercaptoethanol, and 0.1 mg/mL bovine serum albumin",7.2,,30.0,Escherichia coli,,
PMID32634742,reaction_4,in vitro,Phosphatase assay measuring release of free phosphate.,"50 mM imidazole, 0.2 mM EGTA, 5 mM MgCl2, 0.02% beta-mercaptoethanol, and 0.1 mg/mL bovine serum albumin",7.2,,30.0,Escherichia coli,,
PMID32634742,reaction_5,in vitro,Phosphatase assay measuring release of free phosphate.,"50 mM imidazole, 0.2 mM EGTA, 5 mM MgCl2, 0.02% beta-mercaptoethanol, and 0.1 mg/mL bovine serum albumin",7.2,,30.0,Escherichia coli,,
PMID32636308,reaction_1,in vitro,pyruvate kinase/lactate dehydrogenase (PK/LDH) coupled enzyme assay,"32 mM Hepes, 16 mM MgCl2, 240 mM NaCl, 8% (v/v) glycerol, 5 mM phosphoenolpyruvic acid, PK/LDH mix, 0.75 mM NADH",7.4,,35.0,Escherichia coli BL21(DE3) pLysS,pET-15b,Co-expression with GroEL at 16°C for 18 hours.
PMID32636308,reaction_2,in vitro,pyruvate kinase/lactate dehydrogenase (PK/LDH) coupled enzyme assay,"32 mM Hepes, 16 mM MgCl2, 240 mM NaCl, 8% (v/v) glycerol, 5 mM phosphoenolpyruvic acid, PK/LDH mix, 0.75 mM NADH",7.4,,35.0,Escherichia coli,,
PMID32636308,reaction_3,in vitro,pyruvate kinase/lactate dehydrogenase (PK/LDH) coupled enzyme assay,"32 mM Hepes, 16 mM MgCl2, 240 mM NaCl, 8% (v/v) glycerol, 5 mM phosphoenolpyruvic acid, PK/LDH mix, 0.75 mM NADH",7.4,,35.0,,,
PMID32636308,reaction_4,in vitro,pyruvate kinase/lactate dehydrogenase (PK/LDH) coupled enzyme assay,"32 mM Hepes, 16 mM MgCl2, 240 mM NaCl, 8% (v/v) glycerol, 5 mM phosphoenolpyruvic acid, PK/LDH mix, 0.75 mM NADH",7.4,,35.0,,,
PMID32638277,reaction_1,in vitro,Colorimetric assay using a Total Superoxide Dismutase Assay Kit with nitroblue tetrazolium (NBT).,"Provided in Total Superoxide Dismutase Assay Kit (Beyotime Biotechnology, Shanghai, China)",,Not specified for the assay. Fermentation pH was controlled at 7.0.,37.0,Escherichia coli BL21(DE3),"pET-hCu,Zn-SOD (derived from pET-28a(+))",Fed-batch fermentation induced with lactose (10 mL/h feeding rate) at 25 °C. Culture medium supplemented with 800 μM Cu2+ and 20 μM Zn2+.
PMID32639976,reaction_1,in vitro,"Spectrophotometric assay measuring NADH production at 340 nm for kinetics, and HPLC for product identification.",100 mM potassium phosphate,8.0,,25.0,Sphingomonas sp. PAMC 26621,,Cultured in minimal medium containing 1% (w/v) D-ribitol at 15°C
PMID32639976,reaction_2,in vitro,Reductase activity measurement,"Not specified, assumed 100 mM potassium phosphate",8.0,"Not specified, assumed same as forward reaction",25.0,Sphingomonas sp. PAMC 26621,,Cultured in minimal medium containing 1% (w/v) D-ribitol at 15°C
PMID32640001,reaction_1,in vitro,Enzyme reaction with 0.2% (w/v) PASC substrate.,50 mM BisTris-HCl,6.0,,37.0,Pichia pastoris PichiaPink™ cells,pPINK_-GAP_TaCel5A,"Constitutive expression using GAP promoter in BMGY medium at 29°C, 200 rpm for 48h, with 1% glycerol supplementation after 24h."
PMID32640001,reaction_2,in vitro,Enzyme reaction with 0.2% (w/v) PASC substrate.,50 mM BisTris-HCl,6.0,,37.0,Pichia pastoris PichiaPink™ cells,pPINK_-GAP_TaCel5A,"Constitutive expression using GAP promoter in BMGY medium at 29°C, 200 rpm for 48h, with 1% glycerol supplementation after 24h."
PMID32640001,reaction_3,in vitro,Enzyme reaction with 1% (w/v) cellohexaose.,50 mM BisTris-HCl,6.0,,37.0,Pichia pastoris PichiaPink™ cells,pPINK_-GAP_TaCel5A,"Constitutive expression using GAP promoter in BMGY medium at 29°C, 200 rpm for 48h, with 1% glycerol supplementation after 24h."
PMID32640001,reaction_4,in vitro,Enzyme reaction with 1% (w/v) cellopentaose.,50 mM BisTris-HCl,6.0,,37.0,Pichia pastoris PichiaPink™ cells,pPINK_-GAP_TaCel5A,"Constitutive expression using GAP promoter in BMGY medium at 29°C, 200 rpm for 48h, with 1% glycerol supplementation after 24h."
PMID32640001,reaction_5,in vitro,Enzyme reaction with 1% (w/v) tamarind xyloglucan.,50 mM BisTris-HCl,6.0,,37.0,Pichia pastoris PichiaPink™ cells,pPINK_-GAP_TaCel5A,"Constitutive expression using GAP promoter in BMGY medium at 29°C, 200 rpm for 48h, with 1% glycerol supplementation after 24h."
PMID32640001,reaction_6,in vitro,Enzyme reaction with 1% (w/v) tamarind xyloglucan.,50 mM BisTris-HCl,6.0,,37.0,Pichia pastoris PichiaPink™ cells,pPINK_-GAP_TaCel5A,"Constitutive expression using GAP promoter in BMGY medium at 29°C, 200 rpm for 48h, with 1% glycerol supplementation after 24h."
PMID32643247,reaction_1,in vivo,"Transient overexpression in Nicotiana benthamiana leaves, followed by feeding with ethylamine solution.",Leaves were incubated in distilled water containing 1 mg/mL ethylamine.,,Not specified,25.0,Nicotiana benthamiana,pCAMBIA3300,Agrobacterium GV3101-mediated transient expression. Leaves harvested after 6 days for assay.
PMID32643247,reaction_2,in vivo,"Transient overexpression in Nicotiana benthamiana leaves, followed by feeding with ethylamine solution.",Leaves were incubated in distilled water containing 1 mg/mL ethylamine.,,Not specified,25.0,Nicotiana benthamiana,pCAMBIA3300,Agrobacterium GV3101-mediated transient expression. Leaves harvested after 6 days for assay.
PMID32643247,reaction_3,in vivo,"Transient overexpression in Nicotiana benthamiana leaves, followed by feeding with ethylamine solution.",Leaves were incubated in distilled water containing 1 mg/mL ethylamine.,,Not specified,25.0,Nicotiana benthamiana,pCAMBIA3300,Agrobacterium GV3101-mediated transient expression. Leaves harvested after 6 days for assay.
PMID32643247,reaction_4,in vivo,"Transient overexpression in Nicotiana benthamiana leaves, followed by feeding with ethylamine solution.",Leaves were incubated in distilled water containing 1 mg/mL ethylamine.,,Not specified,25.0,Nicotiana benthamiana,pCAMBIA3300,Agrobacterium GV3101-mediated transient expression. Leaves harvested after 6 days for assay.
PMID32643247,reaction_5,in vivo,"Transient overexpression in Nicotiana benthamiana leaves, followed by feeding with ethylamine solution.",Leaves were incubated in distilled water containing 1 mg/mL ethylamine.,,Not specified,25.0,Nicotiana benthamiana,pCAMBIA3300,Agrobacterium GV3101-mediated transient expression. Leaves harvested after 6 days for assay.
PMID32643933,reaction_1,in vitro,Endpoint assay measuring 5'-deoxyadenosine (uncoupled product) and cross-linked PqqA (coupled product) formation by mass spectrometry after a 16-hour reaction.,Not specified,,Assay performed in an anaerobic chamber. pH not specified for activity assay.,,Escherichia coli BL21(DE3) Gold,Not specified,
PMID32645255,reaction_1,in vitro,Substrate conversion and specific activity assays with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_2,in vitro,Substrate conversion and specific activity assays with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_3,in vitro,Substrate conversion and specific activity assays with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_4,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_5,in vitro,Substrate conversion and specific activity assays with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_6,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_7,in vitro,Substrate conversion and specific activity assays with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_8,in vitro,Substrate conversion and specific activity assays with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_9,in vitro,Substrate conversion and specific activity assays with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_10,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_11,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_12,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_13,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_14,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_15,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_16,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_17,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_18,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645255,reaction_19,in vitro,Substrate conversion assay with a cofactor regeneration system (PrnF/ADH).,100 mM Na2HPO4 buffer,,"Not specified, but modeling assumed neutral pH.",25.0,Escherichia coli BL21 (DE3),,
PMID32645646,reaction_1,in vitro,Enzyme activity was examined in permeabilised mitochondria isolated from rat liver. The oxidation of NADH was followed by measuring the decrease in absorbance at 340 nm.,"50 mM K2HPO4, 3 mg/mL fatty acid free bovine serum albumin, 300 µM KCN",7.5,,,,,
PMID32645646,reaction_2,in vitro,Inhibition assay using CYP baculosomes with a fluorogenic substrate. Fluorescence was measured.,,,,37.0,baculovirus-insect cell system,,
PMID32645646,reaction_3,in vitro,Inhibition assay using CYP baculosomes with a fluorogenic substrate. Fluorescence was measured.,,,,37.0,baculovirus-insect cell system,,
PMID32645646,reaction_4,in vitro,Inhibition assay using CYP baculosomes with a fluorogenic substrate. Fluorescence was measured.,,,,37.0,baculovirus-insect cell system,,
PMID32645646,reaction_5,in vitro,Inhibition assay using CYP baculosomes with a fluorogenic substrate. Fluorescence was measured.,,,,37.0,baculovirus-insect cell system,,
PMID32645646,reaction_6,in vitro,Inhibition assay using CYP baculosomes with a fluorogenic substrate. Fluorescence was measured.,,,,37.0,baculovirus-insect cell system,,
PMID32650010,reaction_1,in vitro,Multi-Parametric Surface Plasmon Resonance (MP-SPR) was used to determine the binding stoichiometry of thebaine to T6ODM.,"50 mM TRIS, 150 mM NaCl",7.4,,,,,
PMID32651359,reaction_1,in vitro,Integration assay with pre-cleaved TIR oligonucleotide and supercoiled plasmid target.,"25 mM Tris–Cl, 25 mM NaCl, 5 mM MgCl2, 2 mM DTT, 1X BSA",8.0,,30.0,EXPI293F cells,pD2610-MPB-PB,"Transient PEI transfection, harvested 3 days post-transfection."
PMID32651359,reaction_2,in vitro,Integration assay with pre-cleaved TIR oligonucleotide and supercoiled plasmid target.,"25 mM Tris–Cl, 25 mM NaCl, 5 mM MgCl2, 2 mM DTT, 1X BSA",8.0,,30.0,EXPI293F cells,,
PMID32651359,reaction_3,in vitro,Integration assay with truncated RE TIR oligonucleotide and plasmid target.,"25 mM Tris–Cl, 25 mM NaCl, 5 mM MgCl2, 2 mM DTT, 1X BSA",8.0,,30.0,EXPI293F cells,,
PMID32651359,reaction_4,in vitro,Integration assay with a mini-transposon to determine target site specificity.,"25 mM Tris–Cl, 25 mM NaCl, 5 mM MgCl2, 2 mM DTT, 1X BSA",8.0,,30.0,EXPI293F cells,,
PMID32651359,reaction_5,in vitro,DNA cleavage and hairpin formation assay detected by denaturing TBE-urea gel electrophoresis.,"25 mM Tris–Cl, 25 mM NaCl, 5 mM MgCl2 or CaCl2, 1x BSA, 5% glycerol and 2 mM DTT",8.0,,30.0,EXPI293F cells,,
PMID32651359,reaction_6,in vivo,Excision and integration (colony count) assays in cultured human HT-1080 cells.,Cell culture medium,,Physiological pH in cell culture,37.0,HT-1080 cells,pCMV-HA-PB (for wild-type PB) or hyPBase plasmid,Co-transfection with transposon plasmid using lipofectamine.
PMID32653619,reaction_1,in vitro,Steady-state kinetic parameters were determined using a horseradish peroxidase (HRP)-couple assay with Amplex Red.,100 mM sodium phosphate buffer,6.0,,30.0,Aspergillus nidulans A773,pEXPYR,"Grown in liquid minimal medium with 5% (w/v) maltose, static culture at 37 °C for 48h."
PMID32653619,reaction_2,in vitro,Steady-state kinetic parameters were determined using a horseradish peroxidase (HRP)-couple assay with Amplex Red.,100 mM sodium phosphate buffer,6.0,,30.0,Aspergillus nidulans A773,pEXPYR,"Grown in liquid minimal medium with 5% (w/v) maltose, static culture at 37 °C for 48h."
PMID32653619,reaction_3,in vitro,Steady-state kinetic parameters were determined using a horseradish peroxidase (HRP)-couple assay with Amplex Red.,100 mM sodium phosphate buffer,6.0,,30.0,Aspergillus nidulans A773,pEXPYR,"Grown in liquid minimal medium with 5% (w/v) maltose, static culture at 37 °C for 48h."
PMID32653619,reaction_4,in vitro,Steady-state kinetic parameters were determined using a horseradish peroxidase (HRP)-couple assay with Amplex Red. Product identification was performed by HPLC after 24h incubation at 50°C.,100 mM sodium phosphate buffer,6.0,,30.0,Aspergillus nidulans A773,pEXPYR,"Grown in liquid minimal medium with 5% (w/v) maltose, static culture at 37 °C for 48h."
PMID32653636,reaction_1,in vitro,Biotransformation with purified enzyme or activated lysate.,50 mM triethanolamine buffer (TEA buffer),7.0,,30.0,Escherichia coli,,
PMID32658470,reaction_1,in vitro,Terminal uridylation of model RNA oligonucleotide,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_2,in vitro,Terminal uridylation of model RNA oligonucleotide,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_3,in vitro,Terminal uridylation of model RNA oligonucleotide,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_4,in vitro,Terminal uridylation of model RNA oligonucleotide,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_5,in vitro,Terminal uridylation of poly(A)-tailed sgRNA,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_6,in vitro,Terminal uridylation of poly(A)-tailed sgRNA,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_7,in vitro,Terminal uridylation of poly(A)-tailed sgRNA,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_8,in vitro,Terminal uridylation of poly(A)-tailed sgRNA,"10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1 U/μL RiboLock RNase inhibitor",7.9,at 25 °C,37.0,E. coli,,
PMID32658470,reaction_9,in vitro,in vitro cleavage assay,"20 mM HEPES, 100 mM KCl, 5 mM MgCl2, 1 mM DTT",7.5,,37.0,,,
PMID32659422,reaction_1,in vitro,Spectrophotometric assay monitoring the reduction of DCPIP at 600 nm.,50 mM phosphate buffer,7.0,,50.0,Aspergillus nidulans A773,pEXPYR,Maltose-induced expression
PMID32659673,reaction_1,in vitro,Oxygen consumption assay using a Clarke-type oxygen electrode.,"20 mM Tris-HCl, 0.15 M NaCl",8.0,,25.0,Escherichia coli Rosetta-gamiB (DE3),pMAL-c5x,0.3 mM IPTG at 37 °C for 10 h
PMID32659673,reaction_2,in vitro,Substrate specificity test via oxygen consumption assay using a Clarke-type oxygen electrode.,"20 mM Tris-HCl, 0.15 M NaCl",8.0,,25.0,Escherichia coli Rosetta-gamiB (DE3),pMAL-c5x,0.3 mM IPTG at 37 °C for 10 h
PMID32659673,reaction_3,in vitro,Substrate specificity test via oxygen consumption assay using a Clarke-type oxygen electrode.,"20 mM Tris-HCl, 0.15 M NaCl",8.0,,25.0,Escherichia coli Rosetta-gamiB (DE3),pMAL-c5x,0.3 mM IPTG at 37 °C for 10 h
PMID32659673,reaction_4,in vitro,Substrate specificity test via oxygen consumption assay using a Clarke-type oxygen electrode.,"20 mM Tris-HCl, 0.15 M NaCl",8.0,,25.0,Escherichia coli Rosetta-gamiB (DE3),pMAL-c5x,0.3 mM IPTG at 37 °C for 10 h
PMID32659673,reaction_5,in vitro,"The effect of the enzyme on a complex substrate (wheat flour dough) was evaluated by measuring farinograph properties, dynamic rheological properties, gluten network microstructure (SEM), and final steamed bread quality.",Commercial wheat flour dough system,,Not specified; typical pH of dough.,30.0,Escherichia coli Rosetta-gamiB (DE3),pMAL-c5x,0.3 mM IPTG at 37 °C for 10 h
PMID32661062,reaction_1,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_2,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_3,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_4,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_5,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_6,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_7,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_8,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_9,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_10,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_11,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_12,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_13,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_14,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_15,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_16,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661062,reaction_17,in vitro,Incubation of recombinant enzyme expressed in E. coli cell lysates with 14C-labeled substrate.,"Incubation mixture containing 2-oxoglutarate (100 mM), ascorbate (100 mM), FeSO4 (0.5 mM), and catalase (1 mg/mL).",,Not specified,30.0,Escherichia coli BL21 Star™,pET101/D-TOPO,
PMID32661581,reaction_1,in vitro,Enzyme activity measured by a commercial SOD assay kit (Nanjing Jiancheng Institute of Biological Engineering) based on its ability to inhibit the oxidation of hydroxylamine by the xanthine-xanthine oxidase system.,Phosphate buffer saline (PBS),7.4,Inferred from the use of PBS for temperature stability assays. The actual assay pH was not specified.,,Pichia pastoris GS115,pPIC9K,Induced with 0.5% methanol at pH 6.0.
PMID32661581,reaction_2,in vitro,"Hydroxyl free radical scavenging activity was estimated using a commercial kit from Nanjing Jiancheng Bio-Engineering Institute Co., Ltd.",Not specified,,Not specified,,Pichia pastoris GS115,pPIC9K,Induced with 0.5% methanol at pH 6.0.
PMID32663477,reaction_1,in vitro,Enzymatic assay with purified recombinant RnfC monitoring FMN reduction.,"50 mM PIPES, pH 7, and 2 mM DTE",7.0,,30.0,Escherichia coli BL21(DE3),pET21a-rnfC,"0.25 mM IPTG, 16°C, 20 hours"
PMID32663477,reaction_2,in vitro,Enzymatic assay with purified recombinant MBP-RnfB fusion protein monitoring formazan formation.,"50 mM Tris-HCl, pH 7.5, 2 mM DTE",7.5,,30.0,Escherichia coli BL21(DE3),pMAL-c2-rnfB,"0.5 mM IPTG, 16°C, 20 hours"
PMID32663477,reaction_3,in vitro,UV-Vis spectroscopic monitoring of the reduction of FeS clusters in MBP-RnfB.,"50 mM Tris-HCl buffer, pH 7.7, 2 mM DTE",7.7,,,Escherichia coli BL21(DE3),pMAL-c2-rnfB,"0.5 mM IPTG, 16°C, 20 hours"
PMID32663477,reaction_4,in vitro,Enzymatic assay with heterologously produced and purified Rnf complex.,"Not specified for the assay. Purification was done in lysis buffer (300 mM NaCl, 50 mM NaH2PO4, 10 mM imidazole, pH 8.0).",,,,Escherichia coli BL21(DE3),pT7-7-rnf,"0.66 mM IPTG, 37°C, 3 hours"
PMID32663558,reaction_1,in vitro,Xenobiotic metabolizing activity assay measuring product formation by absorbance at 340 nm.,20 mM phosphate buffer (pH 7.5) containing 150 mM NaCl,7.5,,,Escherichia coli BL21(DE3),,"1 mM IPTG, 20°C, 16 h"
PMID32668380,reaction_1,in vitro,Activity of purified human recombinant 5-LO,"PBS buffer pH 7.4 containing EDTA (1 mM), and ATP (1 mM)",7.4,,37.0,E. coli Bl21 (DE3),,
PMID32668380,reaction_2,in vivo,Activity in intact human polymorphonuclear leukocytes (PMNL),PBS buffer plus glucose (1 mg/mL),,"Not specified, PBS buffer used",37.0,,,
PMID32668380,reaction_3,in vivo,Activity in intact human polymorphonuclear leukocytes (PMNL),PBS buffer plus glucose (1 mg/mL),,"Not specified, PBS buffer used",37.0,,,
PMID32671046,reaction_1,in vitro,Standard phosphoribosyltransferase activity assay for kinetics.,50 mM sodium phosphate buffer,7.0,,50.0,Escherichia coli BL21(DE3),pET28b(+),"0.5 mM IPTG, 37°C, 4h"
PMID32671046,reaction_2,in vitro,Substrate specificity assay.,50 mM Tris-HCl buffer,8.0,,50.0,Escherichia coli BL21(DE3),pET28b(+),"0.5 mM IPTG, 37°C, 4h"
PMID32671046,reaction_3,in vitro,Adenylate kinase activity assay for kinetics.,50 mM sodium phosphate buffer,7.0,,50.0,Escherichia coli BL21(DE3),pET28b(+),"0.5 mM IPTG, 37°C, 4h"
PMID32671046,reaction_4,in vitro,Substrate specificity assay.,50 mM sodium phosphate buffer,7.0,,50.0,Escherichia coli BL21(DE3),pET28b(+),"0.5 mM IPTG, 37°C, 4h"
PMID32672300,reaction_1,in vitro,Whole-cell biotransformation,Not specified,,Not specified,,,,
PMID32672300,reaction_2,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_3,in vivo,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_4,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_5,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_6,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_7,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_8,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_9,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_10,in vivo,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_11,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_12,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_13,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_14,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_15,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_16,in vitro,Whole-cell biotransformation. Data from summary of Table S4 (ESI).,Not specified,,,,,,
PMID32672300,reaction_17,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_18,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_19,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_20,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_21,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_22,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_23,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_24,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_25,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_26,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_27,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_28,in vivo,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_29,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_30,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_31,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_32,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_33,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32672300,reaction_34,in vitro,Whole-cell biotransformation,Not specified,,,,,,
PMID32676302,reaction_1,in vitro,Kinetic constants determined for purified enzyme.,0.05 M Na-phosphate buffer,6.5,,30.0,,,
PMID32676302,reaction_2,in vitro,Kinetic constants determined for purified enzyme.,0.05 M Na-phosphate buffer,6.5,,30.0,,,
PMID32676302,reaction_3,in vitro,Kinetic constants determined for purified enzyme.,0.05 M Na-phosphate buffer,6.5,,30.0,,,
PMID32676302,reaction_4,in vitro,Kinetic constants determined for purified enzyme.,0.05 M Na-phosphate buffer,6.5,,30.0,,,
PMID32681381,reaction_1,in vitro,Fluorometric assay performed on crude protein extracts from transgenic Arabidopsis thaliana leaves.,"GUS assay buffer. Staining buffer composition: 100 mM Na2HPO4, 0.5 mM potassium ferricyanide, 0.5 mM potassium ferrocyanide, 0.1% Triton X, 20% Methanol.",7.0,,37.0,Arabidopsis thaliana (ecotype Col0),pBI121::TaMIOX,"Expression was driven by the TaMIOX promoter, which was induced by abiotic stresses (cold, heat, PEG) or myo-inositol feeding."
PMID32681807,reaction_1,in vitro,Resonance Raman spectroscopy of cryo-trapped intermediates. New experimental data in this study was collected for the T306A mutant.,Enzyme incorporated into Nanodiscs. Buffer details not specified in main text.,,,-196.0,,,
PMID32681807,reaction_2,in vitro,Resonance Raman spectroscopy of cryo-trapped intermediates. New experimental data in this study was collected for the T306A mutant.,Enzyme incorporated into Nanodiscs. Buffer details not specified in main text.,,,-196.0,,,
PMID32682073,reaction_1,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM TcTR, 100 µM T(SH)2",7.5,,30.0,Escherichia coli BL21 (DE3),pET28a,0.5 mM IPTG for 16 h at 25 °C
PMID32682073,reaction_2,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM TcTR, 100 µM T(SH)2",7.5,,30.0,,,
PMID32682073,reaction_3,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM TcTR, 100 µM T(SH)2",7.5,,30.0,,,
PMID32682073,reaction_4,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM TcTR, 100 µM T(SH)2",7.5,,30.0,,,
PMID32682073,reaction_5,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM BbTRXR",7.5,,30.0,,,
PMID32682073,reaction_6,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM BbTRXR",7.5,,30.0,,,
PMID32682073,reaction_7,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM TcTR",7.5,,30.0,,,
PMID32682073,reaction_8,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 U/ml Saccharomyces cerevisiae glutathione reductase, 3 mM GSH",7.5,,30.0,,,
PMID32682073,reaction_9,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM TcTR, 100 µM T(SH)2",7.5,,30.0,,,
PMID32682073,reaction_10,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation,"100 mM TRIS-HCl, 2 mM EDTA, 300 µM NADPH, 1 µM TcTR, 100 µM T(SH)2",7.5,,30.0,,,
PMID32683523,reaction_1,in vivo,Functional characterization by overexpression in transgenic soybean plants and measurement of physiological effects and Pi accumulation.,"Modified Hoagland’s nutrient solution with varying KH2PO4 concentrations (1 µM, 50 µM, 625 µM).",,Not specified for the Hoagland's solution used in pot experiments.,22.0,Glycine max cv. 'YD22',pCAMBIA3301-EsPHT1;4,Constitutive expression via CaMV 35S promoter.
PMID32683863,reaction_1,in vitro,in-crystallo single turnover reaction monitored by serial femtosecond crystallography (SFX) at an X-ray free electron laser (XFEL).,"Crystallization buffer: 100 mM HEPES/MOPS, 30 mM NaI, 30 mM NaBr, 30 mM NaF, 20 % (v/v) glycerol, 10 % (w/v) PEG 4000, and 10 mM FeCl3",7.5,,25.0,sMMOH was isolated from native Methylosinus trichosporium OB3b. MMOB was heterologously expressed in E. coli BL21(DE3).,,
PMID32685828,reaction_1,in vitro,RT maturation assay,"20 mM sodium acetate, pH 5.2",5.2,,37.0,Escherichia coli,,
PMID32685828,reaction_2,in vitro,Proteolysis of LysRS by PR,"25 mM Bis-Tris, 100 mM NaCl",7.0,,37.0,Escherichia coli,,
PMID32686865,reaction_1,in vivo,"Overexpression in HEK293T cells. Product (PI(4,5)P2) levels were visualized by immunofluorescence using a GST-PH-PLCδ1 probe.",Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% of FBS,,Cells were cultured in a humidified incubator at 37°C with 5% of CO2.,37.0,HEK293T cells,pcDNA3.1-FLAG,Constitutive expression under CMV promoter for 48 hours.
PMID32686865,reaction_2,in vitro,Cell-free assay using microsomal membranes from HEK293 cells as a source of both endogenous γ-secretase and its substrate C99-CFP.,"25 mM Tris, pH 7.5, 5 mM β-glycerolphosphate, 2 mM 2-mercaptoethanol, 0.1 mM Na3VO4, 10 mM MgCl2, complete protease inhibitor cocktail, and 0.02 mM EDTA",7.5,,37.0,,,
PMID32687799,reaction_1,in vitro,Transient state kinetics of the oxidative half-reaction using pH-jump methods with a stopped-flow spectrophotometer.,"A mixture of 25 mM acetic acid, 25 mM Bis-Tris, and 50 mM Tris was used to buffer for pHs from 5.2 to 8.5.",,"Studied over a pH range of 5.2 to 8.5. The rates of the three observed phases (hydroperoxyflavin formation, hydroxylation, product release) were not significantly influenced by pH.",5.0,,,
PMID32687799,reaction_2,in vitro,Kinetic isotope effect experiment using stopped-flow spectrophotometry.,"20 mM HEPES, 2 mM DTT",7.5,,5.0,,,
PMID32687799,reaction_3,in vitro,Study of the oxidative half-reaction in the presence of the inhibitor benzoylalanine (BA) using stopped-flow spectrophotometry.,"25 mM acetic acid, 25 mM Bis-Tris, 50 mM Tris",,Studied over a pH range of 5-9.,5.0,,,
PMID32687799,reaction_4,in vitro,Spectrophotometric titration of the hydroperoxyflavin intermediate in the presence of the inhibitor meta-nitrobenzoylalanine (mNBA) using stopped-flow spectrophotometry and CCD detection.,"50 mM acetic acid, 50 mM MES, 100 mM Tris",,Studied over a pH range of 5.5-8.5.,5.0,,,
PMID32688200,reaction_1,in vitro,Biochemical assay measuring NADH consumption by monitoring absorbance at 340 nm.,"150 mM Tris HCl, 80 mM EDTA, and 0.01% Tween-20",7.4,,25.0,,,
PMID32688200,reaction_2,in vitro,"Coupled assay. PDKs phosphorylate PDC, and the remaining PDC activity is then measured by monitoring NADH production at 340 nm.","40 mM Mops, 0.5 mM EDTA, 30 mM KCl, 1.5 mM MgCl2, 0.25 mM acetyl-CoA, 0.05 mM NADH, 2 mM dithiothreitol, 10 mM NaF",7.2,,37.0,,,
PMID32703443,reaction_1,in vitro,Enzyme assay with purified recombinant protein using PA-labeled sugar chain as acceptor substrate.,"50 mM MES-NaOH, pH 6.5, 10 mM MnCl2",6.5,,37.0,Spodoptera frugiperda Sf9 cells,pFastBac™,
PMID32703443,reaction_2,in vitro,Enzyme assay with purified recombinant protein using PA-labeled sugar chain as acceptor substrate.,"50 mM MES-NaOH, pH 6.5, 10 mM MnCl2",6.5,,37.0,Spodoptera frugiperda Sf9 cells,pFastBac™,
PMID32703443,reaction_3,in vitro,Enzyme assay with purified recombinant protein using PA-labeled sugar chain as acceptor substrate.,"50 mM MES-NaOH, pH 6.5, 10 mM MnCl2",6.5,,37.0,Spodoptera frugiperda Sf9 cells,pFastBac™,
PMID32703443,reaction_4,in vitro,Enzyme assay with purified recombinant protein using PA-labeled sugar chain as acceptor substrate.,"50 mM MES-NaOH, pH 6.5, 10 mM MnCl2",6.5,,37.0,Spodoptera frugiperda Sf9 cells,pFastBac™,
PMID32710850,reaction_1,in vitro,"Vectorial phosphorylation assay with purified ecIICIIDMan complex reconstituted into phospholipid vesicles. Soluble PTS components (IIABMan, HPr, EI and PEP) were loaded inside the proteoliposomes.",Phospholipid vesicles,,,,,,
PMID32710850,reaction_2,in vitro,"Non-vectorial (kinase-like) phosphorylation assay with purified ecIICIIDMan complex reconstituted into phospholipid vesicles. D-Glucose and soluble PTS components (IIABMan, HPr, EI and PEP) were added to the outside of the vesicles.",Phospholipid vesicles,,,,,,
PMID32710850,reaction_3,in vitro,"Proteoliposome-based counterflow assay for facilitative exchange of intraliposomal [12C]Mannose against external [3H]Mannose, without phosphorylation.",Proteoliposome,,,,,,
PMID32710850,reaction_4,in vivo,Infection assay using bacteriophage lambda on E. coli mutants. Sensitivity to phage infection was correlated with the presence of functional IIC and IID subunits.,,,,,Escherichia coli,,
PMID32714915,reaction_1_free_enzyme,in vitro,Standard enzyme activity assay with purified free enzyme.,"50 mM Hepes, pH 7.0",7.0,Used for kinetic measurements. Optimal pH is 8.5.,50.0,Escherichia coli BL21(DE3) pLysS,pET16bP-TagalU,"Autoinduction in TB medium at 37°C, then temperature reduction to 20°C for 22h protein production."
PMID32714915,reaction_2_immobilized_enzyme,in vitro,Enzyme activity assay with TaGalU covalently immobilized on amino-functionalized mesostructured cellular foams (MCF).,"50 mM Hepes buffer, pH 7.0",7.0,Used for kinetic measurements. Optimal pH is 7.5.,50.0,Escherichia coli BL21(DE3) pLysS,,
PMID32716961,reaction_1,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_2,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_3,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_4,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_5,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_6,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_7,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_8,in vivo,ChIP-qPCR assay in HCT116 cells,Cells cultured in RPMI-1640 medium,,,37.0,,,
PMID32716961,reaction_9,in vivo,"Western blot analysis in HCT116 cells following VCP knockdown (shRNA), overexpression, and proteasome inhibition.",Cells cultured in RPMI-1640 medium,,,37.0,HCT116,plenti-Flag-VCP,Lentiviral transduction for overexpression studies.
PMID32717224,reaction_1,in vitro,"Steady-state kinetic assay using 500 nM tag-free enzyme, monitoring NADH production at 340 nm. Used to determine Km for hexanal and to study inhibition by DEAB.",100 mM sodium pyrophosphate pH 8.0,8.0,,27.0,Escherichia coli BL21 (DE3),pET-24b(+) or pET-SUMO,0.25 mM IPTG at 18°C for 18-21 hours
PMID32717856,reaction_1,in vitro,Activity assay with product separation on denaturing polyacrylamide gels.,"30 mM HEPES/KOH, 30 mM KCl, 2 mM DTT, 6 mM MgCl2",7.6,,20.0,E. coli BL21 DE3 (∆cca),pET28b (+),
PMID32717856,reaction_2,in vitro,Activity assay with product separation on denaturing polyacrylamide gels.,"30 mM HEPES/KOH, 30 mM KCl, 2 mM DTT, 6 mM MgCl2",7.6,,20.0,E. coli BL21 DE3 (∆cca),pET28b (+),
PMID32717856,reaction_3,in vitro,Activity assay with product separation on denaturing polyacrylamide gels.,"30 mM HEPES/KOH, 30 mM KCl, 2 mM DTT, 6 mM MgCl2",7.6,,20.0,E. coli BL21 DE3 (∆cca),pET28b (+),
PMID32717856,reaction_4,in vitro,Activity assay with product separation on denaturing polyacrylamide gels.,"30 mM HEPES/KOH, 30 mM KCl, 2 mM DTT, 6 mM MgCl2",7.6,,20.0,E. coli BL21 DE3 (∆cca),pET28b (+),
PMID32717856,reaction_5,in vitro,"Substrate specificity analysis using high-throughput sequencing (LOTTE-seq). Substrate was total tRNA from D. discoideum at different developmental stages (0h, 6h, 16h) treated with snake venom phosphodiesterase I to remove the 3'-CCA end. Reaction was performed under non-saturating enzyme conditions.","30 mM HEPES/KOH, 30 mM KCl, 2 mM DTT, 6 mM MgCl2",7.6,,20.0,E. coli BL21 DE3 (∆cca),pET28b (+),
PMID32717856,reaction_6,in vitro,"Substrate specificity analysis using high-throughput sequencing (LOTTE-seq). Substrate was total tRNA from D. discoideum at different developmental stages (0h, 6h, 16h) treated with snake venom phosphodiesterase I to remove the 3'-CCA end. Reaction was performed under non-saturating enzyme conditions.","30 mM HEPES/KOH, 30 mM KCl, 2 mM DTT, 6 mM MgCl2",7.6,,20.0,E. coli BL21 DE3 (∆cca),pET28b (+),
PMID32719456,reaction_1,in vitro,Hoechst 33342 transport assay using inside-out membrane vesicles from L. lactis. Transport measured by fluorescence quenching.,"50 mM HEPES KOH, 2 mM MgCl2, 300 mM KCl, pH 7.4",7.4,,25.0,Lactococcus lactis strain NZ9000 ΔLmrA ΔLmrCD,pHLP5-3C,"Induced by a 1:1,000 dilution of the supernatant of the nisin-producing L. lactis strain NZ9700 for 2 hours at 30°C."
PMID32719456,reaction_2,in vivo,Cell survival assay in L. lactis measuring MIC50 of the antibiotic.,M17 medium supplemented with 0.5% glucose and 5 μg/ml chloramphenicol,,,30.0,Lactococcus lactis strain NZ9000 ΔLmrA ΔLmrCD,pHLP5-3C,"Induced by a 1:1,000 dilution of the supernatant of the nisin-producing L. lactis strain NZ9000 for 2 hours at 30°C."
PMID32719456,reaction_3,in vivo,Cell survival assay in L. lactis measuring MIC50 of the antibiotic.,M17 medium supplemented with 0.5% glucose and 5 μg/ml chloramphenicol,,,30.0,Lactococcus lactis strain NZ9000 ΔLmrA ΔLmrCD,pHLP5-3C,"Induced by a 1:1,000 dilution of the supernatant of the nisin-producing L. lactis strain NZ9000 for 2 hours at 30°C."
PMID32719456,reaction_4,in vivo,Cell survival assay in L. lactis measuring MIC50 of the antibiotic.,M17 medium supplemented with 0.5% glucose and 5 μg/ml chloramphenicol,,,30.0,Lactococcus lactis strain NZ9000 ΔLmrA ΔLmrCD,pHLP5-3C,"Induced by a 1:1,000 dilution of the supernatant of the nisin-producing L. lactis strain NZ9000 for 2 hours at 30°C."
PMID32723819,reaction_1,in vitro,"Enzyme activity assay with 10 mg/mL substrate, 1 μM enzyme, and 2 mM reductant.",20 mM Tris·HCl buffer,8.0,,40.0,Escherichia coli,,"Recombinantly produced using isotope-enriched (13C, 15N) minimal medium or LB."
PMID32723819,reaction_2,in vitro,"Enzyme activity assay with 10 mg/mL substrate, 1 μM enzyme, and 2 mM reductant.",20 mM Tris·HCl buffer,8.0,,40.0,Escherichia coli,,"Recombinantly produced using isotope-enriched (13C, 15N) minimal medium or LB."
PMID32729375,reaction_1,in vitro,Kinetic analysis of forward reaction,100 mM citrate buffer,4.0,,45.0,Escherichia coli BL21(DE3),pColdI,"1 mM isopropyl β-D-thiogalactopyranoside, 16°C, overnight"
PMID32729375,reaction_2,in vitro,Kinetic analysis of forward reaction,100 mM citrate buffer,4.0,,45.0,Escherichia coli BL21(DE3),pColdI,"1 mM isopropyl β-D-thiogalactopyranoside, 16°C, overnight"
PMID32729375,reaction_3,in vitro,Kinetic analysis of reverse reaction,100 mM glycine–NaOH buffer,9.0,,45.0,Escherichia coli BL21(DE3),pColdI,"1 mM isopropyl β-D-thiogalactopyranoside, 16°C, overnight"
PMID32729375,reaction_4,in vitro,Kinetic analysis of reverse reaction,100 mM glycine–NaOH buffer,9.0,,45.0,Escherichia coli BL21(DE3),pColdI,"1 mM isopropyl β-D-thiogalactopyranoside, 16°C, overnight"
PMID32729393,reaction_1,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,Pseudomonas nitroreducens SB32154,,
PMID32729393,reaction_2,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_3,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_4,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_5,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_6,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_7,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_8,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_9,in vitro,Enzyme activity assay with purified enzyme for kinetic parameter determination.,20 mM potassium phosphate buffer,6.0,,30.0,,,
PMID32729393,reaction_10,in vitro,One-pot reaction combining purified BMAL-CHO dehydrogenase and whole E. coli cells expressing P450nov.,phosphate-buffered saline,,Not specified for PBS,28.0,,,
PMID32730353,reaction_1,in vivo,Enzyme was expressed in transgenic tilapia. Fish were fed a diet supplemented with 3% linseed oil for 28 days. Fatty acid composition was analyzed in liver tissue via GC-MS.,in vivo study in tilapia,,,28.0,Tilapia (Oreochromis niloticus),"pT2-TRE-fadsd6-V5-eTcRFP11 (expression vector), pT2-Fabp10-tTA and pT2-CKMb-tTA (transactivator vectors)",Tetracycline-controlled transactivator (tTA) system with liver-specific (Fabp10a) and muscle-specific (CKMb) promoters.
PMID32730353,reaction_2,in vivo,Enzyme was expressed in transgenic tilapia. Fish were fed a diet supplemented with 3% linseed oil for 28 days. Fatty acid composition was analyzed in liver tissue via GC-MS.,in vivo study in tilapia,,,28.0,Tilapia (Oreochromis niloticus),"pT2-TRE-fadsd5-V5-TcCFP13 (expression vector), pT2-Fabp10-tTA and pT2-CKMb-tTA (transactivator vectors)",Tetracycline-controlled transactivator (tTA) system with liver-specific (Fabp10a) and muscle-specific (CKMb) promoters.
PMID32730353,reaction_3,in vivo,Enzyme was expressed in transgenic tilapia. Fish were fed a diet supplemented with 3% linseed oil for 28 days. Fatty acid composition was analyzed in liver tissue via GC-MS.,in vivo study in tilapia,,,28.0,Tilapia (Oreochromis niloticus),"pT2-TRE-fadsd6-V5-eTcRFP11 (expression vector), pT2-Fabp10-tTA and pT2-CKMb-tTA (transactivator vectors)",Tetracycline-controlled transactivator (tTA) system with liver-specific (Fabp10a) and muscle-specific (CKMb) promoters.
PMID32730353,reaction_4,in vivo,Enzyme was expressed in transgenic tilapia. Fish were fed a diet supplemented with 3% linseed oil for 28 days. Fatty acid composition was analyzed in liver tissue via GC-MS.,in vivo study in tilapia,,,28.0,Tilapia (Oreochromis niloticus),"pT2-TRE-fadsd5-V5-TcCFP13 (expression vector), pT2-Fabp10-tTA and pT2-CKMb-tTA (transactivator vectors)",Tetracycline-controlled transactivator (tTA) system with liver-specific (Fabp10a) and muscle-specific (CKMb) promoters.
PMID32730563,reaction_1,in vitro,Oxygen consumption measurement using an Oxygraph Plus system.,Two conditions tested: 100 mM sodium phosphate (for reconstituted DAO assays) and 50 mM sodium pyrophosphate (for holo-DAO assays).,,pH 8.0 (reconstituted DAO) or pH 8.3 (holo-DAO) depending on the assay condition.,25.0,Escherichia coli BL21 (DE3),pET11b,"0.1 mM IPTG, 37°C, 20 h"
PMID32730563,reaction_2,in vitro,Oxygen consumption measurement using an Oxygraph Plus system.,Two conditions tested: 100 mM sodium phosphate (for reconstituted DAO assays) and 50 mM sodium pyrophosphate (for holo-DAO assays).,,pH 8.0 (reconstituted DAO) or pH 8.3 (holo-DAO) depending on the assay condition.,25.0,Escherichia coli BL21 (DE3),pET11b,"0.1 mM IPTG, 37°C, 20 h"
PMID32730563,reaction_3,in vitro,Oxygen consumption measurement using an Oxygraph Plus system.,Two conditions tested: 100 mM sodium phosphate (for reconstituted DAO assays) and 50 mM sodium pyrophosphate (for holo-DAO assays).,,pH 8.0 (reconstituted DAO) or pH 8.3 (holo-DAO) depending on the assay condition.,25.0,Escherichia coli BL21 (DE3),pET11b,"0.1 mM IPTG, 37°C, 20 h"
PMID32731629,reaction_1a,in vitro,Enzyme activity assay measuring inorganic phosphate release after acid hydrolysis of the product L-phosphoarginine.,"100 mM Tris-HCl, 10 mM mercaptoethanol, 200 mM magnesium sulfate",8.6,,30.0,,,
PMID32731629,reaction_1b,in vitro,Enzyme activity assay measuring inorganic phosphate release after acid hydrolysis of the product L-phosphoarginine.,"100 mM Tris-HCl, 10 mM mercaptoethanol, 200 mM magnesium sulfate",8.6,,30.0,,,
PMID32732027,reaction_1,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),pET-45b,"0.2 mM IPTG, 16 °C for 18 h"
PMID32732027,reaction_2,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_3,in vitro,Substrate specificity screening and preparative synthesis.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_4,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_5,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_6,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_7,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_8,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_9,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_10,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_11,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_12,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_13,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_14,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_15,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_16,in vitro,Substrate specificity screening and preparative synthesis.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_17,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_18,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_19,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732027,reaction_20,in vitro,Substrate specificity screening assay.,50 mM Tris-HCl,7.0,,42.0,Escherichia coli BL21 (DE3),,
PMID32732035,reaction_1,in vitro,Spectrophotometric assay monitoring NADH production at 340 nm.,100 mM Tris-Cl,7.0,,25.0,Escherichia coli BL21(DE3),pET-30 (construct named pCK1_bdhX),Induced at 20°C in Terrific Broth.
PMID32732035,reaction_2,in vitro,Spectrophotometric assay monitoring NADH production at 340 nm.,100 mM Tris-Cl,7.0,,25.0,Escherichia coli BL21(DE3),pET-30 (construct named pCK1_bdhX),Induced at 20°C in Terrific Broth.
PMID32732035,reaction_3,in vitro,Spectrophotometric assay monitoring NADH production at 340 nm.,10 mM ethanolamine,11.0,,25.0,Escherichia coli BL21(DE3),pET-30 (construct named pCK1_bdhX),Induced at 20°C in Terrific Broth.
PMID32732035,reaction_4,in vitro,Spectrophotometric assay monitoring NADH production at 340 nm.,10 mM ethanolamine,11.0,,25.0,Escherichia coli BL21(DE3),pET-30 (construct named pCK1_bdhX),Induced at 20°C in Terrific Broth.
PMID32732035,reaction_5,in vitro,Assay performed using crude extract of the bdh (TCK1_3449) knockout mutant.,100 mM Tris-Cl (at pH 7.0) or 10 mM ethanolamine (at pH 12.5),,Assays performed at pH 7.0 and pH 12.5,25.0,,,
PMID32732035,reaction_6,in vitro,Assay performed using crude extract of the bdh (TCK1_3449) knockout mutant.,100 mM Tris-Cl (at pH 7.0) or 10 mM ethanolamine (at pH 12.5),,Assays performed at pH 7.0 and pH 12.5,25.0,,,
PMID32732043,reaction_1,in vitro,Enzyme kinetics study using a spectrophotometric method.,Tris-HCl buffer,9.5,Optimum pH for kinetic analysis.,40.0,,,
PMID32732043,reaction_2,in vitro,Substrate specificity assay,50 mM Tris-HCl buffer (pH 9.0) containing 100 µM Tween 20,9.0,,25.0,,,
PMID32732435,reaction_1,in vitro,"Time-resolved in crystallo reactions monitored by UV-vis microspectroscopy, EPR spectroscopy, and X-ray crystallography. Solution-state kinetics also performed via stopped-flow spectroscopy.","0.1 M Tris·HCl, 0.2 M MgCl2, 20% PEG 8000, with 20% glycerol as cryoprotectant for in crystallo studies.",8.5,0.1 M Tris·HCl,,,,
PMID32735861,reaction_1,in vitro,Spectrophotometric assay with purified enzyme,"50 mM Tris-HCl buffer, 5% (v/v) glycerol, 0.02% (v/v) IGEPAL",8.3,,55.0,Native expression in Aquifex aeolicus VF5,,
PMID32735861,reaction_2,in vitro,Spectrophotometric assay with purified enzyme,"50 mM Tris-HCl buffer, 5% (v/v) glycerol, 0.02% (v/v) IGEPAL",8.3,,55.0,Native expression in Aquifex aeolicus VF5,,
PMID32735861,reaction_3,in vitro,Anaerobic spectrophotometric assay with purified enzyme and reduced MV as electron donor,50 mM potassium phosphate buffer,8.2,,55.0,Native expression in Aquifex aeolicus VF5,,
PMID32735861,reaction_4,in vitro,Colorimetric assay for sulfide production with purified enzyme and reduced MV as electron donor,50 mM potassium phosphate buffer,8.2,,70.0,Native expression in Aquifex aeolicus VF5,,
PMID32735861,reaction_5,in vitro,Polarographic O2 consumption measurement with intact membranes,"polybuffer (MES, PIPES, Tris, Glycine, each at 50 mM)",7.8,,60.0,,,
PMID32735861,reaction_6,in vivo,Polarographic O2 consumption measurement with whole fresh cells,"polybuffer (MES, PIPES, Tris, Glycine, each at 50 mM)",7.8,,60.0,,,
PMID32736636,reaction_1,in vivo,Whole-cell fed-batch bioconversion in engineered Trichoderma sp. LF328 T2,Low phosphate medium with 2 g/L yeast extract and d-glucose as co-substrate.,4.0,pH controlled in bioreactor,35.0,Trichoderma sp. LF328,linearized cassette from modified YEplac195,Constitutive expression via synthetic expression system (SES-B)
PMID32736636,reaction_2,in vivo,Whole-cell bioconversion in engineered Coniochaeta sp. MF729 C1 in 24-well plates,Low phosphate medium with 100 mM PIPPS buffer and d-glucose as co-substrate.,5.5,,28.0,Coniochaeta sp. MF729,linearized cassette from modified YEplac195,Constitutive expression via synthetic expression system (SES-B)
PMID32736636,reaction_3,in vivo,Whole-cell bioconversion from poly-d-galacturonic acid in engineered Trichoderma sp. LF328 T2 in 24-well plates,Low phosphate medium with 100 mM PIPPS buffer and d-xylose as co-substrate.,5.5,,28.0,Trichoderma sp. LF328,linearized cassette from modified YEplac195,Constitutive expression via synthetic expression system (SES-B)
PMID32736636,reaction_4,in vivo,Whole-cell bioconversion from poly-d-galacturonic acid in engineered Coniochaeta sp. MF729 C1 in 24-well plates,Low phosphate medium with 100 mM PIPPS buffer and d-glucose as co-substrate.,5.5,,28.0,Coniochaeta sp. MF729,linearized cassette from modified YEplac195,Constitutive expression via synthetic expression system (SES-B)
PMID32736636,reaction_5,in vivo,Whole-cell bioconversion from citrus pectin in engineered Coniochaeta sp. MF729 C1 in 24-well plates,Low phosphate medium with 100 mM PIPPS buffer and d-glucose as co-substrate.,5.5,,28.0,Coniochaeta sp. MF729,linearized cassette from modified YEplac195,Constitutive expression via synthetic expression system (SES-B)
PMID32736636,reaction_6,in vitro,Enzyme activity assay on culture supernatant,sodium citrate buffer,4.9,This is the optimal pH.,55.0,,,
PMID32736692,reaction_1,in vitro,Enzymatic assay using G25-fraction of crude Cypridina extracts. Product (Cypridina luciferin) formation was measured indirectly via luminescence produced by Cypridina luciferase.,0.5 M glycine-NaOH,7.5,,22.0,,,
PMID32736692,reaction_2,in vitro,"Enzymatic assay using G25-fraction of crude Cypridina extracts. The product, acetyl sulfate, was identified by LC/ESI-TOF-MS.",0.5 M glycine-NaOH,7.5,,22.0,,,
PMID32736692,reaction_3,in vitro,Enzymatic assay using crude extracts of Cypridina specimens. Activity was inferred from stimulation of luminescence.,0.5 M glycine-NaOH,7.5,,22.0,,,
PMID32736692,reaction_4,in vitro,Enzymatic assay using G25-fraction of Cypridina specimens. Activity was inferred from effective stimulation of luminescence.,0.5 M glycine-NaOH,7.5,,22.0,,,
PMID32736692,reaction_5,in vitro,Enzymatic assay using G25-fraction of Cypridina specimens. Activity was inferred from effective stimulation of luminescence.,0.5 M glycine-NaOH,7.5,,22.0,,,
PMID32736692,reaction_6,in vitro,Enzymatic assay using G25-fraction of Cypridina specimens. Activity was inferred from effective stimulation of luminescence.,0.5 M glycine-NaOH,7.5,,22.0,,,
PMID32738969,reaction_1,in vitro,Enzyme activity assay to measure the effect of dammarane-type compounds.,Not specified,,Not specified,,,,
PMID32738969,reaction_2,in vitro,Enzyme activity assay to measure the effect of dammarane saponins.,Not specified,,Not specified,,,,
PMID32744783,reaction_1,in vivo,AMCA uptake efficiency assay,,,in vivo conditions,,Escherichia coli,,
PMID32745463,reaction_1,in vitro,Rate assays for the measurement of catalytic parameters and inhibition studies.,"0.1 M Tris-HCl, pH 8",8.0,,25.0,Escherichia coli BL21,pET-21a(+),"1 mM IPTG, 20°C, 7 hours"
PMID32745463,reaction_2,in vitro,Rate assays for the measurement of catalytic parameters.,"0.1 M Tris-HCl, pH 8",8.0,,25.0,Escherichia coli BL21,pET-21a(+),"1 mM IPTG, 20°C, 7 hours"
PMID32745463,reaction_3,in vitro,Rate assays for the measurement of catalytic parameters and inhibition studies.,"0.1 M Tris-HCl, pH 8",8.0,,25.0,Escherichia coli BL21,pET-21a(+),"1 mM IPTG, 20°C, 10 hours"
PMID32745463,reaction_4,in vitro,Rate assays for the measurement of catalytic parameters.,"0.1 M Tris-HCl, pH 8",8.0,,25.0,Escherichia coli BL21,pET-21a(+),"1 mM IPTG, 20°C, 10 hours"
PMID32745735,reaction_1,in vitro,Enzyme inhibition study to measure IC50 values of synthesized compounds.,"100 mM Tris-HCl, 50 mM KCl, and 5 mM MgCl2",7.5,,25.0,,,
PMID32747548,reaction_1,in vitro,Assay with purified enzyme. Product identified by reversed-phase HPLC and LC-MS.,Not specified,,Not specified,,Escherichia coli,,
PMID32747548,reaction_2,in vitro,Assay with purified enzyme. Product identified by normal-phase HPLC.,Not specified,,Not specified,,Escherichia coli,,
PMID32747548,reaction_3,in vitro,Assay with purified enzyme. Product identified by normal-phase HPLC.,Not specified,,Not specified,,Escherichia coli,,
PMID32747548,reaction_4,in vitro,Assay with purified enzyme. Product identified by normal-phase HPLC. Also observed during co-crystallization attempts.,Not specified,,Not specified,,Escherichia coli,,
PMID32747548,reaction_5,in vitro,Activity measured directly from the supernatant fraction of E. coli lysate.,Not specified,,Not specified,,Escherichia coli,,
PMID32748014,reaction_1,in vitro,Enzyme-coupled assay with pyruvate kinase (PK) and lactate dehydrogenase (LDH) monitoring NADH oxidation at 340 nm.,100 mM HEPES–NaOH,7.4,,30.0,Escherichia coli BL21 (DE3),pET15b,"0.5 mM IPTG, 18°C, 20h"
PMID32750321,reaction_1,in vitro,Amplex Red coupled enzyme assay measuring H2O2 formation.,"50 mM potassium phosphate, pH 7.4",7.4,,22.0,E. coli BL21 (DE3)/pRARE,pTMal (MBP-tagged),"0.1 mM isopropylthiogalactoside, 20 °C, overnight"
PMID32750321,reaction_2,in vitro,Amplex Red coupled enzyme assay measuring H2O2 formation.,"50 mM potassium phosphate, pH 7.4",7.4,,22.0,E. coli BL21 (DE3)/pRARE,pTMal (MBP-tagged),"0.1 mM isopropylthiogalactoside, 20 °C, overnight"
PMID32750321,reaction_3,in vitro,Amplex Red coupled enzyme assay measuring H2O2 formation.,"50 mM potassium phosphate, pH 7.4",7.4,,37.0,E. coli BL21 (DE3)/pRARE,pTMal (MBP-tagged),"0.1 mM isopropylthiogalactoside, 20 °C, overnight"
PMID32750477,reaction_1,in vitro,Kinetic parameter study of wild-type and mutant enzymes.,50 mM potassium phosphate buffer,7.5,Physiological pH,37.0,Escherichia coli Rosetta-gami (DE3),pMAL-p5X,"0.25 mM IPTG, 16°C, overnight"
PMID32752273,reaction_1,in vitro,Direct effect of compounds on GLuc activity was tested using supernatant from S. aureus cultures constitutively expressing GLuc.,"Supernatant from TSB (tryptone soy broth) culture medium, with 20 µM coelenterazine substrate added.",,Not specified.,,Staphylococcus aureus RN4220 pXyl/tet: SpA leader: GLuc,pUNK1 pXyl/tet:SpA leader:GLuc,Constitutive expression from Pxyl/tet promoter.
PMID32761262,reaction_1,in vitro,,"0.1 M Tris–HCl containing 2 M KCl, 20 mM MgCl2, 1 mM CoCl2",8.0,,37.0,Haloferax volcanii H1209,pTA963,"2 mM tryptophan, 42 °C, 18 h"
PMID32761262,reaction_2,in vitro,Coupled assay with pyruvate kinase and lactate dehydrogenase,"0.1 M Tris–HCl containing 2 M KCl, 10 mM MgCl2, 0.3 mM NADH, 1 mM phosphoenolpyruvate",8.0,,37.0,Haloferax volcanii H1209,pTA963,"2 mM tryptophan, 42 °C, 18 h"
PMID32761262,reaction_3,in vitro,,"0.1 M Tris–HCl containing 2 M KCl, 20 mM MgCl2, 1 mM CoCl2",8.0,,37.0,Haloferax volcanii H1209,pTA963,"2 mM tryptophan, 42 °C, 18 h"
PMID32761262,reaction_4,in vitro,Coupled assay with pyruvate kinase and lactate dehydrogenase,"0.1 M Tris–HCl containing 1.5 M KCl, 50 mM MgCl2, 0.3 mM NADH, 1 mM phosphoenolpyruvate",8.0,,37.0,Haloferax volcanii H1209,pTA963,"2 mM tryptophan, 42 °C, 18 h"
PMID32761262,reaction_5,in vitro,,"Not specified for this side reaction, but likely similar to the ribokinase assay conditions.",,,,Haloferax volcanii H1209,pTA963,"2 mM tryptophan, 42 °C, 18 h"
PMID32761262,reaction_6,in vitro,Coupled assay with pyruvate kinase and lactate dehydrogenase,"0.1 M bis–tris containing 1.5 M KCl, 0.3 mM NADH, 2.5 mM phosphoenolpyruvate, 10 mM MgCl2",7.5,,42.0,Haloferax volcanii H1209,pTA963,"2 mM tryptophan, 42 °C, 18 h"
PMID32761262,reaction_7,in vitro,,"0.1 M Tris–HCl containing 2 M KCl, 20 mM MgCl2",8.0,,37.0,Haloferax volcanii H1209,pTA963,"2 mM tryptophan, 42 °C, 18 h"
PMID32761540,reaction_1,in vitro,Kinetic assays performed with microsomal protein extracts from recombinant yeast. In vivo activity was also confirmed in S. cerevisiae WAT11 whole-cell assays.,100 mM Tris-HCl,7.5,Optimum pH determined to be approximately 7.5,27.0,Saccharomyces cerevisiae WAT11,pYES2-CYP71AJ49mut,Induced with 2% galactose at 20 °C for 12 h in SC-U medium.
PMID32761540,reaction_2,in vitro,Kinetic assays performed with microsomal protein extracts from recombinant yeast. In vivo activity was also confirmed in S. cerevisiae WAT11 whole-cell assays.,100 mM Tris-HCl,7.5,Optimum pH determined to be approximately 7.5,27.0,Saccharomyces cerevisiae WAT11,pYES2-CYP71AJ51mut,Induced with 2% galactose at 20 °C for 12 h in SC-U medium.
PMID32762529,reaction_1,in vitro,Enzyme inhibition assay using the dopachrome method.,20 mM phosphate buffer,6.8,,25.0,,,
PMID32763398,reaction_1,in vitro,Analysis of soluble products by MALDI-TOF MS,20 mM Tris-HCl buffer,8.0,,37.0,Brevibacillus chosinensis SP3 strain,pNCMO2,Grown in 2SY broth containing 50 µg/mL neomycin for over 24 h at 30°C.
PMID32763398,reaction_2,in vitro,Analysis of soluble products by MALDI-TOF MS,20 mM Tris-HCl buffer,8.0,,37.0,Brevibacillus chosinensis SP3 strain,pNCMO2,Grown in 2SY broth containing 50 µg/mL neomycin for over 24 h at 30°C.
PMID32763398,reaction_3,in vitro,"Synergistic chitin degradation assay measuring (GlcNAc)2 production. The main catalytic reaction is by SmChiB, boosted by SgLPMO10A.",50 mM ammonium acetate buffer,6.3,,37.0,Brevibacillus chosinensis SP3 strain,pNCMO2,Grown in 2SY broth containing 50 µg/mL neomycin for over 24 h at 30°C.
PMID32763398,reaction_4,in vitro,"Synergistic cellulose degradation assay measuring glucose production. The main catalytic reaction is by a cellulase cocktail, boosted by SgLPMO10A.",50 mM sodium acetate buffer,5.0,,50.0,Brevibacillus chosinensis SP3 strain,pNCMO2,Grown in 2SY broth containing 50 µg/mL neomycin for over 24 h at 30°C.
PMID32763398,reaction_5,in vitro,"Synergistic cellulose degradation assay measuring glucose production. The main catalytic reaction is by a cellulase cocktail, boosted by SgLPMO10A.",50 mM sodium acetate buffer,5.0,,50.0,Brevibacillus chosinensis SP3 strain,pNCMO2,Grown in 2SY broth containing 50 µg/mL neomycin for over 24 h at 30°C.
PMID32763515,reaction_1,in vitro,"Activity assay performed on isolated mitochondria from human aortic endothelial cells (HAECs), measuring the reduction of the NAD+ analogue, 3-acetylpyridine adenine dinucleotide (APAD).","50 mM Tris, 0.5% Brij-35, 1 mg/ml lysolecithin",8.0,,37.0,Immortalized human aortic endothelial cells (HAECs),Lentiviral particles containing EGFP-shNNT with target sequence 5’-CGAGAAGCTAATAGCATTATT-3’,
PMID32764148,reaction_1,in vivo,"Inhibition of PIKfyve was studied by observing its downstream effects on viral entry and infection in SVG-A, MA104, and Vero E6 cells.",Cell culture medium (MEM or DMEM with 10% FBS),7.4,pH of cell culture medium is typically maintained around 7.4,37.0,,,
PMID32768460,reaction_1,in vitro,Enzyme activity measured by following the change in absorbance at 340 nm for the reductive amination reaction.,"100 mM Tris/HCl, 150 mM NH4Cl, 30 mM 2-ketoglutarate, 0.125 mM NADPH",8.0,pH of the standard assay mixture for reductive amination.,,Escherichia coli BL-21 (DE3),pET6XHN,IPTG induced
PMID32768460,reaction_2,in vitro,Enzyme activity measured by following the change in absorbance at 340 nm for the reductive amination reaction.,"100 mM Tris/HCl, 150 mM NH4Cl, 30 mM 2-ketoglutarate, 0.125 mM NADPH",8.0,pH of the standard assay mixture for reductive amination.,,Escherichia coli BL-21 (DE3),pET6XHN,IPTG induced
PMID32768525,reaction_1,in vivo,Metabolomics analysis of cultured 6DT1 mouse mammary cancer cells after CRISPR/Cas9-mediated gene knockout.,"Dulbecco’s Modified Eagle Medium (DMEM) with 25 mM glucose, 2 mM glutamine, 10% heat-inactivated fetal bovine serum, and 1% penicillin and streptomycin.",,"Not specified, standard cell culture conditions.",37.0,6DT1 mouse mammary cancer cell line,,
PMID32768525,reaction_2,in vivo,Metabolomics analysis of cultured 6DT1 mouse mammary cancer cells after CRISPR/Cas9-mediated gene knockout.,"Dulbecco’s Modified Eagle Medium (DMEM) with 25 mM glucose, 2 mM glutamine, 10% heat-inactivated fetal bovine serum, and 1% penicillin and streptomycin.",,"Not specified, standard cell culture conditions.",37.0,6DT1 mouse mammary cancer cell line,,
PMID32770005,reaction_1,in vitro,"Activity determined by following the ADP-dependent release of coenzyme A (HSCoA) from acetyl-CoA using the thiol reagent DTNB, measured at 412 nm.","20 mM Tris-HCl, 40 mM K3PO4, 1 mM MgCl2, 0.1 mM DTNB, 2 mM ADP",8.0,,,Escherichia coli BL21 (DE3) -groEL,pET-28a,0.2 mM isopropyl-β-D-thiogalactoside in a total volume of 1.0 L at 20 °C for 20 h
PMID32770005,reaction_2,in vitro,"Activity measured in the direction of acetate formation by following PPi-dependent and AMP-dependent HSCoA release from acetyl-CoA with the thiol reagent DTNB, measured at 412 nm.","20 mM Tris-HCl, 1.25 M KCl, 1 mM MgCl2, 0.1 mM DTNB, 2 mM AMP, 2 mM PPi",8.0,,,Escherichia coli Rosetta (DE3),pET-28a,0.2 mM isopropyl-β-D-thiogalactoside in a total volume of 500 mL
PMID32770005,reaction_3,in vitro,Activity determined by coupling the reaction with malate dehydrogenase (Mdh) and citrate synthase (Cs) and monitoring the formation of NADH.,,,,,Escherichia coli Rosetta (DE3),pET-28a,0.2 mM isopropyl-β-D-thiogalactoside in a total volume of 500 mL
PMID32770699,reaction_1,in vitro,Photometric measurement of released inorganic phosphate from purified recombinant enzyme. Activity also confirmed in cytoplasmic extracts.,"50 mM Tris-HCl buffer pH 7, 0.2 mM thiamine pyrophosphate (TPP), 10 mM MgCl2",7.0,,25.0,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32770699,reaction_2,in vitro,Coupled enzyme assay with purified recombinant enzyme.,"50 mM Tris-HCl buffer pH 7, 0.2 mM thiamine pyrophosphate (TPP), 10 mM MgCl2",7.0,,25.0,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32770699,reaction_3,in vitro,Coupled photometric assay with purified recombinant enzyme. Activity also detected in cytoplasmic extracts.,"50 mM Tris-HCl buffer pH 7, 0.2 mM thiamine pyrophosphate (TPP), 10 mM MgCl2",7.0,,25.0,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32770699,reaction_4,in vitro,"Coupled photometric assay with purified recombinant enzymes (RPI, RPE, TK).","50 mM Tris-HCl buffer pH 7, 0.2 mM thiamine pyrophosphate (TPP), 10 mM MgCl2",7.0,,25.0,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32770699,reaction_5,in vitro,Coupled photometric assay with purified recombinant enzymes.,"50 mM Tris-HCl buffer pH 7, 0.2 mM thiamine pyrophosphate (TPP), 10 mM MgCl2",7.0,,25.0,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32770699,reaction_6,in vitro,Coupled photometric enzyme assay with purified recombinant enzyme.,"50 mM HEPES buffer pH7, 5 mM MgCl2",7.0,,,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32770699,reaction_7,in vitro,Activity confirmed in a coupled enzyme assay with purified recombinant enzyme.,"50 mM Tris-HCl buffer pH 7, 0.2 mM thiamine pyrophosphate (TPP), 10 mM MgCl2",7.0,,25.0,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32770699,reaction_8,in vitro,Activity confirmed in a coupled enzyme assay with purified recombinant enzyme.,"50 mM Tris-HCl buffer pH 7, 0.2 mM thiamine pyrophosphate (TPP), 10 mM MgCl2",7.0,,25.0,Escherichia coli DH5α,pASK-IBA3 or pASK-IBA5,"200 ng/mL anhydrotetracycline, 25°C, 10h"
PMID32771627,reaction_1,in vivo,Batch fermentation in 1 L DASGIP bioreactors under microaerobic conditions (0.075 vvm).,"Fermentation medium: 120 g L-1 glucose, 7 g L-1 glycerol, 5 g L-1 yeast extract, 3.5 g L-1 tryptone, 0.2 g L-1 MgSO4x7 H2O, 3.5 g L-1 KH2PO4, 2.5 g L-1 K2HPO4, 5 g L-1 ammonium acetate, 4 g L-1 (NH4)2SO4, 3 ml L-1 trace elements.",6.0,Maintained with 2 M NaOH or 1.35 M H3PO4,35.0,Paenibacillus polymyxa DSM 365,,
PMID32771627,reaction_2,in vivo,Continuous fermentation with cell retention in 2 L reactors.,Fermentation medium containing 46.2 g L-1 of glucose.,6.0,Maintained with 2 M NaOH or 1.35 M H3PO4,35.0,Paenibacillus polymyxa DSM 365,,
PMID32775880,reaction_1,in vitro,Preparation of the external aldimine state for Inelastic Neutron Scattering (INS) analysis.,10 mM NH4OAc in D2O with 0.1 mM PLP,7.5,pD = 7.5,4.0,Not specified,,
PMID32776205,reaction_1,in vivo,Measurement of intracellular BCAA content in S. cerevisiae strains grown in SD minimal medium.,"SD minimal medium (1.7 g/L yeast nitrogen base without amino acid, 5 g/L ammonium sulfate, 20 g/L glucose, pH 6.0)",6.0,,30.0,Saccharomyces cerevisiae BY4741bat1Δ,pRS416-BAT1,
PMID32776205,reaction_2,in vivo,Measurement of intracellular BCAA content in S. cerevisiae strains grown in SD minimal medium.,"SD minimal medium (1.7 g/L yeast nitrogen base without amino acid, 5 g/L ammonium sulfate, 20 g/L glucose, pH 6.0)",6.0,,30.0,Saccharomyces cerevisiae BY4741bat1Δ,pRS416-BAT1,
PMID32776205,reaction_3,in vivo,Measurement of intracellular BCAA content in S. cerevisiae strains grown in SD minimal medium.,"SD minimal medium (1.7 g/L yeast nitrogen base without amino acid, 5 g/L ammonium sulfate, 20 g/L glucose, pH 6.0)",6.0,,30.0,Saccharomyces cerevisiae BY4741bat1Δ,pRS416-BAT1,
PMID32776704,reaction_1,in vitro,"Enzyme kinetics assay using isolated (R,S)-SAM diastereomer.",assay buffer,,Not specified in the provided text.,30.0,,,
PMID32776704,reaction_2,in vitro,"Qualitative determination of activity on (S,S)-SAM.",assay buffer,,Not specified in the provided text.,30.0,,,
PMID32777304,reaction_1,in vitro,d-NADH oxidase activity measured in isolated cytoplasmic membranes using a Clarke-type oxygen electrode. This assay measures the overall respiratory chain activity initiated by complex I.,"50 mM MES/NaOH, 50 mM NaCl",6.0,,30.0,Escherichia coli BW25113,,
PMID32777304,reaction_2,in vitro,d-NADH/ferricyanide oxidoreductase activity measured spectrophotometrically at 410 nm in isolated cytoplasmic membranes.,"50 mM MES/NaOH, 50 mM NaCl",6.0,,,Escherichia coli BW25113,,
PMID32777304,reaction_3,in vitro,Succinate oxidase activity measured in isolated cytoplasmic membranes using a Clarke-type oxygen electrode. This assay measures the overall respiratory chain activity initiated by complex II.,"50 mM MES/NaOH, 50 mM NaCl",6.0,,30.0,Escherichia coli BW25113,,
PMID32786824,reaction_1,in vitro,Enzyme activity assay with purified protein. Quantitative determination of kinetic parameters was performed by measuring the rate of substrate decrease by HPLC.,50 mM phosphate buffer containing 2.0 mM GSH and 0.1 mM Fe(NH4)2(SO4)2·6H2O,7.4,Optimal pH determined in Tris-HCl buffer.,30.0,Escherichia coli BL21(DE3),pET29a(+),"0.05 mM IPTG, 16 °C, 8-10 h"
PMID32786824,reaction_2,in vitro,Enzyme activity assay with purified protein. Quantitative determination of kinetic parameters was performed by measuring the rate of substrate decrease by HPLC.,50 mM phosphate buffer containing 2.0 mM GSH and 0.1 mM Fe(NH4)2(SO4)2·6H2O,7.4,Optimal pH determined in Tris-HCl buffer.,30.0,Escherichia coli BL21(DE3),pET29a(+),"0.05 mM IPTG, 16 °C, 8-10 h"
PMID32786824,reaction_3,in vitro,Enzyme activity assay with purified protein. Quantitative determination of kinetic parameters was performed by measuring the rate of substrate decrease by HPLC.,50 mM phosphate buffer containing 2.0 mM GSH and 0.1 mM Fe(NH4)2(SO4)2·6H2O,7.4,Optimal pH determined in Tris-HCl buffer.,30.0,Escherichia coli BL21(DE3),pET24b-dsmD,"0.05 mM IPTG, 16 °C, 8-10 h"
PMID32786824,reaction_4,in vitro,Enzyme activity assay with purified protein. Quantitative determination of kinetic parameters was performed by measuring the rate of substrate decrease by HPLC.,50 mM phosphate buffer containing 2.0 mM GSH and 0.1 mM Fe(NH4)2(SO4)2·6H2O,7.4,Optimal pH determined in Tris-HCl buffer.,30.0,Escherichia coli BL21(DE3),pET24b-dsmD,"0.05 mM IPTG, 16 °C, 8-10 h"
PMID32786835,reaction_1,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.5,Optimal pH for KsdD3,30.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_2,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.5,,30.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_3,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.5,,30.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_4,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.5,,30.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_5,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.0,Optimal pH for KsdD5,35.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_6,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.0,,35.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_7,in vitro,Kinetic assay with purified enzyme and site-directed mutagenesis study,50 mM Tris-HCl,7.0,,35.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_8,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.0,,35.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_9,in vitro,Kinetic assay with purified enzyme,50 mM Tris-HCl,7.0,,35.0,Escherichia coli BL21(DE3),pET-28a,"0.05 mM IPTG, 20°C, 48h"
PMID32786835,reaction_10,in vitro,Bioconversion using cell-free extracts,50 mM Tris-HCl,8.0,,30.0,Escherichia coli BL21(DE3),,
PMID32786835,reaction_11,in vitro,Bioconversion using cell-free extracts,50 mM Tris-HCl,8.0,,30.0,Escherichia coli BL21(DE3),,
PMID32786835,reaction_12,in vitro,Bioconversion using cell-free extracts,50 mM Tris-HCl,8.0,,30.0,Escherichia coli BL21(DE3),,
PMID32786835,reaction_13,in vitro,Bioconversion using cell-free extracts,50 mM Tris-HCl,8.0,,30.0,Escherichia coli BL21(DE3),,
PMID32787249,reaction_1,in vitro,Steady-state activity assay measuring CoQ1 reduction.,"50 mM Tris, pH 8.0, containing 300 mM NaCl and 0.03% DHPC",8.0,,25.0,,,
PMID32787249,reaction_2,in vitro,Stopped-flow spectroscopy,"50 mM Tris, pH 8.0, containing 300 mM NaCl and 0.03% DHPC",8.0,,4.0,,,
PMID32787249,reaction_3,in vitro,Spectrophotometric monitoring of CT complex decay,"50 mM Tris, pH 8.0, containing 300 mM NaCl and 0.03% DHPC",8.0,,20.0,,,
PMID32787249,reaction_4,in vitro,Stopped-flow spectroscopy monitoring the lag in sulfide-induced CT complex formation.,"50 mM Tris, pH 8.0, containing 300 mM NaCl and 0.03% DHPC",8.0,,4.0,,,
PMID32787249,reaction_5,in vitro,Stopped-flow spectroscopy monitoring FAD reduction.,"50 mM Tris, pH 8.0, containing 300 mM NaCl and 0.03% DHPC",8.0,,4.0,,,
PMID32787249,reaction_6,in vitro,Spectrophotometric monitoring of FAD reduction.,"50 mM Tris, pH 8.0, containing 300 mM NaCl and 0.03% DHPC",8.0,,25.0,,,
PMID32787249,reaction_7,in vitro,Spectrophotometric analysis.,"50 mM Tris, pH 8.0, containing 300 mM NaCl and 0.03% DHPC",8.0,,25.0,,,
PMID32789939,reaction_1,in vitro,Kinetic parameter determination with purified enzyme.,100 mM sodium phosphate buffer,7.0,,30.0,E. coli BL21,,"0.5 mM IPTG, 20°C, 12 h"
PMID32789939,reaction_2,in vitro,Kinetic parameter determination with purified enzyme.,100 mM sodium phosphate buffer,7.0,,30.0,E. coli BL21,,
PMID32789939,reaction_3,in vitro,Kinetic parameter determination with purified enzyme.,100 mM sodium phosphate buffer,7.0,,30.0,E. coli BL21,,
PMID32789939,reaction_4,in vitro,Kinetic parameter determination with purified enzyme.,100 mM sodium phosphate buffer,7.0,,30.0,E. coli BL21,,
PMID32789939,reaction_5,in vitro,Kinetic parameter determination with purified enzyme.,100 mM sodium phosphate buffer,7.0,,30.0,E. coli BL21,,
PMID32789939,reaction_6,in vitro,Kinetic parameter determination with purified enzyme.,100 mM sodium phosphate buffer,7.0,,30.0,E. coli BL21,,
PMID32789939,reaction_7,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_8,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_9,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_10,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_11,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_12,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_13,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_14,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_15,in vitro,Kinetic resolution with purified enzyme (10 mg/mL).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_16,in vivo,Whole-cell deracemization using E. coli (ArCHAO) (10 g cdw/L) and E. coli (MVTA) (10 g cdw/L).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_17,in vivo,Whole-cell deracemization using E. coli (ArCHAO) (10 g cdw/L) and E. coli (MVTA) (10 g cdw/L).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_18,in vivo,Whole-cell deracemization using E. coli (ArCHAO) (10 g cdw/L) and E. coli (MVTA) (10 g cdw/L).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_19,in vivo,Whole-cell deracemization using E. coli (ArCHAO) (10 g cdw/L) and E. coli (MVTA) (10 g cdw/L).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_20,in vivo,Whole-cell deracemization using E. coli (ArCHAO) (10 g cdw/L) and E. coli (MVTA) (10 g cdw/L).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32789939,reaction_21,in vivo,Whole-cell deracemization using E. coli (ArCHAO) (10 g cdw/L) and E. coli (MVTA) (10 g cdw/L).,100 mM phosphate buffer,7.0,,30.0,,,
PMID32792488,reaction_1,in vitro,OGDHc activity was measured in isolated mitochondria from HeLa cells using a commercial colorimetric assay (Biovision K678) that detects 2-OG oxidation.,Biovision ketoglutarate dehydrogenase activity assay buffer,,Not specified in the text.,,,,
PMID32792488,reaction_2,in vitro,p-nitrophenyl esterase activity assay using purified recombinant ABHD11-FLAG protein.,"50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.01% bovine serum albumin, 1.4% methanol",7.4,,37.0,HEK293T cells,pCEFL-ABHD11-3XFLAG tag plasmid,
PMID32792488,reaction_3,in vitro,HIF-1α prolyl hydroxylation activity of HeLa cell extracts was measured against a recombinant His-tagged HIF-1α (530-652) protein.,"20 mM HEPES (pH 7.5, 150 mM NaCl and 1 mM DTT)",7.5,,37.0,,,
PMID32792488,reaction_4,in vivo,"Measurement of total genomic 5-hydroxymethylcytosine (5hmC) levels in HeLa cells by dot blot assay, reflecting the integrated activity of TET enzymes in the cell.",,,,37.0,,,
PMID32796124,reaction_1,in vivo,Fatty acid profiling (FAME analysis) of whole seedlings to determine substrate and product levels in different genetic backgrounds. Localization was studied via transient expression in Nicotiana benthamiana.,Plants grown on half-strength Murashige and Skoog (MS) medium with 0.5% (w/v) sucrose and 0.7% (w/v) agar.,,Not specified,22.0,"Arabidopsis thaliana, Nicotiana benthamiana","pGWB605 (for C-terminal sGFP fusion), pGWB517 (for C-terminal 4xMYC fusion)",Constitutive expression under the CaMV 35S promoter for complementation and transient expression assays.
PMID32797038,reaction_1,in vitro,Inhibition assays performed by monitoring flavin fluorescence (FMN to FAD conversion) and by HPLC separation of flavins.,"20 mM PIPES, pH 7.0, 10 mM MgCl2",7.0,,25.0,Escherichia coli BL21(DE3),,
PMID32797038,reaction_2,in vitro,Activity was assayed by HPLC separation of flavins to test inhibitor specificity.,"20 mM PIPES, pH 7.0, 0.8 mM MgCl2",7.0,,25.0,Escherichia coli BL21(DE3),,
PMID32800918,reaction_1,in vivo,In vivo localization of the product (PI4P) using a GFP-2xPHFgOsh2 fluorescent sensor in F. graminearum hyphae.,Not specified for the assay; various growth media used for cultures.,,,,Fusarium graminearum PH-1,pFL2 (for complementation strain),
PMID32803057,reaction_1,in vivo,Whole-cell biocatalysis,100 mM phosphate buffer,7.0,,30.0,,,
PMID32803057,reaction_2,in vivo,Whole-cell biocatalysis with engineered strain,reaction buffer,7.0,pH was continuously tuned to 7.0 to prevent inhibition by acid product.,30.0,,,
PMID32805427,reaction_1,in vitro,"Coupled enzyme assay with pyruvate kinase (PK) and lactate dehydrogenase (LDH), monitoring NADH absorbance decrease at 340 nm.","100 mM HEPES, 10 mM MgCl2",7.5,,30.0,Escherichia coli BL21 (DE3),pQE-2,"0.1 mM IPTG, 18 °C for 18 h"
PMID32808246,reaction_1,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_2,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_3,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_4,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_5,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_6,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_7,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_8,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_9,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_10,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_11,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_12,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_13,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_14,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32808246,reaction_15,in vivo,Whole-cell biotransformation with recombinant E. coli expressing BrSMO.,100 mM potassium phosphate buffer,7.0,Condition for yield and ee determination.,30.0,E. coli BL21 (DE3),pET-BrSMO (derived from pET-28a (+)),"0.05 mM IPTG, 20 °C, 20 h"
PMID32818435,reaction_1,in vitro,"Metabolic flux analysis, functional assays in isolated primary hepatocytes and Caco-2 cells, and in vivo studies in knockout mice.",Minimal medium with 25 mM HEPES for flux analysis.,7.4,pH of minimal medium for flux assay.,37.0,Caco-2 cells; Mus musculus (via AAV delivery),pAAV2/8 system for in vivo expression; unspecified plasmid for Caco-2 transfection,
PMID32818435,reaction_2,in vitro,Enzyme activity measured in primary hepatocyte lysates using a commercial kit.,"Not specified; commercial kit used (Nanjing Jiancheng, A075-1-1).",,,,,,
PMID32818435,reaction_3,in vitro,Enzyme activity measured in primary hepatocyte lysates using a commercial kit.,"Not specified; commercial kit used (Solarbio, BC1085).",,,,,,
PMID32819558,reaction_1,in vivo,Experiments were conducted in cultured mouse embryonic fibroblast (MEF) cells and primary aortic smooth muscle cells (SMC). Superoxide was induced by LY83583 to stimulate enzyme activity.,Cell culture medium,,Not specified,,Mus musculus,,Enzymes were studied via their endogenous expression in mouse embryonic fibroblast (MEF) and aortic smooth muscle cells (SMC).
PMID32821414,reaction_1,in vivo,Transient co-expression of IbPSS1 with a phosphatidylserine biosensor (C2LACT-GFP) in Nicotiana benthamiana leaves. Product formation was measured by increased fluorescence intensity.,"Infiltration buffer for Agrobacterium delivery: 10 mM MES-KOH, 10 mM MgCl2, 200 μM acetosyringone (AS).",5.6,pH of Agrobacterium infiltration buffer. Intracellular pH of reaction not specified.,25.0,Nicotiana benthamiana,pRI201-AN backbone (constructs: pUBI.U4::IbPSS1 and pCaMV35S::C2LACT-GFP),Agro-infiltration into leaves of 4-week-old N. benthamiana plants. Analysis performed 4 days post-inoculation.
PMID32822119,reaction_1,in vitro,Whole-cell biocatalysis using recombinant E. coli (smCR125) co-expressing CR125 and GDH in a biphasic system (p-xylene/buffer).,100 mM NaH2PO4-Na2HPO4 buffer,7.0,"This is the optimal pH used for biotransformation, optimized from a range of 4.0-9.0.",40.0,Escherichia coli BL21(DE3),pCDFDuet-1,Induced with 10 g/L lactose at 28 °C for 8 hours during fermentation.
PMID32823946,reaction_1,in vivo,In vivo kinase activity was measured using a desaturase promoter-β-galactosidase reporter gene fusion in B. subtilis strain CM21.,"Spizizen salts (K2HPO4, 14.8 g/L, KH2PO4, 5.4 g/L, (NH4)2SO4, 2 g/L, tri-Sodium citrate·2H2O 1.9 g/L, and MgSO4·7H2O 0.2 g/L) with supplements.",,Activity was tested over a pH range of 6.0 to 9.0. The enzyme is active at pH ≥ 7.0 and inhibited at pH 6.0.,25.0,Bacillus subtilis JH642-CM21,pHPKS,
PMID32827973,reaction_1,in vitro,Enzyme kinetics and stability assays,0.1 M citrate buffer,5.5,Optimal pH for both free and immobilized enzyme,30.0,,,
PMID32827973,reaction_2,in vitro,Dye decolourization assay,citrate buffer,5.5,,30.0,,,
PMID32827973,reaction_3,in vitro,Dye decolourization assay,citrate buffer,5.5,,30.0,,,
PMID32827973,reaction_4,in vitro,Dye decolourization assay,citrate buffer,5.5,,30.0,,,
PMID32827973,reaction_5,in vitro,Dye decolourization assay,citrate buffer,5.5,,30.0,,,
PMID32828286,reaction_1,in vitro,Spectrophotometric assay at 340 nm.,50 mM Tris-HCl,9.0,,30.0,E. coli BL21(DE3),,
PMID32828286,reaction_2,in vitro,Spectrophotometric assay at 340 nm.,50 mM Tris-HCl,9.0,,30.0,E. coli BL21(DE3),,
PMID32828292,reaction_1,in vivo,Experiments were conducted in HCT-116 human colon cancer cells. Enzyme activity was inferred from an increase in global m6A levels in total RNA after FTO knockdown via siRNA. The specific substrate was identified using RNA immunoprecipitation (RIP) assays.,"Cells were maintained in RPMI-1640 with L-Glutamine and Phenol Red, supplemented with 10% FBS and 1% Penicillin Streptomycin.",,"Not specified, standard cell culture conditions.",37.0,HCT-116 human colon cancer cell line (endogenous expression),,
PMID32828830,reaction_1,in vitro,Activity assay with isolated membrane fraction containing pMMO (pMMOm).,"10 mM phosphate buffer, pH 7.0 containing 0.2 M NaCl",7.0,,40.0,Methylosinus trichosporium OB3b (native source),,
PMID32828830,reaction_2,in vitro,Activity assay with isolated membrane fraction containing pMMO (pMMOm).,"25 mM MOPS buffer, pH 7.0",7.0,,40.0,Methylosinus trichosporium OB3b (native source),,
PMID32829175,reaction_1,in vitro,"Electrochemical characterization (Cyclic Voltammetry, Chronoamperometry) of enzyme covalently immobilized on a 4-ABA grafted reduced graphene oxide electrode (RGO-A/BOD).",100 mM PBS,7.0,,20.0,,,
PMID32829175,reaction_2,in vitro,Electrochemical characterization of enzyme immobilized on a reduced graphene oxide electrode without 4-ABA linker (RGO/BOD).,100 mM PBS,7.0,,20.0,,,
PMID32829175,reaction_3,in vitro,Electrochemical characterization of enzyme immobilized on an electrode with physically adsorbed 4-ABA (RGO-A(N)/BOD).,100 mM PBS,7.0,,20.0,,,
PMID32829175,reaction_4,in vitro,Electrochemical characterization of enzyme immobilized on a 4-ABA modified carbon paper electrode without a reduced graphene oxide layer (R-A/BOD).,100 mM PBS,7.0,,20.0,,,
PMID32829175,reaction_5,in vitro,Electrochemical characterization of physically adsorbed BOD on the RGO-A matrix (RGO-A_ads/BOD).,100 mM PBS,7.0,,20.0,,,
PMID32829175,reaction_6,in vitro,Chronoamperometry of the RGO-A/BOD electrode in a gas diffusion electrode (GDBE) configuration with ambient air supply.,100 mM PBS,7.0,,20.0,,,
PMID32829175,reaction_7,in vitro,"Bioanode in a membrane-less glucose/O2 enzymatic biofuel cell, with mediated electron transfer.",100 mM PBS containing 20 mM glucose,7.0,,20.0,,,
PMID32830039,reaction_1,in vitro,Activity measured in cell-free extracts of Bradyrhizobium sp. strain Ce-3 grown under various conditions.,25 mM acetate buffer,5.0,Buffer used for cell-free extract preparation.,,,,
PMID32830039,reaction_2,in vitro,Activity measured in cell-free extracts of Bradyrhizobium sp. strain Ce-3 grown under various conditions.,25 mM acetate buffer,5.0,Buffer used for cell-free extract preparation.,,,,
PMID32830039,reaction_3,in vitro,Activity measured in cell-free extracts of Bradyrhizobium sp. strain Ce-3 grown under various conditions.,25 mM acetate buffer,5.0,Buffer used for cell-free extract preparation.,,,,
PMID32835992,reaction_1,in vitro,Enzymatic activity assay with purified enzyme,20 mM Tris-HCl buffer,7.5,,30.0,Escherichia coli BL21 (DE3),pET-28a(+),"0.15 mM IPTG, 16 °C, 12 h"
PMID32835992,reaction_2,in vitro,Enzymatic activity assay with purified enzyme,20 mM Tris-HCl buffer,7.5,,30.0,Escherichia coli BL21 (DE3),pET-28a(+),"0.15 mM IPTG, 16 °C, 12 h"
PMID32835992,reaction_3,in vitro,Enzymatic activity assay with purified enzyme,20 mM Tris-HCl buffer,7.5,,30.0,Escherichia coli BL21 (DE3),pET-28a(+),"0.15 mM IPTG, 16 °C, 12 h"
PMID32835992,reaction_4,in vitro,Relative enzymatic activity assay with purified enzyme,20 mM Tris-HCl buffer,7.5,,30.0,Escherichia coli BL21 (DE3),pET-28a(+),"0.15 mM IPTG, 16 °C, 12 h"
PMID32835992,reaction_5,in vitro,Relative enzymatic activity assay with purified enzyme,20 mM Tris-HCl buffer,7.5,,30.0,Escherichia coli BL21 (DE3),pET-28a(+),"0.15 mM IPTG, 16 °C, 12 h"
PMID32835992,reaction_6,in vitro,Relative enzymatic activity assay with purified enzyme,20 mM Tris-HCl buffer,7.5,,30.0,Escherichia coli BL21 (DE3),pET-28a(+),"0.15 mM IPTG, 16 °C, 12 h"
PMID32843629,reaction_1,in vitro,DCIP assay with menadione as the intermediate electron acceptor.,"20 mM MOPS (pH 7.4), 0.005% LMNG, 1 mM menadione, and 100 μM DCIP",7.4,,37.0,Mycobacterium smegmatis mc2 5141,pVV16 with a 10x His tag at the C terminus of the SdhD subunit (MSMEG_1671),
PMID32844401,reaction_1,in vitro,Initial velocity data for kinetic parameter estimation was collected using 9.5 nM UPO. Electroenzymatic batch process experiments were conducted in a 100 mL reactor with 12.5 nM UPO and in situ H2O2 generation via a gas diffusion electrode.,100 mM potassium phosphate buffer,7.0,,25.0,Pichia pastoris,,
PMID32846049,reaction_1,in vitro,Reactions performed with lyophilized cell free extract in controlled reactors. The reaction was coupled with an NAD(P)H oxidase (SmNOX) for cofactor regeneration.,50 mM potassium phosphate buffer,6.5,pH used for high-throughput screening. Process tests were also performed at pH 6.0 and 5.0. Characterization also performed at pH 7.5.,28.0,Escherichia coli,"pLE1A17 (screening), not specified for large scale",Auto-induction with 0.2% (w/w) lactose for screening. Large scale production was in a 30 L stirred fed-batch fermentation.
PMID32846049,reaction_2,in vitro,"Reactions performed with lyophilized cell free extract in controlled reactors, including a 75 L pilot plant scale. The reaction was coupled with an NAD(P)H oxidase (SmNOX) for cofactor regeneration.",50 mM potassium phosphate buffer with 50% (v/v) 2-ethyl-1-hexanol,7.0,,28.0,Escherichia coli,,
PMID32846049,reaction_3,in vitro,Photometric assay used for characterization and for measuring residual activity after heat treatment to determine the melting temperature (Tm50) of enzyme variants.,50 mM Tris-HCl buffer,7.0,,30.0,Escherichia coli,,
PMID32846049,reaction_4,in vitro,Spectrophotometric assay using cell-free or crude extract.,100 mM potassium phosphate buffer,7.5,,20.0,E. coli K12 derivative,pBR322 derived expression vector,0.5% (w/w) L-rhamnose
PMID32846049,reaction_5,in vitro,Spectrophotometric assay using cell-free or crude extract.,100 mM potassium phosphate buffer,7.5,,20.0,E. coli K12 derivative,pBR322 derived expression vector,0.5% (w/w) L-rhamnose
PMID32847739,reaction_1,in vivo,Heterologous expression in Saccharomyces cerevisiae and Lipomyces starkeyi. Fatty acid composition of whole cells was analyzed.,"For S. cerevisiae: SD medium (0.17% Difco yeast nitrogen base, 2% glucose, 0.1% ammonium sulfate, 20 mg/mL uracil, 20 mg/mL histidine, and 20 mg/mL methionine). For L. starkeyi: GY medium.",,Not specified,20.0,Saccharomyces cerevisiae BY4741; Lipomyces starkeyi Dlslig4,pL1177-2-PaFAD2 (for S. cerevisiae); pKS-18S-sNAT1-PaFAD2 (for L. starkeyi),
PMID32847739,reaction_2,in vivo,Heterologous expression in Saccharomyces cerevisiae. Fatty acid composition of whole cells was analyzed.,"SD medium (0.17% Difco yeast nitrogen base, 2% glucose, 0.1% ammonium sulfate, 20 mg/mL uracil, 20 mg/mL histidine, and 20 mg/mL methionine).",,Not specified,20.0,Saccharomyces cerevisiae BY4741,pL1177-2-PaFAD2,
PMID32847739,reaction_3,in vivo,Heterologous expression in Saccharomyces cerevisiae with exogenous linoleic acid supplied. Fatty acid composition of whole cells was analyzed.,SD medium with 0.2 g/L linoleic acid (LA) and 0.25% Tergitol NP-40 added.,,Not specified,20.0,Saccharomyces cerevisiae BY4741,pL1177-2-PaFAD2,
PMID32847739,reaction_4,in vivo,Heterologous expression in Saccharomyces cerevisiae and Lipomyces starkeyi. Fatty acid composition of whole cells was analyzed.,For S. cerevisiae: SD medium. For L. starkeyi: GY medium.,,Not specified,20.0,Saccharomyces cerevisiae BY4741; Lipomyces starkeyi Dlslig4,pKS-18S-sNAT1-LsFAD2 (for L. starkeyi),
PMID32847739,reaction_5,in vivo,Heterologous expression in Saccharomyces cerevisiae. Fatty acid composition of whole cells was analyzed.,SD medium,,Not specified,20.0,Saccharomyces cerevisiae BY4741,,
PMID32851479,reaction_1,in vitro,Enzymatic activity assay monitoring oxidation of methyl viologen at 600 nm.,100 mM Tris-HCl,7.6,,25.0,Isolated from native organism Marinobacter hydrocarbonoclasticus 617,,
PMID32851479,reaction_2,in vitro,Enzymatic activity assay with physiological electron donor.,100 mM Tris-HCl,7.6,,25.0,Isolated from native organism Marinobacter hydrocarbonoclasticus 617,,
PMID32851479,reaction_3,in vitro,Enzymatic activity assay with physiological electron donor.,100 mM Tris-HCl,7.6,,25.0,Isolated from native organism Marinobacter hydrocarbonoclasticus 617,,
PMID32851826,reaction_1,in vitro,Kinetic assays on isolated enzyme,Not specified,7.0,pH for standard potential and activation rate constant measurement,,Marinobacter hydrocarbonoclasticus (native isolation),,
PMID32851826,reaction_2,in vitro,Enzyme isolated under anoxic conditions,Not specified,7.5,pH for redox potential measurement of the CuZ(4Cu2S) center,,Pseudomonas stutzeri (native isolation),,
PMID32851826,reaction_3,in vitro,,Not specified,,,,Wolinella succinogenes (native isolation),,
PMID32861756,reaction_1,in vivo,"Analysis of gene expression (RT-qPCR), protein levels (Western Blot), and product abundance (TLC, Flow Cytometry) in cultured B16F10 (murine) and G-361 (human) melanoma cells under normoxic and hypoxic conditions.",Roswell Park Memorial Institute-1640 medium (RPMI-1640) supplemented with 10% fetal bovine serum,,"Standard cell culture conditions, pH not explicitly stated.",37.0,"B16F10 murine melanoma cells, G-361 human melanoma cells (endogenous expression)",,
PMID32861756,reaction_2,in vivo,Analysis of gene expression (RT-qPCR) and product abundance (TLC) in cultured B16F10 melanoma cells under hypoxic conditions.,Roswell Park Memorial Institute-1640 medium (RPMI-1640) supplemented with 10% fetal bovine serum,,"Standard cell culture conditions, pH not explicitly stated.",37.0,B16F10 murine melanoma cells (endogenous expression),,
PMID32861756,reaction_3,in vivo,Analysis of gene expression (RT-qPCR) in cultured B16F10 melanoma cells under hypoxic conditions.,Roswell Park Memorial Institute-1640 medium (RPMI-1640) supplemented with 10% fetal bovine serum,,"Standard cell culture conditions, pH not explicitly stated.",37.0,B16F10 murine melanoma cells (endogenous expression),,
PMID32866191,reaction_1,in vitro,Activity measured as vanadate-sensitive ATP hydrolysis in plasma membrane preparations from A. chrysogenum cells.,Not specified in the document (references previous work).,,Not specified in the document.,,Acremonium chrysogenum RNCM 408D,pZEN36c,
PMID32866191,reaction_2,in vitro,Activity measured in recombinant S. cerevisiae strains to validate construct functionality.,Not specified in the document.,,Not specified in the document.,,"Saccharomyces cerevisiae SY4, Saccharomyces cerevisiae YPH857","pZEN36-H (for SY4), pZEN36b (for YPH857)",
PMID32869209,reaction_1,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869209,reaction_2,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869209,reaction_3,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869209,reaction_4,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869209,reaction_5,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869209,reaction_6,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869209,reaction_7,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869209,reaction_8,in vitro,Primary assay was biotransformation using permeabilized fission yeast cells (enzyme bags) co-expressing a human CYP4 enzyme and human CPR. Preliminary conversion was also confirmed in human liver microsomes (HLMs).,Not specified for biotransformation assay,,,,Schizosaccharomyces pombe,pCAD1-CPR and pREP1-CYP4Z1,
PMID32869889,reaction_1,in vitro,,0.05 M phosphate buffer,7.4,,35.0,,,
PMID32869889,reaction_2,in vitro,,0.05 M phosphate buffer,7.4,,35.0,,,
PMID32869889,reaction_3,in vitro,,0.05 M phosphate buffer,7.4,,35.0,,,
PMID32869889,reaction_4,in vitro,,0.05 M phosphate buffer,7.4,,35.0,,,
PMID32869889,reaction_5,in vitro,,0.05 M phosphate buffer,7.4,,35.0,,,
PMID32869889,reaction_6,in vitro,,0.05 M phosphate buffer,7.4,,35.0,,,
PMID32869889,reaction_7,in vitro,,0.05 M phosphate buffer,7.4,,35.0,,,
PMID32869889,reaction_8,in vitro,,0.05 M phosphate buffer,6.6,,35.0,,,
PMID32869889,reaction_9,in vitro,,0.05 M phosphate buffer,6.6,,35.0,,,
PMID32869889,reaction_10,in vitro,,0.05 M phosphate buffer,6.6,,35.0,,,
PMID32869889,reaction_11,in vitro,,0.05 M phosphate buffer,6.6,,35.0,,,
PMID32869889,reaction_12,in vitro,,0.05 M phosphate buffer,6.6,,35.0,,,
PMID32869889,reaction_13,in vitro,,0.05 M phosphate buffer,6.6,,35.0,,,
PMID32869889,reaction_14,in vitro,,0.05 M phosphate buffer,6.6,,35.0,,,
PMID32869889,reaction_15,in vitro,,0.05 M phosphate buffer,6.0,,45.0,,,
PMID32869889,reaction_16,in vitro,,0.05 M phosphate buffer,6.0,,45.0,,,
PMID32869889,reaction_17,in vitro,,0.05 M phosphate buffer,6.0,,45.0,,,
PMID32869889,reaction_18,in vitro,,0.05 M phosphate buffer,6.0,,45.0,,,
PMID32869889,reaction_19,in vitro,,0.05 M phosphate buffer,6.0,,45.0,,,
PMID32869889,reaction_20,in vitro,,0.05 M phosphate buffer,6.0,,45.0,,,
PMID32869889,reaction_21,in vitro,,0.05 M phosphate buffer,6.0,,45.0,,,
PMID32880710,reaction_1,in vitro,Direct enzymatic turnover rate measurement in placental microsomes.,Not specified,,Not specified,,,,
PMID32880710,reaction_2,in vitro,Direct enzymatic turnover rate measurement in placental microsomes.,Not specified,,Not specified,,,,
PMID32880710,reaction_3,in vitro,Direct enzymatic turnover rate measurement in placental microsomes.,Not specified,,Not specified,,,,
PMID32880710,reaction_4,in vitro,Direct enzymatic turnover rate measurement in placental microsomes.,Not specified,,Not specified,,,,
PMID32885332,reaction_1,in vitro,Activity assay using lyophilized E. coli cells (DP strain) expressing PPK.,50 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_2,in vitro,Activity assay using lyophilized E. coli cells (DG strain) expressing GMAS.,200 mM Tris-HCl buffer,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_1,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_2,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_3,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_4,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_5,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_6,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_7,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_8,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_9,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_10,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_11,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_12,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_13,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32885332,reaction_3_14,in vitro,One-pot synthesis using lyophilized whole cells (DGP strain) co-expressing GMAS and PPK.,200 mM Tris-HCl,7.0,,35.0,E. coli BL21 (DE3),pETDuet-1-GMAS–PPK,"0.3 mM IPTG, 25°C, 8h"
PMID32886480,reaction_1,in vitro,"Radioactive assays (Denaturing RNA PAGE, Filtration plate, Scintillation Proximity Assay) to quantify RNA product formation. PAGE/Filtration assays were run at 30°C, SPA assay at room temperature.","50 mM Tris-HCl pH 7.5, 8 mM MgCl2, 5 mM DTT, 10% glycerol, and 0.1 U/µL RNAsin",7.5,,30.0,Sf21 insect cells,pFastBac-DUAL,"Infection with P2 baculovirus, 27°C, 48-66 h"
PMID32886480,reaction_2,in vitro,Coupled enzyme assay monitoring pyrophosphate formation via luminescence. Assay performed at Room Temperature.,"50 mM Tris-HCl pH 7.5, 8 mM MgCl2, 5 mM DTT, 10% glycerol, and 0.1 U/µL RNAsin",7.5,,25.0,Sf21 insect cells,pFastBac-DUAL,"Infection with P2 baculovirus, 27°C, 48-66 h"
PMID32894626,reaction_1,in vitro,"Colorimetric assay detecting hydrogen peroxide using 4-aminoantipyrine, phenol, and horseradish peroxidase.",100 mM potassium phosphate buffer (KPB),7.4,,40.0,Escherichia coli SoluBL21,pCold IV-lysox3,"1 mM IPTG, 15°C, 24 h"
PMID32894626,reaction_2,in vitro,"Colorimetric assay detecting hydrogen peroxide using 4-aminoantipyrine, phenol, and horseradish peroxidase.",100 mM potassium phosphate buffer (KPB),7.4,,40.0,Escherichia coli SoluBL21,,
PMID32894626,reaction_3,in vitro,"Colorimetric assay detecting hydrogen peroxide using 4-aminoantipyrine, phenol, and horseradish peroxidase.",100 mM potassium phosphate buffer (KPB),7.4,,40.0,Escherichia coli SoluBL21,,
PMID32894626,reaction_4,in vitro,"Colorimetric assay detecting hydrogen peroxide using 4-aminoantipyrine, phenol, and horseradish peroxidase.",100 mM potassium phosphate buffer (KPB),7.4,,40.0,Escherichia coli SoluBL21,,
PMID32900959,reaction_1,in vivo,"Functional characterization via analysis of downstream physiological effects in whole cells. Activity was inferred from H2S production levels (as a proxy for cytoplasmic L-cysteine), cell survival assays under H2O2 or aminoglycoside stress, and SOS response induction.",LB complete medium or M9 medium with 0.2% glucose,,"Standard bacterial growth media pH, not explicitly stated.",37.0,Escherichia coli MG1655,Chromosomal integration,"Constitutive expression from the pLtetO-1 promoter, which replaced the native promoter. No tetR repressor present in the strains."
PMID32900992,reaction_1,in vivo,Cell-based PC synthetic activity assay using 3H-choline labeling in mouse embryo fibroblasts (MEFs) and human U2OS cells.,Dulbecco’s modiﬁed Eagle medium (DMEM) or Earle’s balanced salt solution (EBSS) for starvation,7.4,Assumed standard cell culture pH,37.0,"Mouse embryo fibroblasts (MEFs), Human osteosarcoma cells (U2OS)","pMXs-IRES-Puro (retroviral vector for stable expression), other plasmids transfected with Lipofectamine 2000/3000",Constitutive expression from retroviral vector or transient transfection.
PMID32900992,reaction_2,in vivo,Stable shRNA knockdown in U2OS cells followed by assessment of autophagic flux and cell survival.,Dulbecco’s modiﬁed Eagle medium (DMEM) or Earle’s balanced salt solution (EBSS) for starvation,7.4,Assumed standard cell culture pH,37.0,Human osteosarcoma cells (U2OS),"shRNA retroviral vectors (TR313975D for CEPT1, TR305398C for CHPT1)",Stable expression via retroviral infection and puromycin selection.
PMID32900992,reaction_3,in vivo,Enzyme activity was inhibited in MEFs using T863 (20 µM) in combination with an ACAT inhibitor. The effect on autophagic flux and isolation membrane formation was measured.,Earle’s balanced salt solution (EBSS),7.4,Assumed standard cell culture pH,37.0,,,
PMID32900992,reaction_4,in vivo,Enzyme activity was inhibited in MEFs using avasimibe (1 µM) in combination with a DGAT1 inhibitor. The effect on autophagic flux and isolation membrane formation was measured.,Earle’s balanced salt solution (EBSS),7.4,Assumed standard cell culture pH,37.0,,,
PMID32900992,reaction_5,in vivo,Enzyme activity was inhibited in MEFs using Atglistatin. The effect on autophagic flux was measured after 8h starvation.,Earle’s balanced salt solution (EBSS),7.4,Assumed standard cell culture pH,37.0,,,
PMID32902709,reaction_1,in vitro,Pantothenate kinase activity assay using D-[1-14C]-pantothenate.,"50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 60 mM NH4Cl",7.5,,30.0,Escherichia coli JM109,pSTV28 derivative (pSTV-coaA),0.1 mM IPTG
PMID32902709,reaction_2,in vivo,Whole-cell assay in E. coli. Enzyme activity was inferred from the increase in downstream fatty acid products and direct measurement of the malonyl-CoA pool using an acyl-CoA cycling method.,M9 minimal medium with 2% glucose and 5 mM pantothenate,,"Not specified, but culture medium pH was noted to be maintained at a higher level in producing strains.",37.0,Escherichia coli JM109,pSTV28 derivative (pSTV-dtsR1-accBCE),0.1 mM IPTG
PMID32902709,reaction_3,in vivo,"Whole-cell fatty acid production in engineered E. coli. Products were extracted, methylated, and analyzed by GC/FID.",M9 minimal medium with 2% glucose and 5 mM pantothenate,,,37.0,Escherichia coli JM109,pQE-60 derivative (pQE-fasA-acpS),0.1 mM IPTG
PMID32905773,reaction_1,in vivo,Knockdown experiments in cultured murine calvarial cells undergoing osteoblast differentiation.,Cell culture medium,,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32905773,reaction_2,in vivo,Inhibition experiments in cultured murine calvarial cells.,Cell culture medium supplemented with Glc and glutamine.,,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32905773,reaction_3,in vivo,Inhibition experiments in cultured murine calvarial cells.,Cell culture medium supplemented with Glc and glutamine.,,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32905773,reaction_4,in vivo,Inhibition experiments in cultured murine calvarial cells.,Cell culture medium supplemented with Glc and glutamine.,,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32905773,reaction_5,in vivo,Inhibition experiments in cultured murine calvarial cells.,Cell culture medium,,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32905773,reaction_6,in vivo,Inhibition experiments in cultured murine calvarial cells.,"Cell culture medium supplemented with glucose, glutamine, and free fatty acids.",,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32905773,reaction_7,in vivo,Inhibition experiments in cultured murine calvarial cells.,"Cell culture medium supplemented with glucose, glutamine, and free fatty acids.",,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32905773,reaction_8,in vivo,Inhibition experiments in cultured murine calvarial cells.,"Cell culture medium supplemented with glucose, glutamine, and free fatty acids.",,"Standard cell culture conditions, pH not specified.",,Primary murine calvarial cells,,
PMID32911631,reaction_1,in vitro,"Recombinant enzyme assay with purified components (XanL[coYcf54], Fd, FNR) and an NADPH regenerating system.","20 mM Tricine and 10 mM HEPES, 25 mM MgCl2, 1 mM DTT, 10 mM glucose-6-phosphate, 0.03 units/µL glucose-6-phosphate dehydrogenase, 0.5 mM NADPH, 90 µg/µL catalase, 0.026% Triton X-100, 0.75 milli-units/µL Spinacia oleracea FNR, 0.5 µg/µL Spinacia oleracea ferredoxin",8.1,,30.0,Escherichia coli ArcticExpress (DE3),pETDuet-1HvXanLYcf54,"1 mM IPTG and 1 mM FeSO4 at OD600 0.5-0.6, followed by growth for 68 h at 15°C."
PMID32912682,reaction_1,in vivo,Shake flask fermentation with recombinant Corynebacterium glutamicum for 4-HIL production.,Optimized fermentation medium,,pH decreased from neutral to ~6.0 at 48h and rose to ~7.0 at 144h.,30.0,Corynebacterium glutamicum ssp. lactofermentum SN01,"pJYW-4 and its derivatives (e.g., pJYW-4-R8-ido, pJYW-4-R8-ido-R15-odhI-vgb)",Constitutive expression
PMID32913059,reaction_1,in vitro,Spectrophotometric assay following the reduction of bovine heart cytochrome c. End product analysis by Membrane Inlet Mass Spectrometry (MIMS).,"50 mM sodium phosphate, 50 mM NaCl",7.5,,60.0,,,
PMID32913059,reaction_2,in vitro,"Spectrophotometric assay following the reduction of 2,6-dichlorophenolindophenol (DCPIP).","20 mM potassium phosphate, 1 mM KCN, 1 mM phenazine ethosulfate, 200 μM DCPIP",7.2,,45.0,,,
PMID32913414,reaction_1,in vitro,Steady-state kinetic measurements by monitoring NADH oxidation.,20 mM KPi buffer (pH 7.5),7.5,,20.0,Rhodococcus erythropolis L88,pNitRC1(hcbA3)c-Hiss,Induced at 20°C
PMID32913414,reaction_2,in vitro,Reconstituted oxidative dehalogenase assay with HcbA1 and HcbA3.,20 mM phosphate buffer (pH 7.5),7.5,,28.0,Rhodococcus erythropolis L88,pCpiRC1(hcbA1)c-HIi,Induced at 28°C for 48 hr
PMID32915249,reaction_1,in vitro,Bidirectional transport assay across MDCKII-MRP1 cell monolayers on transwell inserts.,Opti-MEM buffer,,Not specified,37.0,Madin-Darby Canine Kidney (MDCK)II cells,,Constitutive overexpression
PMID32919113,reaction_1,in vitro,ADP-Glo kinase assay to measure inhibition of SphK2.,"40 mM Tris, 20 mM MgCl2, 0.1mg/mL BSA, 5% DMSO",8.0,,25.0,,,
PMID32921059,reaction_1,in vitro,Horseradish peroxidase (HRP)-coupled spectrophotometric assay measuring oxidation of ABTS at 420 nm.,50 mM Tris HCl buffer,8.0,,25.0,Escherichia coli BL21 (DE3) pRARE,pTBMalE,100 µM Isopropyl-B-D-1-thiogalactopyranoside (IPTG) at 20°C for 24 hours
PMID32928264,reaction_1,in vitro,"Activity measured in patient plasma samples using the DiviTum® assay, a refined ELISA-based method. The assay measures the phosphorylation of Bromodeoxyuridine (BrdU).",Samples were diluted 1/10 in a dilution buffer (composition not specified) and incubated with a reaction mixture.,,Not specified,,Endogenous (human plasma),,
PMID32930481,reaction_1,in vitro,Fluorometric enzyme-activity assay with 50 µM substrate concentration.,"20 mM Tris buffer, 0.1 mM EDTA, 200 mM NaCl",7.5,,25.0,,,
PMID32930481,reaction_2,in vitro,Fluorometric enzyme-activity assay with 50 µM substrate concentration.,"20 mM Tris buffer, 0.1 mM EDTA, 200 mM NaCl, 1 mM dithiothreitol",7.5,,25.0,,,
PMID32931912,reaction_1,in vitro,Enzyme (10 nM) and inhibitor (1 nM to 5 μM) were incubated for 5 min prior to addition of substrates NAD (300 μM) and IMP (250 μM). Production of NADH was monitored by fluorescence.,"50 mM Tris-HCl, 100 mM KCl, 3 mM EDTA, 1 mM dithiothreitol",8.0,,25.0,E. coli,,
PMID32931912,reaction_2,in vitro,Enzyme (20 nM) and inhibitor (1 nM to 5 μM) were incubated for 5 min prior to addition of substrates NAD (60 μM) and IMP (250 μM). Production of NADH was monitored by fluorescence.,"50 mM Tris-HCl, 100 mM KCl, 3 mM EDTA, 1 mM dithiothreitol",8.0,,25.0,E. coli,,
PMID32931912,reaction_3,in vitro,Inhibition assay,Not specified,,Not specified,,,,
PMID32933017,reaction_1,in vitro,SSM-based electrophysiology on native SR vesicles,Buffer containing 100 mM KCl,7.0,Experiment performed at pH 7.0 and 7.8 to demonstrate pH dependence of Ca2+/H+ exchange.,,,,
PMID32933017,reaction_2,in vitro,SSM-based electrophysiology on COS-1 microsomes expressing recombinant ATP7B,Reaction buffer containing dithiothreitol to reduce Cu2+ to Cu+,6.0,Experiment performed at pH 6.0 and 7.8 to demonstrate pH independence.,,COS-1 cells,,
PMID32933017,reaction_3,in vitro,SSM-based electrophysiology on COS-1 microsomes expressing recombinant ATP7A,Reaction buffer containing dithiothreitol to reduce Cu2+ to Cu+,,"pH independence was observed, similar to ATP7B.",,COS-1 cells,,
PMID32933017,reaction_4,in vitro,"SSM-based electrophysiology on purified, reconstituted proteoliposomes containing 90% PC and 10% PS.",,,,,,,
PMID32935896,reaction_1,in vitro,Ketone reduction with cofactor regeneration system.,"250 mM sodium phosphate, 10% glycerol, 1% DMSO",7.0,,25.0,Escherichia coli,,
PMID32935896,reaction_2,in vitro,Ketone reduction with cofactor regeneration system.,"250 mM sodium phosphate, 10% glycerol, 1% DMSO",7.0,,25.0,Escherichia coli,,
PMID32935896,reaction_3,in vitro,Ketone reduction with cofactor regeneration system.,"250 mM sodium phosphate, 10% glycerol, 1% DMSO",7.0,,25.0,Escherichia coli,,
PMID32935896,reaction_4,in vitro,Ketone reduction with cofactor regeneration system.,"250 mM sodium phosphate, 10% glycerol, 1% DMSO",7.0,,25.0,Escherichia coli,,
PMID32935896,reaction_5,in vitro,Ketone reduction with cofactor regeneration system.,"250 mM sodium phosphate, 10% glycerol, 1% DMSO",7.0,,25.0,Escherichia coli,,
PMID32935896,reaction_6,in vitro,Ketone reduction with cofactor regeneration system.,"250 mM sodium phosphate, 10% glycerol, 1% DMSO",7.0,,25.0,Escherichia coli,,
PMID32935896,reaction_7,in vitro,Steady-state kinetic analysis.,,,,,Escherichia coli,,
PMID32936453,reaction_1,in vivo,Whole-cell bioconversion in engineered Saccharomyces cerevisiae LRS6 strain in a 1L BIOSTAT bioreactor.,YP medium supplemented with 2% (w/v) galactose.,6.0,Controlled at 6.0 via automatic addition of 2M NaOH or 2M H2SO4.,30.0,Saccharomyces cerevisiae LRS6,Chromosomal integration at locus 511b.,"CYP725A4 expressed under the GAL1 promoter, and its cognate CPR under the weaker GAL3 promoter."
PMID32936453,reaction_2,in vivo,Whole-cell bioconversion in engineered Saccharomyces cerevisiae LRS6 strain in a 1L BIOSTAT bioreactor.,YP medium supplemented with 2% (w/v) galactose.,6.0,Controlled at 6.0 via automatic addition of 2M NaOH or 2M H2SO4.,30.0,Saccharomyces cerevisiae LRS6,Chromosomal integration at locus RKC3.,Expressed under the GAL1 promoter with a CYC1 terminator.
PMID32936453,reaction_3,in vivo,Side-reaction observed during whole-cell bioconversion in engineered Saccharomyces cerevisiae LRS6 strain in a BioLector Pro microbioreactor.,YP medium supplemented with 4% (w/v) galactose.,5.9,"Uncontrolled, final pH value was approximately 5.9.",30.0,Saccharomyces cerevisiae LRS6,Chromosomal integration at locus RKC3.,Expressed under the GAL1 promoter with a CYC1 terminator.
PMID32936835,reaction_1,in vitro,Alkalization and ammonia extrusion assays in liquid and solid media to assess enzyme function.,"For alkalization: 0.17% YNB, 1% casamino acids (CAA), 0.01% Bromocresol Purple (BCP). For ammonia release: YNB+CAA solid medium with 0.2% glucose, buffered with 50 mM MOPS.",4.0,Initial pH for liquid alkalization assay. Ammonia release assay was performed at pH 7.4.,37.0,Candida albicans,pFA-GFPγ-URA3 (source for PCR cassette),"Expression is repressed by high glucose (2%) and induced in low glucose (0.2%), glycerol, or amino acid-rich media (YNB+CAA)."
PMID32937119,reaction_1,in vitro,pppGpp synthetase activity measured by high-performance liquid chromatography (HPLC).,Not specified,,,,,,
PMID32937119,reaction_2,in vitro,pppGpp hydrolase activity measured by high-performance liquid chromatography (HPLC).,Not specified,,,,,,
PMID32937698,reaction_1,in vivo,Functional characterization via heterologous expression in E. coli WC3110 and transgenic Arabidopsis thaliana.,LB liquid medium (for E. coli assay); 1/5 HS solution (for A. thaliana assay),,Not specified,16.0,Escherichia coli WC3110; Arabidopsis thaliana,"pCold-TF (for E. coli), pSN1305 (for A. thaliana)","1 mM IPTG, 16°C (for E. coli assay)"
PMID32937698,reaction_2,in vivo,Functional characterization via heterologous expression in E. coli WC3110 and transgenic Arabidopsis thaliana.,LB liquid medium (for E. coli assay); 1/5 HS solution (for A. thaliana assay),,Not specified,16.0,Escherichia coli WC3110; Arabidopsis thaliana,"pCold-TF (for E. coli), pSN1305 (for A. thaliana)","1 mM IPTG, 16°C (for E. coli assay)"
PMID32938931,reaction_1,in vivo,Whole-cell DMSP production assay under varying hydrostatic pressure,MBM medium with reduced nitrogen (0.5 mM NH4Cl) and no added methylated sulfur compounds,,,25.0,,,
PMID32938931,reaction_2,in vivo,Whole-cell DMSP production assay under varying hydrostatic pressure,MBM medium with reduced nitrogen (0.5 mM NH4Cl) and no added methylated sulfur compounds,,,25.0,,,
PMID32938931,reaction_3,in vivo,Whole-cell DMSP production assay under varying hydrostatic pressure and survival assay for mutants.,MBM medium with reduced nitrogen (0.5 mM NH4Cl) and no added methylated sulfur compounds,,,25.0,,,
PMID32938931,reaction_4,in vivo,Whole-cell DMSP production assay under varying hydrostatic pressure and survival assay for mutants.,MBM medium with reduced nitrogen (0.5 mM NH4Cl) and no added methylated sulfur compounds,,,25.0,,,
PMID32938938,reaction_1,in vitro,Time-dependent spectroscopic monitoring of NADH production at 340 nm.,"50 mM HEPES-KOH, 20 mM KCl, 1 mM DTT",7.5,,,Neurospora crassa,,
PMID32942681,reaction_1,in vitro,SMS enzyme activity assay using supernatant from sperm homogenate.,"50 mM Tris-HCl, 25 mM KCl",7.4,,37.0,,,
PMID32943628,reaction_1,in vitro,Pre-steady state rapid quench-flow kinetics,"20 mM HEPES pH 7.5, 5 mM MgCl2, 50 mM NaCl",7.5,,22.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32943628,reaction_2,in vitro,Pre-steady state rapid quench-flow kinetics,"20 mM HEPES pH 7.5, 5 mM MgCl2, 50 mM NaCl",7.5,,22.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32943628,reaction_3,in vitro,NTP-analogue incorporation assay,"20 mM HEPES pH 7.5, 50 mM NaCl and 5 mM MgCl2",7.5,,25.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32943628,reaction_4,in vitro,NTP-analogue incorporation assay,"20 mM HEPES pH 7.5, 50 mM NaCl and 5 mM MgCl2",7.5,,25.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32943628,reaction_5,in vitro,NTP-analogue incorporation assay,"20 mM HEPES pH 7.5, 50 mM NaCl and 5 mM MgCl2",7.5,,25.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32943628,reaction_6,in vitro,NTP-analogue incorporation assay,"20 mM HEPES pH 7.5, 50 mM NaCl and 5 mM MgCl2",7.5,,25.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32943628,reaction_7,in vitro,Elongation assay,"20 mM HEPES pH 7.5, 50 mM NaCl and 5 mM MgCl2",7.5,,25.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32943628,reaction_8,in vitro,Pre-steady state rapid quench-flow kinetics,"20 mM HEPES pH 7.5, 5 mM MgCl2, 50 mM NaCl",7.5,,22.0,Escherichia coli BL21/pG-Tf2,pJ404,"250 µM IPTG, 17°C, overnight"
PMID32945115,reaction_1,in vivo,AEC resistance assay in E. coli BL21 cells to test for lysine feedback inhibition.,E. coli BL21 growth medium with 12 mM S-(2-aminoethyl)-L-cysteine (AEC),,,,Escherichia coli BL21,pET-30a,
PMID32945115,reaction_2,in vivo,AEC resistance assay in E. coli BL21 cells to test for lysine feedback inhibition.,E. coli BL21 growth medium with 12 mM S-(2-aminoethyl)-L-cysteine (AEC),,,,Escherichia coli BL21,pET-30a,
PMID32946884,reaction_1,in vivo,Whole-cell biotransformation with resting cells at semi-preparative scale,0.1 M potassium phosphate buffer (pH 7.4) supplemented with 20 mM glucose,7.4,,25.0,E. coli BW25113,pBAD18-TDO,"10 mM L-arabinose, 20°C, 20 h"
PMID32946884,reaction_2,in vivo,Whole-cell biotransformation with resting cells and in vitro with cell-free extracts,0.1 M potassium phosphate buffer (pH 7.4),7.4,,30.0,E. coli BW25113,,
PMID32946884,reaction_3,in vivo,Whole-cell biotransformation with resting cells,0.1 M potassium phosphate buffer (pH 7.4) supplemented with 20 mM glucose,7.4,,30.0,E. coli BW25113,pBAD18-TDO,
PMID32946884,reaction_4,in vivo,Whole-cell biotransformation with resting cells,0.1 M potassium phosphate buffer (pH 7.4) supplemented with 20 mM glucose,7.4,,30.0,E. coli BW25113,,
PMID32949280,reaction_1,in vitro,Kinetic constants determination,100 mM sodium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,pPICZA,Methanol induction at 25°C for 9 days in fed-batch cultivation
PMID32949280,reaction_2,in vitro,Kinetic constants determination,100 mM sodium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,pPICZA,Methanol induction at 25°C for 9 days in fed-batch cultivation
PMID32949280,reaction_3,in vitro,Kinetic constants determination,100 mM sodium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,pPICZA,Methanol induction at 25°C for 9 days in fed-batch cultivation
PMID32949280,reaction_4,in vitro,Kinetic constants determination,100 mM sodium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,pPICZA,Methanol induction at 25°C for 9 days in fed-batch cultivation
PMID32949280,reaction_5,in vitro,Kinetic constants determination,100 mM sodium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,pPICZA,Methanol induction at 25°C for 9 days in fed-batch cultivation
PMID32949280,reaction_6,in vitro,Kinetic constants determination,100 mM sodium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,pPICZA,Methanol induction at 25°C for 9 days in fed-batch cultivation
PMID32949280,reaction_7,in vitro,Kinetic constants determination and routine activity assay,100 mM sodium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,pPICZA,Methanol induction at 25°C for 9 days in fed-batch cultivation
PMID32949280,reaction_8,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_9,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_10,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_11,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_12,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_13,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_14,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_15,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_16,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_17,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_18,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32949280,reaction_19,in vitro,Substrate screening via coupled ABTS-HRP assay,100 mM potassium phosphate buffer,6.0,,25.0,Pichia pastoris X-33,,
PMID32951821,reaction_1,in vitro,Deracemization reaction with purified enzyme and chemical reductant.,100mM potassium phosphate buffer (KPB),8.0,,30.0,,,
PMID32951821,reaction_2,in vitro,Deracemization reaction with purified enzyme and chemical reductant.,100mM glycine-NaOH buffer,9.0,,30.0,,,
PMID32951821,reaction_3,in vitro,Two-enzyme cascade reaction.,"Substitute solution containing 150mM KCN, pH adjusted with HCl",9.0,,30.0,,,
PMID32951821,reaction_4,in vitro,Two-enzyme cascade reaction.,"Not specified, assumed similar to reaction 3",9.0,Assumed from other experiments,30.0,,,
PMID32951821,reaction_5,in vitro,"Two-enzyme cascade reaction, including preparative scale.","Not specified, assumed similar to reaction 3",9.0,Assumed from other experiments,30.0,,,
PMID32958563,reaction_1_FAB2,in vivo,"Analysis of fatty acid composition in seeds and leaves of various T-DNA insertion mutants (single, double, triple, quadruple). Complementation of fab2 mutant.",N/A (in vivo study),,,21.0,Arabidopsis thaliana,,
PMID32958563,reaction_2_AAD1,in vivo,Complementation of fab2 mutant by expressing AAD1 cDNA under the FAB2 promoter.,N/A (in vivo study),,,21.0,Arabidopsis thaliana fab2 mutant,pProFAB2-R1R2-Hygro (derived from pMDC32),Expression from FAB2 promoter (ProFAB21kb)
PMID32958563,reaction_3_AAD5,in vivo,Complementation of fab2 mutant by expressing AAD5 cDNA under the FAB2 promoter.,N/A (in vivo study),,,21.0,Arabidopsis thaliana fab2 mutant,pProFAB2-R1R2-Hygro (derived from pMDC32),Expression from FAB2 promoter (ProFAB21kb)
PMID32958563,reaction_4_AAD6,in vivo,Complementation of fab2 mutant by expressing AAD6 cDNA under the FAB2 promoter.,N/A (in vivo study),,,21.0,Arabidopsis thaliana fab2 mutant,pProFAB2-R1R2-Hygro (derived from pMDC32),Expression from FAB2 promoter (ProFAB21kb)
PMID32961871,reaction_1,in vivo,Enzyme activity was manipulated in mouse pancreatic islets (knockout) and rat INS-1E cells (knockdown/inhibition) to study downstream effects. Activity was confirmed by measuring desaturation ratios of palmitate (16:0).,RPMI medium with supplements for cell culture.,,"Standard cell culture conditions, typically pH ~7.4",37.0,Endogenous expression in Mus musculus pancreatic islets and Rattus norvegicus INS-1E cells.,,
PMID32961871,reaction_2,in vivo,Enzyme activity was manipulated in mouse pancreatic islets (knockout) and rat INS-1E cells (knockdown/inhibition) to study downstream effects. Activity was confirmed by measuring desaturation ratios of stearate (18:0).,RPMI medium with supplements for cell culture.,,"Standard cell culture conditions, typically pH ~7.4",37.0,Endogenous expression in Mus musculus pancreatic islets and Rattus norvegicus INS-1E cells.,,
PMID32961871,reaction_3,in vivo,Quantification of global acetyl histone H4K16 levels in INS-1E cell lysates using a colorimetric kit (EpiQuik Global Acetyl Histone H4K16 Quantification Kit).,"TEB buffer (PBS containing 0.5% Triton X-100, 2 mM PMSF, and 0.02% NaN3)",,"Buffer based on PBS, typically pH 7.4",37.0,Rattus norvegicus INS-1E cells,,
PMID32961871,reaction_4,in vitro,Co-immunoprecipitation from INS-1E cell lysates followed by Western blot with an anti-acetylated lysine antibody to detect changes in DNMT1 acetylation state.,"Precipitation lysis buffer (20 mM Tris, 75 mM NaCl, 15 mM MgCl2, 1 mM EDTA, 0.5% Nonidet P-40, 10% glycerol, protease inhibitors)",8.0,,4.0,Rattus norvegicus INS-1E cells,,
PMID32961948,reaction_1,in vitro,Co-immobilized enzymes in a semi-continuous flow reactor. Also tested with free enzymes.,0.1 M potassium phosphate buffer,6.5,,37.0,Escherichia coli BL21(DE3),pET28b,0.1 mM IPTG
PMID32961948,reaction_2,in vitro,Co-immobilized enzymes in a semi-continuous flow reactor. Also tested with free enzymes.,0.1 M potassium phosphate buffer,6.5,,37.0,Escherichia coli BL21(DE3),pET28b,0.1 mM IPTG
PMID32961948,reaction_3,in vitro,Co-immobilized enzymes in a semi-continuous flow reactor. Also tested with free enzymes.,0.1 M potassium phosphate buffer,6.5,,37.0,Escherichia coli BL21(DE3),pET28b,0.1 mM IPTG
PMID32962020,reaction_1,in vitro,Assay with purified recombinant enzyme,50 mM Na phosphate buffer,7.5,Standard assay pH for kinetic measurements. Optimal pH is 7.2.,25.0,Escherichia coli BL21-AI (DE3),pDEST17,"0.2% (v/v) L-(+)-arabinose, 25 °C, 15 h"
PMID32962020,reaction_2,in vitro,Assay with purified recombinant enzyme,50 mM Na phosphate buffer,7.5,Standard assay pH for kinetic measurements. Optimal pH is 7.2.,25.0,Escherichia coli BL21-AI (DE3),pDEST17,"0.2% (v/v) L-(+)-arabinose, 25 °C, 15 h"
PMID32962020,reaction_3,in vitro,Assay with purified recombinant enzyme,50 mM Na phosphate buffer,7.5,Standard assay pH for kinetic measurements. Optimal pH is 7.2.,25.0,Escherichia coli BL21-AI (DE3),pDEST17,"0.2% (v/v) L-(+)-arabinose, 25 °C, 15 h"
PMID32963009,reaction_1,in vitro,Colorimetric assay monitoring NADH formation using a commercial kit (Amplite colorimetric D-lactate dehydrogenase assay kit).,Manufacturer's supplied assay buffer.,,Not specified in the text.,37.0,Escherichia coli BL21(DE3),pProEX-HTb,"0.6 mM IPTG, 16°C, 20h"
PMID32963009,reaction_2,in vitro,Colorimetric assay monitoring NADH formation using a commercial kit (Amplite colorimetric L-lactate dehydrogenase assay kit).,Manufacturer's supplied assay buffer.,,Not specified in the text.,37.0,Escherichia coli BL21(DE3),pProEX-HTb,"0.6 mM IPTG, 16°C, 20h"
PMID32966327,reaction_1,in vitro,Steady-state kinetic assay,50 mM 2-(N-cyclohexylamino) ethanesulfonic acid (CHES),9.0,,25.0,E. coli BL21(DE3),pET-28a,"0.2 mM isopropyl-β-D-thiogalactopyranoside (IPTG), 25°C, 24 h"
PMID32966327,reaction_2,in vitro,Steady-state kinetic assay,50 mM 2-(N-cyclohexylamino) ethanesulfonic acid (CHES),9.0,,25.0,E. coli BL21(DE3),pET-28a,"0.2 mM isopropyl-β-D-thiogalactopyranoside (IPTG), 25°C, 24 h"
PMID32967812,reaction_1,in vitro,Enzyme activity assay with purified protein,100 mM potassium phosphate buffer,7.0,Standard assay pH for kinetic measurements,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Culture in SC-U medium with 2% (w/v) galactose and 1% (w/v) raffinose at 30°C for 48 h.
PMID32967812,reaction_2,in vitro,Enzyme activity assay with purified protein,100 mM potassium phosphate buffer,7.0,Standard assay pH for kinetic measurements,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Culture in SC-U medium with 2% (w/v) galactose and 1% (w/v) raffinose at 30°C for 48 h.
PMID32967812,reaction_3,in vitro,Enzyme activity assay with purified protein,100 mM potassium phosphate buffer,7.0,Standard assay pH for kinetic measurements,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Culture in SC-U medium with 2% (w/v) galactose and 1% (w/v) raffinose at 30°C for 48 h.
PMID32967812,reaction_4,in vitro,Enzyme activity assay with purified protein,100 mM potassium phosphate buffer,7.0,Standard assay pH for kinetic measurements,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Culture in SC-U medium with 2% (w/v) galactose and 1% (w/v) raffinose at 30°C for 48 h.
PMID32967812,reaction_5,in vitro,Enzyme activity assay with purified protein,100 mM potassium phosphate buffer,7.0,Standard assay pH for kinetic measurements,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Culture in SC-U medium with 2% (w/v) galactose and 1% (w/v) raffinose at 30°C for 48 h.
PMID32967812,reaction_6,in vitro,Enzyme activity assay with purified protein,100 mM potassium phosphate buffer,7.0,Standard assay pH for kinetic measurements,30.0,Saccharomyces cerevisiae INVSc1,pYES2/NT B,Culture in SC-U medium with 2% (w/v) galactose and 1% (w/v) raffinose at 30°C for 48 h.
PMID32971035,reaction_1,in vitro,Spectrophotometric enzyme assay,50 mM sodium citrate,4.0,Optimum pH for Malachite green oxidation,25.0,E. coli BL21 (DE3),pET28c,"0.5 mM IPTG, 15 μM hemin chloride, 20 °C for 16 h"
PMID32971035,reaction_2,in vitro,Spectrophotometric enzyme assay,50 mM sodium citrate,4.0,Optimum pH for Methyl violet oxidation,25.0,E. coli BL21 (DE3),pET28c,"0.5 mM IPTG, 15 μM hemin chloride, 20 °C for 16 h"
PMID32971035,reaction_3,in vitro,Spectrophotometric enzyme assay,50 mM sodium citrate,3.0,Optimum pH for Reactive black 5 oxidation,25.0,E. coli BL21 (DE3),pET28c,"0.5 mM IPTG, 15 μM hemin chloride, 20 °C for 16 h"
PMID32971171,reaction_1,in vitro,Spectrophotometric assay using a kit with a xanthine-xanthine oxidase system to generate the superoxide substrate. Activity was defined as the amount of SOD that inhibited 50% of nitrite production at 550 nm.,50 mM Tris-HCl buffer (pH 7.5) for general characterization. Kinetics were measured at pH 8.2.,8.2,Kinetic parameters were determined at pH 8.2. The optimal pH for activity was found to be 7.4.,37.0,Escherichia coli pG-KJE8/BL21,pCold II,1 mM IPTG at 15°C for 24h
PMID32972135,reaction_1,in vitro,Single QD-based FRET nanosensor assay used for inhibitor screening and IC50 determination.,"50 mM HEPES, 100 μM 2-OG, 100 μM L-ascorbic acid, 150 μM (NH4)2Fe(SO4)2",7.5,,30.0,,,
PMID32972135,reaction_2,in vitro,PAGE-based assay for qualitative inhibitor screening.,"50 mM HEPES, 100 μM 2-OG, 100 μM L-ascorbic acid, 150 μM (NH4)2Fe(SO4)2",7.5,,30.0,,,
PMID32972135,reaction_3,in vitro,Single QD-based FRET nanosensor assay used for inhibitor selectivity testing.,"50 mM HEPES, 100 μM 2-OG, 100 μM L-ascorbic acid, 150 μM (NH4)2Fe(SO4)2",7.5,,30.0,,,
PMID32972135,reaction_4,in vitro,PAGE-based assay for qualitative inhibitor selectivity testing.,"50 mM HEPES, 100 μM 2-OG, 100 μM L-ascorbic acid, 150 μM (NH4)2Fe(SO4)2",7.5,,30.0,,,
PMID32972135,reaction_5,in vitro,Single QD-based FRET nanosensor assay using HeLa cell nuclear extracts as the enzyme source.,"Not specified, assay performed in HeLa cell nuclear extracts.",,,,,,
PMID32974079,reaction_1,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_2,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,25.0,,,
PMID32974079,reaction_3,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_4,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_5,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_6,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_7,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_8,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_9,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,25.0,,,
PMID32974079,reaction_10,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_11,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974079,reaction_12,in vitro,Biotransformation with cell-free extract,"50 mM HEPES buffer, pH 6.5, 150 mM KCl, 20 μM ZnCl2",6.5,,35.0,,,
PMID32974743,reaction_1,in vitro,Enzyme-coupled assay measuring hydrogen peroxide production using peroxidase and o-phenylendiamine.,20-mM Tris-HCl buffer (pH 7.0),7.0,,37.0,Pichia pastoris (GS115),pPIC3.5,Induced with 0.5% methanol.
PMID32978278,reaction_1,in vitro,HJ resolving activity assay,"50 mM Tris-HCl, 1 mM DTT, 10 mM MgCl2",8.0,,,Escherichia coli Rosetta (DE3),pBASSY,"0.2% arabinose, 16°C, 24 h"
PMID32978278,reaction_2,in vitro,HJ resolving activity assay (used as positive control),"50 mM Tris-HCl, 1 mM DTT, 10 mM MgCl2",8.0,,,Escherichia coli Rosetta (DE3),pBASSY,"0.2% arabinose, 16°C, 24 h"
PMID32980349,reaction_1,in vitro,Steady-state kinetic assay measuring corticosterone production from 11-deoxycorticosterone.,Assumed 100 mM potassium phosphate buffer (pH 7.4) based on other assays in the paper. Also contains 50 μM L-α-dilauroyl-sn-glycero-3-phosphocholine.,7.4,Assumed based on other assays in the paper.,37.0,Escherichia coli,,
PMID32980349,reaction_2,in vitro,Steady-state kinetic assay measuring corticosterone production from 11-deoxycorticosterone.,Assumed 100 mM potassium phosphate buffer (pH 7.4) based on other assays in the paper. Also contains 50 μM L-α-dilauroyl-sn-glycero-3-phosphocholine.,7.4,Assumed based on other assays in the paper.,37.0,Escherichia coli,,
PMID32980349,reaction_3,in vitro,Steady-state kinetic assay measuring 25-hydroxyvitamin D3 production from vitamin D3.,Assumed 100 mM potassium phosphate buffer (pH 7.4) based on other assays in the paper.,7.4,Assumed based on other assays in the paper.,37.0,Escherichia coli DH5α,pCWori+,"1 mM IPTG, 1 mM δ-aminolevulinic acid, 6 mM arabinose, 28°C, 48h"
PMID32980349,reaction_4,in vitro,Steady-state kinetic assay measuring 25-hydroxyvitamin D3 production from vitamin D3.,Assumed 100 mM potassium phosphate buffer (pH 7.4) based on other assays in the paper.,7.4,Assumed based on other assays in the paper.,37.0,Escherichia coli DH5α,pCWori+,"1 mM IPTG, 1 mM δ-aminolevulinic acid, 6 mM arabinose, 28°C, 48h"
PMID32980349,reaction_5,in vitro,"Steady-state kinetic assay measuring 3,4-dehydroretinol production from all-trans-retinol.",Assumed 100 mM potassium phosphate buffer (pH 7.4) based on other assays in the paper. Also contains 16 μM L-α-dilauroyl-sn-glycero-3-phosphocholine.,7.4,Assumed based on other assays in the paper.,37.0,Escherichia coli,,
PMID32980349,reaction_6,in vitro,"Steady-state kinetic assay measuring 3,4-dehydroretinol production from all-trans-retinol.",Assumed 100 mM potassium phosphate buffer (pH 7.4) based on other assays in the paper. Also contains 16 μM L-α-dilauroyl-sn-glycero-3-phosphocholine.,7.4,Assumed based on other assays in the paper.,37.0,Escherichia coli,,
PMID32980349,reaction_7,in vitro,Cytochrome c reduction assay. The reduction of Adx by AdR is the rate-limiting step.,100 mM potassium phosphate buffer (pH 7.4),7.4,,,Escherichia coli,,
PMID32980349,reaction_8,in vitro,Cytochrome c reduction assay. The reduction of Adx by AdR is the rate-limiting step.,100 mM potassium phosphate buffer (pH 7.4),7.4,,,Escherichia coli,,
PMID32980741,reaction_1,in vitro,Enzyme inhibition assay measuring ATP consumption using Kinase-Glo® Reagent.,"30 mM HEPES, 150 mM NaCl, 30 mM KCl, 40 mM MgCl2, 1 mM dithiothreitol, 0.1% BSA",7.5,,25.0,,,
PMID32989128,reaction_1,in vitro,In vitro epimerization assay with purified human GALE expressed in insect cells.,Not specified,,,,,,
PMID32989128,reaction_2,in vitro,In vitro epimerization assay with purified human GALE.,Not specified,,,,,,
PMID32989128,reaction_3,in vitro,In vitro epimerization assay with purified human GALE.,Not specified,,,,,,
PMID32989128,reaction_4,in vitro,In vitro epimerization assay with purified human GALE.,Not specified,,,,,,
PMID32989128,reaction_5,in vivo,Biosynthesis in HEK293T cells transiently transfected with mut-AGX1 and fed with a caged precursor (compound 11).,Cell culture medium,,Cellular pH,37.0,HEK293T cells,,
PMID32989128,reaction_6,in vitro,Glycosylation of peptide substrates and membrane protein preparations.,Not specified,,,,,,
PMID32989128,reaction_7,in vitro,Glycosylation of membrane proteins.,Not specified,,,,K-562 cells,,
PMID32989128,reaction_8,in vitro,Glycosylation of peptide substrates.,Not specified,,,,,,
PMID32993872,reaction_1,in vitro,HRP/o-dianisidine spectrophotometric assay for kinetics and UPLC-MS/MS for product analysis.,0.10 mol L–1 disodium pyrophosphate buffer,7.0,Optimal pH for degradation activity.,25.0,E. coli BL21 (DE3),pGEX-6P-1,"0.10 mmol L⁻¹ of IPTG, 28 °C, 6 h"
PMID32993872,reaction_2,in vitro,HRP/o-dianisidine spectrophotometric assay for kinetics.,0.10 mol L–1 disodium pyrophosphate buffer,7.0,Assumed based on optimal conditions for the engineered variant.,25.0,E. coli BL21 (DE3),pGEX-6P-1,
PMID32993872,reaction_3,in vitro,Chemiluminescence assay using whole B. subtilis spores as catalyst.,CBS,9.7,Optimal pH for the CL reaction.,,E.coli Rosetta (DE3),pET-28a,
PMID32993959,reaction_1,in vitro,Coupled reaction using horseradish peroxidase and o-dianisidine to measure H2O2 production. Oxidized o-dianisidine was measured spectrophotometrically at 440 nm.,50 mM sodium/potassium phosphate,8.2,,,Escherichia coli BL21 (DE3)-T1R,pET30a,"1.0 mM IPTG, 18°C, 20 h"
PMID32993959,reaction_2,in vitro,Coupled reaction using horseradish peroxidase and o-dianisidine to measure H2O2 production. Oxidized o-dianisidine was measured spectrophotometrically at 440 nm.,50 mM sodium/potassium phosphate,8.2,,,Escherichia coli BL21 (DE3)-T1R,pET30a,"1.0 mM IPTG, 18°C, 20 h"
PMID32993959,reaction_3,in vitro,Coupled reaction using horseradish peroxidase and o-dianisidine to measure H2O2 production. Oxidized o-dianisidine was measured spectrophotometrically at 440 nm.,50 mM sodium/potassium phosphate,8.2,,,Escherichia coli BL21 (DE3)-T1R,pET30a,"1.0 mM IPTG, 18°C, 20 h"
PMID32998973,reaction_1,in vitro,Biochemical assay measuring pyrophosphate (PPi) production from the aminoacylation reaction using a malachite green absorbance method with purified recombinant ChPheRS.,Not specified,,,,Not specified,,
PMID33001274,reaction_1,in vivo,Growth assay of met5∆ and met10∆ single mutants on minimal medium with different sulfur sources. Mutants grew on sulfide but not on sulfate or sulfite.,YNB medium or Sulfur-free B medium,,Not specified,30.0,,,
PMID33001274,reaction_2,in vivo,"Growth assay of met14∆ mutant on B medium with different sulfur sources. The mutant could grow with sulfite or sulfide, but not with sulfate.",B medium,,Not specified,30.0,,,
PMID33001274,reaction_3,in vivo,"Growth assay of a cys1∆cys3∆ double mutant, which could not grow on cystathionine, in contrast to the cys1∆ single mutant which could.",B medium,,Not specified,30.0,,,
PMID33001274,reaction_4,in vivo,"Growth assay of cys4∆ mutant on B medium. The mutant grew poorly in the presence of cysteine, supporting its role in the reverse transsulfuration pathway.",B medium,,Not specified,30.0,,,
PMID33001274,reaction_5,in vivo,"Growth assay of a met3∆mst1∆cys3∆cys4∆ quadruple mutant, which showed poor growth on any sulfur source, suggesting CYS3 contributes to an alternative sulfide production pathway from cysteine.",B medium,,Not specified,30.0,,,
PMID33001274,reaction_6,in vivo,"Growth assay of a met3∆mst1∆cys3∆cys4∆ quadruple mutant, which showed poor growth on any sulfur source, suggesting CYS4 contributes to an alternative sulfide production pathway from cysteine.",B medium,,Not specified,30.0,,,
PMID33001274,reaction_7,in vivo,"Growth assay of a met3∆mst1∆cys3∆cys4∆ quadruple mutant, which showed poor growth on any sulfur source, suggesting MST1 contributes to an alternative sulfide production pathway from cysteine.",B medium,,Not specified,30.0,,,
PMID33002308,reaction_1,in vivo,The phosphorylation state of endogenous LDHA was assessed in HEK293 cell lysates after siRNA knockdown of PTP1B. The dephosphorylation reaction occurs within the cells prior to lysis and analysis by Phos-tag SDS-PAGE.,,,Physiological pH within HEK293 cells,37.0,HEK293 cells,,Endogenous expression
PMID33002308,reaction_2,in vitro,K-BIPS assay performed on HEK293 cell lysates. The dephosphorylation of endogenous JAK2 by PTP1B was observed indirectly by measuring the amount of subsequently biotinylated JAK2.,"Lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.5% Triton X-100, and 10% glycerol) with added ATP-biotin (2 mM).",7.5,,31.0,HEK293 cells,,Endogenous expression
PMID33008411,reaction_1,in vitro,Activity assay in crude cell-free extracts by monitoring NADH formation at 340 nm.,Tris-HCl buffer,8.0,,37.0,Aspergillus nidulans,,Mycelia transferred to YMM + 1% l-rhamnose as sole carbon source.
PMID33008411,reaction_2,in vitro,"Activity assay in cell-free extracts using p-nitrophenyl-α-l-rhamnopyranoside (pNPR) substrate, measuring p-nitrophenol release at 400 nm.",100 mM McIlvaine buffer (citrate–phosphate buffer),4.0,,50.0,Aspergillus nidulans,,Mycelia transferred to MM containing 1% l-rhamnose as sole carbon source.
PMID33011181,reaction_1,in vivo,"The enzyme's role was investigated through gene knockdown and behavioral assays (courtship conditioning), not direct biochemical assays of the reaction.",,,,,,,
PMID33011272,reaction_1,in vitro,Activity measured in lysates of human neutrophils.,"50 mM Tris-HCl, containing 10 mM MgCl2, 1 mM NAD+ and 5 mM ATP",8.0,,37.0,,,
PMID33011272,reaction_2,in vitro,Phosphorylation of purified recombinant human NADK by commercial PKCδ.,"25 mM MOPS, pH 7.2, 12.5 mM β-glycerophosphate, 25 mM MgCl2, 5 mM EGTA, 2 mM EDTA and 0.2 mM DTT",7.2,,30.0,,,
PMID33011272,reaction_3,in vitro,Activity measured using purified recombinant enzyme expressed in E. coli.,"50 mM Tris-HCl, pH 8, containing 10 mM MgCl2, 1 mM NAD+ and 5 mM ATP",8.0,,37.0,Escherichia coli Rosetta strain,pGEX-6P-1,0.1 mM IPTG at 25°C for 4 h
PMID33011272,reaction_4,in vivo,Measurement of pyridine nucleotide levels in intact human neutrophils following stimulation with PMA.,PBS containing CaCl2 (0.9 mM) and MgCl2 (0.49 mM) (PBS+),,,37.0,,,
PMID33011819,reaction_1,in vivo,Functional verification via overexpression of the functional P28 allele in the white-leaved D10 line and virus-induced gene silencing (VIGS) of BoDFR1 in the pink-leaved P28 line.,in planta,,,25.0,Brassica oleracea var. acephala,pCAMBIA3301-based (35Spro:BoDFR-GUS),Constitutive expression from Cauliflower mosaic virus 35S promoter.
PMID33015914,reaction_1,in vitro,X-ray crystallography of the FTR:Trx-y1 complex. A covalent complex was formed for crystallization.,25 mM Tris-HCl buffer,7.5,,4.0,,,
PMID33015914,reaction_2,in vitro,X-ray crystallography of the FTR:Trx-f2 complex. A covalent complex was formed for crystallization.,25 mM Tris-HCl buffer,7.5,,4.0,,,
PMID33015914,reaction_3,in vitro,X-ray crystallography of the FTR:Trx-m2 complex. A covalent complex was formed for crystallization.,25 mM Tris-HCl buffer,7.5,,4.0,,,
PMID33017394,reaction_1,in vitro,ATP hydrolysis monitored by HPLC in the absence of selenide.,"50 mM Tris-HCl, 50 mM KCl, 5 mM MgCl2, 5 mM DTT",7.5,,26.0,E. coli,,
PMID33017394,reaction_2,in vitro,ATP hydrolysis monitored by HPLC in the absence of selenide.,"50 mM Tris-HCl, 50 mM KCl, 5 mM MgCl2, 5 mM DTT",7.5,,26.0,E. coli,,
PMID33017394,reaction_3,in vivo,Functional complementation assay in SEPHS deficient E. coli strain WL400(DE3). Activity inferred from expression of active formate dehydrogenase H (FDH H) via benzyl viologen assay.,in vivo assay,,in vivo E. coli conditions,30.0,E. coli WL400(DE3),,
PMID33017394,reaction_4,in vivo,Functional complementation assay in SEPHS deficient E. coli strain WL400(DE3). Activity inferred from expression of active formate dehydrogenase H (FDH H) via benzyl viologen assay.,in vivo assay,,in vivo E. coli conditions,30.0,E. coli WL400(DE3),,
PMID33020607,reaction_1,in vitro,Formation and structural analysis of the Pc-PSI-Fd supercomplex by cryo-electron microscopy.,20 mM MES-Tris (pH 7) and 0.05% n-Decyl-α-D-maltoside (αDM),7.0,for Pc-PSI-Fd complex formation,4.0,,,
PMID33020946,reaction_1,in vitro,Enzyme activity assay measuring NAD+ reduction.,"125 mM CAPSO, 60 mM (NH4)2HPO4",8.9,,55.0,Escherichia coli strain Rosetta (DE3),pET15b,"50 μM IPTG, 4 hours at room temperature"
PMID33020946,reaction_2,in vitro,Enzyme activity assay measuring NADH oxidation.,"125 mM MES buffer, 60 mM (NH4)2SO4",5.4,,55.0,Escherichia coli strain Rosetta (DE3),pET15b,"50 μM IPTG, 4 hours at room temperature"
PMID33020946,reaction_3,in vitro,Enzyme activity assay measuring NAD+ reduction.,"125 mM CAPSO, 60 mM (NH4)2HPO4",8.9,,55.0,Escherichia coli strain Rosetta (DE3),pET15b,"50 μM IPTG, 4 hours at room temperature"
PMID33020946,reaction_4,in vitro,Enzyme activity assay measuring NAD+ reduction.,"125 mM CAPSO, 60 mM (NH4)2HPO4",8.9,,55.0,Escherichia coli strain Rosetta (DE3),pET15b,"50 μM IPTG, 4 hours at room temperature"
PMID33020946,reaction_5,in vitro,Enzyme activity assay measuring NAD+ reduction.,"125 mM CAPSO, 60 mM (NH4)2HPO4",8.9,,55.0,Escherichia coli strain Rosetta (DE3),pET15b,"50 μM IPTG, 4 hours at room temperature"
PMID33020946,reaction_6,in vitro,Enzyme activity assay measuring NADH oxidation.,"125 mM MES buffer, 60 mM (NH4)2SO4",5.4,,55.0,Escherichia coli strain Rosetta (DE3),pET15b,"50 μM IPTG, 4 hours at room temperature"
PMID33020946,reaction_7,in vitro,Enzyme activity assay measuring NAD+ reduction.,"125 mM CAPSO, 60 mM (NH4)2HPO4",8.9,,55.0,Escherichia coli strain Rosetta (DE3),pET15b,"50 μM IPTG, 4 hours at room temperature"
PMID33028391,reaction_1,in vivo,"Functional characterization through bacterial growth assays, biofilm formation assays, and cell adhesion assays using wild-type and deletion mutant strains under zinc-restricted (TPEN-treated) and zinc-supplemented conditions.",LB medium or biofilm-inducing medium (BIM),,Not specified,37.0,Enterotoxigenic E. coli C83902,,
PMID33031537,reaction_1,in vitro,Reconstitution of enzymatic activity with radiolabeled (3-3H) lanosterol.,"20 mM MOPS, 50 mM KCl, 5mM MgCl2, 10% (v/v) glycerol",7.4,,,Escherichia coli HMS-174 (DE3),pET17-b,"Cultures supplemented with 1 mM δ-aminolevulinic acid, 1 mM IPTG, and 1 mM FeCl3, and incubated for 20 h at 22 °C and 180 rpm."
PMID33031537,reaction_2,in vitro,Reconstitution of enzymatic activity with radiolabeled (3-3H) eburicol.,"20 mM MOPS, 50 mM KCl, 5mM MgCl2, 10% (v/v) glycerol",7.4,,,Escherichia coli HMS-174 (DE3),pET17-b,"Cultures supplemented with 1 mM δ-aminolevulinic acid, 1 mM IPTG, and 1 mM FeCl3, and incubated for 20 h at 22 °C and 180 rpm."
PMID33031537,reaction_3,in vitro,Reconstitution of enzymatic activity with radiolabeled (3-3H) obtusifoliol.,"20 mM MOPS, 50 mM KCl, 5mM MgCl2, 10% (v/v) glycerol",7.4,,,Escherichia coli HMS-174 (DE3),pET17-b,"Cultures supplemented with 1 mM δ-aminolevulinic acid, 1 mM IPTG, and 1 mM FeCl3, and incubated for 20 h at 22 °C and 180 rpm."
PMID33031917,reaction_1,in vitro,Enzyme activity was measured by monitoring the reduction of ubiquinone-2 via the decrease in absorbance at 275 nm.,"50 mM citrate buffer, 200 mM NaCl",4.0,,30.0,Acidithiobacillus sp. strain SH (native),,
PMID33037220,reaction_1,in vivo,"Inferred from comparative transcriptomics, proteomics, and metabolite measurements on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33037220,reaction_2,in vivo,"Inferred from comparative transcriptomics, proteomics, and 13C-metabolomics on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33037220,reaction_3,in vivo,"Inferred from comparative transcriptomics, proteomics, and 13C-metabolomics on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33037220,reaction_4,in vivo,"Inferred from comparative transcriptomics, proteomics, and 13C-metabolomics on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33037220,reaction_5,in vivo,"Inferred from comparative transcriptomics, proteomics, and 13C-metabolomics on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33037220,reaction_6,in vivo,"Inferred from comparative transcriptomics, proteomics, and 13C-metabolomics on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33037220,reaction_7,in vivo,"Inferred from comparative transcriptomics, proteomics, and 13C-metabolomics on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33037220,reaction_8,in vivo,"Inferred from comparative transcriptomics, proteomics, and 13C-metabolomics on whole cells grown autotrophically.","Basal bicarbonate-buffered medium containing Na2HPO4·2H20 (0.53 g/L), KH2PO4 (0.41 g/L), NH4Cl (0.3 g/L), CaCl2·2H20 (0.11 g/L), MgCl2·6H20 (0.10 g/L), NaCl (0.3 g/L), NaHCO3 (4.0 g/L), Na2S·9H20 (0.48 g/L), trace element solutions, and a vitamins solution.",,,30.0,,,
PMID33038312,reaction_1,in vitro,Steady-state kinetics determined by monitoring oxygen consumption.,"50 mM potassium phosphate, pH 7.4",7.4,,30.0,Escherichia coli BL21(DE3),pET/2NPDnc,"0.2 mM IPTG, 20 °C, ~19 h"
PMID33038312,reaction_2,in vitro,Steady-state kinetics determined by monitoring oxygen consumption.,"50 mM potassium phosphate, pH 7.4",7.4,,30.0,Escherichia coli BL21(DE3),pET/2NPDnc,"0.2 mM IPTG, 20 °C, ~19 h"
PMID33038312,reaction_3,in vitro,Anaerobic reductive half-reaction monitored by stopped-flow spectrophotometry at 372 nm.,Aqueous buffer at pH 7.4 with an oxygen scavenging system (glucose oxidase/glucose).,7.4,,15.0,Escherichia coli BL21(DE3),pET/2NPDnc,"0.2 mM IPTG, 20 °C, ~19 h"
PMID33038544,reaction_1_GRK2_inhibition,in vitro,LANCE Ultra assay was used for IC50 determination. ThermofluorTM thermal shift assay was used for Kd determination.,,,,,,,
PMID33038544,reaction_2_GRK1_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_3_GRK5_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_4_GRK6_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_5_GRK7_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_6_PKA_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_7_PKBalpha_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_8_PKCalpha_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_9_PKCbeta1_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_10_CaMKIIbeta_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_11_ROCK1_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_12_AuroraA_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33038544,reaction_13_Rsk1_selectivity,in vitro,Kinase selectivity panel assay by Eurofins Pharma Discovery Services.,,,,,,,
PMID33043425,reaction_1,in vitro,Enzyme activity and kinetic parameter determination,100 mM sodium phosphate buffer,6.0,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_2,in vitro,Enzyme activity and kinetic parameter determination,100 mM sodium phosphate buffer,7.4,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_3,in vitro,Enzyme activity and kinetic parameter determination,100 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_4,in vitro,Enzyme activity and kinetic parameter determination,100 mM cesium phosphate buffer,6.5,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_5,in vitro,Enzyme activity and kinetic parameter determination,100 mM sodium acetate buffer,5.0,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_6,in vitro,Enzyme activity and kinetic parameter determination,100 mM sodium acetate buffer,5.5,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_7,in vitro,Enzyme activity and kinetic parameter determination,100 mM cesium phosphate buffer,6.5,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_8,in vitro,Enzyme activity and kinetic parameter determination,100 mM sodium acetate buffer,5.5,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_9,in vitro,Enzyme activity and kinetic parameter determination,100 mM sodium phosphate buffer,7.0,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_10,in vitro,Enzyme activity and kinetic parameter determination,100 mM cesium phosphate buffer,6.5,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_11,in vitro,Enzyme activity and kinetic parameter determination,100 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33043425,reaction_12,in vitro,Enzyme activity and kinetic parameter determination,100 mM cesium phosphate buffer,6.5,,25.0,Escherichia coli BL21,pET-23b (+),"1 mM IPTG, 37°C, 4 hours"
PMID33044587,reaction_1,in vitro,Enzyme activity and kinetics assay.,Phosphate buffer,,"The text mentions using a weakly acidic phosphate buffer for storage and pH 4.5 for immobilization, but the specific pH for the kinetic assay is not stated.",,Caldariomyces fumago,,
PMID33044587,reaction_2,in vitro,Degradation of pesticide in artificial wastewater.,"Artificial wastewater prepared from countryside river water, containing various organic solvents and inorganic ingredients.",,"The text mentions testing at 'neutral pH' as a non-optimal condition, but does not specify the exact value.",,Caldariomyces fumago,,
PMID33045667,reaction_1,in vitro,Amperometric biosensor measurement for butanol-1 detection using various sensor designs.,0.1 M phosphate buffer supplemented with 0.1 M KCl,6.0,,,,,
PMID33045667,reaction_2,in vitro,Amperometric biosensor measurement for butanol-1 detection using various sensor designs.,0.1 M phosphate buffer supplemented with 0.1 M KCl,6.0,,,,,
PMID33045667,reaction_3,in vitro,Amperometric biosensor measurement for butanol-1 detection using Design 11.,0.1 M phosphate buffer supplemented with 0.1 M KCl,6.0,,,recombinant Escherichia coli strain,,
PMID33048983,reaction_1,in vivo,Secretion assay in P. aeruginosa cultures,"LB supplemented with 2.5 g/L NaCl, with 5 mM EGTA to induce secretion",,Not specified,,Pseudomonas aeruginosa PAO1 ΔexsE,,Mutations were introduced into the chromosome by allelic exchange.
PMID33048983,reaction_2,in vivo,Secretion assay in P. aeruginosa cultures,"LB supplemented with 2.5 g/L NaCl, with 5 mM EGTA to induce secretion",,Not specified,,Pseudomonas aeruginosa PAO1 ΔexsE,,Mutations were introduced into the chromosome by allelic exchange.
PMID33048983,reaction_3,in vivo,Secretion assay in P. aeruginosa cultures,"LB supplemented with 2.5 g/L NaCl, with 5 mM EGTA to induce secretion",,Not specified,,Pseudomonas aeruginosa PAO1 ΔexsE,,Mutations were introduced into the chromosome by allelic exchange.
PMID33048983,reaction_4,in vivo,Secretion assay in P. aeruginosa cultures,"LB supplemented with 2.5 g/L NaCl, with 5 mM EGTA to induce secretion",,Not specified,,Pseudomonas aeruginosa PAO1 ΔexsE,,Mutations were introduced into the chromosome by allelic exchange.
PMID33049293,reaction_1,in vitro,Continuous fluorescence-based kinetic assay measuring the decrease in 7-hydroxycoumarin fluorescence.,"20 mM Tris, 50 mM NaCl, 10% sucrose, 0.5 mM EDTA, 0.10 μg/μL BSA, pH 7.4",7.4,,,Escherichia coli DH5α,pTrc99A,"IPTG-induced for WT. For W53L and W53A mutants, a modified vector was used for constitutive expression."
PMID33051013,reaction_1,in vitro,Assay performed with partially purified enzyme (ultrafiltrate fraction).,100 mM Tris-HCl buffer,8.0,Apparent optimal pH for this substrate. Activity was similar from pH 5.0 to 8.5.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_2,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",8.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_3,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",8.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_4,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",3.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_5,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",8.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_6,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",3.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_7,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",3.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_8,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",8.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_9,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",8.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_10,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",8.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_11,in vitro,Substrate range determination with partially purified enzyme.,"Various buffers used to test pH range (sodium acetate, potassium phosphate, Tris-HCl).",8.0,Optimal pH for this substrate.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_12,in vitro,Dye decolourisation assay with 1 μM dye.,50 mM potassium phosphate buffer,8.0,Optimal pH for decolourisation.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_13,in vitro,Dye decolourisation assay with 1 μM dye.,50 mM potassium phosphate buffer,8.0,Optimal pH for decolourisation.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_14,in vitro,Dye decolourisation assay with 1 μM dye.,50 mM potassium phosphate buffer,8.0,Optimal pH for decolourisation.,25.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_15,in vitro,Oxidative coupling of phenolic monomers.,100 mM ammonium bicarbonate buffer,8.0,,30.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_16,in vitro,Oxidative coupling of phenolic monomers.,100 mM ammonium bicarbonate buffer,8.0,,30.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_17,in vitro,Oxidative coupling of phenolic monomers.,100 mM ammonium bicarbonate buffer,8.0,,30.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051013,reaction_18,in vitro,Oxidative coupling of phenolic monomers.,100 mM ammonium bicarbonate buffer,8.0,,30.0,Streptomyces albidoflavus BSII#1 (native),,
PMID33051020,reaction_1,in vivo,Repeated batch biotransformation using resting cells in a 5-L stirred bioreactor. Specific activity was measured separately using cell extracts.,Aqueous solution with 80 g/L N-2-hydroxyethyl-glucamine and 20 mM MgSO4,5.0,Maintained by titration of 2 M NaOH. Enzyme activity assay also performed at pH 5.0.,15.0,Gluconobacter oxydans H-8,"pBBR1MCS-5 based vectors (pBBR-sldAB, pGA001-pGA005)",Constitutive expression from gHp0169 promoter
PMID33052678,reaction_1,in vivo,Enzyme was overexpressed in bovine stromal vascular fraction (SVF) cells and fatty acid composition was analyzed by GC-MS after 8 days of differentiation.,"Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS), then induced with a cocktail (0.5 mM IBMX, 1 μM Dex, 5 μg/mL insulin, 1 μM Rosig) and maintained in DMEM with 5 μg/mL insulin.",,Not specified; standard cell culture conditions assumed.,37.0,Bovine stromal vascular fraction (SVF) cells,pHBAD-EF1-MCS-3ﬂag-CMV-GFP shuttle vector packaged into adenovirus (Ad-SCD1),"Bovine SVF cells were infected by adenovirus Ad-SCD1, followed by differentiation induction."
PMID33052678,reaction_2,in vivo,Enzyme was overexpressed in bovine stromal vascular fraction (SVF) cells and fatty acid composition was analyzed by GC-MS after 8 days of differentiation.,"Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS), then induced with a cocktail (0.5 mM IBMX, 1 μM Dex, 5 μg/mL insulin, 1 μM Rosig) and maintained in DMEM with 5 μg/mL insulin.",,Not specified; standard cell culture conditions assumed.,37.0,Bovine stromal vascular fraction (SVF) cells,pHBAD-EF1-MCS-3ﬂag-CMV-GFP shuttle vector packaged into adenovirus (Ad-SCD1),"Bovine SVF cells were infected by adenovirus Ad-SCD1, followed by differentiation induction."
PMID33057913,reaction_1,in vivo,Whole-cell bioconversion in engineered E. coli strains.,LB medium supplemented with 10 g/l of d-galacturonate. A separate experiment was conducted in MOPS minimal medium with co-feeds.,7.2,For MOPS minimal medium experiment only. pH of LB medium was not specified.,30.0,Escherichia coli MG1655(DE3),pRSFDuet-1 (modified for carbenicillin resistance),0.1 mM IPTG
PMID33058282,reaction_1,in vitro,Enzyme activity was assayed by monitoring the decrease in absorbance at 340 nm due to NADH oxidation.,"50 mM potassium phosphate, 0.4 M KCl, 1 mM dithiothreitol",7.0,This is the optimal pH for the enzyme.,30.0,Escherichia coli C41 (DE3) pLysS,pTYB21,1 mM isopropyl 1-thio-β-D-galactoside (IPTG) for 3 h at 37°C
PMID33059448,reaction_1,in vitro,Enzyme activity measured from grape tissue extracts using an enzyme-linked immunosorbent assay (ELISA) kit.,,,,,,,
PMID33063604,reaction_1,in vitro,Kinetic parameter determination using DCIP as an electron acceptor.,100 mM sodium acetate buffer,5.0,,25.0,Termitomyces sp. OE147,,Enzyme purified from the culture supernatant of the native organism grown on cellulose.
PMID33063604,reaction_2,in vitro,Routine measurement of enzyme activity and kinetic parameter determination using DCIP as an electron acceptor.,100 mM sodium acetate buffer,5.0,,25.0,Termitomyces sp. OE147,,Enzyme purified from the culture supernatant of the native organism grown on cellulose.
PMID33063604,reaction_3,in vitro,Kinetic parameter determination using DCIP as an electron acceptor.,100 mM sodium acetate buffer,5.0,,25.0,Termitomyces sp. OE147,,Enzyme purified from the culture supernatant of the native organism grown on cellulose.
PMID33063604,reaction_4,in vitro,Kinetic parameter determination using DCIP as an electron acceptor.,100 mM sodium acetate buffer,5.0,,25.0,Termitomyces sp. OE147,,Enzyme purified from the culture supernatant of the native organism grown on cellulose.
PMID33063604,reaction_5,in vitro,Cellulose hydrolysis experiment to measure the release of reducing sugars over time.,50 mM sodium acetate buffer,4.5,,30.0,Termitomyces sp. OE147,,Enzyme purified from the culture supernatant of the native organism grown on cellulose.
PMID33065002,reaction_1,in vitro,"The reaction is inferred from the cryo-EM structures of the enzyme in three different rotational states, which represent stages of the ATP hydrolysis cycle. No direct kinetic assay was performed.","Not specified for reaction, purification buffer was used for structural studies.",,,,HEK293F cells (endogenous),,
PMID33067793,reaction_1,in vitro,Assay performed using crude fresh leaf extract by measuring formaldehyde degradation. Activity was determined by comparing fresh extract to enzyme-inactivated (liquid nitrogen frozen) extract.,phosphate buffer (PBS),7.8,,,,,
PMID33067793,reaction_2,in vitro,Assay performed using crude fresh leaf extract by measuring formaldehyde degradation. Activity was determined by comparing fresh extract to enzyme-inactivated (liquid nitrogen frozen) extract.,phosphate buffer (PBS),7.8,,,,,
PMID33067793,reaction_3,in vitro,Assay performed using crude fresh leaf extract by measuring formaldehyde degradation. Activity was determined by comparing fresh extract to enzyme-inactivated (liquid nitrogen frozen) extract.,phosphate buffer (PBS),7.8,,,,,
PMID33067793,reaction_4,in vitro,Assay performed using crude fresh leaf extract by measuring formaldehyde degradation. Activity was determined by comparing fresh extract to enzyme-inactivated (liquid nitrogen frozen) extract.,phosphate buffer (PBS),7.8,,,,,
PMID33068553,reaction_1,in vitro,LC-MS/MS based demethylation assay to measure remaining m6A-containing RNA oligonucleotide.,"50 µM HEPES, 50 µM KCl, 1 mM MgCl2, 1 mM 2-oxoglutarate, 2 mM ascorbic acid, 1 mM (NH4)2Fe(SO4)2, 0.2 U/µL SuPERNase In",6.5,,37.0,Codonplus (DE3) E. coli strain,modified pET-28a,"0.2 mM IPTG, 25°C, overnight"
PMID33074120,reaction_1,in vitro,Indirect colorimetric biochemical assay measuring the reduction of DCIP coupled to the oxidation of L-DHO.,"50 mM Tris, 150 mM KCl and 0.8% Triton® X-100, pH 8.0",8.0,,25.0,,,
PMID33079465,reaction_1,in vitro,Colorimetric assay using xanthine/xanthine oxidase to generate superoxide and WST-1 for detection. H2O2 production was confirmed with an ABTS/HRP assay.,Not specified,,Not specified,,,,
PMID33079465,reaction_2,in vitro,Spectrophotometric assay monitoring H2O2 disappearance at 240 nm.,Not specified,,Not specified,,,,
PMID33079465,reaction_3,in vitro,Spectrophotometric assay monitoring a coupled reaction at 340 nm.,Not specified,,Not specified,,,,
PMID33079465,reaction_4,in vitro,Spectroscopic assay using TMB as substrate.,Not specified,,Not specified,,,,
PMID33079465,reaction_5,in vitro,Spectroscopic assay using TMB and H2O2 as substrates.,Not specified,,Not specified,,,,
PMID33079465,reaction_6,in vitro,"Activity assay mentioned in text, with details in supplementary information (Figure S9a-c).",Not specified,,Not specified,,,,
PMID33080111,reaction_1,in vitro,Kinetic analysis of solubilized and nanodisc-embedded human SQOR.,,,Physiological conditions implied.,,,,
PMID33080111,reaction_2,in vitro,Kinetic analysis of solubilized and nanodisc-embedded human SQOR.,,,Physiological conditions implied.,,,,
PMID33080111,reaction_3,in vitro,Kinetic analysis of nucleophile addition to the enzyme's resting trisulfide state.,,,,4.0,,,
PMID33080111,reaction_4,in vitro,Kinetic analysis of alternative nucleophile addition.,,,,4.0,,,
PMID33080111,reaction_5,in vitro,Kinetic analysis of alternative nucleophile addition.,,,,4.0,,,
PMID33080111,reaction_6,in vitro,Kinetic analysis of alternative nucleophile addition.,,,,4.0,,,
PMID33080111,reaction_7,in vitro,Demonstration of substrate promiscuity leading to synthesis of Coenzyme A persulfide (CoA-SSH).,,,,,,,
PMID33080859,reaction_1,in vitro,Immobilized enzyme on a Pt electrode within a flow injection analysis (FIA) system. Amperometric detection of H2O2.,0.1 M Britton-Robinson buffer,,"Studied over a pH range of 5 to 9.5, with specific data reported for pH 5, 7, and 9.",20.0,,,
PMID33080882,reaction_1,in vivo,"Phenotypic analysis of transgenic potato plants (overexpression and silencing lines) under normal, phosphorus-free, and drought stress conditions using hydroponics and pot cultivation.",Hoagland nutrient solution,5.8,pH of media used for potato transformation and culture.,22.0,Solanum tuberosum cv. Desiree,"pBI121 for overexpression (pBI121-StPHT1;7), pBIN19 for silencing (pBIN19-StPHT1;7i)","Transformation via Agrobacterium tumefaciens LBA4404 using leaf explants, followed by regeneration on CIM and SIM media containing kanamycin for selection."
PMID33081987,reaction_1,in vitro,Whole-cell assay using stably transfected HEK-293 cells expressing human 17β-HSD10.,"Minimum Essential Medium (MEM) containing non-essential amino acids (0.1 nM), glutamine (2 mM), sodium pyruvate (1 mM), 10% FBS, penicillin (100 IU/mL), streptomycin (100 μg/mL) and G418 (700 μg/mL).",,"Not specified, standard cell culture conditions.",37.0,HEK-293,pCMVneo-h17βHSD10,"Stably transfected using lipofectin, selected with 700 μg/mL G418."
PMID33081987,reaction_2,in vitro,Whole-cell assay using LNCaP cells overexpressing human 17β-HSD3.,"RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 2 mM L-glutamine, 4.5 g/L D-glucose, 10 mM Hepes, 1 mM sodium pyruvate.",,"Not specified, standard cell culture conditions.",37.0,LNCaP,,
PMID33081987,reaction_3,in vitro,Metabolic stability assay,"50 mM Tris buffer, 10 mM MgCl2",,Not specified,37.0,,,
PMID33081987,reaction_4,in vitro,Metabolic stability assay,"50 mM Tris buffer, 10 mM MgCl2",,Not specified,37.0,,,
PMID33081987,reaction_5,in vitro,Metabolic stability assay,"50 mM Tris buffer, 10 mM MgCl2",,Not specified,37.0,,,
PMID33081987,reaction_6,in vitro,Metabolic stability assay,"50 mM Tris buffer, 10 mM MgCl2",,Not specified,37.0,,,
PMID33081987,reaction_7,in vitro,Metabolic stability assay,"50 mM Tris buffer, 10 mM MgCl2",,Not specified,37.0,,,
PMID33081987,reaction_8,in vitro,Metabolic stability assay,"50 mM Tris buffer, 10 mM MgCl2",,Not specified,37.0,,,
PMID33081987,reaction_9,in vitro,Metabolic stability assay,"50 mM Tris buffer, 10 mM MgCl2",,Not specified,37.0,,,
PMID33082972,reaction_1,in vitro,Enzyme activity assay using supernatant from hypocotyl tissue homogenate.,ice-cold isolation medium,,Not specified,37.0,,,
PMID33088599,reaction_1,in vitro,Ferroxidase assay by monitoring Fe(III)-transferrin complex formation.,0.2 M sodium acetate,7.0,,,Escherichia coli BL21 (DE3),pET21d,"0.1 mM IPTG, 4 h, 30 °C"
PMID33090543,reaction_1,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_2,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_3,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium phosphate buffer,7.0,,25.0,,,
PMID33090543,reaction_4,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_5,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_6,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_7,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_8,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium phosphate buffer,7.0,,25.0,,,
PMID33090543,reaction_9,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_10,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_11,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_12,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_13,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium phosphate buffer,7.0,,25.0,,,
PMID33090543,reaction_14,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33090543,reaction_15,in vitro,Crude enzyme extract from lily bulbs,0.05 M sodium acetate buffer,4.0,,25.0,,,
PMID33091303,reaction_1,in vitro,Enzyme kinetics assay,Not specified,,,,E. coli,,
PMID33091303,reaction_2,in vitro,"Autocatalytic post-translational modification observed by SDS-PAGE, mass spectrometry, and X-ray crystallography.",oxygen-saturated buffer,,,,E. coli,,
PMID33093461,reaction_1,in vivo,"Activity was assayed in human pancreatic cancer cell lines (PANC-1, BxPC-3) by measuring the level of the substrate, H3K36me3, via western blot analysis following various treatments.",Cells were cultured in RPMI 1640 or DMEM medium supplemented with 10% FBS.,,,,,,
PMID33102450,reaction_1,in vivo,Whole-cell bioconversion using resting cells of Pseudomonas putida KT2440.,200 mM phosphate buffer,6.0,Optimal pH determined from a range of 5.5-7.5. Higher pH decreased selectivity by favoring furfuryl alcohol formation.,30.0,Pseudomonas putida KT2440,,Cells were grown in LB medium and induced by adding 4.5 mM 5-hydroxymethylfurfural (HMF) at the middle exponential growth phase to boost catalytic performance.
PMID33102450,reaction_2,in vivo,Whole-cell bioconversion using resting cells of Pseudomonas putida KT2440.,200 mM phosphate buffer,6.0,,30.0,Pseudomonas putida KT2440,,Cells were grown in LB medium and induced by adding 4.5 mM 5-hydroxymethylfurfural (HMF) at the middle exponential growth phase.
PMID33103429,reaction_1,in vitro,Activity assay on cell-free extract of wild-type P. taetrolens.,100 mM acetate buffer,5.5,,30.0,,,
PMID33103429,reaction_2,in vitro,Activity assay on cell-free extract of wild-type P. taetrolens.,100 mM acetate buffer,5.5,,30.0,,,
PMID33103429,reaction_3,in vitro,Activity assay on cell-free extract of wild-type P. taetrolens.,100 mM acetate buffer,5.5,,30.0,,,
PMID33103429,reaction_4,in vitro,Activity assay on cell-free extract of wild-type P. taetrolens.,100 mM acetate buffer,5.5,,30.0,,,
PMID33103429,reaction_5,in vitro,Activity assay on cell-free extract of wild-type P. taetrolens.,100 mM acetate buffer,5.5,,30.0,,,
PMID33103429,reaction_6,in vitro,Activity assay on cell-free extract of wild-type P. taetrolens.,100 mM acetate buffer,5.5,,30.0,,,
PMID33103429,reaction_7,in vitro,Activity assay on cell-free extract of wild-type P. taetrolens.,100 mM acetate buffer,5.5,,30.0,,,
PMID33103429,reaction_8,in vivo,Batch fermentation using wild-type P. taetrolens in a 5 L bioreactor.,"Fermentation medium: 1 g/L beef extract, 2 g/L yeast extract, 5 g/L peptone, 5 g/L NaCl, 200 g/L pure lactose, and 30 g/L CaCO3",,"CaCO3 was added to the medium, but a specific pH value during fermentation was not reported.",25.0,Pseudomonas taetrolens,pDSK519,IPTG induction
PMID33103429,reaction_9,in vivo,Heterologous expression in E. coli Δgcd to confirm activity. LBA production was confirmed by HPLC.,LB medium with 10 μM PQQ,,,37.0,Escherichia coli Δgcd,pKK223-3,1 mM IPTG
PMID33106986,reaction_1,in vitro,Two-step enzyme assay for kinetic measurements.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,pET16bP,"0.1 mM IPTG, 22 °C, 20 h in DYT medium"
PMID33106986,reaction_2,in vitro,Two-step enzyme assay for kinetic measurements.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,pET16bP,"0.1 mM IPTG, 22 °C, 20 h in DYT medium"
PMID33106986,reaction_3,in vitro,Two-step enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_4,in vitro,Two-step enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_5,in vitro,Enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_6,in vitro,Photometric assay for esterase activity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_7,in vitro,Two-step enzyme assay for kinetic measurements.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,pET16bP,"0.1 mM IPTG, 22 °C, 24 h in TB medium"
PMID33106986,reaction_8,in vitro,Two-step enzyme assay for kinetic measurements.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,pET16bP,"0.1 mM IPTG, 22 °C, 24 h in TB medium"
PMID33106986,reaction_9,in vitro,Two-step enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_10,in vitro,Two-step enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_11,in vitro,Enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_12,in vitro,Photometric assay for esterase activity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_13,in vitro,Two-step enzyme assay for kinetic measurements.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,pET16bP,"0.1 mM IPTG, 22 °C, 6 h in TB medium"
PMID33106986,reaction_14,in vitro,Two-step enzyme assay for kinetic measurements.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,pET16bP,"0.1 mM IPTG, 22 °C, 6 h in TB medium"
PMID33106986,reaction_15,in vitro,Two-step enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_16,in vitro,Two-step enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_17,in vitro,Enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_18,in vitro,Photometric assay for esterase activity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_19,in vitro,Two-step enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_20,in vitro,Enzyme assay for substrate specificity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33106986,reaction_21,in vitro,Photometric assay for esterase activity.,Buffer not specified,7.7,,,Escherichia coli BL21 (DE3) pLysS,,
PMID33109721,reaction_1,in vivo,Live cell imaging and functional assays in murine bone-marrow-derived dendritic cells (BMDCs).,"Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% low endotoxin-defined fetal bovine serum, 2 mM L-Gln, 50 μM 2-mercaptoethanol, and 30% granulocyte-macrophage colony-stimulating factor-containing conditioned medium.",,"Standard cell culture conditions, likely pH 7.2-7.4",37.0,Mus musculus bone-marrow-derived dendritic cells,Retroviral and lentiviral vectors,Endogenous expression; shRNA knockdown used for inhibition studies; rescue experiments performed with retroviral transduction of human PI4KIIα constructs.
PMID33109721,reaction_2,in vivo,Live cell imaging and functional assays in murine bone-marrow-derived dendritic cells (BMDCs).,"Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% low endotoxin-defined fetal bovine serum, 2 mM L-Gln, 50 μM 2-mercaptoethanol, and 30% granulocyte-macrophage colony-stimulating factor-containing conditioned medium.",,"Standard cell culture conditions, likely pH 7.2-7.4",37.0,Mus musculus bone-marrow-derived dendritic cells,Lentiviral vectors for shRNA,Endogenous expression; shRNA knockdown used for inhibition studies.
PMID33110062,reaction_1,in vitro,Enzyme activity measurement using insect cell membranes overexpressing SRD5A2.,0.1 M sodium citrate buffer,5.0,,37.0,insect Sf9 cells,pFastBac,Baculovirus infection for 48h at 27°C
PMID33110062,reaction_2,in vivo,The NADP-DHF adduct was formed in Sf9 cells during protein expression and subsequently co-purified and crystallized with the enzyme.,"Purification buffers contained 1.0 μM finasteride, 20 mM HEPES pH 7.5, 100 mM NaCl, 0.01% LMNG, 0.001% CHS.",7.5,pH of purification buffers. Reaction likely occurred in vivo at cellular pH.,27.0,insect Sf9 cells,pFastBac,Baculovirus infection for 48h at 27°C
PMID33113038,reaction_1,in vitro,Polarographic activity assay measuring O2 production with a Clark-type oxygen electrode.,100 mM KPi pH 7.0,7.0,,21.0,E. coli BL21(DE3) pLysS,pET28a-CDBC,"0.5 mM IPTG at OD600=0.5, followed by cultivation at 25 °C for 7 h in TB medium supplemented with 60 μg/mL hemin."
PMID33114668,reaction_1,in vitro,One-pot screening assay for MurA-F enzymes,PiColorlock Assay kit components,,,37.0,,,
PMID33114668,reaction_2,in vitro,Coupled assay for MurC ligase,PiColorlock Assay kit components,,,37.0,,,
PMID33114668,reaction_3,in vitro,Coupled assay for MurD ligase,PiColorlock Assay kit components,,,37.0,,,
PMID33114668,reaction_4,in vitro,Coupled assay for MurE ligase,PiColorlock Assay kit components,,,37.0,,,
PMID33114668,reaction_5,in vitro,Coupled assay for MurF ligase,PiColorlock Assay kit components,,,37.0,,,
PMID33122026,reaction_1,in vitro,Kinetic analysis of purified enzyme using progress curves and initial rates.,"50 mM Tris (pH 8), 5 mM MgCl2, 5 mM NaCl",8.0,,30.0,Escherichia coli BL21(DE3),pCOLA-His-phaBCAp6,
PMID33122026,reaction_2,in vitro,Kinetic analysis of purified enzyme using progress curves.,"50 mM Tris (pH 8), 5 mM MgCl2, 5 mM NaCl",8.0,,30.0,Escherichia coli BL21(DE3),pCOLA-His-phaBCAp6,
PMID33122026,reaction_3,in vitro,Measurement of reverse reaction rate with purified enzyme.,"50 mM Tris (pH 8), 5 mM MgCl2, 5 mM NaCl",8.0,,30.0,Escherichia coli BL21(DE3),pCOLA-His-phaBCAp6,
PMID33122026,reaction_4,in vitro,Kinetic analysis of purified chimeric enzyme using progress curves.,"50 mM Tris (pH 8), 5 mM MgCl2, 5 mM NaCl",8.0,,30.0,Escherichia coli BL21(DE3),pCOLA-duet-1,
PMID33122026,reaction_5,in vitro,Kinetic analysis of purified chimeric enzyme using progress curves.,"50 mM Tris (pH 8), 5 mM MgCl2, 5 mM NaCl",8.0,,30.0,Escherichia coli BL21(DE3),pCOLA-duet-1,
PMID33122026,reaction_6,in vivo,Continuous culture of engineered E. coli under oxygen limiting conditions.,Defined mineral medium with sucrose as sole carbon source.,7.0,Controlled in chemostat,37.0,Escherichia coli MG1655(DE3)Δ5,pCOLA-phaCACnecatorphaBCAp-cscABK,100 µM IPTG
PMID33122065,reaction_1,in vitro,Characterization of the purified enzyme from Bacillus cereus SKIII.,50 mM Tris-HCl buffer,8.0,Optimum pH for enzyme activity.,35.0,Bacillus cereus SKIII,,
PMID33123518,reaction_1,in vitro,DTNB specific activity assay,"20 mM of Tris–HCl, pH 7.0, 200 mM of NaCl, 2 mg/ml of BSA",7.0,,,Escherichia coli Rosetta 2(DE3),pMAL-c5x,"200 µM IPTG, 16°C for 16 h"
PMID33123518,reaction_2,in vitro,NADPH depletion specific activity assay,"20 mM of Tris–HCl, pH 7.0, 200 mM of NaCl, 2 mg/ml of BSA",7.0,,,Escherichia coli Rosetta 2(DE3),pMAL-c5x,"200 µM IPTG, 16°C for 16 h"
PMID33123518,reaction_3,in vitro,NADPH depletion specific activity assay,"20 mM of Tris–HCl, pH 7.0, 200 mM of NaCl, 2 mg/ml of BSA",7.0,,,Escherichia coli Rosetta 2(DE3),pMAL-c5x,"200 µM IPTG, 16°C for 16 h"
PMID33123518,reaction_4,in vitro,DTNB specific activity assay,"20 mM of Tris–HCl, pH 7.0, 200 mM of NaCl, 2 mg/ml of BSA",7.0,,,Escherichia coli Rosetta 2(DE3),pMAL-c5x,"200 µM IPTG, 16°C for 16 h"
PMID33123518,reaction_5,in vivo,Aldehyde production in engineered S. cerevisiae,YNB-URA with 0.2% glucose and 1.8% galactose,,,30.0,Saccharomyces cerevisiae BY4741,pYES2/CT,
PMID33123518,reaction_6,in vivo,Alkane/alkene production in engineered S. cerevisiae,YNB-URA with 1.0% glucose and 1.0% galactose,,,30.0,Saccharomyces cerevisiae BY16OYGA,pGT-ALK,
PMID33124786,reaction_1,in vitro,Polymerase extension assay with MALDI-TOF-MS detection,"1x ThermoPol buffer (20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100)",8.8,,65.0,,,
PMID33124786,reaction_2,in vitro,Polymerase extension assay with MALDI-TOF-MS detection,"1x ThermoPol buffer (20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100)",8.8,,65.0,,,
PMID33124786,reaction_3,in vitro,Polymerase extension assay with MALDI-TOF-MS detection,"1x Thermo Sequenase buffer (26 mM Tris-HCl, 6.5 mM MgCl2)",9.5,,65.0,,,
PMID33124786,reaction_4,in vitro,Polymerase extension assay with MALDI-TOF-MS detection,"10 mM Tris-HCl, 10 mM KCl, 2 mM MgCl2 and 1 mM β-mercaptoethanol",8.0,,30.0,,,
PMID33124786,reaction_5,in vitro,Polymerase extension assay with MALDI-TOF-MS detection,"10 mM Tris-HCl, 10 mM KCl, 2 mM MgCl2 and 1 mM β-mercaptoethanol",8.0,,30.0,,,
PMID33124786,reaction_6,in vitro,Polymerase extension assay with MALDI-TOF-MS detection,"10 mM Tris-HCl, 10 mM KCl, 2 mM MgCl2 and 1 mM β-mercaptoethanol",8.0,,30.0,,,
PMID33124786,reaction_7,in vitro,Polymerase extension assay with MALDI-TOF-MS detection,"10 mM Tris-HCl, 10 mM KCl, 2 mM MgCl2 and 1 mM β-mercaptoethanol",8.0,,30.0,,,
PMID33128494,reaction_1,in vitro,"Coupled enzyme assay with homogentisate 1,2-dioxygenase (HGD) to monitor the generation of maleylacetoacetate at 318 nm.",20 mM HEPES buffer,,pH not specified in the provided text.,30.0,,,
PMID33129593,reaction_1,in vitro,Enzyme-based neddylation activity assay measuring Cullin1-Nedd8 adduct formation by immunoblotting.,"50 mM Tris-HCl containing MgCl2, DTT, and BSA",7.4,,37.0,,,
PMID33129969,reaction_1,in vitro,MnSOD activity was measured in hypothalamic whole cell lysates using a colorimetric assay kit.,"20 mmol/L Tris-HCl, 0.5 mmol/L EDTA, 0.5 mmol/L EGTA, 0.5% (v/v) Triton X-100, and 0.1% (v/v) protease and phosphatase inhibitor cocktails",7.5,,,,,
PMID33129969,reaction_2,in vitro,Total cardiolipin content was measured in hypothalamic tissues using a fluorometric cardiolipin assay kit.,"20 mmol/L Tris-HCl, 0.5 mmol/L EDTA, 0.5 mmol/L EGTA, 0.5% (v/v) Triton X-100, and 0.1% (v/v) protease and phosphatase inhibitor cocktails",7.5,,,,,
PMID33131003,reaction_1,in vitro,Steady-state kinetic assay monitoring oxidation of reduced methyl viologen at 600 nm,"50 mM HEPES, pH 7.00",7.0,Standard assay pH. pH dependence was also studied across a range of 5.5-9.0.,25.0,Escherichia coli K12 (Shuffle T7 lysY #C3027),pBM10C,"Autoinduction medium supplemented with 30 µg/mL kanamycin and 1 mM Na2MoO4, incubated at room temperature for 48 h."
PMID33131003,reaction_2,in vitro,Steady-state kinetic assay monitoring oxidation of reduced methyl viologen at 600 nm,"50 mM HEPES, pH 7.00",7.0,,25.0,Escherichia coli K12 (Shuffle T7 lysY #C3027),pBM10C,"Autoinduction medium supplemented with 30 µg/mL kanamycin and 1 mM Na2MoO4, incubated at room temperature for 48 h."
PMID33131003,reaction_3,in vitro,Steady-state kinetic assay monitoring oxidation of reduced methyl viologen at 600 nm,"50 mM HEPES, pH 7.00",7.0,,25.0,Escherichia coli K12 (Shuffle T7 lysY #C3027),pBM10C,"Autoinduction medium supplemented with 30 µg/mL kanamycin and 1 mM Na2MoO4, incubated at room temperature for 48 h."
PMID33131742,reaction_1,in vitro,Degradation assay with partially purified enzyme.,"50 mM PIPES buffer with 0.1 mM MnSO4, 24 mM glucose, and 3 U/mL glucose oxidase",7.2,,32.0,,,
PMID33131742,reaction_2,in vivo,Degradation by whole cells of B. velezensis Al-Dhabi 140 in a fibrous bed reactor.,Artificial wastewater with optimized nutrient sources,7.0,Optimal pH determined in batch experiments.,35.0,,,
PMID33136147,reaction_1,in vivo,Whole-cell reduction assay in culture medium. Tellurate concentration in the supernatant was measured by HG-AFS after 24h.,Tryptic Soy Broth (TSB) liquid medium supplemented with 500 µM tellurate,,,37.0,,,
PMID33136147,reaction_2,in vivo,Whole-cell reduction assay in culture medium. Selenate concentration in the supernatant was measured by HG-AFS after 24h.,Tryptic Soy Broth (TSB) liquid medium supplemented with 1 mM selenate,,,37.0,,,
PMID33136147,reaction_3,in vitro,Benzyl viologen-dependent colorimetric activity assay performed on an agar plate.,Agar plate,,,,,,
PMID33136147,reaction_4,in vitro,Activity staining on polyacrylamide gels using formate as a substrate.,Polyacrylamide gel,,,,,,
PMID33136147,reaction_5,in vitro,Enzyme assay using reduced methyl viologen as an electron donor.,Not specified,,,,,,
PMID33139950,reaction_1,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing Fre-L3–SttH fusion enzyme.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,pACYC::fre-L3–stth,"0.5 mM IPTG, 18°C, overnight"
PMID33139950,reaction_2,in vivo,Whole-cell reaction using E. coli ΔtnaA co-expressing SttH and Fre.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,,
PMID33139950,reaction_3,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing TnaA. Substrate was provided from the supernatant of a prior halogenase reaction.,Supernatant from Fre-L3-SttH reaction in 50 mM NPB,8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,pCDF::tnaA,"0.5 mM IPTG, 18°C, overnight"
PMID33139950,reaction_4,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing TnaA.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,,
PMID33139950,reaction_5,in vivo,"Part of a consecutive two-cell reaction system. ΔtnaA TnaA+MaFMO cells were used to convert 6-bromoindole (generated in situ) to 6,6'-dibromoindigo.",Supernatant from Fre-L3-SttH reaction in 50 mM NPB,8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,plasmid for TnaA+MaFMO coexpression,"0.1 mM IPTG, 18°C, overnight"
PMID33139950,reaction_6,in vivo,"Part of a consecutive two-cell reaction system. ΔtnaA TnaA+CYP102G4 cells were used to convert 6-bromoindole (generated in situ) to 6,6'-dibromoindigo.",Supernatant from Fre-L3-SttH reaction in 50 mM NPB,8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,plasmid for TnaA+CYP102G4 coexpression,"0.1 mM IPTG, 0.25 mM ALA, 18°C, overnight"
PMID33139950,reaction_7,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing Fre-L3–PyrH fusion enzyme.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,,
PMID33139950,reaction_8,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing Fre-L3–PyrH fusion enzyme.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,,
PMID33139950,reaction_9,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing Fre-L3–Th-Hal fusion enzyme.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,,
PMID33139950,reaction_10,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing Fre-L3–RebH fusion enzyme.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,,
PMID33139950,reaction_11,in vivo,Whole-cell reaction using E. coli ΔtnaA expressing Fre-L3–RebH fusion enzyme.,50 mM Sodium Phosphate Buffer (NPB),8.0,,30.0,Escherichia coli BL21 (DE3) ΔtnaA,,
PMID33140461,reaction_1,in vitro,Standard peroxidase activity assay for kinetic measurements.,"20 mM sodium acetate buffer, pH 5.5",5.5,,30.0,,,
PMID33140461,reaction_2,in vitro,Standard peroxidase activity assay for kinetic measurements.,"20 mM sodium acetate buffer, pH 5.5",5.5,,40.0,,,
PMID33140461,reaction_3,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,30.0,,,
PMID33140461,reaction_4,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,40.0,,,
PMID33140461,reaction_5,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,40.0,,,
PMID33140461,reaction_6,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,40.0,,,
PMID33140461,reaction_7,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,40.0,,,
PMID33140461,reaction_8,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,40.0,,,
PMID33140461,reaction_9,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,30.0,,,
PMID33140461,reaction_10,in vitro,Substrate specificity assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,30.0,,,
PMID33140461,reaction_11,in vitro,Phenol removal assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,25.0,,,
PMID33140461,reaction_12,in vitro,Phenol removal assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,25.0,,,
PMID33140461,reaction_13,in vitro,p-chlorophenol removal assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,25.0,,,
PMID33140461,reaction_14,in vitro,p-chlorophenol removal assay,"20 mM sodium acetate buffer, pH 5.5",5.5,,25.0,,,
PMID33142415,reaction_1_nfk_assay,in vitro,NFK assay. Time-dependent formation of N-formylkynurenine (NFK) was monitored by absorbance at 321 nm.,50 mM potassium phosphate buffer (KPB),6.5,,37.0,Escherichia coli (inferred),,
PMID33142415,reaction_2_kyn_adduct_assay,in vitro,"Kyn adduct assay. Reaction was terminated with TCA, incubated at 65°C to convert NFK to Kynurenine (Kyn), then Kyn was reacted with DMAB and the resulting adduct measured by absorbance at 492 nm.",50 mM potassium phosphate buffer (KPB),6.5,,37.0,Escherichia coli (inferred),,
PMID33142415,reaction_3_nfk_assay,in vitro,NFK assay. Time-dependent formation of N-formylkynurenine (NFK) was monitored by absorbance at 321 nm.,50 mM potassium phosphate buffer (KPB),7.0,,37.0,Escherichia coli (inferred),,
PMID33142415,reaction_4_kyn_adduct_assay,in vitro,"Kyn adduct assay. Reaction was terminated with TCA, incubated at 65°C to convert NFK to Kynurenine (Kyn), then Kyn was reacted with DMAB and the resulting adduct measured by absorbance at 492 nm.",50 mM potassium phosphate buffer (KPB),7.0,,37.0,Escherichia coli (inferred),,
PMID33142418,reaction_1,in vitro,In vitro kinase assay performed by Shanghai ChemPartner Co. Ltd.,Kinase buffer,,,28.0,,,
PMID33142418,reaction_2,in vitro,In vitro kinase assay performed by Shanghai ChemPartner Co. Ltd. using a homology model of FLT3.,Kinase buffer,,,28.0,,,
PMID33142418,reaction_3,in vitro,In vitro drug metabolism in rat liver microsomes,100 mM potassium phosphate buffer with 10 mM MgCl2,7.4,,37.0,,,
PMID33142418,reaction_4,in vitro,In vitro drug metabolism in rat liver microsomes,100 mM potassium phosphate buffer with 10 mM MgCl2,7.4,,37.0,,,
PMID33142418,reaction_5,in vitro,In vitro drug metabolism in rat liver microsomes,100 mM potassium phosphate buffer with 10 mM MgCl2,7.4,,37.0,,,
PMID33142418,reaction_6,in vitro,In vitro drug metabolism in rat liver microsomes,100 mM potassium phosphate buffer with 10 mM MgCl2,7.4,,37.0,,,
PMID33142418,reaction_7,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_8,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_9,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_10,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_11,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_12,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_13,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_14,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_15,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_16,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_17,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_18,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_19,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_20,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_21,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_22,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_23,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33142418,reaction_24,in vitro,KINOMEscan kinase profiling service from Eurofins Discovery,,,,,,,
PMID33144004,reaction_1,in vitro,Enzyme activity assay using crude cell extracts.,50 mM Tris-HCl,7.0,,70.0,Geobacillus thermodenitrificans NG80-2,pUCG18 derivative,"Expressed under its native promoter, induced by 2-nitropropane."
PMID33144004,reaction_2,in vitro,Enzyme activity assay using crude cell extracts.,50 mM Tris-HCl,7.0,,70.0,Geobacillus thermodenitrificans NG80-2,pUCG18 derivative,"Expressed under its native promoter, induced by 2-nitropropane."
PMID33144004,reaction_3,in vivo,Whole-cell degradation by engineered strain NG-S2 in a simulated wastewater bioreactor with mixed substrates.,Thermophilic minimal medium,,,60.0,,,
PMID33144004,reaction_4,in vivo,Whole-cell degradation by engineered strain NG-S2 in a simulated wastewater bioreactor with mixed substrates.,Thermophilic minimal medium,,,60.0,,,
PMID33144004,reaction_5,in vivo,Whole-cell degradation by engineered strain NG-S2 in a simulated wastewater bioreactor with mixed substrates.,Thermophilic minimal medium,,,60.0,,,
PMID33144004,reaction_6,in vivo,Whole-cell degradation by engineered G. thermodenitrificans NG80-2 (strain NG-S5).,Thermophilic minimal medium,,,60.0,Geobacillus thermodenitrificans NG80-2,pUCG18 derivative,"Expressed under its native promoter from G. thermoglucosidasius W-2, induced by 2-nitropropane."
PMID33146219,reaction_1,in vitro,"Bioluminescence activity, kinetics, and spectral measurements","0.10 M Tris-HCl for kinetics. pH profile tested in 0.10 M Sodium Citrate (pH 5-6), Sodium Phosphate (pH 6-8), Tris-HCl (pH 8-9), and CHES (pH 9-10).",8.0,Standard assay pH. Profile studied from pH 5.0 to 10.0.,22.0,E. coli BL21-DE3,pCold vector,"0.4 mM IPTG, 20°C, 6 h"
PMID33146219,reaction_2,in vitro,"Bioluminescence activity, kinetics, and spectral measurements","0.10 M Tris-HCl for kinetics. pH profile tested in 0.10 M Sodium Citrate (pH 5-6), Sodium Phosphate (pH 6-8), Tris-HCl (pH 8-9), and CHES (pH 9-10).",8.0,Standard assay pH. Profile studied from pH 5.0 to 10.0.,22.0,E. coli BL21-DE3,pPro vector,"0.4 mM IPTG, 20°C, 6 h"
PMID33146575,reaction_1,in vitro,Incubation with recombinant human CYP enzyme,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146575,reaction_2,in vitro,Incubation with recombinant human CYP enzyme,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146575,reaction_3,in vitro,Incubation with recombinant human CYP enzyme,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146575,reaction_4,in vitro,Incubation with recombinant human CYP enzyme,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146575,reaction_5,in vitro,Incubation with recombinant human CYP enzyme,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146575,reaction_6,in vitro,Incubation with recombinant human CYP enzyme,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146575,reaction_7,in vitro,Two-step continuous incubation with cDNA-expressed hFMO5,50 mM potassium phosphate buffer,7.4,,37.0,baculovirus-infected insect cells,,
PMID33146575,reaction_8,in vitro,Incubation of FMO5-oxidation products with recombinant human ALDH,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146575,reaction_9,in vitro,Incubation of FMO5-oxidation products with recombinant human AO,50 mM potassium phosphate buffer,7.4,,37.0,Escherichia coli,,
PMID33146857,reaction_1,in vitro,Spectrophotometric assay for enzyme kinetics.,0.1 M sodium acetate buffer,5.0,,30.0,,,
PMID33146857,reaction_2,in vitro,Spectrophotometric assay for enzyme kinetics.,0.1 M sodium acetate buffer,5.0,,30.0,,,
PMID33146857,reaction_3,in vitro,"Degradation assay monitored by spectrophotometry, HPLC, and GC.",acetate buffer,5.0,,30.0,,,
PMID33148525,reaction_1,in vitro,"In crystallo reaction monitoring, substrate trapping via crystal soaking, and enzymatic assays for mutant D283N.",PEG-based crystallization media for in crystallo experiments. Assay buffer for D283N mutant not specified.,,"Crystals were soaked at pH 5.0 to trap the formate-NAD+ ternary complex and at physiological pH (e.g., 7.0) to observe the reaction. pH for D283N mutant assay was not specified.",20.0,Escherichia coli BL21 (DE3),pET-45b+,"Induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) when A600 reached 0.6, followed by 4 h incubation at 30 °C."
PMID33152360,reaction_1,in vitro,Colorimetric assay for kinetic parameter determination of the reverse glycosylation reaction.,"50 mM Hepes, 50 mM KCl, 15 mM MgCl2, 10% DMSO, 0.013% BSA (w/v)",8.0,,37.0,E. coli BL21-CodonPlus (DE3) RIPL,pET28a(+),"0.5 mM IPTG, 20°C, 15 h"
PMID33152360,reaction_2,in vitro,HPLC analysis of forward glycosylation activity.,"50 mM Hepes, 50 mM KCl, 15 mM MgCl2, 10% DMSO, 0.013% BSA (w/v)",8.0,,37.0,E. coli BL21-CodonPlus (DE3) RIPL,pET28a(+),"0.5 mM IPTG, 20°C, 15 h"
PMID33152360,reaction_3,in vitro,HPLC analysis of forward glycosylation activity.,"50 mM Hepes, 50 mM KCl, 15 mM MgCl2, 10% DMSO, 0.013% BSA (w/v)",8.0,,37.0,E. coli BL21-CodonPlus (DE3) RIPL,pET28a(+),"0.5 mM IPTG, 20°C, 15 h"
PMID33155804,reaction_1,in vitro,Enzyme inhibition assay to determine Ki values of various compounds.,"100 mM potassium phosphate buffer (PBS), 0.03% Tween-80 (v/v), 5 mM dithiothreitol (DTT), and 200 mM imidazole",7.4,,25.0,,,
PMID33155804,reaction_2,in vivo,Metabolism study in plant leaves.,Not applicable (in vivo),,Not applicable (in vivo),,,,
PMID33157411,reaction_1,in vivo,Whole-cell biosensor assay where cell growth is dependent on the in vivo rate of the IleRS reaction. Growth was monitored in response to varying external and internal isoleucine concentrations.,"Test medium (TM) containing 30 g/L glucose, 2 g/L yeast extract, 5 g/L (NH4)2SO4, 1 g/L citric acid, 2 g/L KH2PO4, 0.7 g/L MgSO4⋅7H2O, 0.05 g/L FeSO4⋅7H2O, 0.05 g/L MnSO4⋅H2O, and B group vitamins (VB1,VB3,VB5,VB7, and VB12 with each at 0.8 mg/L).",7.0,,37.0,Escherichia coli MG1655M,,
PMID33157411,reaction_2,in vivo,Isoleucine export activity was assessed by overexpressing ygaZH in E. coli MG1655M and measuring the resulting intracellular isoleucine concentration and its effect on cell growth.,"Test medium (TM) containing 30 g/L glucose, 2 g/L yeast extract, 5 g/L (NH4)2SO4, 1 g/L citric acid, 2 g/L KH2PO4, 0.7 g/L MgSO4⋅7H2O, 0.05 g/L FeSO4⋅7H2O, 0.05 g/L MnSO4⋅H2O, and B group vitamins (VB1,VB3,VB5,VB7, and VB12 with each at 0.8 mg/L).",7.0,,37.0,Escherichia coli MG1655M,"pTrcD-PJ23116-ygaZH, pTrcD-PJ23106-ygaZH, pTrcD-PJ23100-ygaZH","Constitutive expression from promoters PJ23116, PJ23106, and PJ23100 with gradually increasing strength."
PMID33159911,reaction_1,in vitro,Targeted metabolomic analysis of medium from cultured Y-organs (YOs).,,,,,,,
PMID33164676,reaction_1,in vitro,Enzyme activity assay with purified recombinant protein. Reaction incubated for 60 min. Products were separated by thin-layer chromatography and stained with iodine.,"50 mM MOPS-NaOH, 20 mM MgCl2, 0.5% w/v Triton X-100",7.5,,30.0,Escherichia coli BL21 (TaKaRa),pColdI,0.5 mM isopropyl β-D-thiogalactoside for 24 h at 15ºC
PMID33164676,reaction_2,in vitro,Enzyme activity assay with purified recombinant protein. Reaction incubated for 60 min. Products were separated by thin-layer chromatography and stained with iodine.,"50 mM MOPS-NaOH, 20 mM MgCl2, 0.5% w/v Triton X-100",7.5,,30.0,Escherichia coli BL21 (TaKaRa),pColdI,0.5 mM isopropyl β-D-thiogalactoside for 24 h at 15ºC
PMID33164676,reaction_3,in vitro,Enzyme activity assay with purified recombinant protein. Reaction incubated for 60 min. Products were separated by thin-layer chromatography and stained with iodine.,"50 mM MOPS-NaOH, 20 mM MgCl2, 0.5% w/v Triton X-100",7.5,,30.0,Escherichia coli BL21 (TaKaRa),pColdI,0.5 mM isopropyl β-D-thiogalactoside for 24 h at 15ºC
PMID33164676,reaction_4,in vitro,Enzyme activity assay with purified recombinant protein. Reaction incubated for 60 min. Products were separated by thin-layer chromatography and stained with iodine.,"50 mM MOPS-NaOH, 20 mM MgCl2, 0.5% w/v Triton X-100",7.5,,30.0,Escherichia coli BL21 (TaKaRa),pColdI,0.5 mM isopropyl β-D-thiogalactoside for 24 h at 15ºC
PMID33166455,reaction_1,in vitro,Enzyme activity assay using purified enzyme and DCIP as an artificial electron acceptor.,50 mM Tris-HCl buffer,7.5,,30.0,,,
PMID33166455,reaction_2,in vitro,Enzyme activity assay using purified enzyme. DCIP method used for kinetics and temperature studies. Peroxidase-4-AA method used for pH studies.,100 mM acetate buffer (for DCIP method),5.5,Standard assay pH for kinetics. Optimal pH is 7.0.,30.0,,,
PMID33166455,reaction_3,in vitro,Enzyme activity assay using purified enzyme and DCIP as an artificial electron acceptor.,100 mM acetate buffer,5.5,,30.0,,,
PMID33166455,reaction_4,in vitro,Enzyme activity assay using purified enzyme and DCIP as an artificial electron acceptor.,100 mM acetate buffer,5.5,,30.0,,,
PMID33166455,reaction_5,in vivo,Whole-cell bioconversion in flask culture using recombinant E. coli.,"NB medium (1 g/L beef extract, 2 g/L yeast extract, 5 g/L peptone, 5 g/L NaCl) with 200 g/L lactose and 10 μM PQQ",,,25.0,Escherichia coli Δgcd,pDSK519 (construct pDSK-PTMQO),1 mM IPTG at mid-log growth phase
PMID33166455,reaction_6,in vivo,Whole-cell bioconversion in flask culture using recombinant E. coli.,NB medium with lactose and PQQ,,,25.0,Escherichia coli Δgcd,pDSK519 (construct pDSK-ECMQO),1 mM IPTG
PMID33168750,reaction_1,in vitro,Single-molecule rotation assay and bulk-phase enzyme-coupled ATPase assay,Reaction buffer with 0.1% LDAO and an ATP regeneration system,,Not specified,25.0,Escherichia coli DK8,pPdF1γCC (+ atp12) derived from pTR19v43,
PMID33168750,reaction_2,in vitro,Single-molecule rotation assay,Reaction buffer with 0.1% LDAO and an ATP regeneration system,,Not specified,25.0,Escherichia coli DK8,pPdF1γCC (+ atp12) derived from pTR19v43,
PMID33170386,reaction_1,in vitro,"Spectrophotometric assay measuring the change in absorbance at 340 nm due to NADH formation. Reaction mixture contained 100 mmol/L sodium phosphate buffer, 50 mmol/L sodium lactate and 1 mmol/L NAD+.",100 mmol/L sodium phosphate buffer,6.5,Optimal pH for oxidation. Assays were performed over a range of pH 5.0-10.0.,25.0,Escherichia coli BL21 (DE3),pET28a,"0.5 mM IPTG, 18 °C, 12 h"
PMID33170386,reaction_2,in vitro,"Spectrophotometric assay measuring the change in absorbance at 340 nm due to NADH oxidation. Reaction mixture contained 100 mmol/L sodium phosphate buffer, 80 mmol/L pyruvate and 4 mmol/L NADH.",100 mmol/L sodium phosphate buffer,8.5,Optimal pH for reduction. Assays were performed over a range of pH 5.0-10.0.,25.0,Escherichia coli BL21 (DE3),pET28a,"0.5 mM IPTG, 18 °C, 12 h"
PMID33171978,reaction_1,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN19,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_2,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN20,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_3,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN21,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_4,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN22,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_5,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN18,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_6,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN23,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_7,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN25,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_8,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN3,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_9,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN24,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_10,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN4,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_11,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN31,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_12,in vivo,Whole-cell biotransformation,"100 mM potassium phosphate (KPi) buffer (pH 7.4) containing 1% (w/v) ammonium sulfate, and 8% (w/v) glucose",7.4,,30.0,Schizosaccharomyces pombe YN27,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_13,in vitro,Enzyme bag assay with permeabilized cells,50 mM NH4HCO3 buffer (pH 7.8),7.8,,37.0,Schizosaccharomyces pombe YN32,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_14,in vitro,Enzyme bag assay with permeabilized cells and luminescence detection,UGT-Glo buffer,7.8,pH of the NH4HCO3 buffer used in the general enzyme bag protocol,37.0,Schizosaccharomyces pombe YN25,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_15,in vitro,Enzyme bag assay with permeabilized cells and luminescence detection,UGT-Glo buffer,7.8,pH of the NH4HCO3 buffer used in the general enzyme bag protocol,37.0,Schizosaccharomyces pombe YN4,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_16,in vitro,Enzyme bag assay with permeabilized cells and luminescence detection,UGT-Glo buffer,7.8,pH of the NH4HCO3 buffer used in the general enzyme bag protocol,37.0,Schizosaccharomyces pombe YN32,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33171978,reaction_17,in vitro,Enzyme bag assay with permeabilized cells and luminescence detection,UGT-Glo buffer,7.8,pH of the NH4HCO3 buffer used in the general enzyme bag protocol,37.0,Schizosaccharomyces pombe YN29,pCAD1 (integrative) and pREP1 (replicating),thiamine-repressible nmt1 promotor
PMID33179162,reaction_1,in vivo,Metabolomic analysis of transgenic wheat (Triticum aestivum cv. Bobwhite) seeds overexpressing TaYUC10.3.,in vivo in wheat seeds,,in vivo study,25.0,Triticum aestivum cv. Bobwhite,pMBX17-TaYUC10.3,Constitutive seed-specific expression via 1Bx17 glutenin subunit gene promoter.
PMID33186840,reaction_1,in vivo,"Whole-cell bioconversion in engineered E. coli strains using a two-stage cultivation strategy. Glucose was used for cell growth, and acetate was used for 3-HP production.","Modified M9 medium (0.25 g/L MgSO4, 1.0 g/L NaCl, 1.0 g/L NH4Cl, 1.0 g/L yeast extract) supplemented with 100 mM potassium phosphate buffer.",7.0,pH was maintained using a pH-stat mode in fed-batch bioreactor experiments.,30.0,Escherichia coli BL21(DE3),"pCDFDuet (for mcr), pACYCDuet (for accADBCbirA)",0.1 mM IPTG
PMID33187806,reaction_1_LmDHFR,in vitro,Enzyme inhibition assay using crude DHFR supernatant from sonicated promastigotes. Activity measured by the initial rate of decrease in NADPH at A340.,"80 µM sodium phosphate buffer, 60 µM NADPH, 60 µM dihydrofolic acid, 250 µM EDTA, 250 µM dithiothreitol",7.0,,,,,
PMID33187806,reaction_2_hDHFR,in vitro,Inhibition studies on recombinant human DHFR (rhDHFR).,Not specified,,Not specified,,,,
PMID33188177,reaction_1,in vitro,Competition assay where this reaction served as the reference reaction. Rate measured by release of soluble 14C-labeled products (NAGeq).,50 mM Bis–Tris buffer,6.1,,25.0,,,
PMID33188177,reaction_2,in vitro,Direct kinetic measurement and use as a reference system in competition assays.,50 mM Bis-Tris buffer,6.1,,25.0,,,
PMID33188177,reaction_3,in vitro,Direct kinetic measurement and use as a reference system in competition assays.,50 mM Bis-Tris buffer,6.1,,25.0,,,
PMID33188177,reaction_4,in vitro,Competition assay against reference enzymes (SmAA10A/CNW and HRP/ABTS) to determine kinetic parameters.,50 mM Bis–Tris buffer,6.1,,25.0,,,
PMID33188177,reaction_5,in vitro,Competition assay against reference enzymes (SmAA10A/CNW and HRP/Amplex Red) to determine kinetic parameters.,50 mM Bis–Tris buffer,6.1,,25.0,,,
PMID33188177,reaction_6,in vitro,Competition assay against reference enzymes (SmAA10A/CNW and HRP/ABTS) to determine kinetic parameters at a single substrate concentration.,50 mM Bis–Tris buffer,6.1,,25.0,,,
PMID33189651,reaction_1,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET expression vector,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_2,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET expression vector,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_3,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET101/D,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_4,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET101/D,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_5,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET101/D,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_6,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET101/D,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_7,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET expression vector,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_8,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET expression vector,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189651,reaction_9,in vitro,Incubation of substrate with supernatant from E. coli expressing the recombinant enzyme.,Supernatant from cell lysate in 50 mM Tris-HCl (pH 7.6)/5 mM EDTA/10% glycerol (v/v),7.6,,4.0,BL21 Star (DE3) E. coli,pET expression vector,"0.1-0.4 mM isopropyl-β-D1-thiogalactopyranoside, room temperature, 5 h"
PMID33189850,reaction_1,in vitro,"Reconstituted system with purified recombinant human P450 11B2, bovine adrenodoxin, and bovine NADPH-adrenodoxin reductase.","50 mM potassium phosphate buffer (pH 7.4), 30 µM L-α-1,2-dilauroyl-sn-glycero-3-phosphocholine",7.4,,37.0,Escherichia coli,,
PMID33189850,reaction_2,in vitro,"Reconstituted system with purified recombinant human P450 11B2, bovine adrenodoxin, and bovine NADPH-adrenodoxin reductase.","50 mM potassium phosphate buffer (pH 7.4), 30 µM L-α-1,2-dilauroyl-sn-glycero-3-phosphocholine",7.4,,37.0,Escherichia coli,,
PMID33189850,reaction_3,in vitro,"Reconstituted system with purified recombinant human P450 11B2, bovine adrenodoxin, and bovine NADPH-adrenodoxin reductase.","50 mM potassium phosphate buffer (pH 7.4), 30 µM L-α-1,2-dilauroyl-sn-glycero-3-phosphocholine",7.4,,37.0,Escherichia coli,,
PMID33189850,reaction_4,in vitro,"Reconstituted system with purified recombinant human P450 11B2, bovine adrenodoxin, and bovine NADPH-adrenodoxin reductase. Reaction time was 20 minutes.","50 mM potassium phosphate buffer (pH 7.4), 30 µM L-α-1,2-dilauroyl-sn-glycero-3-phosphocholine",7.4,,37.0,Escherichia coli,,
PMID33189850,reaction_5,in vitro,"Reconstituted system with purified recombinant human P450 11B2, bovine adrenodoxin, and bovine NADPH-adrenodoxin reductase. Reaction time was 20 minutes.","50 mM potassium phosphate buffer (pH 7.4), 30 µM L-α-1,2-dilauroyl-sn-glycero-3-phosphocholine",7.4,,37.0,Escherichia coli,,
PMID33197770,reaction_1,in vitro,"Experiments in H9C2 cardiomyocytes, including luciferase reporter assays, RNA immunoprecipitation (RIP), and mRNA half-life measurement after Actinomycin D treatment.",Standard cell culture medium,,"Not specified, assumed physiological pH for cell culture (~7.4)",37.0,H9C2 cells,,
PMID33197770,reaction_2,in vitro,NOX activity and ROS levels were measured in ethanol-stimulated H9C2 cardiomyocytes.,Standard cell culture medium,,"Not specified, assumed physiological pH for cell culture (~7.4)",37.0,,,
PMID33197770,reaction_3,ex vivo,Activity measured in mitochondria isolated from mouse hearts. Oxygen consumption rate (respiration) measured in isolated mitochondria and intact neonatal mouse ventricular myocytes (Seahorse assay).,Not specified for direct activity assay. Pyruvate and malate were used as substrates to generate NADH for respiration assays.,,Not specified,,,,
PMID33199626,reaction_1,in vitro,in vitro transcription assay to determine IC50,,,,,,,
PMID33199626,reaction_2,in vitro,in vitro transcription assay to determine IC50,,,,,,,
PMID33199626,reaction_3,in vitro,in vitro transcription assay to determine IC50,,,,,,,
PMID33199626,reaction_4,in vitro,in vitro transcription assay to determine IC50,,,,,,,
PMID33199626,reaction_5,in vitro,Cryo-electron microscopy of de novo promoter melting,,,,,,,
PMID33199626,reaction_6,in vitro,Cryo-electron microscopy of de novo promoter melting,,,,,,,
PMID33200268,reaction_1,in vivo,Functional characterization in recombinant E. coli fed with external substrate.,Luria–Bertani medium. Substrate was dissolved in 70% ethanol before supplementation.,,Not specified,37.0,Escherichia coli BL21 (DE3),pGEX-4T2,"1 mM IPTG induction, 24 h incubation"
PMID33200268,reaction_2,in vivo,Functional characterization in recombinant E. coli fed with external substrate.,Luria–Bertani medium. Substrate was dissolved in 70% ethanol before supplementation.,,Not specified,37.0,Escherichia coli BL21 (DE3),pGEX-4T2,"1 mM IPTG induction, 24 h incubation"
PMID33203703,reaction_1,in vivo,"Functional studies in human colorectal cancer cell lines (SW480, LOVO, HCT8, SW620, HCT116) involving FA2H overexpression, shRNA/siRNA knockdown, and treatment with the enzymatic product (R)-2-OHPA to assess effects on cell proliferation, migration, and signaling pathways. Lipidomics analysis confirmed changes in hydroxylated fatty acid-containing lipids upon FA2H overexpression.","RPMI 1640 medium or DMEM containing 10% FBS, 100 U/mL penicillin G sodium and 100 µg/mL streptomycin sulfate",,"Standard cell culture conditions, pH not explicitly stated.",37.0,"Human colorectal cancer cell lines (HCT8, HCT116, LOVO, RKO, SW480, SW620)",Lentiviral vector encoding human FA2H,
PMID33203750,reaction_1,in vitro,Enzyme activity measured in cell lysates.,"PDH reaction mix (0.5 mM MTT, 2.5 mM MgCl2, 6.5 mM PMS, 0.2 mM thiamine pyrophosphate [TPP], 2 mM sodium pyruvate, 50 mM PBS)",,"50 mM PBS used, pH not specified.",30.0,,,
PMID33203750,reaction_2,in vitro,Enzyme activity measured in cell lysates.,"KGDH reaction mix (0.5 mM MTT, 2.5 mM MgCl2, 6.5 mM PMS, 0.2 mM thiamine pyrophosphate [TPP], 5 mM alpha-ketoglutaric acid potassium salt, 50 mM PBS)",,"50 mM PBS used, pH not specified.",30.0,,,
PMID33203750,reaction_3,in vitro,Enzyme activity measured in cell lysates.,"SDH reaction mix [0.5 mM MTT, 2.5 mM MgCl2, 6.5 mM phenazine methosulfate (PMS), 5 mM sodium succinate, 50 mM PBS]",,"50 mM PBS used, pH not specified.",30.0,,,
PMID33203750,reaction_4,in vitro,"Enzyme activity measured in cell lysates using a commercial F-type ATPase activity assay kit (Genmed, GMS50248.2).",PBS buffer,7.4,,30.0,,,
PMID33210060,reaction_1,in vivo,Measurement of plasma 25-hydroxyvitamin D levels in mice after 16 weeks on a high-fat diet (HFD) versus a regular chow diet.,in vivo,,in vivo conditions,,,,
PMID33215716,reaction_1,in vitro,Substrate specificity assay with purified recombinant protein.,20 mM Tris-HCl,8.0,,45.0,Escherichia coli BL21,pET32a,
PMID33215716,reaction_2,in vitro,Substrate specificity assay with purified recombinant protein.,20 mM Tris-HCl,8.0,,45.0,Escherichia coli BL21,pET32a,
PMID33215716,reaction_3,in vitro,Substrate specificity assay with purified recombinant protein.,20 mM Tris-HCl,8.0,,45.0,Escherichia coli BL21,pET32a,
PMID33215716,reaction_4,in vitro,Substrate specificity assay with purified recombinant protein.,20 mM Tris-HCl,8.0,,45.0,Escherichia coli BL21,pET32a,
PMID33215716,reaction_5,in vitro,Substrate specificity assay with purified recombinant protein.,20 mM Tris-HCl,8.0,,45.0,Escherichia coli BL21,pET32a,
PMID33215716,reaction_6,in vitro,Substrate specificity assay with purified recombinant protein.,20 mM Tris-HCl,8.0,,45.0,Escherichia coli BL21,pET32a,
PMID33215716,reaction_7,in vitro,Enzyme activity assay in crude plant extract from maize leaves using a commercial kit.,"Extraction buffer from Micro NR Assay Kit (BC0085; Beijing Solarbio Science & Technology Co., Ltd., China)",,"Not specified, determined by kit protocol.",25.0,,,
PMID33215716,reaction_8,in vitro,Enzyme activity assay in crude plant extract from maize leaves using a commercial kit.,"Extraction buffer from Micro GS activity Assay Kit (BC0915; Beijing Solarbio Science & Technology Co., Ltd., China)",,"Not specified, determined by kit protocol.",,,,
PMID33215746,reaction_1,in vitro,Spectrophotometric kinetic assay monitoring NADPH oxidation at 340 nm. Isothermal Titration Calorimetry (ITC) was also used to determine binding thermodynamics.,"0.1 M Tris-HCl, 10 mM MgCl2",8.0,,25.0,,,
PMID33219201,reaction_1,in vitro,Activity inferred from phosphorylation levels (Western blot) and metabolic shift (ECAR) in primary astrocyte cultures from WT and Pdk2 KO mice.,"Dulbecco’s Modiﬁed Eagle’s medium (DMEM) with 10% FBS and penicillin/streptomycin, using low glucose (5.5 mM) as control and high glucose (16 mM or 25 mM) for stimulation.",,"Not specified, standard cell culture conditions (typically pH 7.2-7.4).",37.0,Mus musculus,Adenovirus (Ad-PDK2-GFP),Enzyme was studied endogenously in primary astrocytes and mouse hypothalamus. Overexpression was achieved in Pdk2 KO mice by intracerebroventricular injection of Ad-PDK2-GFP (1.0 x 10^9 pfu).
PMID33225381,reaction_1,in vitro,Spectrophotometric assay measuring the increase in absorbance of NADPH at 340 nm. The reaction mixture contained 4 mmol/L TCDCA and 1.6 mmol/L NADP+. Experiments were conducted with free enzyme and enzyme immobilized on epoxy resin and amino-epoxy resin.,50 mmol/L Tris-HCl,9.0,Optimal pH for the immobilization and activity assay.,,Not specified,,
PMID33233217,reaction_1,in vitro,Purified enzyme kinetic assay,,6.5,pH for kinetic measurement of fructose reduction.,90.0,,,
PMID33233217,reaction_2,in vitro,Purified enzyme kinetic assay,,6.1,,80.0,,,
PMID33233217,reaction_3,in vitro,Purified enzyme kinetic assay,,6.1,,60.0,,,
PMID33233217,reaction_4,in vitro,Substrate specificity assay,,,,,,,
PMID33233217,reaction_5,in vitro,Substrate specificity assay,,,,,,,
PMID33233217,reaction_6,in vitro,Substrate specificity assay,,,,,,,
PMID33233217,reaction_7,in vitro,Purified enzyme assay for oxidation reaction,,8.0,Optimal pH for D-mannitol oxidation.,,,,
PMID33233217,reaction_8,in vitro,Purified enzyme assay for oxidation reaction,,,,,,,
PMID33239446,reaction_1,in vivo,Enzyme expressed in HEK293-hACE2 cells. Products were extracted from cell pellets and culture supernatants and quantified by LC-MS.,complete DMEM,,"Standard cell culture conditions, typically pH ~7.4",37.0,HEK293-hACE2 cells,pLX304,Gene with a C-terminal V5 tag was delivered via lentiviral transduction. Cells were analyzed 36h post-transfection.
PMID33240775,reaction_1,in vitro,Enzymatic activity assay using recombinant protein (100 ng) or cell homogenates (2.5 µg).,"50 mM Tris/HCl, 1 mM n-octyl-β-d-glucopyranoside",7.5,,25.0,Escherichia coli BL21,pGEX-4T-1,"0.5 mM IPTG, 37°C for 6 hours"
PMID33241108,reaction_1,in vivo,Metabolic profiling performed on human triple-negative breast cancer (TNBC) cell lines following BBOX1 depletion. In vivo xenograft models were also used to assess the effect of BBOX1 depletion and inhibition on tumor growth.,,,,,Human triple-negative breast cancer (TNBC) cell lines,,
PMID33241249,reaction_1,in vitro,Bioluminescence activity and kinetic characterization assays.,0.10 M Tris-HCl buﬀer,8.0,,22.0,Escherichia coli BL21,pColdII,0.5 mM IPTG at 16 °C overnight
PMID33241249,reaction_2,in vitro,Bioluminescence activity and kinetic characterization assays.,0.10 M Tris-HCl buﬀer,8.0,,22.0,Escherichia coli BL21,pColdII,0.5 mM IPTG at 16 °C overnight
PMID33241249,reaction_3,in vitro,Bioluminescence activity measurement using pre-synthesized luciferyl–adenylate (LH2–AMP) to determine the oxidative constant (kox).,0.1 M Tris-HCl,8.0,,22.0,Escherichia coli BL21,pColdII,0.5 mM IPTG at 16 °C overnight
PMID33241249,reaction_4,in vitro,Bioluminescence activity measurement using pre-synthesized luciferyl–adenylate (LH2–AMP) to determine the oxidative constant (kox).,0.1 M Tris-HCl,8.0,,22.0,Escherichia coli BL21,pColdII,0.5 mM IPTG at 16 °C overnight
PMID33242654,reaction_1,in vitro,Coupled redox assay monitoring NADPH oxidation at 340 nm.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,Escherichia coli BL21 (DE3),pCold-I,0.25 mM IPTG for 16 h at 25 °C
PMID33242654,reaction_2,in vitro,Coupled redox assay monitoring NADPH oxidation at 340 nm.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,Escherichia coli BL21 (DE3),pCold-I,0.25 mM IPTG for 16 h at 25 °C
PMID33242654,reaction_3,in vitro,Coupled redox assay monitoring NADPH oxidation at 340 nm.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,Escherichia coli BL21 (DE3),pMAL-C-TEV,0.25 mM IPTG for 16 h at 25 °C
PMID33242654,reaction_4,in vitro,Coupled redox assay monitoring NADPH oxidation at 340 nm.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,Escherichia coli BL21 (DE3),pMAL-C-TEV,0.25 mM IPTG for 16 h at 25 °C
PMID33242654,reaction_5,in vitro,Coupled redox assay monitoring NADPH oxidation at 340 nm. The glutaredoxin system was found to be more efficient than the thioredoxin system.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,Escherichia coli BL21 (DE3),pET22b,0.25 mM IPTG for 16 h at 25 °C
PMID33242654,reaction_6,in vitro,Coupled redox assay monitoring NADPH oxidation at 340 nm.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,Escherichia coli BL21 (DE3),pET22b,0.25 mM IPTG for 16 h at 25 °C
PMID33242654,reaction_7,in vitro,Coupled redox assay using HClO-treated L. interrogans protein extract as substrate.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,,,
PMID33242654,reaction_8,in vitro,Coupled redox assay using HClO-treated L. interrogans protein extract as substrate.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,,,
PMID33242654,reaction_9,in vitro,Coupled redox assay using HClO-treated L. interrogans protein extract as substrate.,"100 mM potassium phosphate, 2 mM EDTA",7.0,,30.0,,,
PMID33242654,reaction_10,in vitro,Reactivation assay of HClO-inactivated L. interrogans catalase (Lincatalase).,Not specified,,,,,,
PMID33248851,reaction_1,in vitro,Radiolabeled aminoacyl transfer assay monitoring the transfer of 14C-radiolabeled leucine to E. coli total tRNALeu pool.,"20 mM Tris, 100 mM KCl, 10 mM MgCl2, 5 mM β-mercaptoethanol, 5% (v/v) DMSO",7.5,,37.0,Escherichia coli Rosetta (DE3) pLysS,pETRUK-Ng-LeuRS,"ZYP-5052 auto-induction medium supplemented with 1 mM ZnSO4. Grown overnight at 24 °C, then temperature decreased to 18 °C for another 24 h."
PMID33249478,reaction_1,in vivo,"Measurement of serum vitamin D metabolites by liquid chromatography tandem mass spectrometry (LC-MS/MS) in human subjects with different CYP24A1 genotypes (wild-type, heterozygous, homozygous).",Human serum,,Physiological pH,,,,
PMID33249478,reaction_2,in vivo,"Measurement of serum vitamin D metabolites by liquid chromatography tandem mass spectrometry (LC-MS/MS) in human subjects with different CYP24A1 genotypes (wild-type, heterozygous, homozygous).",Human serum,,Physiological pH,,,,
PMID33249835,reaction_1,in vitro,Enzyme activity assay using purified enzyme. Biotransformations were performed using whole cells (resting cells).,100 mM KPB buffer,7.0,,30.0,E. coli BL21 (DE3),pET-28a (+),"0.2 mM IPTG, 16 °C, 24 h"
PMID33257447,reaction_1,in vitro,Promoter activity assay performed on cell suspensions permeabilized with chloroform and SDS.,"Z buffer (50 mM β-mercaptoethanol, 60 mM NaH2PO4, 1 mM MgSO4, 60 mM Na2HPO4, and 10 mM KCl)",7.0,"The pH of Z buffer is typically 7.0, as described in the original Miller assay protocol. It was not explicitly stated in this text.",37.0,Pseudomonas aeruginosa,,
PMID33257538,reaction_1_translocation,in vitro,NanoLuc transport assay using proteoliposomes (PLs).,"20 mM Tris-HCl, 50 mM KCl, 2 mM MgCl2 (TKM buffer), with furimazine and Prionex.",8.0,,25.0,,,
PMID33257538,reaction_2_atpase,in vitro,Steady-state ATPase assay coupled to NADH absorbance decrease.,"TKM buffer (20 mM Tris-HCl pH 8.0, 50 mM KCl, 2 mM MgCl2) with 2 mM phosphoenol pyruvate, pyruvate kinase, lactate dehydrogenase, and 0.2 mM NADH.",8.0,,25.0,,,
PMID33259843,reaction_1,in vitro,Thioredoxin coupled assay measuring NADPH consumption at 340 nm.,100 mM Tris-HCl,8.0,,,E. coli BL21(DE3),pET303/CT-His,0.5 mM IPTG for 18 h at 37 °C
PMID33259843,reaction_2,in vitro,Thioredoxin coupled assay measuring NADPH consumption at 340 nm.,100 mM Tris-HCl,8.0,,,E. coli BL21(DE3),pET303/CT-His,0.5 mM IPTG for 18 h at 37 °C
PMID33259843,reaction_3,in vitro,Pyrogallol assay measuring purpurogallin formation at 420 nm.,50 mM sodium phosphate,7.2,,30.0,E. coli BL21(DE3),pET303/CT-His,0.5 mM IPTG for 18 h at 37 °C
PMID33264024,reaction_1,in vivo,Degradation ability tested in whole-cell mutant X9ΔcehA.,Mineral salt medium (MSM),7.0,,30.0,,,
PMID33264024,reaction_2,in vitro,Enzyme assay with purified recombinant proteins.,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,E. coli BL21 (DE3),pET29a(+),"0.1 mM IPTG, 16 °C, 16 h"
PMID33264024,reaction_3,in vitro,Enzyme assay with purified recombinant proteins.,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,E. coli BL21 (DE3),pET29a(+),"0.1 mM IPTG, 16 °C, 16 h"
PMID33264024,reaction_4,in vitro,,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_5,in vitro,,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_6,in vitro,,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_7,in vitro,,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_8,in vitro,,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_9,in vitro,,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_10,in vitro,Kinetic assay varying NADH concentration with FAD held constant.,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_11,in vitro,Kinetic assay varying FAD concentration with NADH held constant.,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_12,in vitro,Kinetic assay varying NADH concentration with FMN held constant.,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_13,in vitro,Kinetic assay varying FMN concentration with NADH held constant.,"50 mM Tris·H2SO4 buffer (including 10% glycerol, 0.2 mM DTT, and 0.2 mM ascorbic acid)",7.0,,30.0,,,
PMID33264024,reaction_14,in vitro,,50 mM Tris·H2SO4 buffer,7.0,,30.0,,,
PMID33264024,reaction_15,in vitro,,50 mM Tris·H2SO4 buffer,7.0,,30.0,,,
PMID33264024,reaction_16,in vitro,,50 mM Tris·H2SO4 buffer,7.0,,30.0,,,
PMID33264024,reaction_17,in vitro,,50 mM Tris·H2SO4 buffer,7.0,,30.0,,,
PMID33267982,reaction_1,in vitro,Spectrophotometric assay monitoring absorbance at 410 nm,50 mM sodium citrate buffer,6.2,Optimal pH for PPO-2,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_2,in vitro,Spectrophotometric assay monitoring absorbance at 400 nm,50 mM sodium citrate buffer,6.2,Optimal pH for PPO-2,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_3,in vitro,Spectrophotometric assay monitoring absorbance at 481 nm,50 mM sodium citrate buffer,6.2,Optimal pH for PPO-2,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_4,in vitro,Spectrophotometric assay monitoring absorbance at 400 nm,50 mM sodium citrate buffer,6.2,Optimal pH for PPO-2,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_5,in vitro,Spectrophotometric assay monitoring absorbance at 480 nm,50 mM sodium citrate buffer,6.2,Optimal pH for PPO-2,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_6,in vitro,Spectrophotometric assay monitoring absorbance at 475 nm,50 mM sodium citrate buffer,6.2,Optimal pH for PPO-2,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_7,in vitro,Spectrophotometric assay monitoring absorbance at 430 nm,50 mM sodium citrate buffer,6.2,Optimal pH for PPO-2,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_8,in vitro,Spectrophotometric assay monitoring absorbance at 410 nm,50 mM sodium citrate buffer,5.8,Optimal pH for PPO-3,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_9,in vitro,Spectrophotometric assay monitoring absorbance at 400 nm,50 mM sodium citrate buffer,5.8,Optimal pH for PPO-3,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_10,in vitro,Spectrophotometric assay monitoring absorbance at 481 nm,50 mM sodium citrate buffer,5.8,Optimal pH for PPO-3,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_11,in vitro,Spectrophotometric assay monitoring absorbance at 400 nm,50 mM sodium citrate buffer,5.8,Optimal pH for PPO-3,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_12,in vitro,Spectrophotometric assay monitoring absorbance at 480 nm,50 mM sodium citrate buffer,5.8,Optimal pH for PPO-3,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_13,in vitro,Spectrophotometric assay monitoring absorbance at 475 nm,50 mM sodium citrate buffer,5.8,Optimal pH for PPO-3,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_14,in vitro,Spectrophotometric assay monitoring absorbance at 430 nm,50 mM sodium citrate buffer,5.8,Optimal pH for PPO-3,40.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_15,in vitro,Spectrophotometric assay monitoring absorbance at 410 nm,50 mM sodium citrate buffer,6.0,Optimal pH for PPO-4,45.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_16,in vitro,Spectrophotometric assay monitoring absorbance at 400 nm,50 mM sodium citrate buffer,6.0,Optimal pH for PPO-4,45.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_17,in vitro,Spectrophotometric assay monitoring absorbance at 481 nm,50 mM sodium citrate buffer,6.0,Optimal pH for PPO-4,45.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_18,in vitro,Spectrophotometric assay monitoring absorbance at 400 nm,50 mM sodium citrate buffer,6.0,Optimal pH for PPO-4,45.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_19,in vitro,Spectrophotometric assay monitoring absorbance at 480 nm,50 mM sodium citrate buffer,6.0,Optimal pH for PPO-4,45.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_20,in vitro,Spectrophotometric assay monitoring absorbance at 475 nm,50 mM sodium citrate buffer,6.0,Optimal pH for PPO-4,45.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33267982,reaction_21,in vitro,Spectrophotometric assay monitoring absorbance at 430 nm,50 mM sodium citrate buffer,6.0,Optimal pH for PPO-4,45.0,Native enzyme extracted from Vaccinium corymbosum L. fruit,,
PMID33269912,reaction_1,in vivo,The study focuses on inhibition of the BfrB-Bfd complex. Inhibitor binding affinity (Kd) was measured in vitro by fluorescence polarization. Half maximal inhibitory concentration (IC50) was determined in P. aeruginosa PAO1 planktonic cell cultures.,"Defined media for IC50 determination: 50 mM KH2PO4, 7.5 mM (NH4)2SO4, 0.1% (w/v) glucose, 0.5 mM MgSO4·7H2O, 5% v/v nonessential amino acids, 2% v/v essential amino acids, 4 μM (NH4)2Fe(SO4)2, and 0.025% (w/v) hypromellose (HPMC).",7.0,,35.0,,,
PMID33271196,reaction_1,in vitro,Functional assay using recombinant protein transiently expressed in HEK293T cells. Product measured by TR-FIA.,Cell culture medium (not specified),,,,HEK293T,pCAGGS,Transient expression using X-tremeGENE HP DNA Transfection Reagent
PMID33271196,reaction_2,in vitro,Functional assay using recombinant protein transiently expressed in HEK293T cells. Product measured by TR-FIA and TLC.,Cell culture medium (not specified),,,,HEK293T,pCAGGS,Transient expression using X-tremeGENE HP DNA Transfection Reagent
PMID33271196,reaction_3,in vitro,Functional assay using recombinant protein transiently expressed in HEK293T cells. Product measured by TR-FIA and TLC.,Cell culture medium (not specified),,,,HEK293T,pCAGGS,Transient expression using X-tremeGENE HP DNA Transfection Reagent
PMID33271196,reaction_4,in vitro,Functional assay using recombinant protein transiently expressed in HEK293T cells. Product measured by TR-FIA.,Cell culture medium (not specified),,,,HEK293T,pCAGGS,Transient expression using X-tremeGENE HP DNA Transfection Reagent
PMID33271196,reaction_5,in vitro,Functional assay using recombinant protein transiently expressed in HEK293T cells. Product measured by TR-FIA.,Cell culture medium (not specified),,,,HEK293T,pCAGGS,Transient expression using X-tremeGENE HP DNA Transfection Reagent
PMID33271196,reaction_6,in vitro,Functional assay using recombinant protein transiently expressed in HEK293T cells. Product measured by TR-FIA.,Cell culture medium (not specified),,,,HEK293T,pCAGGS,Transient expression using X-tremeGENE HP DNA Transfection Reagent
PMID33271196,reaction_7,in vitro,Functional assay using recombinant protein transiently expressed in HEK293T cells. Product measured by TR-FIA.,Cell culture medium (not specified),,,,HEK293T,pCAGGS,Transient expression using X-tremeGENE HP DNA Transfection Reagent
PMID33275878,reaction_1,in vitro,"The text reviews data from in vitro kinetic and structural studies, as well as in vivo studies in various disease models (e.g., yeast, Drosophila, mouse, rat).",,,Not specified in the text.,,,,
PMID33275878,reaction_2,in vitro,The text reviews data from kinetic studies of PfKMO.,,,Not specified in the text.,,,,
PMID33283454,reaction_1_in_vivo_PS_synthesis,in vivo,Growth complementation of cho1∆ yeast and metabolic labeling with 14C-serine and 32Pi to assess PS synthesis in different cellular compartments.,"Yeast growth media (SCD, YPD, YPGal)",,"Standard yeast media pH, e.g., 6.5 for SCLac.",30.0,Saccharomyces cerevisiae cho1∆ or cho1∆psd2∆,pRS424 derivative (pYU50),Constitutive expression from GPD promoter
PMID33283454,reaction_2_in_vitro_PS_synthesis,in vitro,Enzymatic activity measurement using detergent-solubilized crude mitochondrial membranes from yeast expressing PssA fusions.,"20 mM Tris-HCl, 80 mM KCl, 2 mM MgCl2, 0.2 % Triton X-100, 10 % glycerol, 1 mM CTP",7.5,,30.0,Saccharomyces cerevisiae,,
PMID33283454,reaction_3_in_vivo_PS_decarboxylation,in vivo,Metabolic labeling with L-[14C]serine to monitor the conversion of PssA-synthesized PS to PE. Performed in a cho1∆psd2∆ strain to isolate the Psd1-dependent pathway.,SCD-Trp medium,,,30.0,Saccharomyces cerevisiae cho1∆psd2∆,,
PMID33283454,reaction_4_in_vivo_PE_methylation,in vivo,Metabolic labeling with L-[14C]serine to monitor the conversion of PE to PC. The initial 14C label comes from serine used for PS synthesis.,SCD-Trp medium,,,30.0,Saccharomyces cerevisiae cho1∆psd2∆,,
PMID33289180,reaction_1,in vitro,MPO activity was determined in lysates of Bone Marrow Macrophages (BMMs) using a commercial Mpo Detection Kit.,Not specified; assay performed using a commercial kit according to manufacturer's instructions.,,,,Mus musculus (endogenous in primary Bone Marrow Macrophages); RAW264.7 cells (for overexpression),pCMV6-Mpo-FLAG,Transfection into RAW264.7 cells and BMMs using Lipofectamine 2000.
PMID33289384,reaction_1,in vivo,Whole-cell bioconversion in engineered E. coli strains.,LB medium with 2% glycerol (shake flask) or defined fermentation medium (fed-batch).,7.0,Maintained during fed-batch fermentation.,30.0,Escherichia coli,"pSC103-based, pACYC184-based, or chromosomal integration","Expression driven by trc promoter, induced with 0.5 mM IPTG in fed-batch fermentation."
PMID33292445,reaction_1,in vitro,Activity assays with PASC and Avicel substrates to determine product profile and activity at various temperatures.,50 mM sodium phosphate buffer,6.0,,60.0,Escherichia coli BL21 Star (DE3),pRSET B,"Leaky expression from T7 promoter in Terrific Broth at 37°C for 20h, no inducer added."
PMID33292445,reaction_2,in vitro,Comparative activity assay with Avicel at various temperatures.,50 mM sodium phosphate buffer,6.0,,50.0,Escherichia coli,,
PMID33292445,reaction_3,in vitro,Product profile analysis on cello-oligosaccharides and Avicel.,50 mM sodium phosphate buffer,6.0,,60.0,Escherichia coli,pNIC-CH,
PMID33292445,reaction_4,in vitro,Product profile analysis on cello-oligosaccharides and Avicel.,50 mM sodium phosphate buffer,6.0,,60.0,Escherichia coli,pNIC-CH,
PMID33292448,reaction_1,in vitro,NADH oxidation assay using crude cell extracts and purified proteins.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_2,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_3,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_4,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_5,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_6,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_7,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_8,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_9,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_10,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_11,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_12,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_13,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33292448,reaction_14,in vitro,NADH oxidation assay using crude cell extracts.,100 mM potassium phosphate buffer,7.0,,,Zymomonas mobilis strain 9C,pEZ15Asp,Expression driven by pyruvate decarboxylase promoter (PDC) in RMG medium at 30°C.
PMID33295983,reaction_1,in vitro,Activity assay using crude pheromone gland (PG) extracts.,0.1 mol/liter potassium phosphate buffer,8.0,,,Escherichia coli BL21 (DE3),pET28a,0.2 mmol/liter IPTG at 16°C
PMID33295983,reaction_2,in vitro,In-gel activity staining using crude pheromone gland (PG) extracts.,"0.1 mol/liter Tris–HCl, pH 8.0 (extraction buffer)",8.0,pH of extraction buffer,,Escherichia coli BL21 (DE3),pET28a,0.2 mmol/liter IPTG at 16°C
PMID33295983,reaction_3,in vitro,In-gel activity staining using crude pheromone gland (PG) extracts.,"0.1 mol/liter Tris–HCl, pH 8.0 (extraction buffer)",8.0,pH of extraction buffer,,Escherichia coli BL21 (DE3),pET28a,0.2 mmol/liter IPTG at 16°C
PMID33295983,reaction_4,in vitro,In-gel activity staining using crude pheromone gland (PG) extracts.,"0.1 mol/liter Tris–HCl, pH 8.0 (extraction buffer)",8.0,pH of extraction buffer,,Escherichia coli BL21 (DE3),pET28a,0.2 mmol/liter IPTG at 16°C
PMID33295983,reaction_5,in vitro,In-gel activity staining using crude pheromone gland (PG) extracts.,"0.1 mol/liter Tris–HCl, pH 8.0 (extraction buffer)",8.0,pH of extraction buffer,,Escherichia coli BL21 (DE3),pET28a,0.2 mmol/liter IPTG at 16°C
PMID33303189,reaction_1,in vitro,Activity measured using the membrane fraction from E. coli expressing recombinant PtFMO.,,,,,E. coli,,
PMID33303189,reaction_2,in vivo,Whole-cell biotransformation using E. coli co-expressing PtFMO and PtIGS.,,,,,E. coli,,
PMID33314785,reaction_1,in vivo,"DHFR activity was assessed indirectly through cell survival, gene amplification, and subsequent monoclonal antibody production under methotrexate (MTX) selection pressure in engineered HEK293 cells.",Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 7% dialyzed fetal bovine serum (dFBS),,"Maintained by 5% CO2 atmosphere in a humidified incubator, typical for cell culture (approx. pH 7.2-7.4).",37.0,"dhfr-deficient Human Embryonic Kidney 293 cell line (KO-HEK), derived from HEK293E cells",pdCMV/dhfrC,"Constitutive expression from CMV promoter, followed by selection with increasing concentrations of methotrexate to amplify the gene."
PMID33318976,reaction_1,in vitro,Spectrophotometric assay with purified His-tagged enzyme.,"50 mM Tris, 100 mM NaCl, 5 mM MgCl2, pH 8.0 (Buffer A)",8.0,,30.0,Escherichia coli BL21(DE3),pCOLA-His-phaBCAp6,"0.5 mM IPTG, 25°C, 16h"
PMID33318976,reaction_2,in vitro,Spectrophotometric assay with purified His-tagged enzyme.,"50 mM Tris, 100 mM NaCl, 5 mM MgCl2, pH 8.0 (Buffer A)",8.0,,30.0,Escherichia coli BL21(DE3),pCOLA-His-phaBCAp6,"0.5 mM IPTG, 25°C, 16h"
PMID33318976,reaction_3,in vitro,Spectrophotometric assay with purified His-tagged enzyme.,"50 mM Tris, 100 mM NaCl, 5 mM MgCl2, pH 8.0 (Buffer A)",8.0,,30.0,Escherichia coli BL21(DE3),pCola-phaB-Chimera,"0.5 mM IPTG, 25°C, 16h"
PMID33318976,reaction_4,in vitro,Spectrophotometric assay with purified His-tagged enzyme.,"50 mM Tris, 100 mM NaCl, 5 mM MgCl2, pH 8.0 (Buffer A)",8.0,,30.0,Escherichia coli BL21(DE3),pCola-phaB-Chimera,"0.5 mM IPTG, 25°C, 16h"
PMID33320413,reaction_1,in vitro,Crystals of Av1-CO were pressurized with CO gas (80 psi) followed by X-ray crystallography and EPR spectroscopy to characterize the binding of a second CO molecule.,,,,,,,
PMID33323483,reaction_1,in vitro,Spectrophotometric and native PAGE activity assays on extracts from pgd3 mutant maize to isolate cytosolic activity.,"Extraction buffer: 50 mM Hepes (pH 7.5), 200 mM KCl, 10 mM MgCl2, 2.5 mM EDTA (pH 7.5), and 5% sucrose. Assay conditions: 0.5 mM NADP+, 0.5 mM 6-phosphogluconate, 50 mM Tris·HCl, 5 mM MgCl2.",7.5,,42.0,,,
PMID33323483,reaction_2,in vitro,Spectrophotometric and native PAGE activity assays on extracts from pgd1; pgd2 double mutant maize to isolate plastidic activity.,"Extraction buffer: 50 mM Hepes (pH 7.5), 200 mM KCl, 10 mM MgCl2, 2.5 mM EDTA (pH 7.5), and 5% sucrose. Assay conditions: 0.5 mM NADP+, 0.5 mM 6-phosphogluconate, 50 mM Tris·HCl, 5 mM MgCl2.",7.5,,42.0,,,
PMID33323483,reaction_3,in vitro,Activity and heat stability assays on transgenic endosperm extracts. In vivo complementation of pgd3 mutant phenotype and field trials under heat stress.,"Extraction buffer: 50 mM Hepes (pH 7.5), 200 mM KCl, 10 mM MgCl2, 2.5 mM EDTA (pH 7.5), and 5% sucrose. Assay conditions: 0.5 mM NADP+, 0.5 mM 6-phosphogluconate, 50 mM Tris·HCl, 5 mM MgCl2.",7.5,,50.0,Zea mays,pIPK27-MCSBAR,
PMID33323483,reaction_4,in vitro,Activity and heat stability assays on transgenic endosperm extracts. In vivo complementation of pgd3 mutant phenotype and field trials under heat stress.,"Extraction buffer: 50 mM Hepes (pH 7.5), 200 mM KCl, 10 mM MgCl2, 2.5 mM EDTA (pH 7.5), and 5% sucrose. Assay conditions: 0.5 mM NADP+, 0.5 mM 6-phosphogluconate, 50 mM Tris·HCl, 5 mM MgCl2.",7.5,,50.0,Zea mays,pIPK27-MCSBAR,
PMID33342435,reaction_1,in vitro,"Coupled assay with purified enzyme reconstituted into proteoliposomes, measuring 22Na+ transport and ferredoxin:NAD oxidoreductase (FNO) activity.","100 mM Tris–HCl, 100 mM malic acid, 5 mM MgCl2, 2 mM NaCl, 2 mM DTE, and 4 μM resazurin",7.4,pH for the 22Na+ transport assay. FNO activity was measured at pH 7.7.,30.0,Acetobacterium woodii Δrnf,pMTL_Ptet_rnf,400 nM anhydrotetracycline (aTet)
PMID33348877,reaction_1,in vivo,Cell-based assay. Phosphorylation of ERK1/2 was measured by Western blot in serum-deprived A549 cells stimulated with 100 ng/mL EGF.,Serum-free cell culture medium,,"Standard cell culture conditions, pH not specified.",,,,
PMID33348877,reaction_2,in vivo,Cell-based assay. Phosphorylation was measured by Western blot in HuVEC and hCMEC/D3 cells stimulated with VEGF.,Cell culture medium,,"Standard cell culture conditions, pH not specified.",,,,
PMID33348877,reaction_3,in vivo,Cell-based protein degradation assay. EGFR levels were monitored by Western blot in A549 cells treated with cycloheximide to inhibit protein synthesis.,Cell culture medium,,"Standard cell culture conditions, pH not specified.",,,,
PMID33348877,reaction_4,in vivo,Cell-based apoptosis assay. Caspase 3/7 activity was measured by fluorescence microscopy after adding the fluorogenic substrate to cultured hCMEC/D3 and HuVEC cells.,Cell culture medium containing 2 µM Lapatinib and 8 µM CellEvent Caspase-3/7 Green Detection Reagent,,"Standard cell culture conditions, pH not specified.",,,,
PMID33349631,reaction_1,in vitro,Enzymatic activity assay to determine kinetic parameters.,"33 mM Tris-acetate, 2 mM Mn2+, 3.2 mM NAD",7.4,,,E. coli BL21 (DE3) Codon-Plus strain,pQlinkN,0.4 mM IPTG for 20 h at 24 °C
PMID33349631,reaction_2,in vitro,Enzymatic activity assay to determine kinetic parameters.,"33 mM Tris-acetate, 2 mM Mn2+, 3.2 mM NAD",7.4,,,E. coli BL21 (DE3) Codon-Plus strain,pQlinkN,0.4 mM IPTG for 20 h at 24 °C
PMID33349631,reaction_3,in vitro,Enzymatic activity assay to determine kinetic parameters.,"33 mM Tris-acetate, 2 mM Mn2+, 3.2 mM NAD",7.4,,,E. coli BL21 (DE3) Codon-Plus strain,pQlinkN,0.4 mM IPTG for 20 h at 24 °C
PMID33359168,reaction_1_mKMO,in vitro,"Assay performed using the mitochondrial fraction of mouse liver. Test compounds were pre-incubated for 5 min, then L-kynurenine was added and incubated for 30 min. The amount of generated 3-hydroxykynurenine (3-HK) was measured by LC/MS/MS.",,,,,,,
PMID33359168,reaction_2_hKMO,in vitro,Assay performed using human liver mitochondrial-derived KMO to measure 3-HK production from L-kynurenine.,,,,,,,
PMID33359214,reaction_1,in vivo,Resting cells biotransformation with recombinant E. coli BW25113,water,,Not specified,,E. coli BW25113,,
PMID33359214,reaction_2,in vivo,Resting cells biotransformation with recombinant E. coli BW25113,water,,Not specified,,E. coli BW25113,,
PMID33359308,reaction_1_BV_mediator,in vitro,Mediated catalytic voltammetry using a modified Au electrode.,100 mM PBS buffer,7.2,,,E. coli strain TP100022,,
PMID33359308,reaction_2_AQS_mediator,in vitro,Mediated catalytic voltammetry using a modified Au electrode.,100 mM PBS buffer,7.2,,,E. coli strain TP100022,,
PMID33359609,reaction_1,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_2,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_3,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_4,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_5,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_6,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_7,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_8,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33359609,reaction_9,in vitro,Spectrophotometric enzyme activity assay,100 mM sodium phosphate buffer,6.0,for kinetic studies,30.0,,,
PMID33369525,reaction_1,in vitro,"Enzyme activity and content were measured from fresh leaf extracts using ELISA Kits (PAO content kit MM-6255501, PAO activity kit RJ25335).",Not specified (ELISA kit buffer),,,,Oryza sativa,,
PMID33369525,reaction_2,in vitro,"Enzyme activity was measured from fresh leaf extracts using an ELISA Kit (CLH activity, MM-089001).",Not specified (ELISA kit buffer),,,,Oryza sativa,,
PMID33369525,reaction_3,in vitro,"Enzyme activity was measured from fresh leaf extracts using an ELISA Kit (PPH activity, MM-252601).",Not specified (ELISA kit buffer),,,,Oryza sativa,,
PMID33369525,reaction_4,in vitro,"Enzyme activity was measured from fresh leaf extracts using an ELISA Kit (RCCR activity, MM-6254801).",Not specified (ELISA kit buffer),,,,Oryza sativa,,
PMID33369525,reaction_5,in vitro,"Enzyme activity was measured from fresh leaf extracts using an ELISA Kit (MDCase activity, MM-6255001).",Not specified (ELISA kit buffer),,,,Oryza sativa,,
PMID33375972,reaction_1,in vitro,Enzymatic activity assay on PASC with HPAEC product analysis,20 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,pPICZT,Methanol induction for 72 hours
PMID33375972,reaction_2,in vitro,Enzymatic activity assay on PASC with HPAEC product analysis,20 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,pPICZT,Methanol induction for 72 hours
PMID33375972,reaction_3,in vitro,Enzymatic activity assay on PASC with HPAEC product analysis,20 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,pPICZT,Methanol induction for 72 hours
PMID33375972,reaction_4,in vitro,Enzymatic activity assay on PASC with HPAEC product analysis,20 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,pPICZT,Methanol induction for 72 hours
PMID33375972,reaction_5,in vitro,Enzymatic activity assay on PASC with HPAEC product analysis,20 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,pPICZT,Methanol induction for 72 hours
PMID33375972,reaction_6,in vitro,Enzymatic activity assay on PASC with HPAEC product analysis,20 mM sodium acetate buffer,6.0,,50.0,Pichia pastoris X-33,pPICZT,Methanol induction for 72 hours
PMID33375972,reaction_7,in vitro,Proteolytic removal of C-terminal His6-tag from recombinant LPMOs,50 mM Tris/HCl buffer containing 150 mM NaCl,8.0,,22.0,Escherichia coli Rosetta2,,"1% (w/v) lactose, 20 °C, 16 h"
PMID33375979,reaction_1,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 1.5% (w/v) gluconate,7.4,,30.0,Pseudomonas sp. H9,,
PMID33375979,reaction_2,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 0.4% (w/v) butyrate,7.4,,30.0,Pseudomonas sp. H9,,
PMID33375979,reaction_3,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 0.4% (w/v) valerate,7.4,,30.0,Pseudomonas sp. H9,,
PMID33375979,reaction_4,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 0.4% (w/v) hexanoate,7.4,,30.0,Pseudomonas sp. H9,,
PMID33375979,reaction_5,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 0.4% (w/v) octanoate,7.4,,30.0,Pseudomonas sp. H9,,
PMID33375979,reaction_6,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 0.4% (w/v) octanoate,7.4,,30.0,Pseudomonas sp. H9ΔC1,pBHR-H9C1H16AB (based on pBBR1MCS-2),
PMID33375979,reaction_7,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 1.5% (w/v) gluconate,7.4,,30.0,Pseudomonas sp. H9ΔC1,pBHR-H9C1H16AB (based on pBBR1MCS-2),
PMID33375979,reaction_8,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 0.4% (w/v) octanoate,7.4,,30.0,Pseudomonas sp. H9ΔC1,pBHR-H16CAB (based on pBBR1MCS-2),
PMID33375979,reaction_9,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 1.5% (w/v) gluconate,7.4,,30.0,Pseudomonas sp. H9ΔC1,pBHR-H16CAB (based on pBBR1MCS-2),
PMID33375979,reaction_10,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 0.4% (w/v) octanoate,7.4,,30.0,Pseudomonas sp. H9ΔC1,pBHR-PoC1H16AB (based on pBBR1MCS-2),
PMID33375979,reaction_11,in vivo,PHA accumulation in bacterial culture,Mineral Salt (MS) medium with 1.5% (w/v) gluconate,7.4,,30.0,Pseudomonas sp. H9ΔC1,pBHR-PoC1H16AB (based on pBBR1MCS-2),
PMID33377777,reaction_1,in vitro,Specific activity measurement using reduced benzyl viologen as an artificial electron donor.,,8.5,pH for N2O-reducing activity measurement.,,E. coli,,
PMID33387577,reaction_1_human,in vitro,Activity measured in lysates of a stably expressing HEK-293 cell line (AT8 clone). Incubation time was 10 min. Substrate was 50 nM cortisol (containing [3H]cortisol) and cofactor was 500 μM NAD+.,"TS2 buffer (100 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM MgCl2, 250 mM sucrose, 20 mM Tris-HCl)",7.4,,37.0,HEK-293 cells,pcDNA3.1,
PMID33387577,reaction_2_rat,in vitro,Activity measured in lysates of transiently transfected HEK-293 cells. Incubation time was 20 min. Substrate was 50 nM cortisol (containing [3H]cortisol) and cofactor was 500 μM NAD+.,"TS2 buffer (100 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM MgCl2, 250 mM sucrose, 20 mM Tris-HCl)",7.4,,37.0,HEK-293 cells,pcDNA3.1,
PMID33387577,reaction_3_mouse,in vitro,Activity measured in lysates of transiently transfected HEK-293 cells. Incubation time was 20 min. Substrate was 50 nM cortisol (containing [3H]cortisol) and cofactor was 500 μM NAD+.,"TS2 buffer (100 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM MgCl2, 250 mM sucrose, 20 mM Tris-HCl)",7.4,,37.0,HEK-293 cells,pcDNA3.1,
PMID33387577,reaction_4_zebrafish,in vitro,Activity measured in lysates of transiently transfected HEK-293 cells. Incubation time was 20 min. Substrate was 50 nM cortisol (containing [3H]cortisol) and cofactor was 500 μM NAD+.,"TS2 buffer (100 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM MgCl2, 250 mM sucrose, 20 mM Tris-HCl)",7.4,,37.0,HEK-293 cells,pcDNA3.1,
PMID33389495,reaction_1,in vitro,Spectrophotometric activity assay following NAD+ reduction at 340 nm. Inactivation and reactivation assays were also performed.,"0.1 M Hepes–KOH, 0.1 mM EDTA",8.0,pH 7.0 was used for inactivation assays.,25.0,Escherichia coli ER2566,pTXB1,"0.4 mM IPTG, 37°C, 4h"
PMID33391858,reaction_1,in vitro,Steady-state kinetics and kinetic isotope effect measurements.,"100 mM HEPES, pH 7.0",7.0,,10.0,,,
PMID33391858,reaction_2,in vitro,Steady-state kinetics and kinetic isotope effect measurements.,"100 mM HEPES, pH 7.0",7.0,,10.0,,,
PMID33391858,reaction_3,in vitro,"Steady-state kinetics, KIEs, and pH-rate profiles.","100 mM HEPES, pH 7.0 (for KIEs); 100 mM HEPES and 100 mM CHES (for pH-rate profiles)",7.0,pH-rate profiles were conducted over a range of 6.5-9.0,10.0,,,
PMID33391858,reaction_4,in vitro,"Steady-state kinetics, KIEs, and pH-rate profiles.","100 mM HEPES, pH 7.0 (for KIEs); 100 mM HEPES and 100 mM CHES (for pH-rate profiles)",7.0,pH-rate profiles were conducted over a range of 6.5-9.0,10.0,,,
PMID33395570,reaction_1,in vitro,Chronoamperometry with enzyme-modified flexible thin-film electrode in artificial sweat.,"Artificial sweat (0.5% NaCl, 0.1% KCl, 0.1% Urea, and 2.0 mM D-lactate)",5.4,,37.0,Escherichia coli BL21 (DE3),pET30c(+),Micro-aerobic cultivation for cytochrome b maturation.
PMID33395570,reaction_2,in vitro,Chronoamperometry with enzyme-modified flexible thin-film electrode in artificial sweat for simultaneous detection with lactate.,"Artificial sweat (0.5% NaCl, 0.1% KCl, 0.1% Urea, and 2.0 mM D-lactate)",5.4,,37.0,,,
PMID33411393,reaction_1,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_2,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_3,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_4,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_5,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_6,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_7,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_8,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_9,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_10,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_11,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_12,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_13,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_14,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33411393,reaction_15,in vitro,Enzymatic conversion using recombinant AsqJ.,Not specified in text,,,,,,
PMID33414463,reaction_1,in vivo,Chromatin immunoprecipitation (ChIP) assays performed on human prostate cancer cell lines (PC3) to measure H3K27me3 levels at the CCND1 promoter following KDM6B knockdown or inhibition.,"Simple ChIP Plus Enzymatic Chromatin IP Kit (Cell Signaling Technology, 91820) buffers",,Not specified,37.0,,,
PMID33423475,reaction_1,in vivo,Short-term (1h) Cr(VI) uptake experiments in roots of 4-week-old sulfate-starved Arabidopsis seedlings. Additional functional characterization was performed via heterologous expression in yeast.,Sulfate-free 1/4 Hoagland nutrient solution,,,23.0,Saccharomyces cerevisiae BY4741; Arabidopsis thaliana,pYES2.0 (for yeast expression); pMDC32 (for Arabidopsis overexpression),2% galactose (in yeast)
PMID33423475,reaction_2,in vivo,Short-term (1h) Cr(VI) uptake experiments in roots of 4-week-old sulfate-starved Arabidopsis seedlings. Additional functional characterization was performed via heterologous expression in yeast.,Sulfate-free 1/4 Hoagland nutrient solution,,,23.0,Saccharomyces cerevisiae BY4741,pYES2.0,2% galactose
PMID33428421,reaction_1,in vitro,H2O2 production assay using Amplex Red/horseradish peroxidase,50 mM phosphate buﬀer,6.0,,28.0,Pichia pastoris X33,pPICzαA-PoLPMO9A,Expressed in BMGY medium
PMID33428421,reaction_2,in vitro,Oxidation of GA monitored by UV spectrophotometry,100 mM phosphate buﬀer,6.0,,28.0,Escherichia coli Rosetta (DE3),pET28a-PoDyP,Expressed in LB medium
PMID33428421,reaction_3,in vitro,Enzymatic cascade reaction for grafting gallic acid onto chitosan.,100 mM phosphate buﬀer,6.0,Standard condition used for optimization studies.,28.0,Escherichia coli Rosetta (DE3),pET28a-PoDyP,Expressed in LB medium
PMID33428421,reaction_4,in vitro,Enzyme activity assay,Britton−Robinson buﬀer,4.5,,,Escherichia coli Rosetta (DE3),pET28a-PoDyP,Expressed in LB medium
PMID33436639,reaction_1,in vitro,malachite green assay measuring PPi release,"30 mM HEPES (pH 7.5), 150 mM NaCl, 30 mM KCl, 50 mM MgCl2, 1 mM DTT, 2 U/ml E. coli inorganic pyrophosphatase",7.5,,37.0,Escherichia coli strain B834,"pETM11 (alpha subunit), pETM20 (beta subunit)","0.5 mM IPTG, 16°C, 18h"
PMID33438819,reaction_1,in vitro,In vitro inhibition study with purified enzyme.,Not specified,7.4,Assumed from molecular docking study conditions (pH 7.4 ± 0.5).,25.0,,,
PMID33438819,reaction_2,in vitro,In vitro inhibition study with purified enzyme.,Not specified,7.4,Assumed from molecular docking study conditions (pH 7.4 ± 0.5).,25.0,,,
PMID33438819,reaction_3,in vitro,In vitro inhibition study with purified enzyme.,Not specified,7.4,Assumed from molecular docking study conditions (pH 7.4 ± 0.5).,25.0,,,
PMID33454058,reaction_1,in vitro,FRET-based internally quenched fluorescent (IQF) peptide substrate assay,Not specified,,Not specified,37.0,E. coli,pET-28b(+),
PMID33454058,reaction_2,in vitro,FRET-based internally quenched fluorescent (IQF) peptide substrate assay,Not specified,,Not specified,37.0,E. coli,pET28b-3CLpro,
PMID33455969,reaction_1,in vitro,Formate oxidation activity assay using the supernatant of cell lysate.,"50 mM Tris–HCl buffer (pH 7.6) containing 6 mM benzyl viologen, 20 mM sodium formate, and 0.1% Triton X-100",7.6,,,Escherichia coli BWΔΔ,,
PMID33455969,reaction_2,in vitro,Coupled enzyme assay for formate production using partially purified FDH and hydrogenase.,"50 mM Tris–HCl buffer (pH 7.6) containing 6 mM BV, 1 μg/mL Desulfovibrio vulgaris [NiFe]-hydrogenase, and 0.1% Triton X-100",7.6,,30.0,Escherichia coli BWΔΔ,,
PMID33460502,reaction_1,in vitro,Stopped-flow UV/Vis spectroscopy to monitor Fe²⁺ oxidation at the ferroxidase center (380 nm) and haem oxidation (A558-A571).,"Not specified, experiments at pH 6.5",6.5,,25.0,,,
PMID33460502,reaction_2,in vitro,Stopped-flow UV/Vis spectroscopy to monitor Fe²⁺ oxidation at the ferroxidase center (380 nm) and haem oxidation (A558-A571).,"Not specified, experiments at pH 6.5",6.5,,25.0,,,
PMID33460586,reaction_1,in vitro,Coupling was demonstrated with an isolated complex from Methanothermobacter wolfeii. The crystal structure of the complex from M. thermolithotrophicus was determined.,,,,,,,
PMID33460586,reaction_2,in vitro,FBEB activity was exhibited by the reconstituted enzyme complex after heterologous expression of the encoding genes in E. coli.,,,,,Escherichia coli,,
PMID33460586,reaction_3,in vitro,The reconstituted enzyme complex catalyzed this reaction at a low rate.,,,,,Escherichia coli,,
PMID33460586,reaction_4,in vitro,"The complex was purified from Geobacter metallireducens. Partial activities, including 1,5-dienoyl-CoA:viologen and diaphorase activities, were characterized.",,,,,,,
PMID33460586,reaction_5,in vitro,Interaction with and electron transfer to APS reductase (AprAB) was demonstrated in studies with Desulfovibrio desulfuricans ATCC 2774. The full FBEC reaction is a proposed mechanism based on thermodynamics and genetic evidence.,,,,,,,
PMID33460586,reaction_6,in vitro,The sHdrA subunit from H. denitrificans was recombinantly expressed and characterized biochemically and structurally. The full complex was purified from Aquifex aeolicus. The overall reaction is a model based on these experimental data.,,,,,,,
PMID33460586,reaction_7,in vitro,"The complex was isolated and characterized. It exhibited NAD-specific diaphorase activity, and methylene-H4F reduction was observed with artificial electron donors (reduced benzyl viologen). The full FBEB reaction is a strong proposal based on these findings.",,,,,,,
PMID33460586,reaction_8,in vivo,The role of the complex was investigated through gene disruption experiments and comparative transcriptome analysis. Direct biochemical activity of the purified complex for this specific reaction is not described in the text.,,,,,,,
PMID33460816,reaction_1,in vitro,"Bi-enzyme coupled system for L-tagatose production with NAD+ regeneration, monitored by HPLC.",50 mM Tris-HCl with 30 mM FAD and 3 mM NAD+,9.0,,30.0,Escherichia coli (BL21),pET28a-GatDH,"1 mM IPTG, 15°C, 6h"
PMID33460816,reaction_2,in vitro,Substrate specificity assay monitoring NADH production at 340 nm.,100 mM Tris-HCl,9.0,,35.0,Escherichia coli (BL21),pET28a-GatDH,"1 mM IPTG, 15°C, 6h"
PMID33460816,reaction_3,in vitro,Substrate specificity assay monitoring NADH production at 340 nm.,100 mM Tris-HCl,9.0,,35.0,,,
PMID33460816,reaction_4,in vitro,Substrate specificity assay monitoring NADH production at 340 nm.,100 mM Tris-HCl,9.0,,35.0,,,
PMID33460816,reaction_5,in vitro,Substrate specificity assay monitoring NADH production at 340 nm.,100 mM Tris-HCl,9.0,,35.0,,,
PMID33460816,reaction_6,in vitro,Reductive reaction to determine product chirality by monitoring NADH consumption.,100 mM phosphate buffer,6.5,,,,,
PMID33460816,reaction_7,in vitro,Enzyme activity assay.,"Not specified, likely HEPES buffer as used in purification.",7.5,Optimal pH,35.0,Escherichia coli BL21 (DE3),pET28a-SmNox (subcloned),"1 mM IPTG, 15°C, 6h"
PMID33460820,reaction_1,in vitro,Purified enzyme kinetic assay. In vivo production was also extensively studied in engineered E. coli.,"50 mM sodium phosphate, 5 mM MgCl2",7.6,,,"Escherichia coli BL21(DE3) (for kinetics), Escherichia coli DLF_Z0025 derivatives (for in vivo production)","pHCKan-xyrA, pCASCADE-z, pCDF-pntAB",Phosphate depletion in SM10 No Phosphate media.
PMID33460820,reaction_2,in vitro,Coupled enzyme assay using cell extracts to quantify relative activity.,"45 mM sodium phosphate, 10 mM MgCl2",7.6,,,Escherichia coli DLF_Z0025 derivatives,,Phosphate depletion in SM10 No Phosphate media.
PMID33460820,reaction_3,in vitro,Activity assay using cell extracts to quantify relative activity.,"50 mM Tris-HCl, 2 mM MgCl",7.6,,25.0,Escherichia coli DLF_Z0025 derivatives,,Phosphate depletion in SM10 No Phosphate media.
PMID33467211,reaction_1,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_2,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_3,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_4,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_5,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_6,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_7,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_8,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_9,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_10,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_11,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33467211,reaction_12,in vivo,Metabolite identification in rat plasma after oral administration of 20 mg/kg ilaprazole.,0.5% CMC-Na (vehicle for administration),,,,,,
PMID33469028,reaction_1,in vitro,"Enzymatic assay with 100 ng purified protein, 7.5 nM [3H]-labeled progesterone, 10 nM progesterone, and 0.2 mM NADPH.",PBS buffer with 0.02% DDM,7.4,,37.0,Spodoptera frugiperda (Sf9) cells,pFastBac,
PMID33469028,reaction_2,in vitro,Enzymatic assay with purified protein.,PBS buffer with 0.02% DDM,7.4,,37.0,Spodoptera frugiperda (Sf9) cells,pFastBac,
PMID33469028,reaction_3,in vitro,Enzymatic assay with purified protein.,PBS buffer with 0.02% DDM,7.4,,37.0,Spodoptera frugiperda (Sf9) cells,pFastBac,
PMID33469028,reaction_4,in vivo,Assay performed in transiently transfected HEK293T cells treated with 10 nM [3H]-labeled testosterone. An in vitro assay was also performed on homogenized cell membranes.,Dulbecco’s Modiﬁed Eagle Medium with 10% FBS,7.4,Assumed for cell culture conditions.,37.0,HEK293T cells,,
PMID33475797,reaction_1,in vivo,Analysis of sterol content by HPLC-MS from mycelia of a conditional double mutant (Δerg24B niiA::erg24A) grown under repressive conditions.,Minimal medium (MM) with 10 mM ammonium tartrate as nitrogen source (repressing condition).,6.5,pH of the growth medium.,37.0,Aspergillus fumigatus,,
PMID33476696,reaction_1,in vivo,"Enzyme was overexpressed in IPI-FX cells to study its effect on Porcine deltacoronavirus (PDCoV) replication. The product, 25-hydroxycholesterol, was also added exogenously to cells.",Dulbecco’s modified Eagle’s medium (DMEM) containing 10 % fetal bovine serum,,"Standard cell culture conditions, typically pH ~7.2-7.4",37.0,IPI-FX cells (porcine ileum epithelial cells),pCAGGS-Flag,
PMID33479489,reaction_1,in vivo,Pure culture experiment for isotope fractionation analysis.,bicarbonate-buffered mineral salt medium with 40 mM lactate and 10 mM nominal PCE,,,28.0,,,
PMID33479489,reaction_2,in vivo,Pure culture experiment.,"bicarbonate-buffered mineral salt medium with 5 mM acetate, 148 nM vitamin B12, and H2",,,28.0,,,
PMID33479489,reaction_3,in vivo,Pure culture experiment.,"bicarbonate-buffered mineral salt medium with 5 mM acetate, 148 nM vitamin B12, and H2",,,28.0,,,
PMID33479489,reaction_4,in vivo,Co-culture with S. multivorans.,bicarbonate-buffered mineral salt medium with 25 mM lactate as ultimate electron donor,,,28.0,,,
PMID33479489,reaction_5,in vivo,Co-culture with S. multivorans.,bicarbonate-buffered mineral salt medium with 25 mM lactate as ultimate electron donor,,,28.0,,,
PMID33479489,reaction_6,in vivo,Pure culture experiment to test cofactor functionality.,bicarbonate-buffered mineral salt medium with 5 mM acetate and H2,,,28.0,,,
PMID33479489,reaction_7,in vivo,Pure culture experiment to test cofactor functionality.,bicarbonate-buffered mineral salt medium with 5 mM acetate and H2,,,28.0,,,
PMID33482043,reaction_1,in vitro,Stopped-flow UV/Vis spectrophotometry,"100 mM MES, pH 6.5",6.5,,25.0,,,
PMID33482043,reaction_2,in vitro,"Stopped-flow UV/Vis spectrophotometry, Rapid Freeze-Quench (RFQ) EPR and Mössbauer spectroscopy.","100 mM MES, pH 6.5",6.5,,25.0,,,
PMID33482043,reaction_3,in vitro,EPR spectroscopy with excess H2O2.,"100 mM MES, pH 6.5",6.5,,25.0,,,
PMID33485846,reaction_1,in vitro,Enzyme activity of full-length ACSL1 reconstituted in MSPΔH5 nanodiscs was measured by monitoring AMP formation via HPLC.,"30 mM Tris pH 7.5, 50 mM NaCl, 0.5 mM MgSO4, 2.5 mg/mL cyclodextrin, 200 μM CoA, 1 mM ATP",7.5,,,High Five cells,pFastBac1-His10 vector,Cells were infected with baculovirus for protein production.
PMID33486371,reaction_1,in vitro,Spectrophotometric assay for kinetics and preparative biotransformations for conversion rates.,50 mM TRIS⋅HCl buffer,8.0,,25.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_2,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_3,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_4,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_5,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_6,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_7,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_8,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33486371,reaction_9,in vitro,Preparative biotransformation for conversion rate.,50 mM TRIS⋅HCl buffer,8.0,,28.0,Escherichia coli BL21(DE3),,
PMID33491200,reaction_1_Gp1,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_2_Gp2,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_3_Gp3,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_4_Dp1,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_5_Dp2,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_6_Dp3,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_7_L1,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_8_L2,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33491200,reaction_9_L3,in vitro,Spectrophotometric assay of LOX activity in crude enzyme extract.,0.067 M sodium phosphate buffer (Na2HPO4/NaH2PO4),7.0,pH for kinetic parameter determination.,37.0,,,
PMID33498665,reaction_1,in vitro,Specific enzyme activity measured in cell lysate from MCF7 cells.,"50 mM tris-HCl, 0.2 mM MgCl2, pH 7.6",7.6,,37.0,MCF7 human breast cancer cell line (endogenous expression),,
PMID33498665,reaction_2,in vitro,Specific enzyme activity measured in cell lysate from MCF7 cells.,"50 mM tris-HCl, 0.2 mM MgCl2, pH 7.6",7.6,,37.0,MCF7 human breast cancer cell line (endogenous expression),,
PMID33498665,reaction_3,in vitro,Specific enzyme activity measured in cell lysate from MCF7 cells.,"50 mM tris-HCl, 0.2 mM MgCl2, pH 7.6",7.6,,37.0,MCF7 human breast cancer cell line (endogenous expression),,
PMID33498665,reaction_4,in vitro,Specific enzyme activity measured in cell lysate from MCF7 cells.,"100 mM KH2PO4/K2HPO4, pH 7.4",7.4,,37.0,MCF7 human breast cancer cell line (endogenous expression),,
PMID33498665,reaction_5,in vitro,Specific enzyme activity measured in cell lysate from MCF7 cells using a coupled assay.,"50 mM tris-HCl, pH 7.6",7.6,,37.0,MCF7 human breast cancer cell line (endogenous expression),,
PMID33499007,reaction_1,in vivo,SOD activity was measured in dermal tissue homogenates from Wistar albino rats after a 13-day wound healing experiment.,Tris-buffered saline (TBS),7.4,,,,,
PMID33512000,reaction_1,in vitro,Crude cell extract enzyme assay,32.5 mM MES buffer,6.4,,22.0,Escherichia coli BW25113 (F’),pZE-nagAaGHAb,"0.5 mM IPTG, 30°C, 16-20h"
PMID33512000,reaction_2,in vitro,Crude cell extract enzyme assay,32.5 mM MES buffer,6.4,,22.0,Escherichia coli BW25113 (F’),pZE-salABCD,"0.5 mM IPTG, 30°C, 16-20h"
PMID33512000,reaction_3,in vitro,Crude cell extract enzyme assay,32.5 mM MES buffer,6.4,,22.0,Escherichia coli BW25113 (F’),pZE-hybABCD,"0.5 mM IPTG, 30°C, 16-20h"
PMID33512000,reaction_4,in vivo,Whole-cell bioconversion by strain JYJ05,M9 liquid medium,,"Not specified, assumed standard culture pH ~7.0",30.0,Escherichia coli BW25113 (F’),pZE-mps-hbzf,"0.5 mM IPTG, 30°C"
PMID33512000,reaction_5,in vivo,Whole-cell bioconversion by strain JYJ07,M9 liquid medium,,"Not specified, assumed standard culture pH ~7.0",30.0,Escherichia coli BW25113 (F’),pZE-nagAaGHAb-mps-hbzf,"0.5 mM IPTG, 30°C"
PMID33512000,reaction_6,in vivo,Fed-batch fermentation in a 3-L bioreactor,M9S medium with glycerol feed,7.0,Maintained automatically with 75% (vol/vol) NH4OH,30.0,Escherichia coli BW03 (BW25113(F’) ΔpheA ΔtyrA ΔpykA ΔpykF),pZE-nagAaGHAb and pCS-APTA-EP-mps-hbzf,"0.5 mM IPTG, 30°C"
PMID33512000,reaction_7,in vivo,Whole-cell bioconversion by strain JYJ04 to test substrate specificity,M9 liquid medium,,"Not specified, assumed standard culture pH ~7.0",30.0,Escherichia coli BW25113 (F’),pZE-mps,"0.5 mM IPTG, 30°C"
PMID33522611,reaction_1,in vitro,Spectrophotometric assay measuring the increase in absorbance at 496 nm. The reaction medium contained 10 mM of 3-methyl-2-benzothiazoline hydrazone (MBTH) and 2% of dimethylformamide (DMF).,50 mM acetate buffer,5.0,Optimum pH for activity with 4-methyl catechol.,30.0,,,
PMID33522611,reaction_2,in vitro,Spectrophotometric assay performed under optimum conditions determined with 4-methyl catechol.,50 mM acetate buffer,5.0,Assumed to be performed at the optimum pH determined with 4-methyl catechol.,30.0,,,
PMID33522811,reaction_1,in vitro,Stopped-flow absorption and freeze-quench Mössbauer spectroscopy for intermediate characterization; LC-MS for product quantification.,40 mM sodium HEPES (pH 7.5) buffer,7.5,,5.0,,,
PMID33522811,reaction_2,in vitro,GC-FID for product quantification.,40 mM sodium HEPES (pH 7.5) buffer,7.5,,21.0,,,
PMID33523590,reaction_1_ME_NAD,in vitro,Enzyme kinetics assays,,,,,,,
PMID33523590,reaction_2_ME_NCD,in vitro,Enzyme kinetics assays,,,,,,,
PMID33523590,reaction_3_DLDH_NAD,in vitro,Enzyme kinetics assays,,,,,,,
PMID33523590,reaction_4_DLDH_NCD,in vitro,Enzyme kinetics assays,,,,,,,
PMID33527107,reaction_1,in vitro,"Spectroscopic characterization (Electronic absorption, EPR, Resonance Raman) of the wild-type and N117A mutant enzymes in the fully oxidized state to infer properties related to the catalytic reaction.","50 mM HEPES buffer, pH 7.5 or 50 mM Tris/HCl, pH 7.6",7.5,pH 7.5 for absorption/EPR and pH 7.6 for RR.,-258.15,E. coli BL21 strain,pMJ25,IPTG-inducible tac promotor
PMID33527107,reaction_2,in vitro,pH titration monitored by UV-Vis absorbance at 645 nm to determine the apparent pKa.,"MES, bis–Tris propane, HEPES, Tris–HCl, and glycine–NaOH buffers.",,Titration over a pH range from 5.75 to 9.85.,,E. coli BL21 strain,pMJ25,IPTG-inducible tac promotor
PMID33529432,reaction_1,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_2,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_3,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_4,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_5,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_6,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_7,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_8,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_9,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_10,in vitro,photo-chemo-enzymatic cascade under green light (528 nm),100 mM tricine buffer,7.5,,30.0,,,
PMID33529432,reaction_11,in vitro,Two-step one-pot photo-chemo-enzymatic cascade. The enzymatic reduction follows a photocatalytic oxidation step performed under blue light (455 nm).,KPi buffer,7.5,pH assumed from conditions used for the related AaeUPO reaction in KPi buffer.,30.0,,,
PMID33529432,reaction_12,in vitro,Two-step one-pot photo-chemo-enzymatic cascade. The enzymatic reduction follows a photocatalytic oxidation step performed under blue light (455 nm).,KPi buffer,7.5,pH assumed from conditions used for the related AaeUPO reaction in KPi buffer.,30.0,,,
PMID33529432,reaction_13,in vitro,Two-step one-pot photo-chemo-enzymatic cascade. The enzymatic reduction follows a photocatalytic oxidation step performed under blue light (455 nm).,KPi buffer,7.5,pH assumed from conditions used for the related AaeUPO reaction in KPi buffer.,30.0,,,
PMID33530536,reaction_1,in vitro,Enzyme activity was tested in cell homogenates or using recombinant expression in HEK293T cells. A specific assay using fluorescent lipid substrates combined with HPLC was also mentioned.,Not specified,,Not specified,,HEK293T cells,,
PMID33530536,reaction_2,in vitro,Enzyme activity was tested in cell homogenates or using recombinant expression in HEK293T cells. A specific assay using fluorescent lipid substrates combined with HPLC was also mentioned.,Not specified,,Not specified,,HEK293T cells,,
PMID33530536,reaction_3,in vitro,Enzyme activity was tested in cell homogenates or using recombinant expression in HEK293T cells. The text states that lyso-alkylglycerophosphoethanolamines are accepted substrates.,Not specified,,Not specified,,HEK293T cells,,
PMID33531363,reaction_1,in vitro,Activity of recombinant MDH proteins was measured by monitoring NADPH oxidation at 340 nm.,"50 mM Tris·HCl (pH 7.5), 50 mM NaCl, 0.01 μM MDH, 100 μM NADPH, and 0–200 μM oxaloacetate",7.5,,25.0,Escherichia coli,pET-23c,
PMID33531496,reaction_1,in vitro,Fluorescence-based biochemical assay using a pro-fluorescent peptide substrate (LKGG-AMC).,"Tris-HCl pH 7.3, 1 mM EDTA",7.3,,25.0,E. coli BL21(DE3)-Gold strain,pMCSG53,
PMID33533375,reaction_1,in vitro,Gram-scale reaction and HTE screening.,aqueous solution,,,,,,
PMID33533375,reaction_2,in vitro,,aqueous solution with 10 vol% DMSO,,,,,,
PMID33533375,reaction_3,in vitro,,aqueous solution,,,,,,
PMID33533375,reaction_4,in vitro,,aqueous solution with 10 vol% DMSO,,,,,,
PMID33533375,reaction_5,in vitro,,aqueous solution with 10 vol% DMSO,,,,,,
PMID33533375,reaction_6,in vitro,,aqueous solution with 10 vol% DMSO,,,,,,
PMID33533375,reaction_7,in vitro,,aqueous solution with 10 vol% DMSO,,,,,,
PMID33539931,reaction_1,in vitro,Assays performed with whole cells and cell-free supernatant of B. japonicum E109. Metabolite identification was performed using the enzyme heterologously expressed in Cupriavidus pinatubonensis JMP134.,Yeast Extract Mannitol (YEM) culture medium,,pH was not specified for the main degradation assays conducted in YEM medium.,30.0,Cupriavidus pinatubonensis JMP134,pBS1,5 mM L-arabinose
PMID33548859,reaction_1,in vitro,"The text summarizes experiments from other studies, including work on recombinant eNOS and cultured human trophoblasts [127]. No specific assay conditions are provided in this review.",,,,,,,
PMID33548859,reaction_2,in vitro,This activity is described as occurring under conditions of eNOS uncoupling. No specific assay is detailed in this review.,,,,,,,
PMID33556357,reaction_1,in vitro,Steady-state kinetics of cytochrome c reductase activity,Not specified in text; likely potassium phosphate or Tris-acetate buffer based on cited methods.,7.7,pH dependence studied. Optimal activity for WT requires deprotonation of a group with pKa 6.9 and protonation of a group with pKa 9.6. Assays likely performed at pH 7.7 based on cited methods.,,Escherichia coli (inferred from cited literature),pOR263,
PMID33556357,reaction_2,in vitro,Steady-state kinetics of cytochrome c reductase activity,Not specified in text; likely potassium phosphate or Tris-acetate buffer based on cited methods.,7.7,"pH dependence studied. With NADH, the acidic pKa required for activity was restored for all Trp677 variants, but shifted to a pKa of 7.9. Assays likely performed at pH 7.7 based on cited methods.",,Escherichia coli (inferred from cited literature),pOR263,
PMID33564100,reaction_1,in vitro,In vitro methyltransferase assay using recombinant proteins.,"50 mM Tris-HCl (pH 8.5), 20 mM KCl, 10 mM MgCl2, 10 mM β-mercaptoethanol, and 1.25 M sucrose",8.5,,30.0,E. coli BL21,pGEX-4T-2,"0.02 mM IPTG, 37 °C, 4 h"
PMID33564100,reaction_2,in vitro,In vitro methyltransferase assay using synthetic peptide.,"50 mM Tris-HCl (pH 8.5), 20 mM KCl, 10 mM MgCl2, 10 mM β-mercaptoethanol, and 1.25 M sucrose",8.5,,30.0,E. coli BL21,pGEX-4T-2,"0.02 mM IPTG, 37 °C, 4 h"
PMID33564100,reaction_3,in vitro,In vitro methyltransferase assay using synthetic peptide.,"50 mM Tris-HCl (pH 8.5), 20 mM KCl, 10 mM MgCl2, 10 mM β-mercaptoethanol, and 1.25 M sucrose",8.5,,30.0,E. coli BL21,pGEX-4T-2,"0.02 mM IPTG, 37 °C, 4 h"
PMID33564100,reaction_4,in vitro,In vitro methyltransferase assay using synthetic peptide.,"50 mM Tris-HCl (pH 8.5), 20 mM KCl, 10 mM MgCl2, 10 mM β-mercaptoethanol, and 1.25 M sucrose",8.5,,30.0,E. coli BL21,pGEX-4T-2,"0.02 mM IPTG, 37 °C, 4 h"
PMID33564100,reaction_5,in vitro,In vitro demethylase assay.,"20 mM Tris-HCl (pH 7.3), 150 mM NaCl, 1 mM a-ketoglutarate, 50 mM FeSO4, and 2 mM ascorbic acid",7.3,,37.0,E. coli BL21,pGEX-4T-1,"30 °C, 4 h"
PMID33564100,reaction_6,in vitro,In vitro demethylase assay.,"20 mM Tris-HCl (pH 7.3), 150 mM NaCl, 1 mM a-ketoglutarate, 50 mM FeSO4, and 2 mM ascorbic acid",7.3,,37.0,E. coli BL21,pGEX-4T-1,"30 °C, 4 h"
PMID33564100,reaction_7,in vitro,In vitro demethylase assay.,"20 mM Tris-HCl (pH 7.3), 150 mM NaCl, 1 mM a-ketoglutarate, 50 mM FeSO4, and 2 mM ascorbic acid",7.3,,37.0,E. coli BL21,pGEX-4T-1,"30 °C, 4 h"
PMID33580795,reaction_1,in vitro,APX activity assay on total protein extracts from leaves.,"25 mM Na-phosphate, 0.1 mM EDTA",7.0,,,Arabidopsis thaliana,,
PMID33591179,reaction_1,in vitro,Ultrafast time-resolved fluorescence and transient absorption spectroscopy,Not specified; measurements performed in a quartz cell under air atmosphere.,,,22.0,,,
PMID33591179,reaction_2,in vitro,Ultrafast time-resolved fluorescence and transient absorption spectroscopy,Not specified; measurements performed in a quartz cell under air atmosphere.,,,22.0,,,
PMID33592267,reaction_1,in vitro,Spectrophotometric assay monitoring NADPH production at 340 nm.,50 mM Glycine-NaOH,10.5,,25.0,Escherichia coli BL21 (DE3) plysS,pGEX-6p-2,"0.2 mM IPTG, 16 °C, 12 h"
PMID33592267,reaction_2,in vitro,Spectrophotometric assay monitoring NADPH production at 340 nm.,50 mM Glycine-NaOH,10.5,,25.0,Escherichia coli BL21 (DE3) plysS,pGEX-6p-2,"0.2 mM IPTG, 16 °C, 12 h"
PMID33592267,reaction_3,in vitro,Spectrophotometric assay monitoring NADPH production at 340 nm.,50 mM Glycine-NaOH,10.5,,25.0,Escherichia coli BL21 (DE3) plysS,pGEX-6p-2,"0.2 mM IPTG, 16 °C, 12 h"
PMID33593577,reaction_1,in vitro,MALDI-TOF/TOF analysis of soluble products after 24h incubation.,20 mM ammonium acetate buffer,6.0,,37.0,E. coli BL21 (DE3),reconstructive pET-29a (+),0.5 mM IPTG at 16 °C for 24 h
PMID33593577,reaction_2,in vitro,Colorimetric assay quantifying carboxylate moieties formed on the insoluble α-chitin substrate.,20 mM ammonium acetate,6.0,,37.0,E. coli BL21 (DE3),reconstructive pET-29a (+),0.5 mM IPTG at 16 °C for 24 h
PMID33593577,reaction_3,in vitro,Colorimetric assay quantifying carboxylate moieties formed on the insoluble α-chitin substrate.,20 mM ammonium acetate,6.0,,37.0,E. coli BL21 (DE3),reconstructive pET-29a (+),0.5 mM IPTG at 16 °C for 24 h
PMID33597082,reaction_1,in vivo,"Hydrogen peroxide resistance test. Yeast cells were spotted onto agar medium containing hydrogen peroxide to assess survival and growth, which indicates H2O2 detoxification activity.",YPD agar medium with or without 4 mM hydrogen peroxide,,Not specified,30.0,Saccharomyces cerevisiae,pRS416-CCP1,"The CCP1 gene was cloned with its native promoter and terminator sequences, suggesting constitutive expression from the single-copy vector."
PMID33599267,reaction_1,in vitro,Reconstituted enzyme assay monitoring the redox state of GvTrx-m by AMS labeling and nonreducing SDS-PAGE.,"50 mM Tris-HCl, 100 mM NaCl",7.6,,25.0,Escherichia coli Rosetta (DE3) pLys,In-house vector with N-terminal 8xHis tag and TEV cleavage site,"0.1 mM IPTG, 20°C, overnight"
PMID33599267,reaction_2,in vitro,Coupled enzyme assay monitoring the redox state of GvCP12 by AMS labeling and nonreducing SDS-PAGE.,"50 mM Tris-HCl, 100 mM NaCl",7.6,,25.0,Escherichia coli Rosetta (DE3) pLys,In-house vector with N-terminal 8xHis tag and TEV cleavage site,"0.1 mM IPTG, 20°C, overnight"
PMID33609870,reaction_1,in vivo,Whole-cell biodegradation assay using Psychrobacter sp. ANT206 wild-type and mutant strains.,Mineral Salt Medium (MSM),,pH of MSM not specified.,16.0,Psychrobacter sp. ANT206,,
PMID33609870,reaction_2,in vivo,Whole-cell biodegradation assay using Psychrobacter sp. ANT206 wild-type and mutant strains.,Mineral Salt Medium (MSM),,pH of MSM not specified.,16.0,Psychrobacter sp. ANT206,,
PMID33609915,reaction_1,in vivo,"Antimicrobial activity assay against whole Staphylococcus aureus cells, measured as Minimum Inhibitory Concentration (MIC). The enzyme is the putative target, with inhibition inferred from molecular docking studies.",Fresh media (details not specified),,Not specified,37.0,,,
PMID33610817,reaction_1,in vitro,Spectrophotometric assay measuring NADPH consumption at 340 nm.,100 mM phosphate buffer,7.5,The optimal pH range was determined to be 6.5-7.5.,35.0,,,
PMID33610817,reaction_2,in vitro,Substrate specificity test using 10 mM substrate concentration.,100 mM phosphate buffer,7.5,,25.0,,,
PMID33610817,reaction_3,in vitro,Substrate specificity test using 10 mM substrate concentration.,100 mM phosphate buffer,7.5,,25.0,,,
PMID33610817,reaction_4,in vitro,Substrate specificity test using 10 mM substrate concentration.,100 mM phosphate buffer,7.5,,25.0,,,
PMID33616697,reaction_1,in vitro,Enzyme kinetic analysis,40 mM potassium phosphate buffer,7.0,Optimal pH,30.0,Escherichia coli NEB 5-alpha,pASK5_KFR_TM,"0.2 μg/mL anhydrotetracycline, 4h cultivation"
PMID33616697,reaction_2,in vitro,Enzyme kinetic analysis,40 mM potassium phosphate buffer,7.0,Optimal pH,35.0,Escherichia coli NEB 5-alpha,pASK5_gox0644,"0.2 μg/mL anhydrotetracycline, 4h cultivation"
PMID33616697,reaction_3,in vitro,Enzyme kinetic analysis,40 mM potassium phosphate buffer,7.0,Optimal pH,30.0,Escherichia coli NEB 5-alpha,pASK.3_gox1432.ST,"0.2 μg/mL anhydrotetracycline, 4h cultivation"
PMID33616697,reaction_4,in vitro,Enzyme kinetic analysis,40 mM potassium phosphate buffer,6.0,Optimal pH,40.0,Escherichia coli NEB 5-alpha,pASK5_AKR_Cpast,"0.2 μg/mL anhydrotetracycline, 4h cultivation"
PMID33616697,reaction_5,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_6,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_7,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_8,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_9,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_10,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_11,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,6.0,,30.0,,,
PMID33616697,reaction_12,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,6.0,,30.0,,,
PMID33616697,reaction_13,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,6.0,,30.0,,,
PMID33616697,reaction_14,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,6.0,,30.0,,,
PMID33616697,reaction_15,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,6.0,,30.0,,,
PMID33616697,reaction_16,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,6.0,,30.0,,,
PMID33616697,reaction_17,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,6.0,,30.0,,,
PMID33616697,reaction_18,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_19,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33616697,reaction_20,in vitro,Substrate spectrum analysis with 20 mM substrate and 250 μM NADPH.,40 mM potassium phosphate buffer,7.0,,30.0,,,
PMID33623002,reaction_1,in vitro,Enzyme activity assay on β-chitin with HILIC product analysis.,20 mM Tris-HCL pH 7.0,7.0,,37.0,Escherichia coli BL21 Star (DE3),pNIC-CH,"0.1–0.2 mM IPTG, 22–25 °C, ~16 h"
PMID33624374,reaction_1,in vitro,Activity of recombinant enzymes confirmed by detection of nitrous acid with Saltzman reagent.,Not specified,,Not specified,,,,
PMID33624374,reaction_2,in vivo,"Function was inferred from gene inactivation of azpK in S. griseoplanus and subsequent chemical complementation with 5-hydroxylysine (1), which restored alazopeptin production. Direct in vitro assays were unsuccessful.",,,,,,,
PMID33624374,reaction_3,in vitro,Activity of recombinant enzyme was monitored by the increase in absorbance at 340 nm due to NADH formation.,Not specified,,Not specified,,,,
PMID33624374,reaction_4,in vivo,"Function was determined by gene inactivation, chemical complementation, and heterologous expression in S. albus. Direct in vitro assay was unsuccessful due to the membrane protein nature of AzpL.",,,,,Streptomyces albus,pHKO4-azpLKJI,Expressed under the control of the tipA promoter (PtipA).
PMID33624374,reaction_5,in vitro,"Activity of recombinant enzyme was monitored using 5,5'-dithiobis(2-nitrobenzoic acid) and confirmed by LC-MS.",Not specified,,Not specified,,,,
PMID33624374,reaction_6,in vitro,Activity of recombinant enzyme confirmed by LC-MS detection of the product.,Not specified,,Not specified,,,,
PMID33624374,reaction_7,in vitro,Activity of recombinant enzyme confirmed by LC-MS.,Not specified,,Not specified,,,,
PMID33624374,reaction_8,in vitro,Activity of recombinant enzyme confirmed by LC-MS.,Not specified,,Not specified,,,,
PMID33624374,reaction_9,in vitro,Activity of recombinant enzyme confirmed by LC-MS.,Not specified,,Not specified,,,,
PMID33624785,reaction_1,in vitro,Activity measured in the supernatant (lysate) of cultured 3T3-L1 adipocytes. The lysate was mixed with a substrate solution from a commercial kit.,Enzyme extracting solution and substrate solution from a commercial kit (Cosmo Bio). Specific compositions not provided.,,Not specified for the assay.,,Endogenous expression in 3T3-L1 cells (mouse embryonic fibroblast-derived),,
PMID33624917,reaction_1,in vitro,Enzyme activity and kinetic parameter measurement for oxidative deamination.,Not specified,11.0,Optimum pH for oxidative deamination of substrate 1a.,,,,
PMID33624917,reaction_2,in vitro,Enzyme activity measurement for oxidative deamination.,Not specified,,,,,,
PMID33624917,reaction_3,in vitro,Enzyme activity measurement for oxidative deamination.,Not specified,,,,,,
PMID33624917,reaction_4,in vivo,Preparative scale (30 mL) synthesis using recombinant E. coli cells overexpressing the variant.,Not specified,,,,recombinant E. coli cells,,
PMID33624917,reaction_5,in vivo,Preparative scale (30 mL) synthesis using recombinant E. coli cells overexpressing the variant.,Not specified,,,,recombinant E. coli cells,,
PMID33624917,reaction_6,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33624917,reaction_7,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33624917,reaction_8,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33624917,reaction_9,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33624917,reaction_10,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33624917,reaction_11,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33624917,reaction_12,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33624917,reaction_13,in vitro,Substrate scope testing.,Not specified,,,,,,
PMID33631795,reaction_1,in vitro,Fluorometric assay measuring pyrophosphate (PPi) production from a CoA synthetase reaction.,"100 mM Tris, 0.1% Triton X-100 (v/v), 1 mM dithiothreitol",7.5,,24.0,Escherichia coli DH5AZ1,pZA31,"200 mg/mL anhydrotetracycline, 16°C, overnight"
PMID33631795,reaction_2,in vitro,Fluorometric assay measuring pyrophosphate (PPi) production from a CoA synthetase reaction.,"100 mM Tris, 0.1% Triton X-100 (v/v), 1 mM dithiothreitol",7.5,,24.0,Escherichia coli DH5AZ1,pZA31,"200 mg/mL anhydrotetracycline, 16°C, overnight"
PMID33631795,reaction_3,in vitro,Fluorometric assay measuring pyrophosphate (PPi) production from a CoA synthetase reaction.,"100 mM Tris, 0.1% Triton X-100 (v/v), 1 mM dithiothreitol",7.5,,24.0,Escherichia coli DH5AZ1,pZA31,"200 mg/mL anhydrotetracycline, 16°C, overnight"
PMID33631795,reaction_4,in vitro,Fluorometric assay measuring pyrophosphate (PPi) production from a CoA synthetase reaction.,"100 mM Tris, 0.1% Triton X-100 (v/v), 1 mM dithiothreitol",7.5,,24.0,Escherichia coli DH5AZ1,pZA31,"200 mg/mL anhydrotetracycline, 16°C, overnight"
PMID33631795,reaction_5,in vitro,Fluorometric assay measuring pyrophosphate (PPi) production from a CoA synthetase reaction.,"100 mM Tris, 0.1% Triton X-100 (v/v), 1 mM dithiothreitol",7.5,,24.0,Escherichia coli DH5AZ1,pZA31,"200 mg/mL anhydrotetracycline, 16°C, overnight"
PMID33631795,reaction_6,in vitro,Fluorometric assay measuring pyrophosphate (PPi) production from a CoA synthetase reaction.,"100 mM Tris, 0.1% Triton X-100 (v/v), 1 mM dithiothreitol",7.5,,24.0,Escherichia coli DH5AZ1,pZA31,"200 mg/mL anhydrotetracycline, 16°C, overnight"
PMID33637718,reaction_1,in vitro,Enzymatic activity assay monitoring absorbance at 320 nm.,"20 mM Tris-HCl, 50 µM FeCl2",8.0,,25.0,Escherichia coli BL21(DE3),pET-24a,"0.4 mM IPTG, 16°C, overnight"
PMID33647795,reaction_1,in vivo,"ABA content was quantified in shoots and roots of wild-type, osao3 mutant, and OsAO3-overexpressing rice seedlings under normal and drought stress (150 mM mannitol) conditions.",Kimura B nutrient solution (for plant growth),,,28.0,Oryza sativa,pSuper1300,Constitutive overexpression via Agrobacterium-mediated transformation.
PMID33649331,reaction_1,in vitro,Enzyme activity assay using methyl viologen reduced with sodium dithionite as an electron donor.,50 mM HEPES/Tris (pH 7.0) and 100 mM NaCl,7.0,,,E. coli TUNER (DE3),pET-24a (+),"0.5 mM IPTG, 20 °C, overnight"
PMID33649331,reaction_2,in vitro,Enzyme activity assay using methyl viologen reduced with sodium dithionite as an electron donor.,50 mM HEPES/Tris (pH 7.0) and 100 mM NaCl,7.0,,,E. coli,pET-24a (+),"0.5 mM IPTG, 20 °C, overnight"
PMID33649331,reaction_3,in vitro,Enzyme activity assay using methyl viologen reduced with sodium dithionite as an electron donor.,50 mM HEPES/Tris (pH 7.0) and 100 mM NaCl,7.0,,,BL21 (DE3) E. coli strain,pET-24a (+),"0.5 mM IPTG, 20 °C, overnight"
PMID33649331,reaction_4,in vitro,Enzyme activity assay using methyl viologen reduced with sodium dithionite as an electron donor.,50 mM HEPES/Tris (pH 7.0) and 100 mM NaCl,7.0,,,E. coli,pET-24a (+),"0.5 mM IPTG, 20 °C, overnight"
PMID33656282,reaction_1,in vitro,Steady-state kinetic analysis of capsaicin consumption. Whole-cell bioconversion was also performed to determine conversion rates and product distribution.,"50 mM Na2HPO4, 0.1 mM EDTA, 0.1 mM dithiothreitol, and 10% glycerol",7.4,,30.0,Escherichia coli BL21-CodonPlus (DE3)-RIL,pET28b-sav7469,"0.2 mM IPTG, 0.5 mM 5-ALA, 0.475 mM FeCl3·6H2O, 22°C for 20 h"
PMID33656879,reaction_1,in vitro,"Resonance Raman spectroscopy of the oxy-ferrous complex of CYP17A1 bound with 17α-hydroxyprogesterone, co-incorporated in lipid nanodiscs in the presence and absence of redox-inactive Mn-cytochrome b5.",Not specified,,Not specified,,,,
PMID33656879,reaction_2,in vitro,"Resonance Raman spectroscopy of the oxy-ferrous complex of CYP17A1 bound with 17α-hydroxypregnenolone, co-incorporated in lipid nanodiscs in the presence and absence of redox-inactive Mn-cytochrome b5.",Not specified,,Not specified,,,,
PMID33657378,reaction_1,in vitro,Enzymatic assay of purified recombinant BT2157 on a supernatant containing 3-keto-trehalose.,Not specified,,Not specified,,,,
PMID33657378,reaction_2,in vivo,"Growth assays of individual transposon mutants in VB medium with bile salts, and targeted proteomics analysis of wild-type cells grown in BHIS medium with bile salts.",Varel-Bryant (VB) medium or Brain Heart Infusion Supplemented (BHIS) medium,,Not specified,,,,
PMID33657378,reaction_3,in vivo,Fitness assays of a transposon mutant library in defined minimal media with high ammonium.,Varel-Bryant (VB) medium with glucose as carbon source and ammonium as nitrogen source.,,Not specified,,,,
PMID33657378,reaction_4,in vivo,Fitness assays of a transposon mutant library in defined minimal media with low ammonium.,"Varel-Bryant (VB) medium with glucose as carbon source, where ammonium was replaced with amino acids as the nitrogen source.",,Not specified,,,,
PMID33657378,reaction_5,in vivo,Fitness assays of a transposon mutant library in defined minimal media with high ammonium.,Varel-Bryant (VB) medium with glucose as carbon source and ammonium as nitrogen source.,,Not specified,,,,
PMID33657378,reaction_6,in vivo,Fitness assays of a transposon mutant library in defined minimal media with low ammonium.,"Varel-Bryant (VB) medium with glucose as carbon source, where ammonium was replaced with amino acids as the nitrogen source.",,Not specified,,,,
PMID33662571,reaction_1,in vitro,Total GPx activity was determined in cell lysate using a photometric NADPH-coupled assay.,Not specified,,Not specified in the text.,37.0,Rattus norvegicus RINm5F cells,pLVX-IRES-Neo,"Lentiviral transduction using lentiviral particles produced in 293FT cells, followed by selection with G418 (250 μg/ml)."
PMID33666344,reaction_1,in vitro,Reductase activity measured in cell-free extracts by detection of NADPH depletion.,"50 mM Na-phosphate buffer, pH 7.0",7.0,,30.0,Aspergillus niger,,
PMID33666344,reaction_2,in vitro,Reductase activity measured in cell-free extracts by detection of NADPH depletion.,"50 mM Na-phosphate buffer, pH 7.0",7.0,,30.0,Aspergillus niger,,
PMID33666344,reaction_3,in vitro,"Dehydrogenase activity measured in cell-free extracts by monitoring absorbance changes at 340 nm, corresponding to NAD+ reduction.","100 mM glycine/NaOH buffer, pH 9.6",9.6,,30.0,Aspergillus niger,,
PMID33666344,reaction_4,in vitro,"Dehydrogenase activity measured in cell-free extracts by monitoring absorbance changes at 340 nm, corresponding to NAD+ reduction.","100 mM glycine/NaOH buffer, pH 9.6",9.6,,30.0,Aspergillus niger,,
PMID33666344,reaction_5,in vitro,Reductase activity measured in cell-free extracts by detection of NADPH depletion.,"50 mM Na-phosphate buffer, pH 7.0",7.0,,30.0,Aspergillus niger,,
PMID33666344,reaction_6,in vivo,Activity inferred from growth phenotype of the ΔxkiA mutant on pentose sugars. No direct in vitro enzyme assay was reported in this study.,,,,30.0,Aspergillus niger,,
PMID33666816,reaction_1,in vivo,Whole-cell catalysis in fed-batch fermentation with engineered E. coli strain PM02.,"M-2 medium (5 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl, 0.9 g/L NH4Cl, 14.35 g/L Na2HPO4 12H2O, 2.5 g/L KH2PO4, 40 g/L Glucose, 10 mg/L Alanine, 5 mg/L CaCl2, 5 mg/L MnSO4 4H2O, 10 mg MgSO4 7H2O, 10 mg/L FeSO4-7H2O, 10 mg/L FeCl3 6H2O) with supplementation of 1.2 g/L pimelic acid and 0.2 g/L L-Met. Feeding solution contained 500 g/L glucose.",7.0,Controlled by addition of 30% NH4OH,28.0,Escherichia coli BL21 (DE3),"pACYCDuet-1 (for P. putida pathway), pETDuet-1 (for bioW and sam2)","0.5 mM IPTG was added at OD600=10, and cultivation temperature was shifted to 28°C."
PMID33668802,reaction_1,in vitro,Steady-state kinetic measurements,0.1 M potassium phosphate buffer,7.5,,25.0,E. coli BL21(DE3),,
PMID33675814,reaction_1,in vitro,In situ reaction during co-crystallization for X-ray crystallography. The final structure observed was an abortive complex with NADH and the substrate alcohol.,"50 mM ammonium N-[tris(hydroxymethyl)methyl]-2-aminomethanesulfonate, 0.25 mM EDTA, with up to 25% 2-methyl-2,4-pentanediol (MPD)",7.0,Crystallization buffer pH 7.0 (pH 6.7 at 25 °C),5.0,,,
PMID33675814,reaction_2,in vitro,In situ reaction during co-crystallization for X-ray crystallography. The final structure observed was an abortive complex with NADH and the substrate alcohol.,"50 mM ammonium N-[tris(hydroxymethyl)methyl]-2-aminomethanesulfonate, 0.25 mM EDTA, with up to 25% 2-methyl-2,4-pentanediol (MPD)",7.0,Crystallization buffer pH 7.0 (pH 6.7 at 25 °C),5.0,,,
PMID33675814,reaction_3,in vitro,In situ reaction during co-crystallization for X-ray crystallography. The reaction was inferred from the presence of NADH in the final crystal structure.,"50 mM ammonium N-[tris(hydroxymethyl)methyl]-2-aminomethanesulfonate, 0.25 mM EDTA, with up to 25% 2-methyl-2,4-pentanediol (MPD)",7.0,Crystallization buffer pH 7.0 (pH 6.7 at 25 °C),5.0,,,
PMID33677743,reaction_1,in vitro,Incubation of rubber particles with partially purified Lcp1VH2.,0.2 M TRIS/HCl-buffer,7.0,,30.0,E. coli C41,pET23a(?),
PMID33677743,reaction_2,in vitro,Incubation of rubber particles with partially purified Lcp1VH2.,0.2 M TRIS/HCl-buffer,7.0,,30.0,E. coli C41,pET23a(?),
PMID33677743,reaction_3,in vitro,Incubation of rubber particles with partially purified Lcp1VH2.,0.2 M TRIS/HCl-buffer,7.0,,30.0,E. coli C41,pET23a(?),
PMID33683401,reaction_1,in vivo,"Enzyme activity was assessed by measuring the concentration of the downstream product, mannitol, in cell lysates from various developmental stages of wild-type and mutant strains.",Water (for initial extraction of metabolites),,Not specified,37.0,Aspergillus nidulans,,
PMID33684360,reaction_1,in vitro,Spectrophotometric assay following NADH oxidation at 340 nm.,50 mM potassium phosphate,7.6,,25.0,Escherichia coli Top10,pBAD/Myc-His,"0.1% arabinose, 16 h, 37 °C"
PMID33684554,reaction_1_head,in vitro,Enzymatic spectrophotometric assay on crude tissue homogenate.,"Homogenization buffer (pH 7.3): 150 mM sucrose, 10 mM EDTA, 50 mM imidazole, 0.5% w/v deoxycholic acid. Assay solution: 50 mM imidazole, 189 mM NaCl, 10.5 mM MgCl2, 42 mM KCl, with a coupled enzyme system (LDH, PK).",7.3,pH of homogenization buffer.,25.0,Native in Drosophila melanogaster,,
PMID33684554,reaction_2_thorax,in vitro,Enzymatic spectrophotometric assay on crude tissue homogenate.,"Homogenization buffer (pH 7.3): 150 mM sucrose, 10 mM EDTA, 50 mM imidazole, 0.5% w/v deoxycholic acid. Assay solution: 50 mM imidazole, 189 mM NaCl, 10.5 mM MgCl2, 42 mM KCl, with a coupled enzyme system (LDH, PK).",7.3,pH of homogenization buffer.,25.0,Native in Drosophila melanogaster,,
PMID33684554,reaction_3_abdomen,in vitro,Enzymatic spectrophotometric assay on crude tissue homogenate.,"Homogenization buffer (pH 7.3): 150 mM sucrose, 10 mM EDTA, 50 mM imidazole, 0.5% w/v deoxycholic acid. Assay solution: 50 mM imidazole, 189 mM NaCl, 10.5 mM MgCl2, 42 mM KCl, with a coupled enzyme system (LDH, PK).",7.3,pH of homogenization buffer.,25.0,Native in Drosophila melanogaster,,
PMID33689977,reaction_1,in vitro,Cell-based assay. The inhibitory effect on mitochondrial NADH production was evaluated in 4T1 mouse adenocarcinoma cells treated with inhibitors for 24h. NADH was measured colorimetrically from cell extracts.,RPMI 1640 and DMEM media supplemented with 10% FBS and 1% penicillin-streptomycin,,"Cell culture conditions, pH not explicitly stated.",37.0,,,
PMID33691103,reaction_1,in vitro,Metabolic analysis of genetically modified or inhibitor-treated primary mouse CD8+ T cells during in vitro stimulation with aCD3 + aCD28 mAbs and IL-2.,"Cell culture medium with aCD3 + aCD28 mAbs and IL-2, supplemented with stable isotope tracers (D7-glucose, 13C6-glucose, 13C5,15N2-glutamine) for metabolomics.",,,,Endogenous expression in primary CD8+ T cells from Mus musculus.,,
PMID33691103,reaction_2,in vitro,Inhibition assay in cultured primary mouse CD8+ T cells to assess effects on cell activation and viability.,Cell culture medium with aCD3 + aCD28 mAbs and IL-2.,,,,Endogenous expression in primary CD8+ T cells from Mus musculus.,,
PMID33712158,reaction_1,in vitro,Analysis of soluble products from Avicel degradation by HPAEC-PAD and MALDI-TOF.,50 mM McIlvaine buffer or 50 mM sodium acetate buffer,,Reactions were conducted at pH 5.0 and pH 7.0.,50.0,Aspergillus nidulans A773,pEXPYR,Cultivated in liquid minimal medium supplemented with 2% (w/v) maltose and pyridoxine for 2 days at 37 °C without shaking.
PMID33712158,reaction_2,in vitro,Hydrogen peroxide suppression assay using Amplex Red to probe for substrate specificity.,100 mM BisTris,6.0,,30.0,Aspergillus nidulans A773,pEXPYR,Cultivated in liquid minimal medium supplemented with 2% (w/v) maltose and pyridoxine for 2 days at 37 °C without shaking.
PMID33712158,reaction_3,in vitro,Saccharification assay measuring total reducing sugars released by DNS method.,50 mM sodium acetate buffer,5.0,,50.0,Aspergillus nidulans A773,,
PMID33712158,reaction_4,in vitro,Saccharification assay measuring total reducing sugars released by DNS method.,50 mM sodium acetate buffer,5.0,,50.0,Aspergillus nidulans A773,,
PMID33712158,reaction_5,in vitro,Saccharification assay measuring total reducing sugars released by DNS method.,50 mM sodium acetate buffer,5.0,,50.0,Aspergillus nidulans A773,,
PMID33716610,reaction_1,in vivo,Batch cultivation in a pH-controlled bioreactor to study metabolic shifts and enzyme regulation in living cells. PDC phosphorylation levels were quantified using an indirect flow cytometry protocol.,"Chemically-defined TC-42 medium supplemented with 20 mmol L−1 glucose, 6 mmol L−1 glutamine and 200 nmol L−1 methotrexate.",7.1,Maintained by sparging with CO2 or addition of 0.5 mol L−1 Na2CO3,37.0,"Chinese hamster ovary cells (CHO DP-12, clone #1934)",,
PMID33720428,reaction_1,in vivo,Heterologous expression and complementation in Saccharomyces cerevisiae sur2Δ knockout mutant.,Synthetic dropout (SD) medium lacking uracil and containing 2% galactose and 2% raffinose,,Not specified,30.0,Saccharomyces cerevisiae sur2Δ-null mutant,pYES2-CT,Induction in SD medium lacking uracil and containing 2% galactose and 2% raffinose for 24h at 30°C.
PMID33720428,reaction_2,in vivo,Heterologous expression and complementation in Saccharomyces cerevisiae sur2Δ knockout mutant.,Synthetic dropout (SD) medium lacking uracil and containing 2% galactose and 2% raffinose,,Not specified,30.0,Saccharomyces cerevisiae sur2Δ-null mutant,pYES2-CT,Induction in SD medium lacking uracil and containing 2% galactose and 2% raffinose for 24h at 30°C.
PMID33722570,reaction_1,in vitro,Anaerobic de-bacillithiolation assay monitored by immunoblot analysis.,"50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 10% glycerol",8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET16b,1 mM IPTG at mid-log phase (OD600 of 0.5) for 2 h
PMID33722570,reaction_2,in vitro,De-bacillithiolation assay monitored by immunoblot analysis.,"50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA and 5% glycerol",8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET16b,1 mM IPTG at mid-log phase (OD600 of 0.5) for 2 h
PMID33722570,reaction_3,in vitro,Anaerobic bacilliredoxin reductase assay.,"50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 10% glycerol",8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET16b,"0.3 mM IPTG, overnight at 14 °C"
PMID33722570,reaction_4,in vitro,Anaerobic bacilliredoxin reductase assay.,"50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 10% glycerol",8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET16b,"0.3 mM IPTG, overnight at 14 °C"
PMID33722570,reaction_5,in vitro,Coupled de-bacillithiolation assay with MS/MS quantification.,"50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 10% glycerol",8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET16b,"0.3 mM IPTG, overnight at 14 °C"
PMID33722570,reaction_6,in vitro,Aerobic NADPH oxidase assay monitoring OD340 and H2O2 production.,"50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 10% glycerol",8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET16b,"0.3 mM IPTG, overnight at 14 °C"
PMID33722570,reaction_7,in vivo,Immunopurification and Western blot analysis of FLAG-tagged GapA from B. subtilis mutant strains.,,,,37.0,,,
PMID33722570,reaction_8,in vivo,Immunopurification and Western blot analysis of FLAG-tagged GapB from B. subtilis mutant strains.,,,,37.0,,,
PMID33725631,reaction_1,in vitro,LeuRS inhibition IC50 measurement using [14C] leucine incorporation into tRNA. Precipitated [14C]leucine-tRNALeu was quantified by liquid scintillation counting.,"50 mM HEPES-KOH, 5 mM MgCl2, 45 mM KCl, 1 mM DTT, 0.02%(w/v) BSA",7.8,,37.0,E. coli BL21(DE3)-RIPL,pET21a,
PMID33731920,reaction_1,in vitro,Continuous absorbance-based cyclase assays for kinetics and end-point HPLC-based assays for intermediate identification.,"100 mM TES-NaOH, 50 mM HEPES-NaOH, 10 mM MgCl2, 1 M glycerol, 0.04% β-DDM",7.7,from buffer composition,30.0,Escherichia coli C43(DE3),pET14b-AcsF,0.4 mM IPTG and 0.1 g/L ferric ammonium citrate at 30°C for 24h
PMID33736288,reaction_1,in vitro,malachite green phosphate detection method for PPi release,"30 mM HEPES, 140 mM NaCl",7.2,,37.0,Escherichia coli BL21 (DE3),pET-28a(+),"0.4 mM IPTG, 18°C, 16-18 hrs"
PMID33742545,reaction_1,in vitro,"LPMO activity assay with 1 µM enzyme, 2 mg/ml colloidal chitin, and 1 mM ascorbic acid. Products were analyzed by MALDI-TOF-MS.",0.1 M sodium phosphate buffer,7.0,,37.0,Escherichia coli Bl21-CodonPlus-RIL,pET30b,0.5 mM IPTG at 16 °C overnight
PMID33742545,reaction_2,in vitro,"LPMO activity assay with 1 µM enzyme, hepta-N-acetylchitoheptaose (DP7), and 1 mM ascorbic acid. Products were analyzed by MALDI-TOF-MS.",0.1 M sodium phosphate buffer,7.0,,37.0,Escherichia coli Bl21-CodonPlus-RIL,pET30b,0.5 mM IPTG at 16 °C overnight
PMID33742736,reaction_1,in vitro,Kinetic analysis using p-nitrophenyl glycoside substrate (GalNAcα-pNP).,50 mM sodium phosphate buffer,6.0,,40.0,Escherichia coli BL21 (DE3),"pMAL-c5x (for MBP-BmNag31), pET28a (for BmGH31)","0.1 mM IPTG, 20 °C for 20 h"
PMID33742736,reaction_2,in vitro,Qualitative hydrolysis assay using the truncated BmGH31 construct. Product formation was visualized by thin-layer chromatography (TLC).,50 mM sodium phosphate buffer containing 300 mM NaCl,6.5,Inferred from the enzyme purification buffer conditions.,30.0,Escherichia coli BL21 (DE3),pET28a,"0.1 mM IPTG, 20 °C for 20 h"
PMID33748704,reaction_1,in vitro,Aminoacylation activity of recombinant proteins was determined by measuring the transfer of L-[14C]proline to yeast tRNA.,,,Not specified in the provided text.,,,,
PMID33750541,reaction_1,in vitro,In-situ enzyme activity determination in a high-pressure system by monitoring the rate of ABTS oxidation at 405 nm in a coupled assay with peroxidase.,0.1 M phosphate buffer,7.5,,30.0,,,
PMID33750541,reaction_2,in vitro,In-situ enzyme activity determination in a high-pressure system after heat treatment (50°C for 15 min) to inactivate the L fraction.,0.1 M phosphate buffer,7.5,,50.0,,,
PMID33750543,reaction_1,in vitro,Spectrophotometric coupled assay with horseradish peroxidase (HRP) monitoring ABTS oxidation at 420 nm.,50 mM sodium citrate buffer,6.0,,30.0,Pichia pastoris X33,pPICZ A,Methanol feed for 65h under AOX1 promoter.
PMID33750543,reaction_2,in vitro,Spectrophotometric coupled assay with horseradish peroxidase (HRP) monitoring ABTS oxidation at 420 nm.,50 mM sodium citrate buffer,6.0,,30.0,Pichia pastoris X33,pPICZ A,Methanol feed for 65h under AOX1 promoter.
PMID33750543,reaction_3,in vitro,Spectrophotometric coupled assay with horseradish peroxidase (HRP) monitoring ABTS oxidation at 420 nm.,50 mM sodium citrate buffer,6.0,,30.0,Pichia pastoris X33,pPICZ A,Methanol feed for 65h under AOX1 promoter.
PMID33750543,reaction_4,in vitro,Spectrophotometric coupled assay with horseradish peroxidase (HRP) monitoring ABTS oxidation at 420 nm.,50 mM sodium citrate buffer,6.0,,30.0,Pichia pastoris X33,pPICZ A,Methanol feed for 65h under AOX1 promoter.
PMID33750543,reaction_5,in vitro,Spectrophotometric coupled assay with horseradish peroxidase (HRP) monitoring ABTS oxidation at 420 nm.,50 mM sodium citrate buffer,6.0,,30.0,Pichia pastoris X33,pPICZ A,Methanol feed for 65h under AOX1 promoter.
PMID33750543,reaction_6,in vitro,Spectrophotometric coupled assay with horseradish peroxidase (HRP) monitoring ABTS oxidation at 420 nm.,50 mM sodium citrate buffer,6.0,,30.0,Pichia pastoris X33,pPICZ A,Methanol feed for 65h under AOX1 promoter.
PMID33754169,reaction_1,in vitro,Steady-state kinetics assay,20-mM Tris-HCl,7.0,,25.0,Escherichia coli BL21,pQE-2 TAGZyme expression vector,
PMID33756342,reaction_1,in vitro,Luciferase reporter assay on lysates from transfected cells to measure promoter activity.,passive lysis buffer,,Not specified,37.0,Porcine kidney fibroblast (PKDNF) cells,Custom luciferase reporter vectors with porcine ACE2 promoter variants (ACE2p53-con and ACE2p53-ko),"Transfection with Lipofectamine 2000, measured 36 hours post-transfection."
PMID33763825,reaction_1,in vitro,Spectrophotometric assay monitoring NADH production at 340 nm. Kinetic parameters were measured using nonlinear regression analysis.,100 mM glycine–NaOH buffer,11.0,,25.0,Escherichia coli BL21(DE3),pET-28b-derived vector,0.5 mM isopropyl β-D-1-thiogalactopyranoside at 18 °C and 180 rpm for 20 h
PMID33763825,reaction_2,in vitro,Spectrophotometric assay monitoring NADH production at 340 nm. Kinetic parameters were measured using nonlinear regression analysis.,100 mM glycine–NaOH buffer,11.0,,25.0,Escherichia coli BL21(DE3),pET-28b-derived vector,0.5 mM isopropyl β-D-1-thiogalactopyranoside at 18 °C and 180 rpm for 20 h
PMID33763825,reaction_3,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm. Kinetic parameters were measured using nonlinear regression analysis.,100 mM sodium citrate buffer,6.5,,25.0,Escherichia coli BL21(DE3),pET-28b-derived vector,0.5 mM isopropyl β-D-1-thiogalactopyranoside at 18 °C and 180 rpm for 20 h
PMID33763825,reaction_4,in vitro,Standard reduction reaction assay measuring relative activity.,100 mM sodium citrate buffer,6.5,,25.0,Escherichia coli BL21(DE3),,
PMID33763825,reaction_5,in vitro,Standard oxidation reaction assay measuring relative activity.,100 mM Gly-NaOH buffer,11.0,,25.0,Escherichia coli BL21(DE3),,
PMID33763825,reaction_6,in vitro,Standard oxidation reaction assay measuring relative activity.,100 mM Gly-NaOH buffer,11.0,,25.0,Escherichia coli BL21(DE3),,
PMID33764624,reaction_1,in vitro,Enzyme activity measured by detecting hydrogen peroxide using the 4-aminoantipyrine phenol method.,50 mM borate-NaOH buffer,8.0,,40.0,Escherichia coli JM109,pGOx_mal1_305E,"0.1 mM IPTG, 22°C, 22h"
PMID33764624,reaction_2,in vitro,Enzyme activity measured using 4-aminoantipyrine phenol method or MBTH method.,50 mM KPB,7.4,,50.0,Escherichia coli,,
PMID33764624,reaction_3,in vitro,,,,,,,,
PMID33773110,reaction_1,in vitro,Endpoint sulfite detection assay and kinetic analysis of wild-type and mutant enzymes.,Not specified,,Not specified,,,,
PMID33773110,reaction_2,in vitro,Deuterium-labeling study with GC-MS analysis of products from a coupled reaction with yeast alcohol dehydrogenase.,Not specified,,Not specified,,,,
PMID33774358,reaction_1,in vitro,Enzymatic degradation of sulfamethoxazole in batch experiments.,50 mM succinic buffer,5.0,Optimal pH for degradation. Range tested was pH 4-7.,25.0,Phanerochaete chrysosporium BKMF-1767,,"Enzyme obtained from liquid fermentation medium. Culture incubated on a rotary shaker at 140 rpm, initially at 37°C for 2 days, then at 30°C for subsequent days until maximum activity was reached on day 8."
PMID33779878,reaction_1,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_2,in vitro,Functional assay in Sf9 insect cells,Ex-Cell 420 media,,Not specified,27.0,Sf9 cells,pDEST8,"Baculovirus expression (MOI 1), incubated for 4 days."
PMID33779878,reaction_3,in vitro,Functional assay in Sf9 insect cells,Ex-Cell 420 media,,Not specified,27.0,Sf9 cells,pDEST8,"Baculovirus expression (MOI 1), incubated for 4 days."
PMID33779878,reaction_4,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_5,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_6,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_7,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_8,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_9,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_10,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_11,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_12,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_13,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33779878,reaction_14,in vitro,Functional assay in yeast (Saccharomyces cerevisiae ole1/elo1 strain),"Selective medium containing 2 mM CuSO4, based on SC medium with 0.7% YNB, complete drop-out mix lacking uracil and leucine, 2% glucose, 1% tergitol, 0.01% adenine.",,Not specified,30.0,Saccharomyces cerevisiae (ole1/elo1 strain),pYEX-CHT,2 mM CuSO4 for 48h
PMID33781676,reaction_1,in vivo,Functional characterization by heterologous expression in Saccharomyces cerevisiae BY23849,SD-Ura broth containing 20 g/L raffinose and 5 g/L galactose,,,30.0,Saccharomyces cerevisiae BY23849,pYES2-RtFAD2,Culture in SD-Ura broth with 2% raffinose and 0.5% galactose for 72h
PMID33781676,reaction_2,in vivo,Substrate specificity test by heterologous expression in S. cerevisiae BY23849 with substrate feeding,"SD-Ura broth with 2% raffinose, 0.5% galactose, supplemented with 1% (v/v) palmitoleic acid",,,30.0,Saccharomyces cerevisiae BY23849,,
PMID33781676,reaction_3,in vivo,Test for D15-desaturase activity by heterologous expression in S. cerevisiae BY23849 with substrate feeding,"SD-Ura broth with 2% raffinose, 0.5% galactose, supplemented with 1% (v/v) linoleic acid",,,30.0,Saccharomyces cerevisiae BY23849,,
PMID33781676,reaction_4,in vivo,Whole-cell biocatalysis by overexpressing RtFAD2 in R. toruloides TK16,"Nitrogen-limited broth (0.75 g/L yeast extract, 0.55 g/L (NH4)2SO4, 0.4 g/L KH2PO4, 2 g/L MgSO4·7H2O and 70 g/L dextrose)",,,30.0,Rhodotorula toruloides DMKU3-TK16,pPGPD-ShBle-PGPD-gFAD2-TGPD,
PMID33781676,reaction_5,in vivo,Whole-cell biocatalysis by overexpressing RtFAD2 in thermotolerant R. toruloides L1-1,"Nitrogen-limited broth (0.75 g/L yeast extract, 0.55 g/L (NH4)2SO4, 0.4 g/L KH2PO4, 2 g/L MgSO4·7H2O and 70 g/L dextrose)",,,30.0,Rhodotorula toruloides L1-1,pPGPD-ShBle-PGPD-RtFAD2-TGPD,
PMID33781676,reaction_6,in vivo,Whole-cell biocatalysis by co-overexpressing RtFAD2 and RtFAD1 in R. toruloides TK16,"Nitrogen-limited broth (0.75 g/L yeast extract, 0.55 g/L (NH4)2SO4, 0.4 g/L KH2PO4, 2 g/L MgSO4·7H2O and 70 g/L dextrose)",,,30.0,Rhodotorula toruloides DMKU3-TK16,pPGPD-ShBle-PGPD-gRtFAD2-TGPD and pPGPD-Hyg-PGPD-gRtFAD1-TGPD,
PMID33781676,reaction_7,in vivo,Whole-cell biocatalysis by co-overexpressing RtFAD2 and RtFAD1 in thermotolerant R. toruloides L1-1,"Nitrogen-limited broth (0.75 g/L yeast extract, 0.55 g/L (NH4)2SO4, 0.4 g/L KH2PO4, 2 g/L MgSO4·7H2O and 70 g/L dextrose)",,,30.0,Rhodotorula toruloides L1-1,pPGPD-ShBle-PGPD-gRtFAD2-TGPD and pPGPD-Hyg-PGPD-gRtFAD1-TGPD,
PMID33787231,reaction_1,in vitro,Enzyme kinetics assay to determine inhibition constants (Ki).,"200 mM imidazole, 0.03% Tween 80 (v/v), 100 mM potassium phosphate buﬀer (PBS), 5 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA)",7.4,"from 100 mM potassium phosphate buﬀer (PBS, pH 7.4)",,,,
PMID33793849,reaction_1,in vitro,Uptake assay using heterologously expressed transporter in whole yeast cells (S. cerevisiae HK14 mutant).,Sulfur starvation medium with 50 mM MES-KOH,5.0,Kinetics were measured at pH 5.0. The pH optimum for transport was also determined to be 5.0.,25.0,Saccharomyces cerevisiae HK14 (sul1Δ sul2Δ),pYES2,Induction with 2% galactose in sulfur starvation medium for 2 days at 30°C.
PMID33793908,reaction_1,in vivo,"Analysis of CRISPR/Cas9 generated osyuc11 mutants, including measurement of free auxin (IAA) content in caryopses and phenotypic rescue by exogenous auxin application.",,,,,,,
PMID33793908,reaction_2,in vivo,"Analysis of CRISPR/Cas9 generated osyuc9 mutants and their phenotypes (seed weight, chalkiness).",,,,,,,
PMID33793908,reaction_3,in vivo,Analysis of CRISPR/Cas9 generated osyuc12 mutants to investigate its role in endosperm cellularization.,,,,,,,
PMID33793908,reaction_4,in vivo,"Analysis of ostar1 mutants and their phenotypes (seed weight, chalkiness).",,,,,,,
PMID33793924,reaction_1,in vitro,Kinetic analysis with purified recombinant protein.,"33 mM potassium phosphate buffer, pH 7.0",7.0,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33793924,reaction_2,in vitro,"Kinetic analysis with purified recombinant protein, used as a positive control.","33 mM potassium phosphate buffer, pH 7.0",7.0,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33793924,reaction_3,in vitro,Product identification with purified recombinant protein.,"100 mM Tris-HCl, pH 7.5, 5 mM MgCl2, and 10% glycerol (v/v)",7.5,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33793924,reaction_4,in vitro,Product identification with purified recombinant protein.,"100 mM Tris-HCl, pH 7.5, 5 mM MgCl2, and 10% glycerol (v/v)",7.5,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33793924,reaction_5,in vitro,Product identification with purified recombinant protein.,"100 mM Tris-HCl, pH 7.5, 5 mM MgCl2, and 10% glycerol (v/v)",7.5,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33793924,reaction_6,in vitro,Kinetic analysis with purified recombinant protein.,"100 mM Tris-HCl, pH 7.5, 5 mM MgCl2, and 10% glycerol (v/v)",7.5,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33793924,reaction_7,in vitro,Kinetic analysis with purified recombinant protein.,"100 mM Tris-HCl, pH 7.5, 5 mM MgCl2, and 10% glycerol (v/v)",7.5,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33793924,reaction_8,in vitro,Kinetic analysis with purified recombinant protein.,"100 mM Tris-HCl, pH 7.5, 5 mM MgCl2, and 10% glycerol (v/v)",7.5,,25.0,Escherichia coli Rosetta2(DE3)pLysS,,
PMID33797764,reaction_1,in vivo,Yeast complementation assay,SD medium without nitrogen supplemented with 100 μM peptide,,Standard SD medium,28.0,Saccharomyces cerevisiae Δopt1 (BY4741 background),pDR196,
PMID33797764,reaction_2,in vivo,Yeast complementation assay,SD medium without nitrogen supplemented with 100 μM peptide,,Standard SD medium,28.0,Saccharomyces cerevisiae Δopt1 (BY4741 background),pDR196,
PMID33797764,reaction_3,in vivo,Yeast complementation assay,SD medium without nitrogen supplemented with 100 μM peptide,,Standard SD medium,28.0,Saccharomyces cerevisiae Δopt1 (BY4741 background),pDR196,
PMID33797764,reaction_4,in vivo,Yeast complementation assay,SD medium without nitrogen supplemented with 100 μM peptide,,Standard SD medium,28.0,Saccharomyces cerevisiae Δopt1 (BY4741 background),pDR196,
PMID33797764,reaction_5,in vivo,Yeast complementation assay,SD medium without nitrogen supplemented with 100 μM peptide,,Standard SD medium,28.0,Saccharomyces cerevisiae Δopt1 (BY4741 background),pDR196,
PMID33797895,reaction_1,in vitro,Steady-state kinetic parameters were determined using partially purified enzymes. In vivo activity was assessed by expressing mutants in E. coli and measuring product formation.,,,Not specified in text,,E. coli BAP1,,
PMID33797895,reaction_2,in vitro,Steady-state kinetic parameters were determined using partially purified enzymes. In vivo activity was assessed by expressing mutants in E. coli and measuring product formation.,,,Not specified in text,,E. coli BAP1,,
PMID33797895,reaction_3,in vivo,Production of aloesin in engineered E. coli BL21(DE3) expressing the GtCGT mutant.,,,,,E. coli BL21(DE3),,
PMID33797895,reaction_4,in vivo,Conversion assay by feeding luteolin to E. coli expressing GtCGT or its mutant.,,,,,E. coli BL21(DE3),,
PMID33797895,reaction_5,in vivo,Conversion assay by feeding apigenin to E. coli expressing GtCGT or its mutant.,,,,,E. coli BL21(DE3),,
PMID33797895,reaction_6,in vivo,Conversion assay by feeding naringenin to E. coli expressing GtCGT or its mutant.,,,,,E. coli BL21(DE3),,
PMID33799204,reaction_1,in vitro,Reductase activity measured by incubation of substrate with crude extracts of date palm leaves.,0.1 M sodium acetate,5.5,,26.0,Phoenix dactylifera L.,,
PMID33799204,reaction_2,in vitro,Reductase activity measured by incubation of substrate with crude extracts of date palm leaves.,0.1 M sodium acetate,5.5,,26.0,Phoenix dactylifera L.,,
PMID33799204,reaction_3,in vitro,Reductase activity measured by incubation of substrate with crude extracts of date palm leaves.,0.1 M sodium acetate,5.5,,26.0,Phoenix dactylifera L.,,
PMID33799204,reaction_4,in vitro,Hydroxylation activity measured with LD fractions from date palm leaves.,Not specified,,,,Phoenix dactylifera L.,,
PMID33802034,reaction_1,in vitro,Activity assay with crude cell extract (CE).,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33802034,reaction_2,in vivo,Upscaled biotransformation with whole-cell SMO.,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33802034,reaction_3,in vivo,Upscaled biotransformation with whole-cell SMO.,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33802034,reaction_4,in vitro,Activity screening with crude cell extract (CE).,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33802034,reaction_5,in vivo,Upscaled biotransformation with whole-cell SMO.,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33802034,reaction_6,in vivo,Upscaled biotransformation with whole-cell SMO.,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33802034,reaction_7,in vitro,Activity screening with crude cell extract (CE).,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33802034,reaction_8,in vivo,Upscaled biotransformation with whole-cell SMO.,100 mM potassium phosphate buffer,8.0,,30.0,Escherichia coli BL21(DE3),pET28b(+),Induced with 0.25 mM IPTG at 30°C after reaching 15 gDCW/L in HCD fermentation.
PMID33804376,reaction_1,in vitro,"Enzyme activity was assessed based on the amount of released 3,4-dihydroxyphenylalanine (L-DOPA) from 50 mM L-tyrosine.",10 mM Tris-HCl buffer,7.0,Standard assay pH. Optimal pH for activity is 7.5.,37.0,,,
PMID33804376,reaction_2,in vitro,"Enzyme activity was assessed based on the amount of released 3,4-dihydroxyphenylalanine (L-DOPA) from 50 mM L-tyrosine.",10 mM Tris-HCl buffer,7.0,Standard assay pH. Optimal pH for activity is 7.5.,37.0,,,
PMID33811992,reaction_1,in vitro,AminoPhenyl Fluorescein (APF) assay measuring MPO chlorination activity. A human neutrophil assay was also used for compounds 12 and 17.,Not specified,,,,,,
PMID33811992,reaction_2,in vitro,Assay to measure inhibition of TPO for selectivity profiling.,Not specified,,,,,,
PMID33811992,reaction_3,in vitro,Assay to measure inhibition of EPX for selectivity profiling.,Not specified,,,,,,
PMID33812916,reaction_1,in vitro,"Biochemical and theoretical studies including kinetic experiments, mutagenesis, and crystallography.",Not specified,,pH-dependence of activity was studied.,,,,
PMID33812916,reaction_2,in vitro,,Not specified,,,,,,
PMID33812916,reaction_3,in vitro,Kinetic experiments and pH-dependence studies were performed.,Not specified,,pH-dependence of activity was studied.,,,,
PMID33812916,reaction_4,in vitro,,Not specified,,,,,,
PMID33812916,reaction_5,in vitro,Site-directed mutagenesis studies performed.,Not specified,,,,,,
PMID33812916,reaction_6,in vitro,,Not specified,,,,,,
PMID33812916,reaction_7,in vitro,,Not specified,,,,,,
PMID33812916,reaction_8,in vitro,Biochemical studies revealed the oxidative cyclization reaction.,Not specified,,,,,,
PMID33812916,reaction_9,in vitro,,Not specified,,,,,,
PMID33812916,reaction_10,in vitro,,Not specified,,,,,,
PMID33812916,reaction_11,in vitro,,Not specified,,,,,,
PMID33812916,reaction_12,in vitro,,Not specified,,,,,,
PMID33812916,reaction_13,in vitro,,Not specified,,,,,,
PMID33812916,reaction_14,in vitro,,Not specified,,,,,,
PMID33818657,reaction_1,in vitro,Kinetic parameters were determined for the oxidative deamination of L-alanine by monitoring NADH formation spectrophotometrically at 340 nm.,100 mM sodium carbonate–sodium bicarbonate buffer,10.5,,25.0,E. coli BL21 (DE3),pET28a(+),"1 mM IPTG, 4 h at 37 °C"
PMID33824313,reaction_1,in vitro,Enzymatic activity assay performed on liver lysates.,"20 mM Na–Hepes, 0.2 M NaCl, pH 7.0, containing catalase (0.04 mg/ml).",7.0,,25.0,Endogenous expression in Mus musculus liver,,
PMID33842213,reaction_1,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_2,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_3,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_4,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_5,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_6,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_7,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_8,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_9,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_10,in vitro,Reductase activity assay,PBS buffer,7.0,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_11,in vitro,Dehydrogenase activity assay,glycine buffer,9.6,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_12,in vitro,Dehydrogenase activity assay,glycine buffer,9.6,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_13,in vitro,Dehydrogenase activity assay,glycine buffer,9.6,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842213,reaction_14,in vitro,Dehydrogenase activity assay,glycine buffer,9.6,,25.0,Escherichia coli BL21(DE3)pLysS,pET-28a(+),"0.1 mM IPTG, 12°C, overnight"
PMID33842839,reaction_1_DET,in vitro,Direct Electron Transfer (DET) on a rotating pyrolytic graphite edge disc electrode,"Buffer mix containing MES, HEPES, TAPS, CHES, sodium acetate (15 mM each) and NaCl (100 mM)",,Tested over a pH range from 6.4 to 8.8,25.0,E. coli,,
PMID33842839,reaction_2_MET,in vitro,Mediated Electron Transfer (MET) with enzyme embedded in a PV2 redox hydrogel on a rotating glassy carbon disc electrode,50 mM Tris/citrate buffer with 100 mM KI,7.4,Data from fit shown for pH 7.4. Tested over a range from pH 6.4 to 8.8.,25.0,E. coli,,
PMID33842839,reaction_3_biofuel_cell_anode,in vitro,Anode of a H2/O2 biofuel cell using a PV2/DdHydAB film on either a flat glassy carbon or a high surface area gas-breathing electrode.,50 mM potassium phosphate buffer,7.4,,,E. coli,,
PMID33842839,reaction_4_electrolyser_cathode,in vitro,Cathode of an electrolyser half-cell for H2 production using a PV2/DdHydAB film on a MTI carbon foam electrode.,200 mM Tris/citrate buffer with 100 mM KCl,6.4,,,E. coli,,
PMID33844097,reaction_1,in vitro,Kinetic parameters were determined by measuring the decrease of absorbance at 340 nm using NADH as the substrate.,50 mM phosphate buffer,7.5,Kinetics were determined at pH 7.5. pH profiles were also determined from pH 4.0 to 8.0.,,Escherichia coli BL21 (DE3),pET-28a,"0.1 mM IPTG, 15 °C, 6 h"
PMID33844297,reaction_1,in vitro,"Initial rate measurement based on ε-CL formation for isolated enzyme, suspended cells, and biofilms.","100 mM potassium phosphate buffer, pH = 7.4 (Kpi buffer)",7.4,,30.0,Pseudomonas taiwanensis VLB120,pSEVA_CHMO,"1 mM IPTG after 3 h of cultivation (OD450 ~0.5), followed by 6 h incubation."
PMID33844297,reaction_2,in vitro,Spectrophotometric activity assay and biotransformation for conversion measurement.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_3,in vitro,Spectrophotometric activity assay and biotransformation for conversion measurement.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_4,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_5,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_6,in vitro,Spectrophotometric activity assay and biotransformation for conversion measurement.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_7,in vitro,Spectrophotometric activity assay and biotransformation for conversion measurement.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_8,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_9,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_10,in vitro,Spectrophotometric activity assay and biotransformation for conversion measurement.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_11,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_12,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_13,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_14,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_15,in vitro,Spectrophotometric activity assay and biotransformation for conversion measurement.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_16,in vitro,Spectrophotometric activity assay.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33844297,reaction_17,in vitro,Spectrophotometric activity assay and biotransformation for conversion measurement.,100 mM Kpi buffer (pH = 7.4),7.4,,30.0,,,
PMID33845332,reaction_1,in vivo,"Enzyme activity was inferred from its downstream effects on Senecavirus A (SVA) replication after overexpression of CH25H in cell lines. The product, 25HC, was also tested exogenously.",Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 % fetal bovine serum (FBS),,Not specified; standard cell culture conditions assumed.,37.0,"BHK-21 (Baby hamster kidney-21) cells, IB-RS-2 (pig kidney) cells",pCAGGS vector with a 3' HA-tag or Myc-tag,Transfection with Lipofectamine3000
PMID33845332,reaction_2,in vivo,Co-immunoprecipitation and ubiquitination assays performed in IB-RS-2 cells to demonstrate interaction and subsequent degradation.,"RIPA Lysis Buffer for analysis, DMEM for cell culture.",,Not specified.,37.0,IB-RS-2 cells,"pCAGGS-HA, pCAGGS-Myc, pCAGGS-Flag, Ub-HA, Ub-K48-HA, Ub-K63-HA",Co-transfection of plasmids.
PMID33846091,reaction_1,in vitro,Activity assay with purified His-tagged protein,50 mM HEPES-NaOH,7.0,,30.0,Escherichia coli BL21(DE3),"pET-HMFO-His, derived from pET-28a(+)","0.1 mM IPTG, 40 h incubation at 16 or 25 °C"
PMID33846091,reaction_2,in vivo,Whole cell biocatalysis using E. coli coexpressing PfFDDC and UbiX,50 mM HEPES-NaOH,7.0,,30.0,Escherichia coli BL21(DE3),pET-PfFDDC/UbiX,"0.1 mM IPTG, 1 mM MnCl2, 40 h incubation at 16 or 25 °C"
PMID33846091,reaction_3,in vivo,Whole cell biocatalysis using E. coli coexpressing PfFDDC and UbiX,50 mM HEPES-NaOH,7.0,,30.0,Escherichia coli BL21(DE3),pET-PfFDDC/UbiX,"0.1 mM IPTG, 1 mM MnCl2, 40 h incubation at 16 or 25 °C"
PMID33846091,reaction_4,in vivo,One-pot whole cell biocatalysis,50 mM HEPES-NaOH,7.0,,20.0,Escherichia coli BL21(DE3),pRSF-HMFO and pET-PfFDDC/UbiX,"0.1 mM IPTG, 1 mM MnCl2, 40 h incubation at 16 or 25 °C"
PMID33846823,reaction_1,in vitro,Enzyme kinetic analysis for oxidation reaction.,50 mM Tris-HCl,7.5,,30.0,E. coli BL21(DE3),pET28a,"1 mM IPTG, 16 °C, 16 h"
PMID33846823,reaction_2,in vitro,Enzyme kinetic analysis for oxidation reaction.,50 mM Tris-HCl,7.5,,30.0,E. coli BL21(DE3),pET28a,"1 mM IPTG, 16 °C, 16 h"
PMID33846823,reaction_3,in vitro,Kinetic resolution of racemic camphor. Wild-type characterization and final resolution process were performed at pH 5.0. Mutant screening was performed at pH 7.5 with a formate/formate dehydrogenase recycling system.,50 mM citrate-phosphate buffer (pH 5.0) or 50 mM Tris-HCl (pH 7.5 for screening),5.0,"Optimal pH for reduction is 4.5, but assays were run at 5.0 due to protein precipitation. Mutant screening was at pH 7.5.",30.0,E. coli BL21(DE3),pET28a,"1 mM IPTG, 16 °C, 16 h"
PMID33852289,reaction_1,in vitro,UV-vis spectrophotometric assay monitoring absorbance increase at 305 nm due to Fe2+ oxidation.,10 mM MOPS,7.0,,20.0,Escherichia coli BL21 (DE3),pGEX-6p-1,"0.1 mM IPTG, 18 h, 25 °C"
PMID33852289,reaction_2,in vitro,UV-vis spectrophotometric assay monitoring absorbance increase at 305 nm due to Fe2+ oxidation.,10 mM MOPS,7.0,,20.0,,,
PMID33852856,reaction_1,in vivo,Quantification of sphingolipid levels in wild-type and mutant SH-SY5Y cells by HPLC-MS/MS.,DMEM/F12 medium supplemented with 10% fetal bovine serum,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_2,in vivo,Quantification of sphingolipid levels in wild-type and mutant SH-SY5Y cells by HPLC-MS/MS.,DMEM/F12 medium supplemented with 10% fetal bovine serum,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_3,in vivo,Quantification of sphingolipid levels in wild-type and mutant SH-SY5Y cells by HPLC-MS/MS.,DMEM/F12 medium supplemented with 10% fetal bovine serum,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_4,in vivo,Quantification of sphingolipid levels in wild-type and mutant SH-SY5Y cells by HPLC-MS/MS.,DMEM/F12 medium supplemented with 10% fetal bovine serum,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_5,in vivo,Quantification of sphingolipid levels in wild-type and mutant SH-SY5Y cells by HPLC-MS/MS.,DMEM/F12 medium supplemented with 10% fetal bovine serum,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_6,in vivo,Quantification of sphingolipid levels in wild-type and mutant SH-SY5Y cells by HPLC-MS/MS.,DMEM/F12 medium supplemented with 10% fetal bovine serum,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_7,in vivo,Quantification of sphingolipid levels in wild-type and mutant SH-SY5Y cells by HPLC-MS/MS.,DMEM/F12 medium supplemented with 10% fetal bovine serum,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_8,in vivo,"Phenotypic analysis of ifc-knockout (ifc-KO) flies, which show dihydroceramide accumulation and can be rescued by human DEGS1 overexpression.",,,,25.0,Drosophila melanogaster,,
PMID33852856,reaction_9,in vivo,Functional and morphological rescue of ifc-KO photoreceptors by RNAi knockdown of Nox (BL32902) and Duox (BL32433) and by chemical inhibition.,,,,25.0,Drosophila melanogaster,"UAS-RNAi (TRiP.HMS00691, TRiP.HMS00429)",GMR-Gal4 driver
PMID33852856,reaction_10,in vivo,Measurement of superoxide levels using DHE staining in DEGS1H132R SH-SY5Y cells treated with inhibitors.,DMEM/F12 medium,,,37.0,SH-SY5Y human neuroblastoma cells,,
PMID33852856,reaction_11,in vivo,Overexpression in ifc-KO photoreceptors to test for rescue of neurodegeneration phenotypes.,,,,25.0,Drosophila melanogaster,UAS-Sod1,GMR-Gal4 driver
PMID33852856,reaction_12,in vivo,Overexpression in ifc-KO photoreceptors to test for rescue of neurodegeneration phenotypes.,,,,25.0,Drosophila melanogaster,UAS-Sod2.M,GMR-Gal4 driver
PMID33852856,reaction_13,in vivo,Overexpression in ifc-KO photoreceptors to test for rescue of neurodegeneration phenotypes.,,,,25.0,Drosophila melanogaster,UAS-Cat.A,GMR-Gal4 driver
PMID33857841,reaction_1,in vitro,Continuous fluorometric assay measuring the formation of protoporphyrin IX. Autoxidation rates were subtracted.,"0.1 M potassium phosphate buffer (pH 7.4), 5 mM FAD, 5 mM DTT, 1 mM EDTA, 0.2 M imidazole, and 0.03% Tween 80 (v/v)",7.4,,25.0,Escherichia coli BL21(DE3)pLysS,pHPPO-X,"1 mM IPTG, 25°C, 4h"
PMID33861588,reaction_1,in vitro,Oxidation of apoA-I followed by functional assays. Two forms of substrate were tested: lipid-free apoA-I (assessed for cholesterol efflux) and lipid-associated apoA-I (assessed for LCAT activation).,phosphate buffer,7.4,,,Escherichia coli,,
PMID33862020,reaction_1,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm.,20 mM Tris pH 7.5,7.5,,23.0,E. coli Rosetta2 (DE3)pLysS,,"100 μM IPTG, 16 °C, 20 h"
PMID33862020,reaction_2,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm.,20 mM Tris pH 7.5,7.5,,23.0,E. coli BL21 (DE3),pHISG28,"1 mM IPTG, 16 °C, 18-20 h"
PMID33862020,reaction_3,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm.,20 mM Tris pH 7.5,7.5,,23.0,E. coli BL21 (DE3),pHISG28,"1 mM IPTG, 16 °C, 18-20 h"
PMID33862020,reaction_4,in vitro,Spectrophotometric assay monitoring NADH oxidation at 340 nm.,20 mM Tris pH 7.5,7.5,,23.0,E. coli BL21 (DE3),pHISG28,"1 mM IPTG, 16 °C, 18-20 h"
PMID33864196,reaction_1,in vitro,Spectrometric monitoring of ABTS oxidation using crude laccase solution from cell-free supernatant.,100 mM potassium phosphate buffer,6.0,Standard assay condition. Optimal activity was observed at pH 8.0.,30.0,Streptomyces sp. LAO,,
PMID33864621,reaction_1,in vitro,Continuous kinetic assay using a fluorogenic substrate (Arg-Leu-Arg-Gly-Gly-AMC).,"50 mmol/L HEPES, pH 7.5, 2 mmol/L DTT",7.5,,,Escherichia coli Rosetta (DE3),pET-11a,0.2 mmol/L IPTG and 0.5 mmol/L zinc acetate at 16 °C for 16 h
PMID33867026,reaction_1,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_2,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_3,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_4,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_5,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_6,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ at 20°C for 2 days.
PMID33867026,reaction_7,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_8,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_9,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylomonas sp. LW13,,Expressed from His-tagged chromosomal insert. Cultures grown under methane with 30μM Ce³⁺ at 30°C.
PMID33867026,reaction_10,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylotenera mobilis JLW8,,Expressed from His-tagged chromosomal insert in a double xoxF4 mutant. Cultures grown on methanol with 30μM Ce³⁺ at 30°C.
PMID33867026,reaction_11,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylotenera mobilis JLW8,,Expressed from His-tagged chromosomal insert in a double xoxF4 mutant. Cultures grown on methanol with 30μM Ce³⁺ at 30°C.
PMID33867026,reaction_12,in vitro,Spectrophotometric assay monitoring PMS-mediated reduction of DCPIP at 600 nm.,"100mM Tris-HCl buffer, 45mM NH4Cl, 1mM PMS, 150μM DCPIP",9.0,Standard assay pH.,26.0,Methylorubrum extorquens AM1,pCM80-PxoxF,Induced with 0.5% v/v methanol and 30μM Ce³⁺ overnight at 30°C.
PMID33867026,reaction_13,in vitro,Qualitative spectrophotometric assay monitoring the absorbance of XoxG4 at 550 nm after addition of purified XoxF5.,Not specified,,,,Methylomonas sp. LW13,,Expressed from His-tagged chromosomal insert. Cultures grown under methane with 30μM Ce³⁺ at 30°C.
PMID33876533,reaction_1,in vitro,steady-state kinetics,"Not specified, but ionic strength noted to be important (e.g., 150 mM KCl or 100 mM NaCl).",10.0,pH was raised to 10.0 to make the chemical step rate-limiting under steady-state conditions.,20.0,,,
PMID33876533,reaction_2,in vitro,pre-steady-state cryo-kinetics,Aqueous buffer with 30% methanol as cosolvent.,8.5,pH 8.5 reflects physiological conditions where the hydride is transferred to mostly protonated substrates.,20.0,,,
PMID33876533,reaction_3,in vitro,pre-steady-state kinetics to study cosolvent effect,"Aqueous buffer, with and without 30% methanol.",8.5,,0.0,,,
PMID33890631,reaction_1,in vitro,"Standard reaction mixture composed of buffer, substrate, NADP+, and enzyme. Activity measured by NADPH formation at 340 nm.",100 mM glycine–NaOH buffer,9.5,,55.0,Escherichia coli Rosetta-Gami (DE3),pET28b (+),"1.0 mM IPTG, 28°C, 16h"
PMID33890631,reaction_2,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_3,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_4,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_5,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_6,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_7,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_8,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_9,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_10,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33890631,reaction_11,in vitro,,100 mM glycine–NaOH buffer,9.5,,55.0,,,
PMID33895325,reaction_1,in vivo,Lipid translocation assay performed on cultured MIN6 cells to measure phosphatidylserine flipping at the plasma membrane.,Hank’s balanced salt solution with 15 mM MgCl2 (HBSS-15 mM MgCl2),,Not specified,20.0,MIN6 cells (mouse pancreatic β cell line),Lentiviral vector,Transfection with lentiviral particles (2x10^7 TU/ml; MOI=20) for 72 hours.
PMID33895365,reaction_1,in vivo,Stable expression in Arabidopsis thaliana and transient expression in Nicotiana benthamiana.,in planta,,,22.0,"Arabidopsis thaliana (Col-0), Nicotiana benthamiana","pPDC-4G, pPDC-5G (Arabidopsis); pPMS057 (tobacco)",
PMID33895365,reaction_2,in vivo,Stable expression in Arabidopsis thaliana and transient expression in Nicotiana benthamiana.,in planta,,,22.0,"Arabidopsis thaliana (Col-0), Nicotiana benthamiana","pAroG (into QsuB background), pPDC-5G, pTKan-pC4H::schl3::QsuB",
PMID33899864,reaction_1,in vitro,Time-course of biotransformation using a reductase-free system with purified enzyme.,50 mM tricine buffer,8.5,,14.0,Escherichia coli BL21(DE3),pET15b,"0.5 mM IPTG, 25 °C, 14 h"
PMID33899864,reaction_2,in vitro,DoE study for optimization of reductase-free Baeyer-Villiger oxidation.,50 mM tricine buffer,8.5,,30.0,Escherichia coli BL21(DE3),pET15b,"0.5 mM IPTG, 25 °C, 14 h"
PMID33899864,reaction_3,in vitro,DoE study for optimization of reductase-free Baeyer-Villiger oxidation.,50 mM tricine buffer,8.5,,30.0,Escherichia coli BL21(DE3),pET15b,"0.5 mM IPTG, 25 °C, 14 h"
PMID33901808,reaction_1,in vitro,Coupled enzyme assay using recombinant protein or Caco-2 cell lysates. Products H2S and H2O2 were detected.,"HEPES-buffered saline (HBS; 50 mM HEPES, 150 mM NaCl, pH 7.4)",7.4,,37.0,Escherichia coli BL21 and KRX,"Twin-Strep-tag pASG-IBA102 vector, DHFR control template vector","0.6 mM IPTG for BL21 strain or 0.06% (w/v) rhamnose for KRX strain, at 22°C for 3 h."
PMID33901808,reaction_2,in vitro,Enzymatic generation of methanethiol for a coupled assay. Product formation was confirmed by GC-MS analysis of the headspace.,"HEPES-buffered saline (HBS; 50 mM HEPES, 150 mM NaCl, pH 7.4)",7.4,,37.0,Escherichia coli BL21 and KRX,DHFR control template vector,"0.6 mM IPTG for BL21 strain or 0.06% (w/v) rhamnose for KRX strain, at 22°C for 3 h."
PMID33902660,reaction_1,in vitro,"Spectroscopic analysis of ligand binding and conformational dynamics using Fourier transform infrared spectroscopy (FTIR) for H/D exchange, time-resolved fluorescence spectroscopy for intrinsic fluorescence and anisotropy, and 8-Anilino-1-naphthalenesulfonic acid (ANS) binding assays.","100 mM phosphate buffer pH 7.4 containing 20% glycerol, 1 mM β-mercaptoethanol, 0.1% Tween-20",7.4,,20.0,E. coli,,
PMID33910055,reaction_1,in vitro,Conversion assay performed for 24h with 20 mM substrate and 20 μM AOX.,100 mM potassium phosphate,7.5,,35.0,,,
PMID33910055,reaction_2,in vitro,"Conversion assay: 20 mM substrate, 20 μM AOX, 24h. Kinetics assay: 200 mM substrate, 0.2 μM AOX.",100 mM potassium phosphate,7.5,,35.0,,,
PMID33910055,reaction_3,in vitro,"Conversion assay: 20 mM substrate, 20 μM AOX, 24h. Kinetics assay: 200 mM substrate, 0.2 μM AOX.",100 mM potassium phosphate,7.5,,35.0,,,
PMID33910055,reaction_4,in vitro,"Conversion assay: 20 mM substrate, 20 μM AOX, 24h. Kinetics assay: 200 mM substrate, 0.2 μM AOX.",100 mM potassium phosphate,7.5,,35.0,,,
PMID33913984,reaction_1,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_2,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_3,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_4,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_5,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_6,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_7,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_8,in vitro,"Semi-preparative scale synthesis. Reaction mixture (50 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated at room temperature.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_9,in vitro,"Analytical scale synthesis with modified concentrations. Reaction mixture (3 mL) with 30 μM enzyme, 10 mM (R)-pantoate, 20 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_10,in vitro,"Semi-preparative scale synthesis. Reaction mixture (10 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated at room temperature.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_11,in vitro,"Semi-preparative scale synthesis. Reaction mixture (10 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated at room temperature.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_12,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_13,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_14,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_15,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_16,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_17,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_18,in vitro,"Analytical scale synthesis. Reaction mixture (3 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated for 24 h.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33913984,reaction_19,in vitro,"Semi-preparative scale synthesis. Reaction mixture (10 mL) with 7 μM enzyme, 20 mM (R)-pantoate, 10 mM amine, 20 mM ATP, 10 mM MgCl2, incubated at room temperature.",100 mM Tris-HCl buffer,9.0,,25.0,,,
PMID33922867,reaction_1,in vitro,Enzyme activity measured in crude leaf extracts of transgenic tobacco plants.,50 mM malonate buffer,4.5,,4.0,Nicotiana tabacum cv. Petite Havana,pBIN-VP (derived from pBin19),Constitutive expression under the CaMV 35S promoter fused to the tobacco mosaic virus translational enhancer (TMVL).
PMID33929595,reaction_1,in vitro,Enzyme activity and kinetic parameters were determined using purified enzyme.,100 mM Tri-HCl buffer,8.5,pH for kinetic parameter determination. Optimal pH was assayed between 7.0-10.0.,30.0,E. coli BL21 (DE3),pET-28a,0.1 mM IPTG
PMID33929818,reaction_1_Pf_cPRS,in vivo,72h DAPI growth inhibition assay with P. falciparum parasites (strain 3D7).,Parasite culture medium,,,,Plasmodium falciparum,,
PMID33929818,reaction_2_Hs_PRS,in vivo,Human cellular protein synthesis inhibition assay using T-REx 293 cells transfected with a plasmid encoding a proline-rich peptide.,Cell culture medium,,,,T-REx 293 cells,Plasmid encoding proline-rich peptide,
PMID33942867,reaction_1,in vitro,Kinetic analysis performed using UPLC.,HEPES/NaOH,7.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_2,in vitro,Kinetic analysis performed using UPLC.,HEPES/NaOH,7.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_3,in vitro,Kinetic analysis performed using UPLC.,HEPES/NaOH,7.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_4,in vitro,Kinetic analysis performed using UPLC.,HEPES/NaOH,7.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_5,in vitro,Spectrophotometric assay,100 mm Tris/HCl,8.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_6,in vitro,UPLC analysis,HEPES/NaOH,7.0,Assumed from UPLC analysis conditions,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_7,in vitro,UPLC analysis,HEPES/NaOH,7.0,Assumed from UPLC analysis conditions,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_8,in vitro,Spectrophotometric assay,100 mm Tris/HCl,8.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_9,in vitro,Spectrophotometric assay,100 mm Tris/HCl,8.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33942867,reaction_10,in vitro,Spectrophotometric assay,100 mm Tris/HCl,8.0,,80.0,Escherichia coli BL21(DE3),"pET15b/OCC_10945, co-expressed with pGro7 chaperone plasmid",0.5 mM IPTG for 3h at 37°C. Chaperone induced with 0.5 mg/mL L-arabinose.
PMID33950676,reaction_1,in vitro,"Steady-state kinetic assay monitoring the reduction of 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) at 412 nm.","50 mM sodium phosphate (pH 7.4), 250 mM NaCl, 10 mM EDTA, 0.05% Tween (for kinetics) or 100 mM potassium phosphate (pH 7.4) and 10 mM EDTA (for IC50 measurements).",7.4,,,Escherichia coli BL21 (DE3),"pSUABC (for WT), SUMO-fusion vector (for U597C mutant)","1 mM IPTG at O.D. = 0.6, followed by 3 hours of induction at 37 °C (for U597C mutant)."
PMID33951868,reaction_1,in vivo,"Whole-cell Cd(II) accumulation assay in engineered E. coli strains (WT, ΔzntA, pYYDT-zntA) to assess efflux activity. Cells were incubated with 1 mM CdCl2 and 0.5 mM Na2SeO3.",Luria-Bertani (LB) medium,4.5,pH of the LB medium during the 4-hour incubation.,37.0,Escherichia coli JM109,pYYDT-zntA,
PMID33955667,reaction_1,in vivo,Quantification of intracellular solutes by LC-MS in wild-type and mutant strains.,M63 minimal medium with 2.5 M NaCl,7.2,,37.0,Chromohalobacter salexigens CHR61,,
PMID33955667,reaction_2,in vivo,Quantification of intracellular solutes by LC-MS in wild-type and mutant strains.,M63 minimal medium with 2.5 M NaCl,7.2,,45.0,Chromohalobacter salexigens CHR61,,
PMID33957387,reaction_1,in vitro,Fluorescence-based inhibition assay detecting H2O2 via Amplex Red and horseradish peroxidase (HRP).,Not specified,,Not specified,25.0,,,
PMID33957387,reaction_2,in vitro,Fluorescence-based inhibition assay using Ac-peptide substrate.,1x assay buffer (modiﬁed Tris Buffer),,Not specified,25.0,,,
PMID33957387,reaction_3,in vitro,Fluorescence-based inhibition assay using Ac-peptide substrate.,1x assay buffer (modiﬁed Tris Buffer),,Not specified,25.0,,,
PMID33957387,reaction_4,in vitro,Fluorescence-based inhibition assay using Ac-peptide substrate.,1x assay buffer (modiﬁed Tris Buffer),,Not specified,25.0,,,
PMID33957387,reaction_5,in vitro,Fluorescence-based inhibition assay using Ac-peptide substrate.,1x assay buffer (modiﬁed Tris Buffer),,Not specified,25.0,,,
PMID33957387,reaction_6,in vitro,Fluorescence-based inhibition assay using Ac-peptide substrate.,1x assay buffer (modiﬁed Tris Buffer),,Not specified,25.0,,,
PMID33957387,reaction_7,in vitro,Fluorescence-based inhibition assay using Ac-peptide substrate.,1x assay buffer (modiﬁed Tris Buffer),,Not specified,25.0,,,
PMID33957387,reaction_8,in vitro,MAO-Glo assay kit (Promega),Not specified,,Not specified,25.0,,,
PMID33957387,reaction_9,in vitro,MAO-Glo assay kit (Promega),Not specified,,Not specified,25.0,,,
PMID33957387,reaction_10,in vitro,Cytochrome P450 inhibition assay,Not specified,,Not specified,37.0,,,
PMID33957387,reaction_11,in vitro,Cytochrome P450 inhibition assay,Not specified,,Not specified,37.0,,,
PMID33957387,reaction_12,in vitro,Cytochrome P450 inhibition assay,Not specified,,Not specified,37.0,,,
PMID33957387,reaction_13,in vitro,Cytochrome P450 inhibition assay,Not specified,,Not specified,37.0,,,
PMID33957387,reaction_14,in vitro,Cytochrome P450 inhibition assay,Not specified,,Not specified,37.0,,,
PMID33957387,reaction_15,in vitro,Metabolic stability assay,100 mM potassium phosphate buffer,,Not specified,37.0,,,
PMID33957387,reaction_16,in vitro,Metabolic stability assay,100 mM potassium phosphate buffer,,Not specified,37.0,,,
PMID33957387,reaction_17,in vitro,Metabolic stability assay,100 mM potassium phosphate buffer,,Not specified,37.0,,,
PMID33957387,reaction_18,in vitro,Metabolic stability assay,100 mM potassium phosphate buffer,,Not specified,37.0,,,
PMID33964174,reaction_1,in vitro,Activity assay with purified enzyme.,100 mM sodium phosphate/citrate buffer,4.4,,,Saccharomyces cerevisiae BJ5465,pJRoC30,"Expression in hemoglobin expression medium at 25°C, induced by galactose."
PMID33964174,reaction_2,in vitro,Activity assay with purified enzyme.,100 mM potassium phosphate buffer,7.0,,,Saccharomyces cerevisiae BJ5465,pJRoC30,"Expression in hemoglobin expression medium at 25°C, induced by galactose."
PMID33969584,reaction_1,in vitro,Aminoacylation assay measuring pyrophosphate (PPi) release via a malachite green assay.,"30 mM HEPES (pH 7.5), 150 mM NaCl, 30 mM KCl, 50 mM MgCl2, 1 mM DTT, 2 U/ml E. coli inorganic pyrophosphatase",7.5,,37.0,Escherichia coli BL-21 strain,,"Expressed in accordance with methods already published [13,18]."
PMID33977577,reaction_1,in vivo,Whole-cell decolorization assay using live Staphylococcus sp. strain MEH038S cells.,Nutrient broth (beef extract 1 g/L; yeast extract 2 g/L; peptone 5 g/L; sodium chloride 5 g/L),6.5,Optimal pH for decolorization. High efficiency (>90%) observed over pH 6-9.5.,35.0,Staphylococcus sp. MEH038S,,
PMID33978969,reaction_1,in vitro,Enzyme assays with heterologously expressed P450 in yeast microsomes.,0.1M NaPi buffer,7.0,Optimal pH for activity.,27.0,Saccharomyces cerevisiae strain WAT21,pYeDP60_GW® or pYeDP60,
PMID33979123,reaction_1,in vitro,Cell-free ELISA-type binding inhibition assay. Also tested in pseudovirus entry assays (BacMam and VSV-ΔG based).,"Binding buffer: 20 mM HEPES, pH 6.8. Blocking buffer: SuperBlock (PBS).",6.8,,25.0,,,
PMID33979123,reaction_2,in vitro,Cell-free ELISA-type binding assay.,"Binding buffer: 20 mM HEPES, pH 6.8. Blocking buffer: SuperBlock (PBS).",6.8,,25.0,,,
PMID33979123,reaction_3,in vitro,Cell-free ELISA-type binding inhibition assay.,"Binding buffer: 20 mM HEPES, pH 6.8. Blocking buffer: SuperBlock (PBS).",6.8,,25.0,,,
PMID33979123,reaction_4,in vitro,Cell-free ELISA-type binding assay.,"Binding buffer: 20 mM HEPES, pH 6.8. Blocking buffer: SuperBlock (PBS).",6.8,,25.0,,,
PMID33979649,reaction_1,in vitro,Enzyme kinetics assay,"20 mM Tris-HCl, 100 mM NaCl, 5 mM 2-hydroxy-1-ethanethiol, pH 7.8",7.8,,,Escherichia coli BL21(DE3),modified pET32a,"0.1 mM IPTG, 16°C for 18 hours, with 0.1 mM zinc chloride"
PMID33979649,reaction_2,in vitro,Enzyme kinetics and inhibitor screening (HTS) assay,"20 mM Tris-HCl, 100 mM NaCl, 5 mM 2-hydroxy-1-ethanethiol, pH 7.8",7.8,,,Escherichia coli BL21(DE3),modified pET32a,"0.1 mM IPTG, 16°C for 18 hours, with 0.1 mM zinc chloride"
PMID33979649,reaction_3,in vitro,IC50 determination assay,"20 mM Tris-HCl, 100 mM NaCl, 5 mM 2-hydroxy-1-ethanethiol, pH 7.8",7.8,,37.0,Escherichia coli BL21(DE3),modified pET32a,"0.1 mM IPTG, 16°C for 18 hours, with 0.1 mM zinc chloride"
PMID33979649,reaction_4,in vivo,Cellular cleavage assay in HEK293T cells,DMEM cell culture medium,,Physiological pH,37.0,HEK293T cells,,
PMID33979649,reaction_5,in vitro,Qualitative cleavage assay,Not specified,,,,Escherichia coli BL21(DE3),,
PMID33979649,reaction_6,in vivo,Cellular deISGylation assay in A549 cells,DMEM cell culture medium,,Physiological pH,37.0,A549 cells,,
PMID33979735,reaction_1,in vivo,Cell-based assay measuring inhibition of leucine-dependent S6K phosphorylation in SW620 human colon cancer cells.,"Leucine-free RPMI 1640 media, then stimulated with leucine-containing DMEM for 15 min.",,,37.0,,,
PMID33979735,reaction_2,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_3,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_4,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_5,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_6,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_7,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_8,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_9,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33979735,reaction_10,in vitro,Microsomal stability assay with 1 mg/mL pooled human liver microsomal protein and 1 mM NADPH.,0.1 mM PBS,,,37.0,,,
PMID33983672,reaction_1,in vitro,Intrinsic tryptophan fluorescence quenching was used to determine the substrate-binding affinity (Kd) of the detergent-solubilized protein.,"20 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 0.04% (wt/vol) DDM",7.5,,25.0,Escherichia coli C41(DE3),pMR4-styMdtM-TEV-His8,"0.1 mM IPTG, 30°C, 3 hours"
PMID33983672,reaction_2,in vitro,Intrinsic tryptophan fluorescence quenching was used to determine the substrate-binding affinity (Kd) of the detergent-solubilized protein.,"20 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 0.04% (wt/vol) DDM",7.5,,25.0,Escherichia coli C41(DE3),pMR4-styMdtM-TEV-His8,"0.1 mM IPTG, 30°C, 3 hours"
PMID33983672,reaction_3,in vitro,Intrinsic tryptophan fluorescence quenching was used to determine the substrate-binding affinity (Kd) of the detergent-solubilized protein.,"20 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 0.04% (wt/vol) DDM",7.5,,25.0,Escherichia coli C41(DE3),pMR4-styMdtM-TEV-His8,"0.1 mM IPTG, 30°C, 3 hours"
PMID33983672,reaction_4,in vitro,Intrinsic tryptophan fluorescence quenching was used to determine the substrate-binding affinity (Kd) of the detergent-solubilized protein.,"20 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 0.04% (wt/vol) DDM",7.5,,25.0,Escherichia coli C41(DE3),pMR4-styMdtM-TEV-His8,"0.1 mM IPTG, 30°C, 3 hours"
PMID33990581,reaction_1,in vitro,Enzyme activity assays with purified protein.,"50 mM Tris-HCl, 10% (w/v) glycerol, pH 7.0",7.0,,30.0,E. coli Rosetta (DE3),pET-duet-1,"0.5 mM IPTG, 16 °C, overnight"
PMID33990581,reaction_2,in vitro,Enzyme activity assays with purified protein.,"50 mM Tris-HCl, 10% (w/v) glycerol, pH 7.0",7.0,,30.0,E. coli Rosetta (DE3),pET-duet-1,"0.5 mM IPTG, 16 °C, overnight"
PMID33990581,reaction_3,in vitro,Enzyme activity assays with purified protein.,"50 mM Tris-HCl, 10% (w/v) glycerol, pH 7.0",7.0,,30.0,E. coli Rosetta (DE3),pET-duet-1,"0.5 mM IPTG, 16 °C, overnight"
PMID33990581,reaction_4,in vitro,Enzyme activity assays with purified protein.,"50 mM Tris-HCl, 10% (w/v) glycerol, pH 7.0",7.0,,30.0,E. coli Rosetta (DE3),pET-duet-1,"0.5 mM IPTG, 16 °C, overnight"
PMID33990581,reaction_5,in vitro,Enzyme activity assays with purified protein.,"50 mM Tris-HCl, 10% (w/v) glycerol, pH 7.0",7.0,,30.0,E. coli Rosetta (DE3),pET-duet-1,"0.5 mM IPTG, 16 °C, overnight"
PMID33990581,reaction_6,in vitro,Enzyme activity assays with purified protein.,"50 mM Tris-HCl, 10% (w/v) glycerol, pH 7.0",7.0,,30.0,E. coli Rosetta (DE3),pET-duet-1,"0.5 mM IPTG, 16 °C, overnight"
PMID33996018,reaction_1,in vitro,Bicelle activity assay to assess 13C-methane oxidation activity.,"25 mM PIPES, 250 mM NaCl, 0.02% DDM, with DMPC:CHAPSO (2.8:1) bicelles.",7.2,,30.0,Methylococcus capsulatus (Bath),,Enzyme was isolated from natively grown M. capsulatus (Bath) cells.
PMID33999624,reaction_1,in vitro,A coupled enzyme assay was used to quantitatively analyze the inhibitory rate of HPPD inhibitors by monitoring maleylacetoacetate at 318 nm.,Synthesized compounds were dissolved in DMSO.,,Not specified,,,,
PMID34010508,reaction_1,in vitro,CYP121 in vitro enzyme inhibition assay,PBS buffer,7.2,,30.0,Escherichia coli K12 BL21 (DE3),pHAT2/cyp121,
PMID34019767,reaction_1,in vitro,Cleavage of CFP-YFP fusion protein substrate and native protein from bovine heart lysates.,25 mM HEPES (pH 7.4) containing 0.1% Tween-20,7.4,,23.0,BL21(DE3) pLysS E. coli,pet15b,"0.5 mM IPTG, 17 °C, ~17 h"
PMID34019767,reaction_2,in vitro,Cleavage of CFP-YFP fusion protein substrate and native protein from human serum.,MPER,7.6,pH of MPER used in serum assay,23.0,BL21(DE3) pLysS E. coli,pet15b,"0.5 mM IPTG, 17 °C, ~17 h"
PMID34019767,reaction_3,in vitro,Cleavage of CFP-YFP fusion protein substrates and a recombinant FOXP3 fragment.,MPER,,,23.0,BL21(DE3) pLysS E. coli,pet15b,"0.5 mM IPTG, 17 °C, ~17 h"
PMID34019767,reaction_4,in vitro,Cleavage of CFP-YFP fusion protein substrate.,,,,23.0,BL21(DE3) pLysS E. coli,pet15b,"0.5 mM IPTG, 17 °C, ~17 h"
PMID34043997,reaction_1,in vitro,Enzyme activity assay with detergent-solubilized mitochondria,"50 mM Tris, 1 mg/mL palmitoyl-lysophosphatidylcholine, 0.1% Brij-35, 2 μM rotenone",8.0,,37.0,,,
PMID34043997,reaction_2,in vitro,Enzyme activity assay with detergent-solubilized mitochondria,"33 mM Tris, 1 mM MgCl2, 0.1% Triton X-100, 0.1 mM NADP+",7.4,,37.0,,,
PMID34043997,reaction_3,in vitro,Enzyme activity assay with detergent-solubilized mitochondria,"33 mM Tris, 5 mM MnCl2, 0.1% Triton X-100, 0.3 mM NADP+",7.4,,37.0,,,
PMID34043997,reaction_4,in vitro,Enzyme activity assay with detergent-solubilized mitochondria,"33 mM Tris, 1 mM MgCl2, 0.1% Triton X-100, 270 μM ADP, 1 mM NADP+",7.4,,37.0,,,
PMID34043997,reaction_5,in vitro,Enzyme activity assay with detergent-solubilized mitochondria,"33 mM Tris, 1 mM MgCl2, 0.1% Triton X-100, 270 μM ADP, 0.5 mM NAD+",7.4,,37.0,,,
PMID34043997,reaction_6,in vitro,Enzyme activity assay with detergent-solubilized mitochondria,"50 mM Tris, 0.1% Triton X-100, 50 μM acetyl-CoA, and 100 μM 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB)",8.0,,37.0,,,
PMID34043997,reaction_7,in vitro,Indirect enzyme activity assay based on inhibition of superoxide-driven NADH oxidation in skeletal muscle homogenate supernatants.,"50 mM potassium phosphate buffer, 0.25 mM NADH, 5 mM EDTA, 2.5 mM MnSO4, 4 mM KCN",7.4,,37.0,,,
PMID34043997,reaction_8,in vitro,Enzyme activity assay with detergent-disrupted isolated mitochondria and supernatant from homogenate.,"225 mM manitol, 75 mM sucrose, 10 mM KCl, 10 mM Tris, 10 mM KH2PO4, 2 mM MgCl2, 500 μM EGTA, 1 mM NADP+, 0.1% Triton X-100",7.15,,37.0,,,
PMID34048880,reaction_1,in vitro,succinate-gloTM JmjC demethylase/hydroxylase assay,Not specified,,Not specified,,Escherichia coli BL21 (DE3),pET-28a,N-terminal 6xHistidine (His6) tag
PMID34053981,reaction_1,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_2,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_3,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_4,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_5,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_6,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_7,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_8,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_9,in vitro,Chemoenzymatic synthesis of N-acyl amides.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34053981,reaction_10,in vitro,Detection of reaction intermediate.,"Not specified, but required MgCl2.",,,,Escherichia coli,,
PMID34055457,reaction_1,in vitro,Neutron and X-ray crystallography of a pseudo-Michaelis complex (ecDHFR-folate-NADP+) to investigate the protonation step of the catalytic mechanism.,"15% PEG 400, 100 mM MnCl2, 100 mM NaAc, in D2O",4.5,Neutron diffraction data collected at pH 4.5. Compared with a structure at pH 7.0.,18.0,,,
PMID34056479,reaction_1,in vitro,m6A antibody-based ELISA enzyme inhibition assay using EpiQuik m6A RNA methylation Quantification Colorimetric Kit,"50 mM Tris-HCl, 300 μM 2OG, 280 μM (NH4)2Fe(SO4)2 and 2 mM L-ascorbic acid",7.5,,25.0,Baculovirus expression system,,
PMID34060308,reaction_1,in vitro,,Not specified,,Not specified,,,,
PMID34060308,reaction_2,in vitro,,Not specified,,Not specified,,,,
PMID34060308,reaction_3,in vitro,,Not specified,,Not specified,,,,
PMID34060308,reaction_4,in vitro,,Not specified,,Not specified,,,,
PMID34060308,reaction_5,in vivo,Cotranslational cysteine conversion in the Endoplasmic Reticulum.,Cellular environment (Endoplasmic Reticulum),,Physiological pH of the ER,37.0,"HEK-293 cells, CHO cells",,
PMID34060308,reaction_6,in vitro,,Not specified,9.0,"pH 9 mentioned in the context of using DTT to ensure the cysteine thiol is in its free, reduced state for conversion.",,,,
PMID34065782,reaction_1,in vitro,Functional enzyme expressed in E. coli JM109 cells.,,,,,Escherichia coli JM109,,
PMID34065782,reaction_2,in vitro,Functional enzyme expressed in E. coli JM109 cells.,,,,,Escherichia coli JM109,,
PMID34065782,reaction_3,in vitro,Functional enzyme expressed in E. coli JM109 cells.,,,,,Escherichia coli JM109,,
PMID34065782,reaction_4,in vitro,Functional enzyme expressed in E. coli BL21(DE3) cells.,,,,,Escherichia coli BL21(DE3),,
PMID34065782,reaction_5,in vitro,Functional enzyme expressed in E. coli BL21(DE3) cells. This substrate is preferred over N-debenzoyl-2'-deoxy-taxol.,,,,,Escherichia coli BL21(DE3),,
PMID34065782,reaction_6,in vitro,Functional enzyme expressed in E. coli BL21(DE3) cells. This is a tested surrogate substrate.,,,,,Escherichia coli BL21(DE3),,
PMID34065782,reaction_7,in vitro,Enzyme characterized to use taxusin as a substrate.,,,,,,,
PMID34065782,reaction_8,in vitro,Enzyme characterized to use taxusin as a substrate.,,,,,,,
PMID34065782,reaction_9,in vitro,Enzyme characterized to convert the product of T7βOH.,,,,,,,
PMID34065782,reaction_10,in vitro,Enzyme characterized to convert the product of T2αOH.,,,,,,,
PMID34065782,reaction_11,in vivo,Reaction characterized in Ginkgo biloba cells.,,,,,Ginkgo biloba cells,,
PMID34065782,reaction_12,in vitro,Enzyme isolated from Taxus plants and characterized.,,,,,,,
PMID34065782,reaction_13,in vitro,Enzyme isolated from Taxus plants and tested with alternative acyl donors.,,,,,,,
PMID34065782,reaction_14,in vitro,Enzyme isolated from Taxus plants and tested with alternative acyl donors.,,,,,,,
PMID34065782,reaction_15,in vitro,Enzyme isolated from Taxus plants and tested with alternative acyl donors.,,,,,,,
PMID34069008,reaction_1,in vitro,Spectrophotometric assay measuring the release of CoA from 3HB-CoA at 412 nm using DTNB.,100 mM Tris-HCl buffer,7.8,,25.0,,,
PMID34069008,reaction_2,in vivo,Whole-cell biosynthesis in A. vinelandii ∆Avin_16040 mutant strain.,MMPHA minimal medium with 30 g/L fructose as primary carbon source and 2 g/L sodium 4-hydroxybutyrate as precursor.,7.0,,30.0,Azotobacter vinelandii ∆Avin_16040,,
PMID34069008,reaction_3,in vivo,Whole-cell biosynthesis in A. vinelandii ∆Avin_16040 mutant strain.,"MMPHA minimal medium with 30 g/L fructose as primary carbon source and 2 g/L 1,4-butanediol as precursor.",7.0,,30.0,Azotobacter vinelandii ∆Avin_16040,,
PMID34069008,reaction_4,in vivo,Whole-cell biosynthesis in A. vinelandii ∆Avin_16040 mutant strain.,MMPHA minimal medium with 30 g/L fructose as primary carbon source and 2 g/L gamma-butyrolactone as precursor.,7.0,,30.0,Azotobacter vinelandii ∆Avin_16040,,
PMID34069008,reaction_5,in vivo,Whole-cell biosynthesis in A. vinelandii ∆Avin_16040 mutant strain.,MMPHA minimal medium with 30 g/L fructose as primary carbon source and 2 g/L sodium heptanoate as precursor.,7.0,,30.0,Azotobacter vinelandii ∆Avin_16040,,
PMID34069008,reaction_6,in vivo,Whole-cell biosynthesis using heterologously expressed enzyme.,"MMPHA minimal medium with 30 g/L fructose as primary carbon source and 2 g/L 1,4-butanediol as precursor.",7.0,,30.0,Cupriavidus necator Re2058,pCB113,
PMID34069009,reaction_1,in vivo,Whole-cell biotransformation using engineered E. coli.,"M9 medium (glucose (0.4%, w/v), Na2HPO4 (40 mM), NaCl (0.25%, w/v), KH2PO4 (17 mM), NH4Cl (19 mM), MgSO4 (2 mM), MCaCl2 (1 mM))",,,28.0,Escherichia coli BL21* (DE3),Co-expression of P2 (pRSFDuet-HpaCB) and P3 (pETDuet-HpaBC),1 mM IPTG
PMID34069009,reaction_2,in vivo,Whole-cell biotransformation using engineered E. coli.,"M9 medium (glucose (0.4%, w/v), Na2HPO4 (40 mM), NaCl (0.25%, w/v), KH2PO4 (17 mM), NH4Cl (19 mM), MgSO4 (2 mM), MCaCl2 (1 mM))",,,28.0,Escherichia coli BL21* (DE3),Co-expression of P2 (pRSFDuet-HpaCB) and P3 (pETDuet-HpaBC),1 mM IPTG
PMID34069009,reaction_3,in vivo,Whole-cell biotransformation using engineered E. coli.,"M9 medium (glucose (0.4%, w/v), Na2HPO4 (40 mM), NaCl (0.25%, w/v), KH2PO4 (17 mM), NH4Cl (19 mM), MgSO4 (2 mM), MCaCl2 (1 mM))",,,28.0,Escherichia coli BL21* (DE3),Co-expression of P2 (pRSFDuet-HpaCB) and P3 (pETDuet-HpaBC),1 mM IPTG
PMID34069009,reaction_4,in vivo,Whole-cell biotransformation using engineered E. coli.,"M9 medium (glucose (0.4%, w/v), Na2HPO4 (40 mM), NaCl (0.25%, w/v), KH2PO4 (17 mM), NH4Cl (19 mM), MgSO4 (2 mM), MCaCl2 (1 mM))",,,28.0,Escherichia coli BL21* (DE3),Co-expression of P2 (pRSFDuet-HpaCB) and P3 (pETDuet-HpaBC),1 mM IPTG
PMID34069009,reaction_5,in vivo,Whole-cell biotransformation using engineered E. coli.,"M9 medium (glucose (0.4%, w/v), Na2HPO4 (40 mM), NaCl (0.25%, w/v), KH2PO4 (17 mM), NH4Cl (19 mM), MgSO4 (2 mM), MCaCl2 (1 mM))",,,28.0,Escherichia coli BL21* (DE3),Co-expression of P2 (pRSFDuet-HpaCB) and P3 (pETDuet-HpaBC),1 mM IPTG
PMID34069009,reaction_6,in vivo,Whole-cell biotransformation using engineered E. coli.,"M9 medium (glucose (0.4%, w/v), Na2HPO4 (40 mM), NaCl (0.25%, w/v), KH2PO4 (17 mM), NH4Cl (19 mM), MgSO4 (2 mM), MCaCl2 (1 mM))",,,28.0,Escherichia coli BL21* (DE3),Co-expression of P2 (pRSFDuet-HpaCB) and P3 (pETDuet-HpaBC),1 mM IPTG
PMID34078898,reaction_1,in vitro,Assay with microsomal protein from recombinant yeast. Substrate concentration was 100 µM.,Microsomes were prepared in TEK and TESB buffers. The reaction system contained 0.5 mg resuspended microsomal protein in a 500 μL volume.,,Not specified,,Saccharomyces cerevisiae (WAT11 strain),pESC-His,
PMID34078898,reaction_2,in vitro,Assay with microsomal protein from recombinant yeast. Substrate concentration was 100 µM.,Microsomes were prepared in TEK and TESB buffers. The reaction system contained 0.5 mg resuspended microsomal protein in a 500 μL volume.,,Not specified,,Saccharomyces cerevisiae (WAT11 strain),pESC-His,
PMID34078898,reaction_3,in vitro,Assay with microsomal protein from recombinant yeast. Substrate concentration was 100 µM.,Microsomes were prepared in TEK and TESB buffers. The reaction system contained 0.5 mg resuspended microsomal protein in a 500 μL volume.,,Not specified,,Saccharomyces cerevisiae (WAT11 strain),pESC-His,
PMID34080200,reaction_1,in vivo,Functional complementation and efflux assay in Saccharomyces cerevisiae ∆fre1 strain.,Yeast Nitrogen Base (YNB) medium for growth. Ferric reduction assay in 5 mM MES buffer.,5.5,pH of the ferric reduction activity assay buffer.,23.5,Saccharomyces cerevisiae ∆fre1,pFL61,
PMID34080200,reaction_2,in vivo,Efflux assay using 13C-labeled ascorbate injected into Xenopus laevis oocytes.,"ND96 medium (NaCl 96mM, KCl 2mM, 1.8mM MgCl2, CaCl2 1mM, 2.5mM Na-Pyruvate, HEPES-NaOH pH7.4)",5.5,"Efflux was measured at pH 5.5, 6.5, and 7.5. Optimal pH for efflux among those tested was 5.5.",20.0,Xenopus laevis oocytes,modified pGEM-HE vector,cRNA synthesized using HiScribe T7 ARCA mRNA Kit and injected (32 ng) into oocytes.
PMID34080200,reaction_3,in vivo,Quantification of ascorbate in vacuoles isolated from leaf protoplasts of wild-type and atdtx25-1 mutant plants.,"Vacuole isolation buffers (lysis buffer, vacuole buffer).",7.5,Vacuole buffer pH was 7.5. Lysis buffer pH was 8.0.,10.0,Arabidopsis thaliana,,
PMID34091695,reaction_1,in vivo,Functional complementation of Arabidopsis hy2-1 mutant by ectopic expression of the CsHY2 gene. Phenotype rescue (normal hypocotyl length) was observed.,,,,,Arabidopsis thaliana hy2-1,pCAMBIA3301-EGFP (containing 35S:CsHY2-EGFP construct),Constitutive expression via CaMV35S promoter. Transformed using Agrobacterium tumefaciens GV3101 via floral dip method.
PMID34112370,reaction_1,in vitro,Activity measured in isolated membrane fraction,25 mM MOPS buffer,7.0,,,,,
PMID34112370,reaction_2,in vitro,Activity measured in isolated membrane fraction,25 mM MOPS buffer,7.0,,,,,
PMID34123216,reaction_1,in vitro,Spectrophotometric measurement of NADH production at 340 nm for kinetic studies.,100 mM sodium phosphate buffer,7.0,,30.0,E. coli BL21(DE3),pET28b(+),"1 mM IPTG, 3 h at 37 °C"
PMID34123216,reaction_2,in vitro,Spectrophotometric measurement of NADH production at 340 nm for kinetic studies.,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_3,in vitro,Kinetic resolution of racemic substrate using soluble or immobilized enzyme with a cofactor recycling system.,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_4,in vitro,Spectrophotometric measurement of NADH production at 340 nm for kinetic studies.,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_5,in vitro,Spectrophotometric measurement of NADH production at 340 nm for kinetic studies.,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_6,in vitro,Spectrophotometric measurement of NADH production at 340 nm for kinetic studies.,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_7,in vitro,Spectrophotometric measurement of NADH production at 340 nm for kinetic studies.,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_8,in vitro,Kinetic resolution of racemic substrate using immobilized enzyme.,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_9,in vitro,Activity assay,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123216,reaction_10,in vitro,Activity assay,100 mM sodium phosphate buffer,7.0,,30.0,,,
PMID34123320,reaction_1,in vitro,Specific activity assay under 1 atm Ar,"Not specified, assay performed at pH 7.3",7.3,,30.0,Azotobacter vinelandii,,
PMID34123320,reaction_2,in vitro,Specific activity assay under 1 atm N2,"Not specified, assay performed at pH 7.3",7.3,,30.0,Azotobacter vinelandii,,
PMID34123320,reaction_3,in vitro,Freeze-trap EPR spectroscopy of turnover intermediate,"200 mM MOPS, 20 mM ATP, 20 mM MgCl2, 1 mg/mL BSA, 0.4 mg/mL creatine phosphokinase, 20 mM dithionite",7.3,,,Azotobacter vinelandii,,
PMID34142217,reaction_1,in vitro,Activity measured by quantifying the production of inorganic phosphate from leaf tissue homogenate.,37.5 mM Tris-MES buffer,6.5,,37.0,,,
PMID34142217,reaction_2,in vitro,Activity measured from leaf tissue extract.,ice-cold distilled water for extraction,,,,,,
PMID34142217,reaction_3,in vitro,Activity measured from leaf tissue extract after inactivating α-amylase at low pH.,ice-cold distilled water for extraction,,,,,,
PMID34142217,reaction_4,in vitro,Activity measured from leaf tissue extract.,"100 mM Hepes, 20 mM Glc-6-P, 4 mM Fru-6-P, 3 mM UDP-Glc, 5 mM MgCl2, and 1 mM EDTA",7.5,,,,,
PMID34142217,reaction_5,in vitro,Activity measured from leaf tissue extract.,"50 mM Hepes, 15 mM MgCl2, 25 mM Fru, and 25 mM UDP-Glc",7.5,,,,,
PMID34142217,reaction_6,in vitro,Activity measured by estimating liberated glucose using the Nelson–Somogyi method.,1 M sodium acetate,4.5,,,,,
PMID34142217,reaction_7,in vitro,Activity measured by determining L-cysteine concentration.,"100 mM Tris-HCl, 5 mM Na2S, 33.4 mM dithiothreitol, and 5 mM O-acetyl serine",7.5,,37.0,,,
PMID34142217,reaction_8,in vitro,Assayed by coupling reaction with OASTL forming Cys.,"Not specified, coupled with OASTL assay.",,,,,,
PMID34142217,reaction_9,in vitro,Activity measured by the release of H2S from L-Cys.,"100 mM TRIS/HCl, 2.5 mM dithiothreitol, 0.8 mM l-Cys",9.0,,37.0,,,
PMID34142217,reaction_10,in vitro,Activity measured by the release of H2S from D-Cys.,"100 mM Tris-HCl, 2.5 mM dithiothreitol, 0.8 mM d-Cys",8.0,,37.0,,,
PMID34142217,reaction_11,in vitro,Activity determined by inhibiting the photochemical reduction of nitroblue tetrazolium.,Not specified,,,,,,
PMID34142217,reaction_12,in vitro,Activity measured by the increase in absorbance at 420 nm due to guaiacol oxidation.,"50 mM potassium phosphate buffer, 1% hydrogen peroxide, 1% guaiacol",6.1,,,,,
PMID34142217,reaction_13,in vitro,Activity measured by the decrease in absorbance at 240 nm due to H2O2 consumption.,"25 mM sodium phosphate buffer, 10 mM H2O2",7.0,,,,,
PMID34142217,reaction_14,in vitro,Activity measured by the decrease in absorbance at 290 nm due to H2O2-dependent oxidation of ascorbate.,"50 mM potassium phosphate, 0.1 mM EDTA, 0.1 mM H2O2 and 0.5 mM ascorbate",7.0,,,,,
PMID34142217,reaction_15,in vitro,Activity measured by the decrease in absorbance of NADPH at 340 nm.,"100 mM phosphate buffer, 0.1 µM EDTA, 0.05 mM NADPH, and 3.0 mM oxidized glutathione",7.8,,,,,
PMID34142217,reaction_16,in vitro,Activity determined by estimating the amount of porphobilinogen formed.,Not specified,,,,,,
PMID34142217,reaction_17,in vitro,,50% acetone,,,40.0,,,
PMID34142217,reaction_18,in vitro,Activity measured by titrating against 0.05 N HCl.,"phosphate buffer, bromothymol blue, and methyl red indicators",6.8,,,,,
PMID34156250,reaction_1,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34156250,reaction_2,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34156250,reaction_3,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34156250,reaction_4,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34156250,reaction_5,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34156250,reaction_6,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34156250,reaction_7,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34156250,reaction_8,in vitro,Kinetic measurements of initial reaction velocities using a spectrophotometer.,50 mM Tris-HCl,9.0,,,Escherichia coli BL21(DE3),pGEX-6P-SG,"0.5 mM IPTG, 0.5 mM CuSO4, 19 °C, 60 h"
PMID34163896,reaction_1,in vitro,"SPE-MS turnover, inhibition, and kinetic assays","50 mM HEPES, pH 7.5, with L-ascorbic acid",7.5,,20.0,,,
PMID34163896,reaction_2,in vitro,SPE-MS kinetic assays,"50 mM HEPES, pH 7.5, with L-ascorbic acid",7.5,,20.0,,,
PMID34163896,reaction_3,in vitro,SPE-MS kinetic assays,"50 mM HEPES, pH 7.5, with L-ascorbic acid",7.5,,20.0,,,
PMID34163896,reaction_4,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_5,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_6,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_7,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_8,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_9,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_10,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_11,in vitro,Assay performed in the absence of 2OG with 330 µM of the alternative cosubstrate.,"50 mM HEPES, pH 7.5",7.5,,20.0,,,
PMID34163896,reaction_12,in vitro,NMR assay with ~100x higher enzyme concentration than SPE-MS assays.,,,,,,,
PMID34171691,reaction_1,in vitro,Spectrophotometric assay measuring NADPH oxidation at 340 nm in crude enzyme extracts from plant shoots.,"50 mmol⋅L-1 MOPS, 50 mmol⋅L-1 MES",6.5,,30.0,,,
PMID34171691,reaction_2,in vitro,Spectrophotometric assay measuring NADPH oxidation at 340 nm in crude enzyme extracts from plant roots and shoots.,"50 mmol⋅L-1 MOPS, 50 mmol⋅L-1 MES",6.5,,30.0,,,
PMID34171691,reaction_3,in vitro,Spectrophotometric assay measuring NADPH oxidation at 340 nm in crude enzyme extracts from plant roots and shoots.,"50 mmol⋅L-1 MOPS, 50 mmol⋅L-1 MES",6.5,,30.0,,,
PMID34189909,reaction_1,in vitro,Mechanism-based inactivation assay using recombinant human CYP3A4 Supersomes.,100 mM potassium phosphate buffer,7.4,,37.0,Supersomes (Corning Gentest),,
PMID34189909,reaction_2,in vitro,Mechanism-based inactivation assay using recombinant human CYP3A5 Supersomes.,100 mM potassium phosphate buffer,7.4,,37.0,Supersomes (Corning Gentest),,
PMID34204515,reaction_1,in vitro,Spectrophotometric assay monitoring NADPH absorbance decrease at 340 nm,"50 mM Tris–HCl, pH 7.5",7.5,,25.0,E. coli,pBAD vector,"0.02% arabinose, 24 °C, overnight"
PMID34204515,reaction_2,in vitro,Spectrophotometric assay monitoring NADPH absorbance increase at 340 nm,"50 mM Tris–HCl, pH 7.5",7.5,,25.0,E. coli,pBAD vector,"0.02% arabinose, 24 °C, overnight"
PMID34204515,reaction_3,in vitro,Biotransformation with product analysis by GCMS,"Tris–HCl buffer (50 mM, pH 7.5)",7.5,,24.0,E. coli,pBAD vector,"0.02% arabinose, 24 °C, overnight"
PMID34205296,reaction_1,in vitro,Enzyme activity assay on crude extract from leaf tissues.,100 mM sodium phosphate buffer,6.6,,37.0,,,
PMID34205296,reaction_2,in vitro,Enzyme activity assay on crude extract from leaf tissues.,100 mM sodium phosphate buffer,6.6,,37.0,,,
PMID34205296,reaction_3,in vitro,Enzyme activity assay on crude extract from leaf tissues.,50 mM phosphate buffer,6.0,,,,,
PMID34246414,reaction_1,in vivo,Time-resolved FRET (TR-FRET) binding assay in living HEK293 cells.,Cell culture medium (not specified),,,,HEK293 cells,,
PMID34246414,reaction_2,in vivo,TR-FRET binding assay in living HEK293 cells co-expressing TMPRSS2.,Cell culture medium (not specified),,,,HEK293 cells,,
PMID34246414,reaction_3,in vivo,TR-FRET binding assay in living HEK293 cells with addition of exogenous heparin (3 mg/mL).,Cell culture medium (not specified),,,,HEK293 cells,,
PMID34246414,reaction_4,in vivo,TR-FRET binding assay in living HEK293 cells co-expressing CD4.,Cell culture medium (not specified),,,,HEK293 cells,,
PMID34246414,reaction_5,in vivo,TR-FRET binding assay in living HEK293 cells.,Cell culture medium (not specified),,,,HEK293 cells,,
PMID34246414,reaction_6,in vivo,TR-FRET binding assay in living HEK293 cells co-expressing TMPRSS2.,Cell culture medium (not specified),,,,HEK293 cells,,
PMID34262629,reaction_1,in vitro,"Kinetic resolution, kinetic parameter determination, and specific activity measurement.","Tris-HCl 100 mM, pH 9 (for kinetics/specific activity) or Tris-HCl 100 mM, 500 mM NaCl, pH 8 (for resolution)",9.0,"pH 9 for kinetics and specific activity, pH 8 for kinetic resolution.",20.0,E. coli BL21 (DE3),pET15b,"1 mM IPTG, 28°C, overnight"
PMID34262629,reaction_2,in vitro,Kinetic resolution and specific activity measurement.,"Tris-HCl 100 mM, pH 9 (for specific activity) or Tris-HCl 100 mM, 500 mM NaCl, pH 8 (for resolution)",8.0,"pH 8 for kinetic resolution, pH 9 for specific activity.",20.0,E. coli BL21 (DE3),pET15b,"1 mM IPTG, 28°C, overnight"
PMID34262629,reaction_3,in vitro,Reduction of ketone with cofactor regeneration.,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_4,in vitro,Reduction of pure ketone enantiomer with cofactor regeneration.,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_5,in vitro,Reduction of pure ketone enantiomer with cofactor regeneration.,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_6,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_7,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_8,in vitro,,Tris-HCl 100 mM,9.0,,,,,
PMID34262629,reaction_9,in vitro,,Tris-HCl 100 mM,9.0,,,,,
PMID34262629,reaction_10,in vitro,,Tris-HCl 100 mM,9.0,,,,,
PMID34262629,reaction_11,in vitro,,Tris-HCl 100 mM,9.0,,,,,
PMID34262629,reaction_12,in vitro,,Tris-HCl 100 mM,9.0,,,,,
PMID34262629,reaction_13,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_14,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_15,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_16,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_17,in vitro,,Tris-HCl 100 mM,9.0,,,,,
PMID34262629,reaction_18,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_19,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_20,in vitro,,Tris-HCl 100 mM,9.0,,,,,
PMID34262629,reaction_21,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_22,in vitro,,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_23,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_24,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_25,in vitro,,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_26,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_27,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_28,in vitro,,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_29,in vitro,,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_30,in vitro,,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_31,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_32,in vitro,,"Tris-HCl 100 mM, 500 mM NaCl",8.0,,20.0,,,
PMID34262629,reaction_33,in vitro,,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34262629,reaction_34,in vitro,,"citrate buffer (50 mM, 500 mM NaCl)",5.5,,20.0,,,
PMID34264440,reaction_1,in vitro,Enzyme inhibition assay. Data from 401 compounds was used to build QSAR models. Compounds were classified as ACTIVE if they inhibited TryS by more than 50% at concentrations ≤ 30 µM.,Not specified,,Not specified,,,,
PMID34289079,reaction_1,in vitro,Enzyme activity assay and part of a multi-enzyme cascade reaction for 3SL synthesis.,"100 mM Tris/HCl buffer, pH 8.0, with 1 mg/ml BSA (for individual assays) or with 20 mM MgCl2 and 0.2 mM L-cysteine (for cascade reactions).",8.0,,37.0,E. coli BL21 (DE3),pET22b(+),"1 mM isopropyl β‐D‐thiogalactopyranoside, 25°C, 20 h"
PMID34289079,reaction_2,in vitro,Enzyme activity assay and part of a multi-enzyme cascade reaction for 3SL synthesis.,"100 mM Tris/HCl buffer, pH 8.0, with 1 mg/ml BSA (for individual assays) or with 20 mM MgCl2 and 0.2 mM L-cysteine (for cascade reactions).",8.0,,37.0,E. coli BL21 (DE3),pC21e1,"1 mM isopropyl β‐D‐thiogalactopyranoside, 25°C, 20 h"
PMID34289079,reaction_3,in vitro,Enzyme activity assay and part of a multi-enzyme cascade reaction for 3SL synthesis.,"100 mM Tris/HCl buffer, pH 8.0, with 1 mg/ml BSA (for individual assays) or with 20 mM MgCl2 and 0.2 mM L-cysteine (for cascade reactions).",8.0,,37.0,E. coli BL21 (DE3),pC21e1,"1 mM isopropyl β‐D‐thiogalactopyranoside, 37°C, 20 h"
PMID34289079,reaction_4,in vitro,Enzyme activity assay and part of a multi-enzyme cascade reaction for 3SL synthesis.,"100 mM Tris/HCl buffer, pH 8.0, with 1 mg/ml BSA (for individual assays) or with 20 mM MgCl2 and 0.2 mM L-cysteine (for cascade reactions).",8.0,,37.0,E. coli,,
PMID34289079,reaction_5,in vitro,Side reaction measured as part of enzyme characterization.,"100 mM Tris/HCl buffer, pH 8.0",8.0,,37.0,,,
PMID34290951,reaction_1,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation at 340 nm,"50 mM Tris–HCl buffer (pH 7.5), 1 mM EDTA",7.5,,37.0,Escherichia coli BL21(DE3),pET28a-ncgl2478,
PMID34290951,reaction_2,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation at 340 nm,"50 mM Tris–HCl buffer (pH 7.5), 1 mM EDTA",7.5,,37.0,Escherichia coli BL21(DE3),pET28a-ncgl2478,
PMID34290951,reaction_3,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation at 340 nm,50 mM potassium phosphate buffer (pH 7.6),7.6,,25.0,Escherichia coli BL21(DE3),pET28a-ncgl2478,
PMID34290951,reaction_4,in vitro,Turbidity assay monitoring insulin precipitation at A600,Not specified,,,,Escherichia coli BL21(DE3),pET28a-ncgl2478,
PMID34290951,reaction_5,in vitro,Methylene blue RNA intercalating assay at 659 nm,Not specified,,,,Escherichia coli BL21(DE3),pET28a-ncgl2478,
PMID34290951,reaction_6_control,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation at 340 nm,"50 mM Tris–HCl buffer (pH 7.5), 1 mM EDTA",7.5,,37.0,Escherichia coli BL21(DE3),pET28a-mrx1,
PMID34290951,reaction_7_control,in vitro,Coupled spectrophotometric assay monitoring NADPH oxidation at 340 nm,50 mM potassium phosphate buffer (pH 7.6),7.6,,25.0,Escherichia coli BL21(DE3),pET28a-mrx1,
PMID34290951,reaction_8_control,in vitro,Turbidity assay monitoring insulin precipitation at A600,Not specified,,,,Escherichia coli BL21(DE3),pET28a-mrx1,
PMID34292356,reaction_1,in vivo,Heterologous expression of T66des9 in Aurantiochytrium limacinum SR21 and analysis of fatty acid profile from cell culture.,"Fat accumulation medium: (in g/l) glucose (40), NH4Cl (0.7), KH2PO4 (0.3), Na2SO4 (18), MgSO4x7H2O (0.25), CaCl2x2H2O (0.2), KCl (0.4), Tris-base (6.1), maleic acid (5.8), and yeast extract (0.3), supplemented with trace mineral solution and vitamin solution.",7.0,Adjusted with NaOH,28.0,Aurantiochytrium limacinum SR21,pEMR24,Expression driven by constitutive endogenous GAPDH promoter.
PMID34294705,reaction_1,in vitro,35SO42- uptake assay using purified protein reconstituted into liposomes (proteoliposomes).,"20 mM MES pH 5.5, 5 mM KCl, 150 mM NaCl",5.5,"External buffer pH. Transport was driven by a pH gradient, typically pH 7.5 inside the liposome and pH 5.5 outside.",,High Five (Trichoplusia ni) insect cells,modified pFastBac Dual expression vector,"Infection with P3 baculovirus, grown at 27 °C for 48-60 h"
PMID34295569,reaction_1,in vitro,Enzyme kinetic assays using purified proteins.,,,,,Escherichia coli MX203,,
PMID34295569,reaction_2,in vitro,Enzyme kinetic assays using purified proteins.,,,,,Escherichia coli MX203,,
PMID34297466,reaction_1,in vitro,Solid supported membrane (SSM) biosensing with native SR vesicles or reconstituted proteoliposomes. Charge movement (Ca2+ translocation) was measured after ATP concentration jumps.,"100 mM KCl, 25 mM MOPS, 0.25 mM EGTA, 1 mM MgCl2, 1 mM DTT, with either 10 μM or 0.35 μM free Ca2+.",7.0,25 mM MOPS buffer,22.5,,,
PMID34306835,reaction_1_DCIP,in vitro,"Spectrophotometric assay following the reduction of 120 μM 2,6-dichloroindophenol (DCIP) at 520 nm.","11 mM PBS buffer, pH 7.4 (11 mM potassium phosphate buffer, 8 g/L NaCl, 0.2 g/L KCl)",7.4,,37.0,Komagataella phaffii,,Recombinant production in 1 L shaking flasks on 200 mL of YPD medium containing 1.5% (v/v) methanol for induction of the AOX promoter for 72 h.
PMID34306835,reaction_2_cyt_c,in vitro,Spectrophotometric assay following the reduction of 80 μM cytochrome c at 550 nm.,"11 mM PBS buffer, pH 7.4 (11 mM potassium phosphate buffer, 8 g/L NaCl, 0.2 g/L KCl)",7.4,,37.0,Komagataella phaffii,,Recombinant production in 1 L shaking flasks on 200 mL of YPD medium containing 1.5% (v/v) methanol for induction of the AOX promoter for 72 h.
PMID34306835,reaction_3_O2,in vitro,"Indirect spectrophotometric assay following the oxidation of 50 μM Amplex Red at 560 nm, catalyzed by horseradish peroxidase.","11 mM PBS buffer, pH 7.4 (11 mM potassium phosphate buffer, 8 g/L NaCl, 0.2 g/L KCl)",7.4,,37.0,Komagataella phaffii,,Recombinant production in 1 L shaking flasks on 200 mL of YPD medium containing 1.5% (v/v) methanol for induction of the AOX promoter for 72 h.
PMID34315109,reaction_1,in vitro,Stopped-flow kinetic assay monitoring intrinsic fluorescence decay,50 mM sodium phosphate buffer pH 7.4 containing 100 μM DTPA,7.4,,25.0,Escherichia coli BL21(DE3),pET15b,"1 mM IPTG, 3 h incubation"
PMID34315109,reaction_2,in vitro,Stopped-flow kinetic assay monitoring intrinsic fluorescence decay,50 mM sodium phosphate buffer pH 7.4 containing 100 μM DTPA,7.4,,25.0,Escherichia coli BL21(DE3),pET15b,"1 mM IPTG, 3 h incubation"
PMID34315109,reaction_3,in vivo,Bactericidal activity assay on whole cells,Minimal medium,7.4,,37.0,,,
PMID34315109,reaction_4,in vivo,Bactericidal activity assay on whole cells,Minimal medium,7.4,,37.0,,,
PMID34315109,reaction_5,in vivo,Bactericidal activity assay on whole cells,Minimal medium,7.4,,37.0,,,
PMID34315853,reaction_1,in vivo,"Cell-based assays in human granulosa cell lines (KGN, COV434) including RNA stability assays with actinomycin D, luciferase reporter assays, and RNA immunoprecipitation (RIP-qPCR).",DMEM containing 10% FBS and 100 IU/mL penicillin-streptomycin,,"Standard cell culture conditions at 37°C and 5% CO2, implying physiological pH.",37.0,Human ovarian granulosa cell lines KGN and COV434,pLV-U6-[shRNA] CMV-EGFP-T2A-puromycin (knockdown); pLV-CMV-[FTO] PGK-EGFP-T2A-puromycin (overexpression),Lentiviral transduction followed by selection with 2 µg/mL puromycin for 72 h.
PMID34327042,reaction_1,in vitro,Stopped-flow spectrophotometry for binding kinetics and spectrophotometric monitoring of NADH oxidation for catalytic activity.,20 mM potassium MOPS buffer (pH 7.4) containing 200 mM KCl for binding assays. Catalytic assays used a similar system.,7.4,,23.0,Escherichia coli,,
PMID34327042,reaction_2,in vitro,Stopped-flow spectrophotometry for binding kinetics and spectrophotometric monitoring of NADH oxidation for catalytic activity.,20 mM potassium MOPS buffer (pH 7.4) containing 200 mM KCl for binding assays. Catalytic assays used a similar system.,7.4,,23.0,Escherichia coli,,
PMID34327042,reaction_3,in vitro,Stopped-flow spectrophotometry for binding kinetics and spectrophotometric monitoring of NADH oxidation for catalytic activity.,20 mM potassium MOPS buffer (pH 7.4) containing 200 mM KCl for binding assays. Catalytic assays used a similar system.,7.4,,23.0,Escherichia coli,,
PMID34327042,reaction_4,in vitro,Spectrophotometric monitoring of NADH oxidation for catalytic activity.,20 mM potassium MOPS buffer (pH 7.4) containing 200 mM KCl for binding assays. Catalytic assays used a similar system.,7.4,,23.0,Escherichia coli,,
PMID34327042,reaction_5,in vitro,Spectrophotometric monitoring of NADH oxidation for catalytic activity.,20 mM potassium MOPS buffer (pH 7.4) containing 200 mM KCl for binding assays. Catalytic assays used a similar system.,7.4,,23.0,Escherichia coli,,
PMID34340545,reaction_1,in vitro,Activity measured by monitoring SAM production by HPLC.,"25 mM HEPES, pH 7.5, 100 mM KCl, 10 mM MgCl2, 1 mM DTT",7.5,,37.0,Escherichia coli BL21(DE3),pET24a,"0.4 mM IPTG, 30°C, overnight"
PMID34340545,reaction_2,in vitro,Activity measured by monitoring MTA production by HPLC.,"25 mM HEPES, pH 7.5, 100 mM KCl, 10 mM MgCl2, 1 mM DTT",7.5,,37.0,Escherichia coli DH5aZ1,pZA31,"0.2 mg/ml anhydrotetracycline (aTc), 20°C, overnight"
PMID34358993,reaction_1,in vitro,Inhibition of ACE2-RBD binding measured using a COVID-19 Spike-ACE2 Binding Assay Kit (RayBiotech).,Compounds were dissolved in DMSO. Assay performed in solution provided by the commercial kit.,,Not specified,,,,
PMID34364941,reaction_1,in vitro,Protease activity-based high-throughput screening using a fluorogenic peptide substrate.,"50 mM HEPES, pH 7.5, 5 mM DTT and 0.1 mg/ml BSA",7.5,,25.0,Escherichia coli BL21 (DE3),pET28a,IPTG induction at 16 °C for 16 h
PMID34364941,reaction_2,in vivo,Immunoblotting assay in HEK293T cells to detect restoration of protein ISGylation levels upon inhibitor treatment. A luciferase-based IFN-β reporter assay was also used to measure downstream effects.,Cell lysis buffer (1x passive lysis buffer),,Cellular conditions,,HEK293T cells,"Plasmids encoding Myc-tagged ISG15, SARS-CoV2 PLpro-EGFP, pcDNA3.1-UBE1L (E1), UBCH8 (E2), or 3XFlag-HERC5 (E3)",Co-transfection using Lipofectamine 2000
PMID34382711,reaction_1_EcFPR,in vitro,NADPH-ferricyanide diaphorase activity assay,50 mM Tris–HCl,8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET205,"250 μM IPTG, 20°C, 16 h"
PMID34382711,reaction_2_PcFPR,in vitro,NADPH-ferricyanide diaphorase activity assay,50 mM Tris–HCl,8.0,,25.0,Escherichia coli,pET-TEV,
PMID34382711,reaction_3_BaFPR,in vitro,NADPH-ferricyanide diaphorase activity assay,50 mM Tris–HCl,8.0,,25.0,Escherichia coli,pET-TEV,
PMID34382711,reaction_4_LepFNR,in vitro,NADPH-ferricyanide diaphorase activity assay,50 mM Tris–HCl,8.0,,25.0,Escherichia coli,pET-TEV,
PMID34382711,reaction_5_PeaFNR,in vitro,NADPH-ferricyanide diaphorase activity assay,50 mM Tris–HCl,8.0,,25.0,Escherichia coli BL21(DE3) pLysS,pET205,"250 μM IPTG, 20°C, 16 h"
PMID34417645,reaction_1,in vitro,Kinetic parameters were determined by monitoring uric acid consumption via HPLC-DAD. In vivo studies were also performed in mice.,Na2HPO4-NaH2PO4 buffer,6.0,This is the optimal pH for the reaction.,35.0,,,
PMID34420183,reaction_1,in vitro,Fluorogenic assay using tetrapeptide substrate Z-LRGG-AMC to determine optimal conditions for high-throughput screening.,"50 mM MES, 100 mM NaCl, 0.5 mM EDTA, 5 mM DTT, 0.1 mg/ml BSA",6.5,"Optimal pH. Activity was tested over a range of pH 4.0-9.5 in various buffers (sodium phosphate, sodium acetate, MES, HEPES, Tris).",30.0,Escherichia coli BL21 (DE3),pET28a,0.5 mM IPTG and 100 µM ZnSO4 at 19 °C overnight.
PMID34423563,reaction_1,in vitro,Fluorometric inhibition assay with 50 µM Z-LRGG-AMC substrate to determine IC50 values.,"20 mM Tris, 300 mM NaCl, 2 mM DTT, pH 7.5",7.5,,37.0,E. coli,pBAD-sfGFP-PLPro,"0.2% L-arabinose, 20°C, 24h"
PMID34423563,reaction_2,in vitro,Fluorometric inhibition assay with 5 µM Ub-AMC protein substrate to further characterize potent inhibitors.,"20 mM Tris, 300 mM NaCl, pH 7.5",7.5,,37.0,E. coli,pBAD-sfGFP-PLPro,"0.2% L-arabinose, 20°C, 24h"
PMID34425699,reaction_1,in vivo,Whole-cell biotransformation assay with recombinant E. coli BL21(DE3) expressing the enzyme system.,Mineral salts broth (MSB),7.0,,30.0,Escherichia coli BL21(DE3),pETDuet-DCB,"0.3 mM IPTG, 30°C, 5 h"
PMID34425699,reaction_2,in vivo,Whole-cell nitrite assay with recombinant E. coli.,Mineral salts broth (MSB),7.0,,30.0,,,
PMID34425699,reaction_3,in vivo,Whole-cell nitrite assay with recombinant E. coli.,Mineral salts broth (MSB),7.0,,30.0,,,
PMID34425699,reaction_4,in vivo,Whole-cell nitrite assay with recombinant E. coli.,Mineral salts broth (MSB),7.0,,30.0,Escherichia coli BL21(DE3),pETDuet-NTD,
PMID34425699,reaction_5,in vitro,Kinetic measurements with purified H6-DccA.,50 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli,pET-28a(+),
PMID34425699,reaction_6,in vitro,Kinetic measurements with purified H6-DccA.,50 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli,pET-28a(+),
PMID34425699,reaction_7,in vitro,Kinetic measurements with purified H6-DccA.,50 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli,pET-28a(+),
PMID34425699,reaction_8,in vitro,Kinetic measurements with purified H6-DccA.,50 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli,pET-28a(+),
PMID34425699,reaction_9,in vitro,Kinetic measurements with purified H6-DccA.,50 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli,pET-28a(+),
PMID34425699,reaction_10,in vitro,Kinetic measurements with purified H6-DccA.,50 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli,pET-28a(+),
PMID34425699,reaction_11,in vitro,"Sequential catalytic assay using crude extract from E. coli co-expressing DccA and DccB, with 3,4-dichlorocatechol as the starting substrate.",50 mM Tris-HCl buffer,8.0,,25.0,Escherichia coli,pET-28a(+),
PMID34604672,reaction_1,in vitro,Aminoacylation assay measuring incorporation of [14C]-L-Thr into tRNA.,"50 mM HEPES-NaOH, 20 mM MgCl2, 5 mM β-mercaptoethanol, 30 mM KCl, 100 μg/mL BSA",7.5,,37.0,Escherichia coli BL21(DE3)pLysS,pET28b,0.25 mM IPTG for 3 h at 37 °C
PMID35073743,reaction_1,in vitro,Uptake assay with 14C-labeled isoleucine in whole cells of a B. anthracis mutant expressing BrnQ3.,R medium lacking BCAAs,,,37.0,Bacillus anthracis ΔilvDΔbrnQ2-6,pAW285,1% xylose
PMID35073743,reaction_2,in vitro,Uptake assay with 14C-labeled valine in whole cells of a B. anthracis mutant expressing BrnQ3.,R medium lacking BCAAs,,,37.0,Bacillus anthracis ΔilvDΔbrnQ2-6,pAW285,1% xylose
PMID35073743,reaction_3,in vitro,Uptake assay with 14C-labeled isoleucine in whole cells of a B. anthracis mutant expressing BrnQ4.,R medium lacking BCAAs,,,37.0,Bacillus anthracis ΔilvDΔbrnQ2-6,pAW285,1% xylose
PMID35073743,reaction_4,in vitro,Uptake assay with 14C-labeled valine in whole cells of a B. anthracis mutant expressing BrnQ4.,R medium lacking BCAAs,,,37.0,Bacillus anthracis ΔilvDΔbrnQ2-6,pAW285,1% xylose
PMID35073743,reaction_5,in vitro,Uptake assay with 14C-labeled isoleucine in whole cells of a B. anthracis mutant expressing BrnQ5.,R medium lacking BCAAs,,,37.0,Bacillus anthracis ΔilvDΔbrnQ2-6,pAW285,1% xylose
PMID35073743,reaction_6,in vitro,Uptake assay with 14C-labeled valine in whole cells of a B. anthracis mutant expressing BrnQ5.,R medium lacking BCAAs,,,37.0,Bacillus anthracis ΔilvDΔbrnQ2-6,pAW285,1% xylose
PMID35229477,reaction_1,in vivo,Non-invasive Micro-test (NMT) measurement of net NO3- influx at the root mature zone of seedlings.,"NMT test solution (5 mM NH4Cl, 0.5 mM KNO3, 0.1 mM CaCl2 and 0.3 mM MES)",4.8,Experiments were conducted at pH 6.0 and 4.8. Lower pH (4.8) enhanced NO3- influx.,25.0,,,
PMID35229477,reaction_2,in vivo,Non-invasive Micro-test (NMT) measurement of net NO3- efflux at the root mature zone of seedlings.,"NMT test solution (5 mM NH4Cl, 0.1 mM KNO3, 0.1 mM CaCl2 and 0.3 mM MES)",4.8,Experiments were conducted at pH 6.0 and 4.8. Lower pH (4.8) induced NO3- efflux.,25.0,,,
PMID35285984,reaction_1,in vitro,Spectrophotometric assay monitoring NADPH consumption at 340 nm. The reaction requires the FldA/FpR1/NADPH reduction system.,50 mM Tris-HCl,8.0,,37.0,Escherichia coli XL1-blue,pBAD-HisGcpE and pRSF-ISC,ISC operon induced with 100 µM IPTG at 30°C. IspG expression induced with 0.1% L-arabinose at 23°C overnight.
PMID35380453,reaction_1,in vivo,Analysis of sterol composition by GC-MS/MS from whole C. albicans cells grown without drug treatment.,"YPD medium (1% yeast extract, 2% peptone, 2% dextrose)",,Not specified,37.0,Candida albicans,,"Endogenous expression from various promoters (PVPS21, PYPT52, PACT1, PENO1) replacing the native ERG3 promoter in an erg3D heterozygous background."
PMID35380453,reaction_2,in vivo,Analysis of sterol composition by GC-MS/MS from whole C. albicans cells treated with fluconazole.,YPD broth supplemented with 5 mg/liter fluconazole,,Not specified,37.0,Candida albicans,,"Endogenous expression from various promoters (PVPS21, PYPT52, PACT1, PENO1) replacing the native ERG3 promoter in an erg3D heterozygous background."
PMID35435705,reaction_1,in vitro,Substrate binding to the purified TcyK substrate-binding protein (amino acids 38-286) was measured using Isothermal Titration Calorimetry (ITC) and validated with tryptophan fluorescence spectroscopy.,Not specified,,Not specified,,Escherichia coli,,"The substrate-binding protein TcyK (amino acids 38-286, without the membrane-anchoring domain) was overexpressed."
PMID35435705,reaction_2,in vitro,Substrate binding to the purified TcyK substrate-binding protein (amino acids 38-286) was measured using Isothermal Titration Calorimetry (ITC). TCEP was used as a reducing agent.,Not specified,,Not specified,,Escherichia coli,,"The substrate-binding protein TcyK (amino acids 38-286, without the membrane-anchoring domain) was overexpressed."
PMID35515322,reaction_1,in vitro,Enzyme inhibition assay measuring uric acid formation by monitoring absorbance at 295 nm.,Phosphate buffered saline,7.4,Not explicitly stated for inhibition assay. Inferred from 'phosphate buffered saline' used in fluorescence assay (section 2.4) and standard PBS pH.,25.0,,,
PMID35517366,reaction_1,in vitro,,100 mM Tris–HCl buﬀer,7.5,,30.0,E. coli BL21(DE3),pMAL-C2X,"0.5 mM isopropyl-1-thio-b-D-galactopyranoside, 17°C for 16 h"
PMID35517366,reaction_2,in vitro,,100 mM Tris–HCl buﬀer,7.5,,30.0,E. coli BL21(DE3),,
PMID35517366,reaction_3,in vitro,,100 mM Tris–HCl buﬀer,7.5,,30.0,E. coli BL21(DE3),,
PMID35517366,reaction_4,in vitro,,100 mM potassium phosphate buﬀer,7.0,,30.0,E. coli,,
PMID35517366,reaction_5,in vitro,,100 mM potassium phosphate buﬀer,7.0,,37.0,E. coli,,
PMID35517366,reaction_6,in vitro,One-pot cascade reaction,100 mM potassium phosphate buﬀer,7.5,,33.0,,,
PMID35517366,reaction_7,in vitro,One-pot cascade reaction,100 mM potassium phosphate buﬀer,7.5,,33.0,,,
PMID35517366,reaction_8,in vitro,One-pot cascade reaction,100 mM potassium phosphate buﬀer,7.5,,33.0,,,
PMID35517366,reaction_9,in vitro,One-pot cascade reaction,100 mM potassium phosphate buﬀer,7.5,,33.0,,,
PMID35517366,reaction_10,in vitro,One-pot cascade reaction,100 mM potassium phosphate buﬀer,7.5,,33.0,,,
PMID35517366,reaction_11,in vitro,One-pot cascade reaction,100 mM potassium phosphate buﬀer,7.5,,33.0,,,
PMID35521286,reaction_1,in vitro,Enzyme kinetics study and inhibitor screening.,,,,,,,
PMID35530214,reaction_1,in vivo,Resting cell assay with recombinant Saccharomyces cerevisiae.,50 mM potassium phosphate buffer (KPi),7.4,,30.0,Saccharomyces cerevisiae CEN.PK2-1Ca,p352-HC3,Constitutive expression using HXT7 promoter for HPO and CYC1 promoter for AtCPR.
PMID35530214,reaction_2,in vivo,Resting cell assay with recombinant Saccharomyces cerevisiae.,50 mM potassium phosphate buffer (KPi),7.4,,30.0,Saccharomyces cerevisiae CEN.PK2-1Ca,p352-A1HC,Constitutive expression from TDH3 promoter.
PMID35530214,reaction_3,in vivo,De novo production in bi-phasic batch cultivation.,SD medium with n-dodecane overlay,,,25.0,Saccharomyces cerevisiae CEN.PK2-1Ca,p181-V2H,Constitutive expression from TEF1 promoter.
PMID35542350,reaction_1,in vitro,Activity of free and immobilized enzyme was assayed by monitoring NADPH oxidation at 340 nm.,Na2HPO4/NaH2PO4 buffer,7.5,The pH of the PBS buffer used for nanoflower synthesis and washing was 7.5. The assay buffer pH was not explicitly stated but is assumed to be similar.,25.0,Escherichia coli DH5a,,"Details not provided, cited from a previous study (ref 6)."
PMID35625344,reaction_1,in vivo,Antibiotic sensitivity assay (IC50 determination) using whole cells.,Luria broth (LB) medium,,"Not specified, assays conducted in LB medium.",37.0,Pseudomonas aeruginosa PAO1,,
PMID35625344,reaction_2,in vivo,Kinetics of novobiocin accumulation in whole cells and antibiotic sensitivity assays (IC50 determination).,LB medium,,"Not specified, assays conducted in LB medium.",37.0,Pseudomonas aeruginosa PAO1,,
PMID35721870,reaction_1,in vitro,Analytical-scale reactions with purified enzyme.,Not specified,,,,Escherichia coli,,Purified using metal-affinity chromatography.
PMID35721870,reaction_2,in vitro,Analytical-scale reactions with purified enzyme.,Not specified,,,,Escherichia coli,,Purified using metal-affinity chromatography.
PMID35721870,reaction_3,in vitro,"Analytical-scale and scaled-up reactions with purified enzyme. For scale-up, enzyme loading was 0.1-0.4% molar ratio to the substrate.",Not specified,,,,Escherichia coli,,Purified using metal-affinity chromatography.
PMID35721870,reaction_4,in vitro,"Analytical-scale and scaled-up reactions with purified enzyme. For scale-up, enzyme loading was 0.1-0.4% molar ratio to the substrate.",Not specified,,,,Escherichia coli,,Purified using metal-affinity chromatography.
PMID35721870,reaction_5,in vitro,"Analytical-scale and scaled-up reactions with purified enzyme. For scale-up, enzyme loading was 0.1-0.4% molar ratio to the substrate.",Not specified,,,,Escherichia coli,,Purified using metal-affinity chromatography.
PMID35721870,reaction_6,in vitro,"Analytical-scale and scaled-up reactions with purified enzyme. For scale-up, enzyme loading was 0.1-0.4% molar ratio to the substrate.",Not specified,,,,Escherichia coli,,Purified using metal-affinity chromatography.
PMID35766403,reaction_1,in vitro,"Coupled, continuous pyrophosphate-release assay using the EnzChek Pyrophosphate assay kit.","EnzChek Pyrophosphate assay kit buffer supplemented with 4 mM MgCl2 and 10 mM DTT. Purified enzyme was stored in 50 mM Tris-HCl, 200 mM NaCl, 1 mM MgCl2, 10% glycerol, 1 mM DTT.",,Not specified for the assay. The enzyme dialysis buffer was at pH 7.5.,37.0,Escherichia coli BL21,pET15-b,1 mM IPTG for 2 h at 37°C
